,pagenumber,form,OID,Domain,order,PreText,Question,CDASH,CDASHTYPE,SDTM,SDTMTYPE,codename,codelist,class,x,y,height,width
0,1.0,Subject Identifier,SUB_ID,,2.0,Subject Enrollment ID,,ENRID,SANOFI,,,,,question,70.866,666.671,15.744,108.54
1,1.0,Subject Identifier,SUB_ID,DM,3.0,Subject Identifier for the Study,What is the subject identifier?,SUBJID,IG,DM.SUBJID,IG,,,question,70.866,649.671,15.744,149.172
2,1.0,Subject Identifier,SUB_ID,,4.0,System Date,,SYSDAT,SANOFI,,,,,question,70.866,632.671,15.744,60.924
3,2.0,IVRS Library,IVRS_ALL,SV,2.0,First Visit/Screening Date,What [is/was] the date of the visit?,VISDAT,IG,SVSTDTC;SVENDTC,SANOFI,,,question,70.866,666.671,15.744,125.172
4,2.0,IVRS Library,IVRS_ALL,,3.0,First Run In Visit Date,,DSRUDAT,SANOFI,,,,,question,70.866,649.671,15.744,109.896
5,2.0,IVRS Library,IVRS_ALL,IVRS,4.0,Visit Identifier,,RDVISREF,SANOFI,RDVISREF,SANOFI,,,question,70.866,632.671,15.744,70.896
6,2.0,IVRS Library,IVRS_ALL,DS,5.0,Randomization Date/First IMP Allocation Date,What was the [protocol milestone/disposition event/other event name] date?,DSSTDAT,IG,DSSTDTC,IG,,,question,70.866,615.671,15.744,227.712
10,2.0,IVRS Library,IVRS_ALL,DS,6.0,Randomization Time/First IMP Allocation Time,What was the [protocol milestone/disposition event/other event name] time?,DSSTTIM,IG,DSSTDTC,IG,,,question,70.866,598.671,15.744,233.04
12,2.0,IVRS Library,IVRS_ALL,IVRS;RAND,7.0,Randomization Number,,RDRAND,SANOFI,RDRAND,SANOFI,,,question,70.866,581.671,15.744,115.536
13,2.0,IVRS Library,IVRS_ALL,IVRS;RAND,8.0,Randomization Block Number,,RDBLKNB,SANOFI,RDBLKNB,SANOFI,,,question,70.866,564.671,15.744,147.168
14,2.0,IVRS Library,IVRS_ALL,IVRS;RAND,9.0,Randomization Sequence Number,,RDSEQNB,SANOFI,RDSEQNB,SANOFI,,,question,70.866,547.671,15.744,164.472
15,2.0,IVRS Library,IVRS_ALL,IVRS;RAND,10.0,Stratification Factor 1,,RDSTRAT1,SANOFI,RDSTRAT1,SANOFI,,,question,70.866,530.671,15.744,105.18
16,2.0,IVRS Library,IVRS_ALL,IVRS;RAND,11.0,Stratification Factor 2,,RDSTRAT2,SANOFI,RDSTRAT2,SANOFI,,,question,70.866,513.671,15.744,105.18
17,2.0,IVRS Library,IVRS_ALL,IVRS;RAND,12.0,Stratification Factor 3,,RDSTRAT3,SANOFI,RDSTRAT3,SANOFI,,,question,70.866,496.671,15.744,105.18
18,2.0,IVRS Library,IVRS_ALL,IVRS;RAND,13.0,Stratification Factor 4,,RDSTRAT4,SANOFI,RDSTRAT4,SANOFI,,,question,70.866,479.671,15.744,105.18
19,2.0,IVRS Library,IVRS_ALL,IVRS;RAND,14.0,Stratification Factor 5,,RDSTRAT5,SANOFI,RDSTRAT5,SANOFI,,,question,70.866,462.671,15.744,105.18
20,2.0,IVRS Library,IVRS_ALL,IVRS,15.0,Treatment Number as Planned,,RDTTNBX,SANOFI,RDTTNBX,SANOFI,,,question,70.866,445.671,15.744,146.148
21,2.0,IVRS Library,IVRS_ALL,IVRS;RAND,16.0,Treatment Arm as Planned,,RDARM,SANOFI,RDARM,SANOFI,,,question,70.866,428.671,15.744,128.832
22,2.0,IVRS Library,IVRS_ALL,IVRS,17.0,Subgroup Information as Planned 1,,RDGROUP1,SANOFI,RDGROUP1,SANOFI,,,question,70.866,411.671,15.744,170.556
23,2.0,IVRS Library,IVRS_ALL,IVRS,18.0,Subgroup Information as Planned 2,,RDGROUP2,SANOFI,RDGROUP2,SANOFI,,,question,70.866,394.671,15.744,170.556
24,2.0,IVRS Library,IVRS_ALL,IVRS,19.0,Subgroup Information as Planned 3,,RDGROUP3,SANOFI,RDGROUP3,SANOFI,,,question,70.866,377.671,15.744,170.556
25,2.0,IVRS Library,IVRS_ALL,IVRS,20.0,Treatment Side as Planned,,RDSIDE,SANOFI,RDSIDE,SANOFI,LAT_01,LEFT;RIGHT,question,70.866,360.671,15.744,128.16
26,2.0,IVRS Library,IVRS_ALL,IVRS,21.0,Category for Treatment,,RDTTCAT,SANOFI,RDTTCAT,SANOFI,,,question,70.866,325.671,15.744,113.172
27,2.0,IVRS Library,IVRS_ALL,IVRS,22.0,Date of Treatment Allocation,,RDALDAT,SANOFI,RDALDTC,SANOFI,,,question,70.866,308.671,15.744,141.444
28,2.0,IVRS Library,IVRS_ALL,IVRS,23.0,Time of Treatment Allocation,,RDALTIM,SANOFI,RDALDTC,SANOFI,,,question,70.866,291.671,15.744,144.108
29,2.0,IVRS Library,IVRS_ALL,IVRS,24.0,Date of Treatment Allocation (IVRS/IWRS),,RDALGDAT,SANOFI,RDALGDTC,SANOFI,,,question,70.866,274.671,15.744,213.06
30,2.0,IVRS Library,IVRS_ALL,IVRS,25.0,Time of Treatment Allocation (IVRS/IWRS),,RDALGTIM,SANOFI,RDALGDTC,SANOFI,,,question,70.866,257.671,15.744,215.724
31,2.0,IVRS Library,IVRS_ALL,IVRS,26.0,Is there a blind broken?,,RDBKUNB,SANOFI,RDBKUNB,SANOFI,,,question,70.866,240.671,15.744,113.208
32,2.0,IVRS Library,IVRS_ALL,IVRS,27.0,Local Date of blind broken,,RDBKDAT,SANOFI,RDBKDDTC,SANOFI,,,question,70.866,223.671,15.744,129.852
33,2.0,IVRS Library,IVRS_ALL,IVRS,28.0,Function of the blind breaker,,RDBKWHO,SANOFI,RDBKWHO,SANOFI,DSCBWHOR,ESMS;INVESTIGATOR;PHARMACIST;STUDY NURSE,question,70.866,206.671,15.744,139.86
34,2.0,IVRS Library,IVRS_ALL,,29.0,IVRS original export date and time,,EXPRTDT,SANOFI,,,,,question,70.866,139.671,15.744,168.804
35,2.0,IVRS Library,IVRS_ALL,,30.0,IVRS Transaction ID,,RDSPID,SANOFI,,,,,question,70.866,122.671,15.744,102.564
36,3.0,Visit Date,SV_01,,2.0,Was the visit performed?,,VISYN,SANOFI,,,NY_YN,Y;N,question,70.866,666.671,15.744,120.84
37,3.0,Visit Date,SV_01,,3.0,"If yes, provide the date:",,PROMPT_VISDAT,SANOFI,,,,,question,70.866,631.659,15.948,113.52
38,3.0,Visit Date,SV_01,SV,4.0,Date of Visit,What [is/was] the date of the visit?,VISDAT,IG,SVSTDTC;SVENDTC,SANOFI,,,question,80.866,614.671,15.744,61.92
39,4.0,Inclusion/Exclusion,IE_NC,SUPPDM;SUPPIE,2.0,Protocol Version,,IEVERS,SANOFI,IEVERS,SANOFI,PROTVER,ORIGINAL PROTOCOL;AMENDMENT 1;AMENDMENT 2;AMENDMENT 3;AMENDMENT 4;AMENDMENT 5;AMENDMENT 6;AMENDMENT 7;AMENDMENT 8;AMENDMENT 9;AMENDMENT 10;VERSION 1;VERSION 2;VERSION 3,question,70.866,666.671,15.744,81.6
40,4.0,Inclusion/Exclusion,IE_NC,,3.0,Did the subject meet all eligibility criteria?,Were all eligibility criteria met?,IEYN,IG,,,NY_YN,Y;N,question,70.866,439.671,15.744,205.632
41,4.0,Inclusion/Exclusion,IE_NC,,4.0,"If no, specify Criterion Category(ies) and Number(s).",,PROMPT_IECAT_IETEST,SANOFI,,,,,question,70.866,404.659,15.948,256.416
42,4.0,Inclusion/Exclusion,IE_NC,IE,5.0,Criterion Category,What was the category of the criterion?,IECAT,IG,IECAT,IG,IECAT,EXCLUSION;INCLUSION,question,70.866,387.671,15.744,90.216
43,4.0,Inclusion/Exclusion,IE_NC,,6.0,Criterion Number and Description,,IETESTDS,SANOFI,,,,,question,70.866,352.671,15.744,164.82
44,4.0,Inclusion/Exclusion,IE_NC,IE,7.0,Criterion Number,What was the identifier of the inclusion criterion the subject did not meet or the exclusion criterion the subject met ?,IETESTCD,IG,IETESTCD,IG,,,question,70.866,335.671,15.744,85.572
45,4.0,Inclusion/Exclusion,IE_NC,,8.0,Technical field for Dynamic searchlist needs,,IETECHFLD,SANOFI,,,IE_TI,TECHDUMVAL;ORIGINAL PROTOCOL#_#I01;ORIGINAL PROTOCOL#_#I02;ORIGINAL PROTOCOL#_#I03;ORIGINAL PROTOCOL#_#E01;ORIGINAL PROTOCOL#_#E02;ORIGINAL PROTOCOL#_#E03;ORIGINAL PROTOCOL#_#E04;ORIGINAL PROTOCOL#_#E05;ORIGINAL PROTOCOL#_#E06;ORIGINAL PROTOCOL#_#E07;ORIGINAL PROTOCOL#_#E08;ORIGINAL PROTOCOL#_#E09;ORIGINAL PROTOCOL#_#E10;ORIGINAL PROTOCOL#_#E11;ORIGINAL PROTOCOL#_#E12;ORIGINAL PROTOCOL#_#E13;ORIGINAL PROTOCOL#_#E14;ORIGINAL PROTOCOL#_#E15;ORIGINAL PROTOCOL#_#E16;ORIGINAL PROTOCOL#_#E17;ORIGINAL PROTOCOL#_#E18;ORIGINAL PROTOCOL#_#E19;ORIGINAL PROTOCOL#_#E20;ORIGINAL PROTOCOL#_#E21;ORIGINAL PROTOCOL#_#E22;ORIGINAL PROTOCOL#_#E23,question,70.866,318.671,15.744,214.68
46,8.0,Informed Consent Date,DS_IC_DAT,,2.0,Informed Consent,,PROMPT_DSDECOD,SANOFI,,,,,question,70.866,666.659,15.948,86.268
47,8.0,Informed Consent Date,DS_IC_DAT,DS,3.0,INFORMED CONSENT OBTAINED,What was the subject's status?,DSDECOD,IG,DSDECOD,IG,INFCST,INFORMED ASSENT OBTAINED FROM JUVENILE;INFORMED CONSENT OBTAINED;INFORMED CONSENT OBTAINED FOR ARCHIVED BIOPSY;INFORMED CONSENT OBTAINED FOR ARCHIVED BLOOD SAMPLES;INFORMED CONSENT OBTAINED FOR CHILD REACHING AGE OF MAJORITY;INFORMED CONSENT OBTAINED FOR DRUG METABOLISM ENZYME;INFORMED CONSENT OBTAINED FOR FRESH BIOPSY;INFORMED CONSENT OBTAINED FOR HIV TESTING;INFORMED CONSENT OBTAINED FOR PHARMACOGENETIC ANALYSIS;INFORMED CONSENT OBTAINED FOR PHARMACOGENETIC BANKING;INFORMED CONSENT OBTAINED FOR PHARMACOGENOMIC;INFORMED CONSENT OBTAINED FOR PHARMACOKINETICS;INFORMED CONSENT OBTAINED FOR STUDY;INFORMED CONSENT OBTAINED FOR USE OF DATA AND SAMPLES FOR FUTURE RESEARCH;INFORMED CONSENT OBTAINED TO PERFORM AUTOPSY;INFORMED CONSENT OBTAINED TO PERFORM HEFH GENOTYPING;INFORMED CONSENT OBTAINED TO USE PREVIOUS HEFH GENOTYPING,question,70.866,649.671,15.744,185.22
48,8.0,Informed Consent Date,DS_IC_DAT,DS,3.0,INFORMED CONSENT OBTAINED,"What was the subject's status?; If [DSDECOD], specify",DSTERM,IG,DSTERM,IG,,,question,70.866,649.671,15.744,185.22
49,8.0,Informed Consent Date,DS_IC_DAT,DS,4.0,INFORMED CONSENT OBTAINED,What was the subject's status?,DSDECOD,IG,DSDECOD,IG,INFCST,INFORMED ASSENT OBTAINED FROM JUVENILE;INFORMED CONSENT OBTAINED;INFORMED CONSENT OBTAINED FOR ARCHIVED BIOPSY;INFORMED CONSENT OBTAINED FOR ARCHIVED BLOOD SAMPLES;INFORMED CONSENT OBTAINED FOR CHILD REACHING AGE OF MAJORITY;INFORMED CONSENT OBTAINED FOR DRUG METABOLISM ENZYME;INFORMED CONSENT OBTAINED FOR FRESH BIOPSY;INFORMED CONSENT OBTAINED FOR HIV TESTING;INFORMED CONSENT OBTAINED FOR PHARMACOGENETIC ANALYSIS;INFORMED CONSENT OBTAINED FOR PHARMACOGENETIC BANKING;INFORMED CONSENT OBTAINED FOR PHARMACOGENOMIC;INFORMED CONSENT OBTAINED FOR PHARMACOKINETICS;INFORMED CONSENT OBTAINED FOR STUDY;INFORMED CONSENT OBTAINED FOR USE OF DATA AND SAMPLES FOR FUTURE RESEARCH;INFORMED CONSENT OBTAINED TO PERFORM AUTOPSY;INFORMED CONSENT OBTAINED TO PERFORM HEFH GENOTYPING;INFORMED CONSENT OBTAINED TO USE PREVIOUS HEFH GENOTYPING,question,70.866,140.671,15.744,185.22
50,8.0,Informed Consent Date,DS_IC_DAT,DS,4.0,INFORMED CONSENT OBTAINED,"What was the subject's status?; If [DSDECOD], specify",DSTERM,IG,DSTERM,IG,,,question,70.866,140.671,15.744,185.22
51,8.0,Informed Consent Date,DS_IC_DAT,DS,5.0,Date of Informed Consent,What was the [protocol milestone/disposition event/other event name] date?,DSSTDAT,IG,DSSTDTC,IG,,,question,70.866,109.671,15.744,125.544
55,9.0,Informed Consent for Future Use of Data and Samples,DS_IC_FUTURE,DS,2.0,INFORMED CONSENT OBTAINED,What was the subject's status?,DSDECOD,IG,DSDECOD,IG,INFCST,INFORMED ASSENT OBTAINED FROM JUVENILE;INFORMED CONSENT OBTAINED;INFORMED CONSENT OBTAINED FOR ARCHIVED BIOPSY;INFORMED CONSENT OBTAINED FOR ARCHIVED BLOOD SAMPLES;INFORMED CONSENT OBTAINED FOR CHILD REACHING AGE OF MAJORITY;INFORMED CONSENT OBTAINED FOR DRUG METABOLISM ENZYME;INFORMED CONSENT OBTAINED FOR FRESH BIOPSY;INFORMED CONSENT OBTAINED FOR HIV TESTING;INFORMED CONSENT OBTAINED FOR PHARMACOGENETIC ANALYSIS;INFORMED CONSENT OBTAINED FOR PHARMACOGENETIC BANKING;INFORMED CONSENT OBTAINED FOR PHARMACOGENOMIC;INFORMED CONSENT OBTAINED FOR PHARMACOKINETICS;INFORMED CONSENT OBTAINED FOR STUDY;INFORMED CONSENT OBTAINED FOR USE OF DATA AND SAMPLES FOR FUTURE RESEARCH;INFORMED CONSENT OBTAINED TO PERFORM AUTOPSY;INFORMED CONSENT OBTAINED TO PERFORM HEFH GENOTYPING;INFORMED CONSENT OBTAINED TO USE PREVIOUS HEFH GENOTYPING,question,70.866,666.671,15.744,185.22
56,9.0,Informed Consent for Future Use of Data and Samples,DS_IC_FUTURE,DS,2.0,INFORMED CONSENT OBTAINED,"What was the subject's status?; If [DSDECOD], specify",DSTERM,IG,DSTERM,IG,,,question,70.866,666.671,15.744,185.22
57,9.0,Informed Consent for Future Use of Data and Samples,DS_IC_FUTURE,DS,3.0,INFORMED CONSENT OBTAINED,What was the subject's status?,DSDECOD,IG,DSDECOD,IG,INFCST,INFORMED ASSENT OBTAINED FROM JUVENILE;INFORMED CONSENT OBTAINED;INFORMED CONSENT OBTAINED FOR ARCHIVED BIOPSY;INFORMED CONSENT OBTAINED FOR ARCHIVED BLOOD SAMPLES;INFORMED CONSENT OBTAINED FOR CHILD REACHING AGE OF MAJORITY;INFORMED CONSENT OBTAINED FOR DRUG METABOLISM ENZYME;INFORMED CONSENT OBTAINED FOR FRESH BIOPSY;INFORMED CONSENT OBTAINED FOR HIV TESTING;INFORMED CONSENT OBTAINED FOR PHARMACOGENETIC ANALYSIS;INFORMED CONSENT OBTAINED FOR PHARMACOGENETIC BANKING;INFORMED CONSENT OBTAINED FOR PHARMACOGENOMIC;INFORMED CONSENT OBTAINED FOR PHARMACOKINETICS;INFORMED CONSENT OBTAINED FOR STUDY;INFORMED CONSENT OBTAINED FOR USE OF DATA AND SAMPLES FOR FUTURE RESEARCH;INFORMED CONSENT OBTAINED TO PERFORM AUTOPSY;INFORMED CONSENT OBTAINED TO PERFORM HEFH GENOTYPING;INFORMED CONSENT OBTAINED TO USE PREVIOUS HEFH GENOTYPING,question,70.866,157.671,15.744,185.22
58,9.0,Informed Consent for Future Use of Data and Samples,DS_IC_FUTURE,DS,3.0,INFORMED CONSENT OBTAINED,"What was the subject's status?; If [DSDECOD], specify",DSTERM,IG,DSTERM,IG,,,question,70.866,157.671,15.744,185.22
865,9.0,Informed Consent for Future Use of Data and Samples,DS_IC_FUTURE,,4.0,Informed Consent Obtained for Use of Data and Samples for Future Research?,,DSYN,SANOFI,,,,,question,70.866,98.671,15.744,292.056
59,10.0,Demographics,DM_DOB,,13.0,Year of Birth,,BRTHYR,SANOFI,,,,,question,70.866,666.671,15.744,63.924
60,10.0,Demographics,DM_DOB,,14.0,Date of Birth,,BRTHDTYM,SANOFI,,,,,question,70.866,649.671,15.744,63.252
61,10.0,Demographics,DM_DOB,,14.0,Date of Birth,,BRTHDATC,SANOFI,,,,,question,70.866,649.671,15.744,63.252
62,10.0,Demographics,DM_DOB,BR,14.0,Date of Birth,What is the subject's date of birth?,BRTHDAT,IG,BRTHDTC,IG,,,question,70.866,649.671,15.744,63.252
63,10.0,Demographics,DM_DOB,,15.0,Age,,AGEC,SANOFI,,,,,question,70.866,632.671,15.744,19.98
64,10.0,Demographics,DM_DOB,AG,15.0,Age,What is the subject's age?,AGE,IG,AGE,IG,,,question,70.866,632.671,15.744,19.98
65,10.0,Demographics,DM_DOB,,16.0,Age,,AGEC,SANOFI,,,,,question,70.866,615.671,15.744,19.98
66,10.0,Demographics,DM_DOB,AG,16.0,Age,What is the subject's age?,AGE,IG,AGE,IG,,,question,70.866,615.671,15.744,19.98
67,10.0,Demographics,DM_DOB,AG,17.0,Unit,What is the age unit used?,AGEU,IG,AGEU,IG,AGEU,HOURS;DAYS;WEEKS;MONTHS;YEARS,question,70.866,598.671,15.744,21.312
68,10.0,Demographics,DM_DOB,SE,18.0,Sex,What is the sex of the subject?,SEX,IG,SEX,IG,SEX,M;F,question,70.866,515.671,15.744,17.988
69,10.0,Demographics,DM_DOB,ET,19.0,Ethnicity,Do you consider yourself Hispanic/Latino or not Hispanic/Latino?,ETHNIC,IG,ETHNIC,IG,ETHNIC,HISPANIC OR LATINO;NOT HISPANIC OR LATINO;NOT REPORTED;UNKNOWN,question,70.866,480.671,15.744,43.932
70,10.0,Demographics,DM_DOB,,20.0,Race (Check all that apply):,,PROMPT_RACE,SANOFI,,,,,question,70.866,413.659,15.948,135.816
71,10.0,Demographics,DM_DOB,DM,21.0,American Indian or Alaska Native,,RAIAN,SANOFI,RACE,SANOFI,,,question,80.866,396.671,15.744,165.12
72,10.0,Demographics,DM_DOB,DM,22.0,Black or African American,,RBLACK,SANOFI,RACE,SANOFI,,,question,80.866,379.671,15.744,130.812
73,10.0,Demographics,DM_DOB,DM,23.0,Native Hawaiian or Other Pacific Islander,,RNHOPI,SANOFI,RACE,SANOFI,,,question,80.866,362.671,15.744,202.044
74,10.0,Demographics,DM_DOB,DM,24.0,White,,RWHITE,SANOFI,RACE,SANOFI,,,question,80.866,345.671,15.744,29.28
75,10.0,Demographics,DM_DOB,DM,25.0,Asian,,RASIAN,SANOFI,RACE,SANOFI,,,question,80.866,328.671,15.744,27.972
76,10.0,Demographics,DM_DOB,DM,26.0,Not Reported,,RNREP,SANOFI,RACE,SANOFI,,,question,80.866,311.671,15.744,64.932
77,10.0,Demographics,DM_DOB,,26.0,Not Reported,,RANREP,SANOFI,,,,,question,80.866,311.671,15.744,64.932
78,10.0,Demographics,DM_DOB,DM,27.0,Unknown,,RUNK,SANOFI,RACE,SANOFI,,,question,80.866,294.671,15.744,47.328
79,10.0,Demographics,DM_DOB,,27.0,Unknown,,RAUNK,SANOFI,,,,,question,80.866,294.671,15.744,47.328
80,10.0,Demographics,DM_DOB,,28.0,"If Asian, specify the origin reported by the subject. Check all that apply.",,PROMPT_ASIAN,SANOFI,,,,,question,80.866,277.659,15.948,345.924
81,10.0,Demographics,DM_DOB,,29.0,Chinese,,RCHINESE,SANOFI,,,,,question,70.866,260.671,15.744,38.616
82,10.0,Demographics,DM_DOB,,30.0,Japanese,,RJAPAN,SANOFI,,,,,question,80.866,243.671,15.744,42.6
83,10.0,Demographics,DM_DOB,,31.0,Asian Indian,,RAINDIAN,SANOFI,,,,,question,80.866,226.671,15.744,61.608
84,10.0,Demographics,DM_DOB,,32.0,Korean,,RKOREAN,SANOFI,,,,,question,80.866,209.671,15.744,35.292
85,10.0,Demographics,DM_DOB,,33.0,Other Asian Origin,,RAOTHER,SANOFI,,,,,question,80.866,192.671,15.744,92.58
86,10.0,Demographics,DM_DOB,,34.0,"If Other, Specify.",,RAOTHSP,SANOFI,,,,,question,80.866,175.671,15.744,83.916
87,10.0,Demographics,DM_DOB,DM,35.0,Not Reported,,RNREP,SANOFI,RACE,SANOFI,,,question,80.866,158.671,15.744,64.932
88,10.0,Demographics,DM_DOB,,35.0,Not Reported,,RANREP,SANOFI,,,,,question,80.866,158.671,15.744,64.932
89,10.0,Demographics,DM_DOB,DM,36.0,Unknown,,RUNK,SANOFI,RACE,SANOFI,,,question,80.866,141.671,15.744,47.328
90,10.0,Demographics,DM_DOB,,36.0,Unknown,,RAUNK,SANOFI,,,,,question,80.866,141.671,15.744,47.328
91,11.0,Influenza Like Illness,CE_VAC_ILI,CE,2.0,Category for Clinical Event,What is the category of the clinical event?,CECAT,IG,CECAT,IG,CECAT,ALLERGIC REACTION;BONE FRACTURE;HYPERSENSITIVITY/ALLERGIC REACTION;HYPOGLYCEMIC EVENTS;HYPOGLYCEMIC SYMPTOMS;INJECTION SITE REACTION;MULTIPLE SCLEROSIS;NEUROLOGIC DISORDER;SUSPECTED DENGUE EVENT;SUSPECTED OR CONFIRMED CEREBROVASCULAR EVENT;SUSPECTED OR CONFIRMED DIABETIC KETOACIDOSIS;SUSPECTED OR CONFIRMED HEART FAILURE;SUSPECTED OR CONFIRMED MYOCARDIAL INFARCTION / UNSTABLE ANGINA;SUSPECTED INFLUENZA EVENT,question,70.866,666.671,15.744,132.816
869,11.0,Influenza Like Illness,CE_VAC_ILI,,23.0,Did the subject experience any Influenza Like Illness since last visit?,Were any clinical events experienced?,CEYN,IG,,,,,question,70.866,365.671,15.744,302.568
870,11.0,Influenza Like Illness,CE_VAC_ILI,,27.0,"If the subject experienced influenza like illness, provide all the action taken.  If not, leave all the fields blank.",,PROMPT_CE,SANOFI,,,,,question,70.866,330.671,15.744,461.328
92,11.0,Influenza Like Illness,CE_VAC_ILI,CE,29.0,Episode ID,What is the clinical event identifier?,CESPID,IG,CESPID,IG,,,question,70.866,296.671,15.744,54.288
93,11.0,Influenza Like Illness,CE_VAC_ILI,CE,30.0,Clinical Event Term,What is the clinical event term?,CETERM,IG,CETERM,IG,,,question,70.866,279.671,15.744,97.836
94,11.0,Influenza Like Illness,CE_VAC_ILI,CE,31.0,Pre-specified?,,CEPRESP,IG,CEPRESP,IG,NY_YN,Y;N,question,70.866,262.671,15.744,68.556
95,11.0,Influenza Like Illness,CE_VAC_ILI,,35.0,Medication,,CEACMED,SANOFI,,,,,question,70.866,227.671,15.744,54.588
96,11.0,Influenza Like Illness,CE_VAC_ILI,,36.0,Health Care Visit,,CEACTHC,SANOFI,,,,,question,70.866,210.671,15.744,83.868
97,11.0,Influenza Like Illness,CE_VAC_ILI,,37.0,Hospitalized,,CEACTHO,SANOFI,,,,,question,70.866,193.671,15.744,60.576
98,11.0,Influenza Like Illness,CE_VAC_ILI,,38.0,No Action Taken,,CEACTN,SANOFI,,,,,question,70.866,176.671,15.744,83.244
99,11.0,Influenza Like Illness,CE_VAC_ILI,,39.0,Duration,,CEDUR,SANOFI,,,,,question,70.866,159.671,15.744,42.624
100,11.0,Influenza Like Illness,CE_VAC_ILI,,40.0,Duration Unit,,CEDURU,SANOFI,,,UNIT,%;% INHIBITION;%(v/v);%(w/v);%(w/w);%/min;%cells/area;/100 HPFs;/100 WBC;/10^3 cells;/HPF;/L;/LPF;/VF;/dL;/day;/h;/kg;/mL;/mm3;/month;/nL;/pL;/uL;/wk;/year;1/dilution;100 IU/mL;10^10/L;10^11/L;10^12 IU/L;10^12/L;10^3 CFU;10^3 CFU/g;10^3 CFU/mL;10^3 DNA copies/mL;10^3 RNA copies/mL;10^3 copies/mL;10^3 organisms;10^3 organisms/g;10^3 organisms/mL;10^3/L;10^3/hpf;10^3/mm3;10^3/mm4;10^3/uL;10^4/L;10^4/hpf;10^5/L;10^5/hpf;10^6 CFU;10^6 CFU/g;10^6 CFU/mL;10^6 DNA copies/mL;10^6 IU;10^6 IU/mL;10^6 RNA copies/mL;10^6 copies/mL;10^6 organisms;10^6 organisms/g;10^6 organisms/mL;10^6 organisms/mg;10^6/L;10^6/g;10^6/hpf;10^6/mm3;10^6/uL;10^7/L;10^8/L;10^9 CFU;10^9 CFU/g;10^9 CFU/mL;10^9 organisms;10^9 organisms/g;10^9 organisms/mL;10^9 organisms/mg;10^9/L;AFU;AI;AMPULE;APL U/mL;APPLICATION;ASC;AU;AU/mL;AU/min;AgU/mL;Antibody Unit;BAG;BAR;BAU;BAU/mL;BE/mL;BEATS/MIN;BISCUIT;BLOCKS;BOLUS;BOTTLE;BOX;BREATHS/MIN;BU;BU/mL;Bq;Bq/L;Bq/g;Bq/kg;Bq/mL;Bq/mg;Bq/uL;Bq/ug;C;CAE;CAN;CAPFUL;CAPLET;CAPSULE;CARTRIDGE;CASE;CCID 50/dose;CCID 50/mL;CFU/g;CFU/mL;CIGAR;CIGARETTE;COAT;COI;CONTAINER;CUP;CYLINDER;Ci;Ci/L;Ci/g;Ci/kg;Ci/mL;Ci/mg;Ci/uL;Ci/ug;Coulomb;Ct;DAYS;DAgU;DAgU/mL;DIOPTER;DISK;DNA copies/mL;DPM;DRUM;EID 50/dose;EID 50/mL;ELISA unit;ELISA unit/dose;ELISA unit/mL;EU;Enzyme U;F;FEU;FINGERTIP UNIT;Farad;Frames/s;GBq;GBq/g;GBq/mg;GBq/ug;GI/L;GLASS;GPL U/mL;Gauss;Gy;HAU/100 uL;HEP;HOMEOPATHIC DILUTION;HOURS;HPF;Hb Fract.;Hemolytic Unit;Henry;Hounsfield Unit;Hz;IMPLANT;INDEX VALUE;INHALATION;IU;IU/L;IU/dL;IU/g;IU/kg;IU/kg/h;IU/mL;IU/mg;IU^4;IV;Immune Status Ratio (ISR);JAR;Joule;KALLIKREIN INHIBITOR UNIT;KIT;L;L/L;L/h;L/h/m2;L/kg;L/min;L/min/m2;L/s;LB;LOZENGE;LPF;Log10 ELISA unit;Log10 ELISA unit/dose;Log10 GEq/mL;Log10 PFU/mL;MBq;MBq/uL;MESF;MFI;MHz;MONTHS;MPL U/mL;Mile;NEBULE;NEEDLE GAUGE;NIU;Newton;PACK;PACKAGE;PACKET;PATCH;PELLET;PFU;PFU/dose;PFU/mL;PIPE;PIXEL;PIXELS/cm;PIXELS/in;PNU/mL;POINT;POUCH;PRESSOR UNITS;PUFF;Pa;Pack Year;Perfusion unit;Perfusion unit*sec;QUANTITY SUFFICIENT;RATIO;RING;RNA copies/mL;Rad;Roentgen;SACHET;SBE/mL;SCO;SCOOPFUL;SFC;SFC/10^6 PBMC;SPRAY;SQU/mL;STANDARD DRINK/day;STEPS;STRIP;SUPPOSITORY;SYRINGE;Shock Wave;Siemens;Signals/cells;Sv;TABLET;TAMPON;TCID 50/dose;TI/L;TRACE;TROCHE;TUBE;Tbsp;Tesla;Torr;U;U.CARR;U/L;U/animal;U/cL;U/dL;U/g;U/g/day;U/g/h;U/g/min;U/kg;U/kg/day;U/kg/h;U/kg/min;U/m2;U/m2/day;U/m2/h;U/m2/min;U/mL;U/mg;U/mmol;V;V/sec;VIAL;VIRTUAL PIXEL;WAFER;WEEKS;Watt;Weber;YEARS;ag;amol;amp;amu;anti-Xa IU;anti-Xa IU/mL;atm;bel;cGy;cL;cal;cc;cd;cells/mm3;cells/uL;cg;cm;cm H2O;cm/min;cm/s;cm2;cmol;cmol/L;copies/mL;copies/uL;cpm;cs;cy/cm;cycle/min;cycle/sec;dB;dL;damol/L;deg;dmol;dpm/0.5 mL;dpm/100mg;dpm/mL;dpm/mg;dram;dyn;eq;fL;fg;fmol;fmol/L;fmol/g;foz_br;foz_us;fraction of 1;ft;ft2;ft3;g;g/24h;g/L;g/animal;g/animal/day;g/animal/wk;g/cage;g/cage/day;g/cage/wk;g/cm2;g/dL;g/day;g/g;g/g Creatinine;g/g/day;g/kg;g/kg/day;g/m2;g/m2/day;g/mol;grain;gtt;hPa;in;in2;kAU/L;kBq;kBq/uL;kDa;kHz;kIU;kN/cm2;kPa;kPa/L/sec;kU/L;kUSP;kat;kcal;kg;kg/L;kg/cm;kg/cm2;kg/m2;km;km/h;ks;lbf;lm;log EID 50/dose;log10 CCID 50/dose;log10 CFU/g;log10 CFU/mL;log10 IU/mL;log10 TCID 50/dose;log10 copies/mL;lx;m;m/sec;m/sec2;m2;m3;mCi;mCi/L;mCi/kg;mEq;mEq/L;mEq/dL;mEq/day;mEq/g;mEq/kg;mEq/mL;mEq/mmol;mEq/uL;mEq/ug;mIU/L;mIU/mL;mJoule/cm2;mL;mL/animal;mL/animal/day;mL/animal/wk;mL/breath;mL/cage;mL/cage/day;mL/cage/wk;mL/cm;mL/cm H2O;mL/dL;mL/day;mL/g;mL/g/day;mL/g/h;mL/g/min;mL/h;mL/h/uL of lysat;mL/kg;mL/kg/day;mL/kg/h;mL/kg/min;mL/m2;mL/m2/day;mL/m2/h;mL/m2/min;mL/min;mL/min/1.73m2;mL/min/SSA;mL/min/mmHg;mL/mmHg;mL/mmHg/min/L;mL/s;mL/sec/1.73m2;mOsm;mOsm/kg;mPa;mU/L;mU/mL;mV;mV*min;mV2/Hz;mcg/dL;mg;mg%;mg/24h;mg/L;mg/L FEU;mg/animal;mg/dL;mg/day;mg/g;mg/g Creatinine;mg/g/day;mg/g/h;mg/g/min;mg/h;mg/kg;mg/kg/day;mg/kg/h;mg/kg/min;mg/m2;mg/m2/day;mg/m2/h;mg/m2/min;mg/mL/min;mg/min;mg/mmol Creatinine;mg/mol;min;mkat;mm;mm/2h;mm/h;mm/min;mm/sec;mm2;mm3;mmHg;mmHg/L/min;mmHg/sec;mmol;mmol FA/mL/h;mmol/L;mmol/day;mmol/g;mmol/kg;mmol/min/kPa;mmol/min/kPa/L;mmol/mol;mmol^2/L^2;mol;mol/L;mol/g;mol/mL;mol/mg;mol/mol;mph;msec;nCi;nL;nU/cL;nU/mL;ng;ng/L;ng/dL;ng/mL;nkat;nkat/L;nm;nmol;nmol BCE/L;nmol BCE/mmol;nmol/L;nmol/dL;nmol/hr/mg protein;nmol/mL/min;nmol/min/mg protein;nsec;ohm;osm;oz;pL;per min;per sec;pg;pg/L;pg/dL;pg/mL;pkat;pm;pmol;pmol/L;pmol/min/uL of lysat;pmol/punch/hr;pools/day;pools/h;ppb;ppm;ppth;pptr;psec;psi;pt_br;pt_us;rpm;sABC;sMEC;scm;sec;titer;tsp;tuberculin unit;tuberculin unit/mL;uCi;uCi/L;uCi/kg;uEq;uEq/L;uIU/mL;uL;uL/mL;uOsM;uU/mL;uV;uV*sec;ug;ug/L;ug/animal;ug/dL;ug/day;ug/g/day;ug/g/h;ug/g/min;ug/h;ug/kg;ug/kg/day;ug/kg/h;ug/kg/min;ug/m2;ug/m2/day;ug/m2/h;ug/m2/min;ug/mL;ug/mL/h;ug/min;ugEq;ukat;ukat/L;um;um2;umol;umol/L;umol/L/min;umol/L/sec;umol/day;umol/mg/min;umol/min;usec;v/v;yd;NONE;OTHER,question,70.866,121.671,15.744,66.936
101,11.0,Influenza Like Illness,CE_VAC_ILI,,41.0,Laboratory confirmed?,,CELBCFYN,SANOFI,,,NY_YN,Y;N,question,70.866,102.671,15.744,110.856
871,12.0,Subject Medical History,MH_NPR_01,,2.0,"List significant past or current diagnoses, for the following Body Systems: Blood and Lymphatic / Cardiovascular / Gastrointestinal / Hepatobiliary / Neurological / Psychiatric / Renal and urinary / Respiratory / Endocrine and metabolic / Neoplasms benign, malignant and unspecified / Musculoskeletal and connective tissue.",,PROMPT_MHYN,SANOFI,,,,,question,70.866,666.659,15.948,468.612
872,12.0,Subject Medical History,MH_NPR_01,,6.0,Has the subject experienced any significant past and/or current diseases?,Were any medical conditions or events reported?; Has the subject had any medical conditions or events?,MHYN,IG,,,,,question,70.866,607.671,15.744,300.936
102,12.0,Subject Medical History,MH_NPR_01,,8.0,"If yes, complete the following questions.",,PROMPT_MHSPID,SANOFI,,,,,question,70.866,572.659,15.948,192.108
103,12.0,Subject Medical History,MH_NPR_01,MH,9.0,Unique ID,What is the medical condition or event identifier?,MHSPID,IG,MHSPID,IG,,,question,70.866,555.671,15.744,50.964
104,12.0,Subject Medical History,MH_NPR_01,MH,10.0,Medical History Term,What is the medical condition or event term?,MHTERM,IG,MHTERM,IG,,,question,70.866,538.671,15.744,107.196
105,12.0,Subject Medical History,MH_NPR_01,MH,11.0,Ongoing at Inclusion,Is the medical condition or event ongoing?,MHONGO,IG,MHENRF; MHENRTPT,IG,,,question,70.866,521.671,15.744,101.256
874,13.0,Influenza Vaccination History,CM_VAC_ALL,CM,0.0,"\Trade Name/Manufacturer/Valence\ (If Unknown, enter 'UNK')",What was the (concomitant) [medication/treatment/therapy] (name/term)?,CMTRT,IG,CMTRT,IG,,,unassigned,-100.0,760.0,15.0,100.0
875,13.0,Influenza Vaccination History,CM_VAC_ALL,CM,0.0,Dosage,What was the individual dose of the (concomitant) [mediation/treatment/therapy]?,CMDSTXT,IG,CMDOSTXT; CMDOSE,IG,,,unassigned,-100.0,760.0,15.0,100.0
876,13.0,Influenza Vaccination History,CM_VAC_ALL,CM,0.0,Route of Administration,What was the route of administration of the (concomitant) [medication/treatment/therapy]?,CMROUTE,IG,CMROUTE,IG,ROUTE_03,INTRADERMAL;INTRAMUSCULAR OR SUBCUTANEOUS;NASAL;UNKNOWN,unassigned,-100.0,760.0,15.0,100.0
877,13.0,Influenza Vaccination History,CM_VAC_ALL,SUPPCM,0.0,"Did the subject experience any reaction following administration? (If Yes, specify the reaction)",,CMREACYN,SANOFI,CMREACYN,SANOFI,NY_YNU,Y;N;U,unassigned,-100.0,760.0,15.0,100.0
878,13.0,Influenza Vaccination History,CM_VAC_ALL,SUPPCM,0.0,Specify Reaction,,CMREACSP,SANOFI,CMREACSP,SANOFI,,,unassigned,-100.0,760.0,15.0,100.0
106,13.0,Influenza Vaccination History,CM_VAC_ALL,CM,2.0,Category for Medication,What is the category for the (concomitant) [medication/treatment/therapy]?,CMCAT,IG,CMCAT,IG,CMCAT,ANTI-CANCER THERAPY;ANTI-HYPERGLYCEMIC THERAPY;ANTIBIOTIC;ASTHMA CONTROLLER;ASTHMA RELIEVER;BASAL INSULIN;HISTORY OF ANTI-HYPERGLYCEMIC THERAPY;HISTORY OF LIPID MODIFYING THERAPY;HISTORY OF VACCINATION;HYPOGLYCEMIC TREATMENT;LIPID LOWERING THERAPY;LIPID MODIFYING THERAPY EXCLUDING STATIN;MEDICATION;NON-MEDICATION THERAPY;RESCUE THERAPY;SAE COMPLEMENTARY INFORMATION;STATIN THERAPY;SYSTEMIC CORTICOID THERAPY;OTHER;MEDICATIONS IMPACTING OR THAT MAY HAVE AN IMPACT ON THE EVALUATION OF THE SAFETY;MEDICATIONS IMPACTING OR THAT MAY HAVE AN IMPACT ON THE IMMUNE RESPONSE;MEDICATIONS IMPACTING OR THAT MAY HAVE AN IMPACT ON BOTH THE SAFETY AND THE IMMUNE RESPONSE,question,70.866,666.671,15.744,118.524
873,13.0,Influenza Vaccination History,CM_VAC_ALL,,29.0,"Record information related only to \Influenza /Japanese Encephalitis/Yellow Fever/Diphtheria/Tetanus/Pneumococcal/Meningococcal/Licensed Dengue \vaccinations. Other vaccinations should be recorded in the Reportable Medications page.Use exact spelling.",,PROMPT_CMFLH_01,SANOFI,,,,,question,70.866,263.659,15.948,367.92
107,13.0,Influenza Vaccination History,CM_VAC_ALL,CM,33.0,Vaccination History Type,What is the subcategory for the (concomitant) [medication/treatment/therapy]?,CMSCAT,IG,CMSCAT,IG,CMSCAT,ANTIBIOTIC;ANTIBIOTICS;DIPHTHERIA VACCINE;HIGHLIGHTED DOSE;JAPANESE ENCEPHALITIS VACCINE;LICENSED DENGUE VACCINE;MENINGOCOCCAL VACCINE;NON-STUDY VACCINES;PNEUMOCOCCAL VACCINE;POST STUDY TREATMENT;PRIOR STUDY TREATMENT;SEASONAL INFLUENZA VACCINE;TETANUS VACCINE;YELLOW FEVER VACCINE,question,70.866,201.671,15.744,124.512
108,14.0,Influenza Vaccination History,CM_VAC_ALL,CM,2.0,Pre-Specified?,,CMPRESP,SANOFI,CMPRESP,SANOFI,NY_YN,Y;N,question,70.866,583.671,15.744,70.56
109,14.0,Influenza Vaccination History,CM_VAC_ALL,,3.0,Year of Vaccination,,CMTERM,SANOFI,,,,,question,70.866,548.671,15.744,97.188
110,14.0,Influenza Vaccination History,CM_VAC_ALL,CM,4.0,"Vaccination received? (If Yes, provide Details)",Did the subject take [pre-specified (concomitant) medication/treatment/therapy/dose]?; Has the subject taken [pre-specified (concomitant) medication/treatment/therapy/dose]?,CMOCCUR,IG,CMOCCUR,IG,NY_YNU,Y;N;U,question,70.866,503.671,15.948,225.012
111,14.0,Influenza Vaccination History,CM_VAC_ALL,CM,5.0,Date of Last Administration,What was the (concomitant) [medication/treatment/therapy/dose] start date?,CMSTDAT,IG,CMSTDTC,IG,,,question,70.866,452.671,15.744,134.832
112,14.0,Influenza Vaccination History,CM_VAC_ALL,CM,6.0,Vaccination History Type,What is the subcategory for the (concomitant) [medication/treatment/therapy]?,CMSCAT,IG,CMSCAT,IG,CMSCAT,ANTIBIOTIC;ANTIBIOTICS;DIPHTHERIA VACCINE;HIGHLIGHTED DOSE;JAPANESE ENCEPHALITIS VACCINE;LICENSED DENGUE VACCINE;MENINGOCOCCAL VACCINE;NON-STUDY VACCINES;PNEUMOCOCCAL VACCINE;POST STUDY TREATMENT;PRIOR STUDY TREATMENT;SEASONAL INFLUENZA VACCINE;TETANUS VACCINE;YELLOW FEVER VACCINE,question,70.866,432.671,15.744,124.512
113,14.0,Influenza Vaccination History,CM_VAC_ALL,CM,7.0,Pre-Specified?,,CMPRESP,SANOFI,CMPRESP,SANOFI,NY_YN,Y;N,question,70.866,205.671,15.744,70.56
114,14.0,Influenza Vaccination History,CM_VAC_ALL,,8.0,Year of Vaccination,,CMTERM,SANOFI,,,,,question,70.866,170.671,15.744,97.188
115,14.0,Influenza Vaccination History,CM_VAC_ALL,CM,9.0,"Vaccination received? (If Yes, provide Details)",Did the subject take [pre-specified (concomitant) medication/treatment/therapy/dose]?; Has the subject taken [pre-specified (concomitant) medication/treatment/therapy/dose]?,CMOCCUR,IG,CMOCCUR,IG,NY_YNU,Y;N;U,question,70.866,125.671,15.948,225.012
116,14.0,Influenza Vaccination History,CM_VAC_ALL,CM,10.0,Date of Last Administration,What was the (concomitant) [medication/treatment/therapy/dose] start date?,CMSTDAT,IG,CMSTDTC,IG,,,question,70.866,74.671,15.744,134.832
117,15.0,Influenza Vaccination History,CM_VAC_ALL,CM,2.0,Vaccination History Type,What is the subcategory for the (concomitant) [medication/treatment/therapy]?,CMSCAT,IG,CMSCAT,IG,CMSCAT,ANTIBIOTIC;ANTIBIOTICS;DIPHTHERIA VACCINE;HIGHLIGHTED DOSE;JAPANESE ENCEPHALITIS VACCINE;LICENSED DENGUE VACCINE;MENINGOCOCCAL VACCINE;NON-STUDY VACCINES;PNEUMOCOCCAL VACCINE;POST STUDY TREATMENT;PRIOR STUDY TREATMENT;SEASONAL INFLUENZA VACCINE;TETANUS VACCINE;YELLOW FEVER VACCINE,question,70.866,666.671,15.744,124.512
118,15.0,Influenza Vaccination History,CM_VAC_ALL,CM,3.0,Pre-Specified?,,CMPRESP,SANOFI,CMPRESP,SANOFI,NY_YN,Y;N,question,70.866,439.671,15.744,70.56
119,15.0,Influenza Vaccination History,CM_VAC_ALL,,4.0,Year of Vaccination,,CMTERM,SANOFI,,,,,question,70.866,404.671,15.744,97.188
120,15.0,Influenza Vaccination History,CM_VAC_ALL,CM,5.0,"Vaccination received? (If Yes, provide Details)",Did the subject take [pre-specified (concomitant) medication/treatment/therapy/dose]?; Has the subject taken [pre-specified (concomitant) medication/treatment/therapy/dose]?,CMOCCUR,IG,CMOCCUR,IG,NY_YNU,Y;N;U,question,70.866,359.671,15.948,225.012
121,15.0,Influenza Vaccination History,CM_VAC_ALL,CM,6.0,Date of Last Administration,What was the (concomitant) [medication/treatment/therapy/dose] start date?,CMSTDAT,IG,CMSTDTC,IG,,,question,70.866,308.671,15.744,134.832
122,15.0,Influenza Vaccination History,CM_VAC_ALL,CM,7.0,Vaccination History Type,What is the subcategory for the (concomitant) [medication/treatment/therapy]?,CMSCAT,IG,CMSCAT,IG,CMSCAT,ANTIBIOTIC;ANTIBIOTICS;DIPHTHERIA VACCINE;HIGHLIGHTED DOSE;JAPANESE ENCEPHALITIS VACCINE;LICENSED DENGUE VACCINE;MENINGOCOCCAL VACCINE;NON-STUDY VACCINES;PNEUMOCOCCAL VACCINE;POST STUDY TREATMENT;PRIOR STUDY TREATMENT;SEASONAL INFLUENZA VACCINE;TETANUS VACCINE;YELLOW FEVER VACCINE,question,70.866,288.671,15.744,124.512
123,16.0,Influenza Vaccination History,CM_VAC_ALL,CM,2.0,Pre-Specified?,,CMPRESP,SANOFI,CMPRESP,SANOFI,NY_YN,Y;N,question,70.866,666.671,15.744,70.56
124,16.0,Influenza Vaccination History,CM_VAC_ALL,,3.0,Year of Vaccination,,CMTERM,SANOFI,,,,,question,70.866,631.671,15.744,97.188
125,16.0,Influenza Vaccination History,CM_VAC_ALL,CM,4.0,"Vaccination received? (If Yes, provide Details)",Did the subject take [pre-specified (concomitant) medication/treatment/therapy/dose]?; Has the subject taken [pre-specified (concomitant) medication/treatment/therapy/dose]?,CMOCCUR,IG,CMOCCUR,IG,NY_YNU,Y;N;U,question,70.866,586.671,15.948,225.012
126,16.0,Influenza Vaccination History,CM_VAC_ALL,CM,5.0,Date of Last Administration,What was the (concomitant) [medication/treatment/therapy/dose] start date?,CMSTDAT,IG,CMSTDTC,IG,,,question,70.866,535.671,15.744,134.832
127,17.0,History of Flu Diagnosis,MH_VAC_FLU,MH,2.0,MH Category,What was the category of the medical history?,MHCAT,IG,MHCAT,IG,MHCAT,ALLERGY;ASTHMA;BLOOD DISORDER;CARDIOVASCULAR DISORDER;DIABETES;DISEASE HISTORY;EPISTAXIS;HEPATOBILIARY DISORDER;HYPERLIPOPROTEINEMIA;JUVENILE IDIOPATHIC ARTHRITIS;MEDICAL OR SURGICAL;MULTIPLE SCLEROSIS;NEUROLOGIC DISORDER;POLYPOSIS;POMPE DISEASE;RENAL DISORDER;RESPIRATORY DISORDER;RHEUMATOLOGIC DISORDER;RHINOSINUSITIS;SAE COMPLEMENTARY INFORMATION;SCLERODERMA;OTHER,question,70.866,666.671,15.744,66.276
128,17.0,History of Flu Diagnosis,MH_VAC_FLU,,26.0,Record information related only to Influenza disease history.,,PROMPT_MHFLH_01,SANOFI,,,,,question,70.866,299.659,15.948,292.38
129,17.0,History of Flu Diagnosis,MH_VAC_FLU,MH,27.0,Pre-Specified?,,MHPRESP,IG,MHPRESP,IG,NY_YN,Y;N,question,70.866,279.671,15.744,70.56
130,17.0,History of Flu Diagnosis,MH_VAC_FLU,MH,28.0,Type of Infection,What is the medical condition or event term?,MHTERM,IG,MHTERM,IG,,,question,70.866,244.671,15.744,83.904
131,17.0,History of Flu Diagnosis,MH_VAC_FLU,MH,29.0,Evaluation Interval,,MHEVINTX,SANOFI,MHEVINTX,SANOFI,,,question,70.866,213.671,15.744,92.196
879,17.0,History of Flu Diagnosis,MH_VAC_FLU,MH,30.0,"Was infection experienced during the evaluation interval? (If Yes, Provide Details)",Did the subject have [pre-specified medical condition/event/group of medical conditions]; Is the [pre-specified medical occurring ]?,MHOCCUR,IG,MHOCCUR,IG,,,question,70.866,196.671,15.948,314.568
132,17.0,History of Flu Diagnosis,MH_VAC_FLU,MH,40.0,Date,What was the medical condition or event start date?,MHSTDAT,IG,MHSTDTC,IG,,,question,70.866,145.671,15.744,22.62
133,17.0,History of Flu Diagnosis,MH_VAC_FLU,MH,41.0,Specify Symptoms,What is the medical condition or event term?,MHTERM1,IG,MHTERM,IG,,,question,70.866,128.671,15.744,90.936
134,17.0,History of Flu Diagnosis,MH_VAC_FLU,MH,42.0,Pre-Specified?,,MHPRESP,IG,MHPRESP,IG,NY_YN,Y;N,question,70.866,108.671,15.744,70.56
135,17.0,History of Flu Diagnosis,MH_VAC_FLU,MH,43.0,Type of Infection,What is the medical condition or event term?,MHTERM,IG,MHTERM,IG,,,question,70.866,73.671,15.744,83.904
136,18.0,History of Flu Diagnosis,MH_VAC_FLU,MH,2.0,Evaluation Interval,,MHEVINTX,SANOFI,MHEVINTX,SANOFI,,,question,70.866,635.671,15.744,92.196
137,18.0,History of Flu Diagnosis,MH_VAC_FLU,MH,5.0,Date,What was the medical condition or event start date?,MHSTDAT,IG,MHSTDTC,IG,,,question,70.866,553.671,15.744,22.62
138,18.0,History of Flu Diagnosis,MH_VAC_FLU,MH,6.0,Specify Symptoms,What is the medical condition or event term?,MHTERM1,IG,MHTERM,IG,,,question,70.866,536.671,15.744,90.936
139,18.0,History of Flu Diagnosis,MH_VAC_FLU,MH,7.0,Pre-Specified?,,MHPRESP,IG,MHPRESP,IG,NY_YN,Y;N,question,70.866,516.671,15.744,70.56
140,18.0,History of Flu Diagnosis,MH_VAC_FLU,MH,8.0,Type of Infection,What is the medical condition or event term?,MHTERM,IG,MHTERM,IG,,,question,70.866,481.671,15.744,83.904
141,18.0,History of Flu Diagnosis,MH_VAC_FLU,MH,9.0,Evaluation Interval,,MHEVINTX,SANOFI,MHEVINTX,SANOFI,,,question,70.866,450.671,15.744,92.196
142,18.0,History of Flu Diagnosis,MH_VAC_FLU,MH,12.0,Date,What was the medical condition or event start date?,MHSTDAT,IG,MHSTDTC,IG,,,question,70.866,368.671,15.744,22.62
143,18.0,History of Flu Diagnosis,MH_VAC_FLU,MH,13.0,Specify Symptoms,What is the medical condition or event term?,MHTERM1,IG,MHTERM,IG,,,question,70.866,351.671,15.744,90.936
144,18.0,History of Flu Diagnosis,MH_VAC_FLU,MH,14.0,Pre-Specified?,,MHPRESP,IG,MHPRESP,IG,NY_YN,Y;N,question,70.866,331.671,15.744,70.56
145,18.0,History of Flu Diagnosis,MH_VAC_FLU,MH,15.0,Type of Infection,What is the medical condition or event term?,MHTERM,IG,MHTERM,IG,,,question,70.866,296.671,15.744,83.904
146,18.0,History of Flu Diagnosis,MH_VAC_FLU,MH,16.0,Evaluation Interval,,MHEVINTX,SANOFI,MHEVINTX,SANOFI,,,question,70.866,265.671,15.744,92.196
147,18.0,History of Flu Diagnosis,MH_VAC_FLU,MH,19.0,Date,What was the medical condition or event start date?,MHSTDAT,IG,MHSTDTC,IG,,,question,70.866,183.671,15.744,22.62
148,18.0,History of Flu Diagnosis,MH_VAC_FLU,MH,20.0,Specify Symptoms,What is the medical condition or event term?,MHTERM1,IG,MHTERM,IG,,,question,70.866,166.671,15.744,90.936
149,19.0,Blood Sampling,CD_SER,,2.0,Central Data Category,,CDCAT,SANOFI,,,CDTYP,APPADL;BANKING;BIOMARKERS;CELL-MEDIATED IMMUNITY;CENTRAL IMAGING;CLAMP;DIAGNOSTIC;DRUG METABOLISM ENZYME;ECG TELEMETRY;ECHOCARDIOGRAM;ELECTRONIC PATIENT-REPORT OUTCOME SYSTEM;FUNCTIONAL TEST;GENETIC VARIATION;HEFH GENOTYPING;HOLTER;IW-SP;NASAL MUCOSA BRUSHING FOR RNA AND CYTOLOGY;NASAL SECRETION SAMPLING;NASAL SWABS FOR MICROBIOME;OPHTHALMOLOGICAL TEST;PQAT;PHARMACODYNAMICS;PHARMACOGENETIC ANALYSIS;PHARMACOGENETIC BANKING;PSYCHOMETRIC TEST;PULMONARY FUNCTION TESTS;SEROLOGY;TUMOR BIOPSY;VIROLOGY;VAS;WRSM,question,70.866,666.671,15.744,107.832
150,19.0,Blood Sampling,CD_SER,,3.0,Specimen Type,,CDSPEC,SANOFI,,,SPECTYPE,ADIPOSE TISSUE;AMNIOTIC FLUID;AQUEOUS HUMOR;ARTERIAL BLOOD;ARTERIAL CORD BLOOD;ATHEROSCLEROTIC PLAQUE;BILE;BLOOD;BONE;BONE MARROW;BREAST MILK;BUFFY COAT;CALCULUS;CAPILLARY BLOOD;CARDIAC MUSCLE TISSUE;CEREBROSPINAL FLUID;CERUMEN;CIRCULATING TUMOR CELL;COLOSTRUM;CORD BLOOD;CORD SERUM;DIALYSIS FLUID;DRIED BLOOD SPOT;EMESIS;ERYTHROCYTES;EXPIRED AIR;EXUDATE;FIBROBLAST;FLUID;GASTRIC CONTENTS;HAIR;HAIR FOLLICLE;INFRANATANT- PLASMA;INFRANATANT- PLEURAL FLUID;INFRANATANT- SERUM;INTERSTITIAL FLUID;ISOLATE;LAVAGE FLUID;LEUCOCYTES;LOCHIA;LUNG SURFACTANT;LYMPH;LYSATE;MECONIUM;MENSTRUAL BLOOD;MUCUS;MUSCLE TISSUE;NAIL;NASAL;NASOPHARYNGEAL;PERIPHERAL BLOOD;PERIPHERAL BLOOD MONONUCLEAR CELL;PERSPIRATION;PHARYNGEAL;PLASMA;PLATELET;PLATELET POOR PLASMA;PLATELET RICH PLASMA;PLEURAL FLUID;PROSTATIC FLUID;PUS;SALIVA;SEBUM;SEMEN;SEMINAL FLUID;SERUM;SKELETAL MUSCLE TISSUE;SMEGMA;SMOOTH MUSCLE TISSUE;SOFT TISSUE;SPUTUM;STOOL;STRIATED MUSCLE TISSUE;SUPERNATANT- CELLS;SUPERNATANT- PLASMA;SUPERNATANT- PLEURAL FLUID;SUPERNATANT- SERUM;SYNOVIAL FLUID;TISSUE;TRANSUDATE;TUMOR TISSUE;URINE;VENOUS BLOOD;VENOUS CORD BLOOD;VITREOUS HUMOR;WHOLE BLOOD;OTHER,question,70.866,81.671,15.744,74.904
151,22.0,Blood Sampling,CD_SER,,2.0,Sample ID,,CDREFID,SANOFI,,,,,question,70.866,503.671,15.744,51.612
152,22.0,Blood Sampling,CD_SER,,3.0,Was the sample collected?,,CDPERF,SANOFI,,,NY_YN,Y;N,question,70.866,486.671,15.744,127.44
153,22.0,Blood Sampling,CD_SER,,4.0,Reason sample not collected,,CDPERFRS,SANOFI,,,,,question,70.866,451.671,15.744,136.8
154,22.0,Blood Sampling,CD_SER,,5.0,"If yes, complete the following questions.",,PROMPT_CDPERF,SANOFI,,,,,question,70.866,434.659,15.948,192.108
155,22.0,Blood Sampling,CD_SER,,6.0,Date of Collection,,CDDAT,SANOFI,,,,,question,70.866,417.671,15.744,88.536
156,22.0,Blood Sampling,CD_SER,,7.0,Comment,,CDCOVAL,SANOFI,,,,,question,70.866,400.671,15.744,47.28
157,23.0,Vaccination,EX_08,EX,2.0,Treatment Name,What was the study treatment?,EXTRT,IG,EXTRT,IG,,,question,70.866,666.671,15.744,80.856
158,23.0,Vaccination,EX_08,,3.0,Has vaccination been performed?,,EXOCCUR,SANOFI,,,NY_YN,Y;N,question,70.866,621.671,15.744,160.776
159,23.0,Vaccination,EX_08,,4.0,Reason Vaccination Not Performed,,EXREASND,SANOFI,,,,,question,70.866,586.671,15.744,170.796
160,23.0,Vaccination,EX_08,,5.0,"If yes, complete the following questions.",,PROMPT_EXSTDAT,SANOFI,,,,,question,70.866,569.659,15.948,192.108
161,23.0,Vaccination,EX_08,EX,6.0,Date,What was the [intended/actual] [study treatment/dose] [start] date?,EXSTDAT,IG,EXSTDTC,IG,,,question,80.866,552.671,15.744,22.62
162,23.0,Vaccination,EX_08,EX,7.0,Dose Number,What is the study treatment label identifier?,EXREFID,IG,EXREFID,IG,,,question,80.866,535.671,15.744,66.948
163,23.0,Vaccination,EX_08,EX,8.0,Route,What was the route of administration (of the study treatment)?,EXROUTE,IG,EXROUTE,IG,ROUTE_05,INTRAMUSCULAR;INTRADERMAL;SUBCUTANEOUS,question,80.866,518.671,15.744,28.632
164,23.0,Vaccination,EX_08,EX,9.0,Site of Administration,What was the anatomical location of the (study treatment) administration?,EXLOC,IG,EXLOC,IG,LOC_01,UPPER ARM;BUTTOCK;THIGH,question,80.866,467.671,15.744,107.22
165,23.0,Vaccination,EX_08,EX,10.0,Side,What was the side of the anatomical location of the (study treatment) administration?,EXLAT,IG,EXLAT,IG,LAT_01,LEFT;RIGHT,question,80.866,416.671,15.744,21.312
166,23.0,Vaccination,EX_08,,11.0,Comment,,EXCOVAL,SANOFI,,,,,question,80.866,381.671,15.744,47.28
884,24.0,Immediate Unsolicited Systemic Events,AE_VAC_IMUSE,,2.0,Did any unsolicited systemic adverse events occur within 30 minutes after vaccination?,,AEIMYN,SANOFI,,,,,question,70.866,666.671,15.744,290.34
167,25.0,Injection Site Pain,FA_VAC_PAIN,FA,2.0,Category of Reaction,What [is/was] the [type/category/name] (of the [measurement/test/examination/specimen/sample])?,FACAT,IG,FACAT,IG,AECAT,ADVERSE EVENT;ADVERSE EVENT OF SPECIAL INTEREST;ALLERGIC REACTION;ALT INCREASE;ASTHMA EXACERBATION EVENT;BLEEDING EVENT;BONE FRACTURE;DRUG ALLERGY EVENT;EPISTAXIS EVENT;FOREIGN BODY REACTION EVENT;HYPERCALCEMIA;HYPOGLYCEMIA;INCREASED CALCITONIN;INCREASED LIPASE/AMYLASE;INFECTION EVENT;INJECTION SITE REACTION;METABOLIC ACIDOSIS EVENT;NEUROLOGIC DISORDER;OVERDOSE;PANCREATIC EVENT;PERIPHERAL NEUROPATHY EVENT;PREGNANCY;RENAL FAILURE;SERIOUS HYPOGLYCEMIA;SOLICITED;SUSPECTED OR CONFIRMED CEREBROVASCULAR EVENT;SUSPECTED OR CONFIRMED DIABETIC KETOACIDOSIS;SUSPECTED OR CONFIRMED HEART FAILURE;SUSPECTED OR CONFIRMED MYOCARDIAL INFARCTION / UNSTABLE ANGINA;UNSOLICITED;VASCULITIS EVENT;OTHER,question,70.866,666.671,15.744,102.528
168,25.0,Injection Site Pain,FA_VAC_PAIN,FA,3.0,Subcategory of Reaction,What [is/was] the [type/subcategory/name] (of the [measurement/test/examination/specimen/sample])?,FASCAT,IG,FASCAT,IG,AESCAT_01,ADMINISTRATION SITE;SYSTEMIC,question,70.866,77.671,15.744,118.524
169,26.0,Injection Site Pain,FA_VAC_PAIN,FA,2.0,Solicited Reaction Name,[Sponsored-defined phrase],FAOBJ,IG,FAOBJ,IG,,,question,70.866,647.671,15.744,119.808
885,26.0,Injection Site Pain,FA_VAC_PAIN,,3.0,Did the subject report Injection Site Pain at least once between Day 00 and Day 07 after vaccination?,,PROMPT_FA_01,SANOFI,,,,,question,70.866,630.659,15.948,426.204
171,26.0,Injection Site Pain,FA_VAC_PAIN,,5.0,Injection Site Pain,,FAOCCUR,SANOFI,,,NY_YN,Y;N,question,70.866,599.671,15.744,88.548
172,26.0,Injection Site Pain,FA_VAC_PAIN,,9.0,"If the answer is NO, then leave all the fields below blank.",,PROMPT_FA_02,SANOFI,,,,,question,70.866,564.659,15.948,274.68
173,26.0,Injection Site Pain,FA_VAC_PAIN,,10.0,Action Taken (Check all that apply),,PROMPT_FAACN,SANOFI,,,,,question,70.866,547.671,15.948,173.448
174,26.0,Injection Site Pain,FA_VAC_PAIN,,11.0,None,,FAACTN,SANOFI,,,,,question,80.866,530.671,15.744,25.98
175,26.0,Injection Site Pain,FA_VAC_PAIN,,12.0,Medication,,FAACMED,SANOFI,,,,,question,80.866,513.671,15.744,54.588
176,26.0,Injection Site Pain,FA_VAC_PAIN,,13.0,Health Care Provider Contact,,FAACTHC,SANOFI,,,,,question,80.866,496.671,15.744,142.14
177,26.0,Injection Site Pain,FA_VAC_PAIN,,14.0,Hospitalized,,FAACTHO,SANOFI,,,,,question,80.866,479.671,15.744,60.576
887,26.0,Injection Site Pain,FA_VAC_PAIN,,15.0,"Enter the Maximum daily Intensity from Day 00 to Day 07. If the Intensity is missing, select Unknown.",,PROMPT_INT,SANOFI,,,,,question,70.866,462.659,15.948,439.536
890,26.0,Injection Site Pain,FA_VAC_PAIN,,16.0,"Enter the Maximum Intensity considering the interval from Day 08 until the End Date. If the Intensity is missing, select Unknown.",,PROMPT_MXINT,SANOFI,,,,,question,70.866,448.659,15.948,48.972
178,26.0,Injection Site Pain,FA_VAC_PAIN,,17.0,Intensity at Day 00,,FAINT00,SANOFI,,,AESEVMD_02,MILD;MODERATE;SEVERE;UNKNOWN;NONE,question,80.866,431.671,15.744,91.572
179,26.0,Injection Site Pain,FA_VAC_PAIN,,41.0,Intensity at Day 01,,FAINT01,SANOFI,,,AESEVMD_02,MILD;MODERATE;SEVERE;UNKNOWN;NONE,question,80.866,348.671,15.744,91.572
180,26.0,Injection Site Pain,FA_VAC_PAIN,,42.0,Intensity at Day 02,,FAINT02,SANOFI,,,AESEVMD_02,MILD;MODERATE;SEVERE;UNKNOWN;NONE,question,80.866,265.671,15.744,91.572
181,26.0,Injection Site Pain,FA_VAC_PAIN,,43.0,Intensity at Day 03,,FAINT03,SANOFI,,,AESEVMD_02,MILD;MODERATE;SEVERE;UNKNOWN;NONE,question,80.866,182.671,15.744,91.572
182,26.0,Injection Site Pain,FA_VAC_PAIN,,44.0,Intensity at Day 04,,FAINT04,SANOFI,,,AESEVMD_02,MILD;MODERATE;SEVERE;UNKNOWN;NONE,question,80.866,99.671,15.744,91.572
886,27.0,Injection Site Pain,FA_VAC_PAIN,,0.0,Discontinuation of study vaccination,,FAACNC,SANOFI,,,,,unassigned,-100.0,760.0,15.0,100.0
183,27.0,Injection Site Pain,FA_VAC_PAIN,,2.0,Intensity at Day 05,,FAINT05,SANOFI,,,AESEVMD_02,MILD;MODERATE;SEVERE;UNKNOWN;NONE,question,80.866,631.671,15.744,91.572
184,27.0,Injection Site Pain,FA_VAC_PAIN,,3.0,Intensity at Day 06,,FAINT06,SANOFI,,,AESEVMD_02,MILD;MODERATE;SEVERE;UNKNOWN;NONE,question,80.866,548.671,15.744,91.572
185,27.0,Injection Site Pain,FA_VAC_PAIN,,4.0,Intensity at Day 07,,FAINT07,SANOFI,,,AESEVMD_02,MILD;MODERATE;SEVERE;UNKNOWN;NONE,question,80.866,465.671,15.744,91.572
888,27.0,Injection Site Pain,FA_VAC_PAIN,,22.0,"If a reaction is ongoing after Day 07, enter the Maximum Intensity available at the time of reporting.",,PROMPT_ONGOING,SANOFI,,,,,question,70.866,382.659,15.948,433.212
186,27.0,Injection Site Pain,FA_VAC_PAIN,,24.0,Ongoing after Day 07?,,FAONGO,SANOFI,,,,,question,80.866,351.671,15.744,110.232
889,27.0,Injection Site Pain,FA_VAC_PAIN,,25.0,"When the End Date is obtained, ensure that the Maximum Intensity is still correct while considering the interval from Day 8 until the End Date.",,PROMPT_FASEV1,SANOFI,,,,,question,70.866,334.659,15.948,480.156
187,27.0,Injection Site Pain,FA_VAC_PAIN,,27.0,End date,,FAENDAT,SANOFI,,,,,question,80.866,303.671,15.744,42.276
188,27.0,Injection Site Pain,FA_VAC_PAIN,,30.0,Maximum Intensity after Day 07,,FAINTMX,SANOFI,,,AESEVMD_01,MILD;MODERATE;SEVERE;UNKNOWN,question,80.866,255.671,15.744,157.836
189,27.0,Injection Site Pain,FA_VAC_PAIN,,31.0,Caused Study Termination,,FADIS,SANOFI,,,NY_YN,Y;N,question,70.866,188.671,15.744,128.532
190,27.0,Injection Site Pain,FA_VAC_PAIN,,32.0,Intensity Method at Day 00,,FAMETH00,SANOFI,,,,,question,70.866,153.671,15.744,131.88
191,27.0,Injection Site Pain,FA_VAC_PAIN,,33.0,Intensity Method at Day 01,,FAMETH01,SANOFI,,,,,question,70.866,136.671,15.744,131.88
192,27.0,Injection Site Pain,FA_VAC_PAIN,,34.0,Intensity Method at Day 02,,FAMETH02,SANOFI,,,,,question,70.866,119.671,15.744,131.88
193,27.0,Injection Site Pain,FA_VAC_PAIN,,35.0,Intensity Method at Day 03,,FAMETH03,SANOFI,,,,,question,70.866,102.671,15.744,131.88
194,27.0,Injection Site Pain,FA_VAC_PAIN,,36.0,Intensity Method at Day 04,,FAMETH04,SANOFI,,,,,question,70.866,85.671,15.744,131.88
195,27.0,Injection Site Pain,FA_VAC_PAIN,,37.0,Intensity Method at Day 05,,FAMETH05,SANOFI,,,,,question,70.866,68.671,15.744,131.88
196,28.0,Injection Site Pain,FA_VAC_PAIN,,2.0,Intensity Method at Day 06,,FAMETH06,SANOFI,,,,,question,70.866,666.671,15.744,131.88
197,28.0,Injection Site Pain,FA_VAC_PAIN,,3.0,Intensity Method at Day 07,,FAMETH07,SANOFI,,,,,question,70.866,649.671,15.744,131.88
198,28.0,Injection Site Pain,FA_VAC_PAIN,,4.0,Maximum Intensity Method,,FAMETHMX,SANOFI,,,,,question,70.866,632.671,15.744,135.216
199,29.0,Injection Site Erythema,FA_VAC_ERYTHEMA,FA,2.0,Category of Reaction,What [is/was] the [type/category/name] (of the [measurement/test/examination/specimen/sample])?,FACAT,IG,FACAT,IG,AECAT,ADVERSE EVENT;ADVERSE EVENT OF SPECIAL INTEREST;ALLERGIC REACTION;ALT INCREASE;ASTHMA EXACERBATION EVENT;BLEEDING EVENT;BONE FRACTURE;DRUG ALLERGY EVENT;EPISTAXIS EVENT;FOREIGN BODY REACTION EVENT;HYPERCALCEMIA;HYPOGLYCEMIA;INCREASED CALCITONIN;INCREASED LIPASE/AMYLASE;INFECTION EVENT;INJECTION SITE REACTION;METABOLIC ACIDOSIS EVENT;NEUROLOGIC DISORDER;OVERDOSE;PANCREATIC EVENT;PERIPHERAL NEUROPATHY EVENT;PREGNANCY;RENAL FAILURE;SERIOUS HYPOGLYCEMIA;SOLICITED;SUSPECTED OR CONFIRMED CEREBROVASCULAR EVENT;SUSPECTED OR CONFIRMED DIABETIC KETOACIDOSIS;SUSPECTED OR CONFIRMED HEART FAILURE;SUSPECTED OR CONFIRMED MYOCARDIAL INFARCTION / UNSTABLE ANGINA;UNSOLICITED;VASCULITIS EVENT;OTHER,question,70.866,666.671,15.744,102.528
200,29.0,Injection Site Erythema,FA_VAC_ERYTHEMA,FA,3.0,Subcategory of Reaction,What [is/was] the [type/subcategory/name] (of the [measurement/test/examination/specimen/sample])?,FASCAT,IG,FASCAT,IG,AESCAT_01,ADMINISTRATION SITE;SYSTEMIC,question,70.866,77.671,15.744,118.524
201,30.0,Injection Site Erythema,FA_VAC_ERYTHEMA,FA,3.0,Solicited Reaction Name,[Sponsored-defined phrase],FAOBJ,IG,FAOBJ,IG,,,question,70.866,647.671,15.744,119.808
891,30.0,Injection Site Erythema,FA_VAC_ERYTHEMA,,4.0,Did the subject report Injection Site Erythema at least once between Day 00 and Day 07 after vaccination?,,PROMPT_FA_01,SANOFI,,,,,question,70.866,630.659,15.948,450.168
203,30.0,Injection Site Erythema,FA_VAC_ERYTHEMA,,6.0,Injection Site Erythema,,FAOCCUR,SANOFI,,,NY_YN,Y;N,question,70.866,599.671,15.744,113.832
204,30.0,Injection Site Erythema,FA_VAC_ERYTHEMA,,9.0,"If the answer is NO, then leave all the fields below blank.",,PROMPT_FA_02,SANOFI,,,,,question,70.866,564.659,15.948,274.68
205,30.0,Injection Site Erythema,FA_VAC_ERYTHEMA,,10.0,Action Taken (Check all that apply),,PROMPT_FAACN,SANOFI,,,,,question,70.866,547.671,15.948,173.448
206,30.0,Injection Site Erythema,FA_VAC_ERYTHEMA,,11.0,None,,FAACTN,SANOFI,,,,,question,80.866,530.671,15.744,25.98
207,30.0,Injection Site Erythema,FA_VAC_ERYTHEMA,,12.0,Medication,,FAACMED,SANOFI,,,,,question,80.866,513.671,15.744,54.588
208,30.0,Injection Site Erythema,FA_VAC_ERYTHEMA,,13.0,Health Care Provider Contact,,FAACTHC,SANOFI,,,,,question,80.866,496.671,15.744,142.14
209,30.0,Injection Site Erythema,FA_VAC_ERYTHEMA,,14.0,Hospitalized,,FAACTHO,SANOFI,,,,,question,80.866,479.671,15.744,60.576
893,30.0,Injection Site Erythema,FA_VAC_ERYTHEMA,,15.0,"Enter the Maximum daily Measurement from Day 00 to Day 07. If the Measurement is missing, enter 'UNK' for Unknown.",,PROMPT_MEAS,SANOFI,,,,,question,70.866,462.659,15.948,457.272
896,30.0,Injection Site Erythema,FA_VAC_ERYTHEMA,,16.0,"Enter the Maximum Measurement considering the interval from Day 08 until the End Date. If the Measurement is missing, enter 'UNK' for Unknown.",,PROMPT_MXMEAS,SANOFI,,,,,question,70.866,448.659,15.948,126.348
210,30.0,Injection Site Erythema,FA_VAC_ERYTHEMA,,17.0,Measurement at Day 00,,FAMEAS00,SANOFI,,,,,question,75.866,431.671,15.744,114.864
211,30.0,Injection Site Erythema,FA_VAC_ERYTHEMA,,21.0,Measurement at Day 01,,FAMEAS01,SANOFI,,,,,question,75.866,341.671,15.744,114.864
212,30.0,Injection Site Erythema,FA_VAC_ERYTHEMA,,24.0,Measurement at Day 02,,FAMEAS02,SANOFI,,,,,question,75.866,251.671,15.744,114.864
213,30.0,Injection Site Erythema,FA_VAC_ERYTHEMA,,27.0,Measurement at Day 03,,FAMEAS03,SANOFI,,,,,question,75.866,161.671,15.744,114.864
214,30.0,Injection Site Erythema,FA_VAC_ERYTHEMA,,30.0,Measurement at Day 04,,FAMEAS04,SANOFI,,,,,question,75.866,71.671,15.744,114.864
892,31.0,Injection Site Erythema,FA_VAC_ERYTHEMA,,0.0,Discontinuation of study vaccination,,FAACNC,SANOFI,,,,,unassigned,-100.0,760.0,15.0,100.0
897,31.0,Injection Site Erythema,FA_VAC_ERYTHEMA,,2.0,"If the reaction is too large to measure, check 'NM' for Non Measurable",,FAMSNMMX,SANOFI,,,,,question,80.866,666.671,15.744,280.008
215,31.0,Injection Site Erythema,FA_VAC_ERYTHEMA,,4.0,Measurement at Day 05,,FAMEAS05,SANOFI,,,,,question,75.866,614.671,15.744,114.864
216,31.0,Injection Site Erythema,FA_VAC_ERYTHEMA,,7.0,Measurement at Day 06,,FAMEAS06,SANOFI,,,,,question,75.866,524.671,15.744,114.864
217,31.0,Injection Site Erythema,FA_VAC_ERYTHEMA,,10.0,Measurement at Day 07,,FAMEAS07,SANOFI,,,,,question,75.866,434.671,15.744,114.864
894,31.0,Injection Site Erythema,FA_VAC_ERYTHEMA,,20.0,"If a reaction is ongoing after Day 07, enter the Maximum Measurement available at the time of reporting.",,PROMPT_ONGOING,SANOFI,,,,,question,70.866,344.659,15.948,457.212
218,31.0,Injection Site Erythema,FA_VAC_ERYTHEMA,,22.0,Ongoing after Day 07?,,FAONGO,SANOFI,,,,,question,80.866,313.671,15.744,110.232
895,31.0,Injection Site Erythema,FA_VAC_ERYTHEMA,,23.0,"When the End Date is obtained, ensure that the Maximum Measurement is still correct while considering the interval from Day 8 until the End Date.",,PROMPT_FASEV1,SANOFI,,,,,question,70.866,296.659,15.948,444.54
219,31.0,Injection Site Erythema,FA_VAC_ERYTHEMA,,25.0,End date,,FAENDAT,SANOFI,,,,,question,80.866,265.671,15.744,42.276
220,31.0,Injection Site Erythema,FA_VAC_ERYTHEMA,,28.0,Maximum Measurement after Day 07,,FAMEASMX,SANOFI,,,,,question,75.866,217.671,15.744,181.128
221,31.0,Injection Site Erythema,FA_VAC_ERYTHEMA,,33.0,Measurement Unit,,FAMEASU,SANOFI,,,UNIT,%;% INHIBITION;%(v/v);%(w/v);%(w/w);%/min;%cells/area;/100 HPFs;/100 WBC;/10^3 cells;/HPF;/L;/LPF;/VF;/dL;/day;/h;/kg;/mL;/mm3;/month;/nL;/pL;/uL;/wk;/year;1/dilution;100 IU/mL;10^10/L;10^11/L;10^12 IU/L;10^12/L;10^3 CFU;10^3 CFU/g;10^3 CFU/mL;10^3 DNA copies/mL;10^3 RNA copies/mL;10^3 copies/mL;10^3 organisms;10^3 organisms/g;10^3 organisms/mL;10^3/L;10^3/hpf;10^3/mm3;10^3/mm4;10^3/uL;10^4/L;10^4/hpf;10^5/L;10^5/hpf;10^6 CFU;10^6 CFU/g;10^6 CFU/mL;10^6 DNA copies/mL;10^6 IU;10^6 IU/mL;10^6 RNA copies/mL;10^6 copies/mL;10^6 organisms;10^6 organisms/g;10^6 organisms/mL;10^6 organisms/mg;10^6/L;10^6/g;10^6/hpf;10^6/mm3;10^6/uL;10^7/L;10^8/L;10^9 CFU;10^9 CFU/g;10^9 CFU/mL;10^9 organisms;10^9 organisms/g;10^9 organisms/mL;10^9 organisms/mg;10^9/L;AFU;AI;AMPULE;APL U/mL;APPLICATION;ASC;AU;AU/mL;AU/min;AgU/mL;Antibody Unit;BAG;BAR;BAU;BAU/mL;BE/mL;BEATS/MIN;BISCUIT;BLOCKS;BOLUS;BOTTLE;BOX;BREATHS/MIN;BU;BU/mL;Bq;Bq/L;Bq/g;Bq/kg;Bq/mL;Bq/mg;Bq/uL;Bq/ug;C;CAE;CAN;CAPFUL;CAPLET;CAPSULE;CARTRIDGE;CASE;CCID 50/dose;CCID 50/mL;CFU/g;CFU/mL;CIGAR;CIGARETTE;COAT;COI;CONTAINER;CUP;CYLINDER;Ci;Ci/L;Ci/g;Ci/kg;Ci/mL;Ci/mg;Ci/uL;Ci/ug;Coulomb;Ct;DAYS;DAgU;DAgU/mL;DIOPTER;DISK;DNA copies/mL;DPM;DRUM;EID 50/dose;EID 50/mL;ELISA unit;ELISA unit/dose;ELISA unit/mL;EU;Enzyme U;F;FEU;FINGERTIP UNIT;Farad;Frames/s;GBq;GBq/g;GBq/mg;GBq/ug;GI/L;GLASS;GPL U/mL;Gauss;Gy;HAU/100 uL;HEP;HOMEOPATHIC DILUTION;HOURS;HPF;Hb Fract.;Hemolytic Unit;Henry;Hounsfield Unit;Hz;IMPLANT;INDEX VALUE;INHALATION;IU;IU/L;IU/dL;IU/g;IU/kg;IU/kg/h;IU/mL;IU/mg;IU^4;IV;Immune Status Ratio (ISR);JAR;Joule;KALLIKREIN INHIBITOR UNIT;KIT;L;L/L;L/h;L/h/m2;L/kg;L/min;L/min/m2;L/s;LB;LOZENGE;LPF;Log10 ELISA unit;Log10 ELISA unit/dose;Log10 GEq/mL;Log10 PFU/mL;MBq;MBq/uL;MESF;MFI;MHz;MONTHS;MPL U/mL;Mile;NEBULE;NEEDLE GAUGE;NIU;Newton;PACK;PACKAGE;PACKET;PATCH;PELLET;PFU;PFU/dose;PFU/mL;PIPE;PIXEL;PIXELS/cm;PIXELS/in;PNU/mL;POINT;POUCH;PRESSOR UNITS;PUFF;Pa;Pack Year;Perfusion unit;Perfusion unit*sec;QUANTITY SUFFICIENT;RATIO;RING;RNA copies/mL;Rad;Roentgen;SACHET;SBE/mL;SCO;SCOOPFUL;SFC;SFC/10^6 PBMC;SPRAY;SQU/mL;STANDARD DRINK/day;STEPS;STRIP;SUPPOSITORY;SYRINGE;Shock Wave;Siemens;Signals/cells;Sv;TABLET;TAMPON;TCID 50/dose;TI/L;TRACE;TROCHE;TUBE;Tbsp;Tesla;Torr;U;U.CARR;U/L;U/animal;U/cL;U/dL;U/g;U/g/day;U/g/h;U/g/min;U/kg;U/kg/day;U/kg/h;U/kg/min;U/m2;U/m2/day;U/m2/h;U/m2/min;U/mL;U/mg;U/mmol;V;V/sec;VIAL;VIRTUAL PIXEL;WAFER;WEEKS;Watt;Weber;YEARS;ag;amol;amp;amu;anti-Xa IU;anti-Xa IU/mL;atm;bel;cGy;cL;cal;cc;cd;cells/mm3;cells/uL;cg;cm;cm H2O;cm/min;cm/s;cm2;cmol;cmol/L;copies/mL;copies/uL;cpm;cs;cy/cm;cycle/min;cycle/sec;dB;dL;damol/L;deg;dmol;dpm/0.5 mL;dpm/100mg;dpm/mL;dpm/mg;dram;dyn;eq;fL;fg;fmol;fmol/L;fmol/g;foz_br;foz_us;fraction of 1;ft;ft2;ft3;g;g/24h;g/L;g/animal;g/animal/day;g/animal/wk;g/cage;g/cage/day;g/cage/wk;g/cm2;g/dL;g/day;g/g;g/g Creatinine;g/g/day;g/kg;g/kg/day;g/m2;g/m2/day;g/mol;grain;gtt;hPa;in;in2;kAU/L;kBq;kBq/uL;kDa;kHz;kIU;kN/cm2;kPa;kPa/L/sec;kU/L;kUSP;kat;kcal;kg;kg/L;kg/cm;kg/cm2;kg/m2;km;km/h;ks;lbf;lm;log EID 50/dose;log10 CCID 50/dose;log10 CFU/g;log10 CFU/mL;log10 IU/mL;log10 TCID 50/dose;log10 copies/mL;lx;m;m/sec;m/sec2;m2;m3;mCi;mCi/L;mCi/kg;mEq;mEq/L;mEq/dL;mEq/day;mEq/g;mEq/kg;mEq/mL;mEq/mmol;mEq/uL;mEq/ug;mIU/L;mIU/mL;mJoule/cm2;mL;mL/animal;mL/animal/day;mL/animal/wk;mL/breath;mL/cage;mL/cage/day;mL/cage/wk;mL/cm;mL/cm H2O;mL/dL;mL/day;mL/g;mL/g/day;mL/g/h;mL/g/min;mL/h;mL/h/uL of lysat;mL/kg;mL/kg/day;mL/kg/h;mL/kg/min;mL/m2;mL/m2/day;mL/m2/h;mL/m2/min;mL/min;mL/min/1.73m2;mL/min/SSA;mL/min/mmHg;mL/mmHg;mL/mmHg/min/L;mL/s;mL/sec/1.73m2;mOsm;mOsm/kg;mPa;mU/L;mU/mL;mV;mV*min;mV2/Hz;mcg/dL;mg;mg%;mg/24h;mg/L;mg/L FEU;mg/animal;mg/dL;mg/day;mg/g;mg/g Creatinine;mg/g/day;mg/g/h;mg/g/min;mg/h;mg/kg;mg/kg/day;mg/kg/h;mg/kg/min;mg/m2;mg/m2/day;mg/m2/h;mg/m2/min;mg/mL/min;mg/min;mg/mmol Creatinine;mg/mol;min;mkat;mm;mm/2h;mm/h;mm/min;mm/sec;mm2;mm3;mmHg;mmHg/L/min;mmHg/sec;mmol;mmol FA/mL/h;mmol/L;mmol/day;mmol/g;mmol/kg;mmol/min/kPa;mmol/min/kPa/L;mmol/mol;mmol^2/L^2;mol;mol/L;mol/g;mol/mL;mol/mg;mol/mol;mph;msec;nCi;nL;nU/cL;nU/mL;ng;ng/L;ng/dL;ng/mL;nkat;nkat/L;nm;nmol;nmol BCE/L;nmol BCE/mmol;nmol/L;nmol/dL;nmol/hr/mg protein;nmol/mL/min;nmol/min/mg protein;nsec;ohm;osm;oz;pL;per min;per sec;pg;pg/L;pg/dL;pg/mL;pkat;pm;pmol;pmol/L;pmol/min/uL of lysat;pmol/punch/hr;pools/day;pools/h;ppb;ppm;ppth;pptr;psec;psi;pt_br;pt_us;rpm;sABC;sMEC;scm;sec;titer;tsp;tuberculin unit;tuberculin unit/mL;uCi;uCi/L;uCi/kg;uEq;uEq/L;uIU/mL;uL;uL/mL;uOsM;uU/mL;uV;uV*sec;ug;ug/L;ug/animal;ug/dL;ug/day;ug/g/day;ug/g/h;ug/g/min;ug/h;ug/kg;ug/kg/day;ug/kg/h;ug/kg/min;ug/m2;ug/m2/day;ug/m2/h;ug/m2/min;ug/mL;ug/mL/h;ug/min;ugEq;ukat;ukat/L;um;um2;umol;umol/L;umol/L/min;umol/L/sec;umol/day;umol/mg/min;umol/min;usec;v/v;yd;NONE;OTHER,question,70.866,127.671,15.744,89.556
222,31.0,Injection Site Erythema,FA_VAC_ERYTHEMA,,34.0,Caused Study Termination,,FADIS,SANOFI,,,NY_YN,Y;N,question,70.866,108.671,15.744,128.532
223,31.0,Injection Site Erythema,FA_VAC_ERYTHEMA,,35.0,Measurement Method at Day 00,,FAMETH00,SANOFI,,,,,question,70.866,73.671,15.744,155.172
224,32.0,Injection Site Erythema,FA_VAC_ERYTHEMA,,2.0,Measurement Method at Day 01,,FAMETH01,SANOFI,,,,,question,70.866,666.671,15.744,155.172
225,32.0,Injection Site Erythema,FA_VAC_ERYTHEMA,,3.0,Measurement Method at Day 02,,FAMETH02,SANOFI,,,,,question,70.866,649.671,15.744,155.172
226,32.0,Injection Site Erythema,FA_VAC_ERYTHEMA,,4.0,Measurement Method at Day 03,,FAMETH03,SANOFI,,,,,question,70.866,632.671,15.744,155.172
227,32.0,Injection Site Erythema,FA_VAC_ERYTHEMA,,5.0,Measurement Method at Day 04,,FAMETH04,SANOFI,,,,,question,70.866,615.671,15.744,155.172
228,32.0,Injection Site Erythema,FA_VAC_ERYTHEMA,,6.0,Measurement Method at Day 05,,FAMETH05,SANOFI,,,,,question,70.866,598.671,15.744,155.172
229,32.0,Injection Site Erythema,FA_VAC_ERYTHEMA,,7.0,Measurement Method at Day 06,,FAMETH06,SANOFI,,,,,question,70.866,581.671,15.744,155.172
230,32.0,Injection Site Erythema,FA_VAC_ERYTHEMA,,8.0,Measurement Method at Day 07,,FAMETH07,SANOFI,,,,,question,70.866,564.671,15.744,155.172
231,32.0,Injection Site Erythema,FA_VAC_ERYTHEMA,,9.0,Maximum Measurement Method,,FAMETHMX,SANOFI,,,,,question,70.866,547.671,15.744,158.508
232,33.0,Injection Site Ecchymosis,FA_VAC_ECCHYMOSIS,FA,2.0,Category of Reaction,What [is/was] the [type/category/name] (of the [measurement/test/examination/specimen/sample])?,FACAT,IG,FACAT,IG,AECAT,ADVERSE EVENT;ADVERSE EVENT OF SPECIAL INTEREST;ALLERGIC REACTION;ALT INCREASE;ASTHMA EXACERBATION EVENT;BLEEDING EVENT;BONE FRACTURE;DRUG ALLERGY EVENT;EPISTAXIS EVENT;FOREIGN BODY REACTION EVENT;HYPERCALCEMIA;HYPOGLYCEMIA;INCREASED CALCITONIN;INCREASED LIPASE/AMYLASE;INFECTION EVENT;INJECTION SITE REACTION;METABOLIC ACIDOSIS EVENT;NEUROLOGIC DISORDER;OVERDOSE;PANCREATIC EVENT;PERIPHERAL NEUROPATHY EVENT;PREGNANCY;RENAL FAILURE;SERIOUS HYPOGLYCEMIA;SOLICITED;SUSPECTED OR CONFIRMED CEREBROVASCULAR EVENT;SUSPECTED OR CONFIRMED DIABETIC KETOACIDOSIS;SUSPECTED OR CONFIRMED HEART FAILURE;SUSPECTED OR CONFIRMED MYOCARDIAL INFARCTION / UNSTABLE ANGINA;UNSOLICITED;VASCULITIS EVENT;OTHER,question,70.866,666.671,15.744,102.528
233,33.0,Injection Site Ecchymosis,FA_VAC_ECCHYMOSIS,FA,3.0,Subcategory of Reaction,What [is/was] the [type/subcategory/name] (of the [measurement/test/examination/specimen/sample])?,FASCAT,IG,FASCAT,IG,AESCAT_01,ADMINISTRATION SITE;SYSTEMIC,question,70.866,77.671,15.744,118.524
234,34.0,Injection Site Ecchymosis,FA_VAC_ECCHYMOSIS,FA,3.0,Solicited Reaction Name,[Sponsored-defined phrase],FAOBJ,IG,FAOBJ,IG,,,question,70.866,647.671,15.744,119.808
898,34.0,Injection Site Ecchymosis,FA_VAC_ECCHYMOSIS,,4.0,Did the subject report Injection Site Ecchymosis at least once between Day 00 and Day 07 after vaccination?,,PROMPT_FA_01,SANOFI,,,,,question,70.866,630.659,15.948,460.152
236,34.0,Injection Site Ecchymosis,FA_VAC_ECCHYMOSIS,,6.0,Injection Site Ecchymosis,,FAOCCUR,SANOFI,,,NY_YN,Y;N,question,70.866,599.671,15.744,125.172
237,34.0,Injection Site Ecchymosis,FA_VAC_ECCHYMOSIS,,9.0,"If the answer is NO, then leave all the fields below blank.",,PROMPT_FA_02,SANOFI,,,,,question,70.866,564.659,15.948,274.68
238,34.0,Injection Site Ecchymosis,FA_VAC_ECCHYMOSIS,,10.0,Action Taken (Check all that apply),,PROMPT_FAACN,SANOFI,,,,,question,70.866,547.671,15.948,173.448
239,34.0,Injection Site Ecchymosis,FA_VAC_ECCHYMOSIS,,11.0,None,,FAACTN,SANOFI,,,,,question,80.866,530.671,15.744,25.98
240,34.0,Injection Site Ecchymosis,FA_VAC_ECCHYMOSIS,,12.0,Medication,,FAACMED,SANOFI,,,,,question,80.866,513.671,15.744,54.588
241,34.0,Injection Site Ecchymosis,FA_VAC_ECCHYMOSIS,,13.0,Health Care Provider Contact,,FAACTHC,SANOFI,,,,,question,80.866,496.671,15.744,142.14
242,34.0,Injection Site Ecchymosis,FA_VAC_ECCHYMOSIS,,14.0,Hospitalized,,FAACTHO,SANOFI,,,,,question,80.866,479.671,15.744,60.576
900,34.0,Injection Site Ecchymosis,FA_VAC_ECCHYMOSIS,,15.0,"Enter the Maximum daily Measurement from Day 00 to Day 07. If the Measurement is missing, enter 'UNK' for Unknown.",,PROMPT_MEAS,SANOFI,,,,,question,70.866,462.659,15.948,457.272
903,34.0,Injection Site Ecchymosis,FA_VAC_ECCHYMOSIS,,16.0,"Enter the Maximum Measurement considering the interval from Day 08 until the End Date. If the Measurement is missing, enter 'UNK' for Unknown.",,PROMPT_MXMEAS,SANOFI,,,,,question,70.866,448.659,15.948,126.348
243,34.0,Injection Site Ecchymosis,FA_VAC_ECCHYMOSIS,,17.0,Measurement at Day 00,,FAMEAS00,SANOFI,,,,,question,75.866,431.671,15.744,114.864
244,34.0,Injection Site Ecchymosis,FA_VAC_ECCHYMOSIS,,21.0,Measurement at Day 01,,FAMEAS01,SANOFI,,,,,question,75.866,341.671,15.744,114.864
245,34.0,Injection Site Ecchymosis,FA_VAC_ECCHYMOSIS,,24.0,Measurement at Day 02,,FAMEAS02,SANOFI,,,,,question,75.866,251.671,15.744,114.864
246,34.0,Injection Site Ecchymosis,FA_VAC_ECCHYMOSIS,,27.0,Measurement at Day 03,,FAMEAS03,SANOFI,,,,,question,75.866,161.671,15.744,114.864
247,34.0,Injection Site Ecchymosis,FA_VAC_ECCHYMOSIS,,30.0,Measurement at Day 04,,FAMEAS04,SANOFI,,,,,question,75.866,71.671,15.744,114.864
899,35.0,Injection Site Ecchymosis,FA_VAC_ECCHYMOSIS,,0.0,Discontinuation of study vaccination,,FAACNC,SANOFI,,,,,unassigned,-100.0,760.0,15.0,100.0
904,35.0,Injection Site Ecchymosis,FA_VAC_ECCHYMOSIS,,2.0,"If the reaction is too large to measure, check 'NM' for Non Measurable",,FAMSNMMX,SANOFI,,,,,question,80.866,666.671,15.744,280.008
248,35.0,Injection Site Ecchymosis,FA_VAC_ECCHYMOSIS,,4.0,Measurement at Day 05,,FAMEAS05,SANOFI,,,,,question,75.866,614.671,15.744,114.864
249,35.0,Injection Site Ecchymosis,FA_VAC_ECCHYMOSIS,,7.0,Measurement at Day 06,,FAMEAS06,SANOFI,,,,,question,75.866,524.671,15.744,114.864
250,35.0,Injection Site Ecchymosis,FA_VAC_ECCHYMOSIS,,10.0,Measurement at Day 07,,FAMEAS07,SANOFI,,,,,question,75.866,434.671,15.744,114.864
901,35.0,Injection Site Ecchymosis,FA_VAC_ECCHYMOSIS,,20.0,"If a reaction is ongoing after Day 07, enter the Maximum Measurement available at the time of reporting.",,PROMPT_ONGOING,SANOFI,,,,,question,70.866,344.659,15.948,457.212
251,35.0,Injection Site Ecchymosis,FA_VAC_ECCHYMOSIS,,22.0,Ongoing after Day 07?,,FAONGO,SANOFI,,,,,question,80.866,313.671,15.744,110.232
902,35.0,Injection Site Ecchymosis,FA_VAC_ECCHYMOSIS,,23.0,"When the End Date is obtained, ensure that the Maximum Measurement is still correct while considering the interval from Day 8 until the End Date.",,PROMPT_FASEV1,SANOFI,,,,,question,70.866,296.659,15.948,444.54
252,35.0,Injection Site Ecchymosis,FA_VAC_ECCHYMOSIS,,25.0,End date,,FAENDAT,SANOFI,,,,,question,80.866,265.671,15.744,42.276
253,35.0,Injection Site Ecchymosis,FA_VAC_ECCHYMOSIS,,28.0,Maximum Measurement after Day 07,,FAMEASMX,SANOFI,,,,,question,75.866,217.671,15.744,181.128
254,35.0,Injection Site Ecchymosis,FA_VAC_ECCHYMOSIS,,33.0,Measurement Unit,,FAMEASU,SANOFI,,,UNIT,%;% INHIBITION;%(v/v);%(w/v);%(w/w);%/min;%cells/area;/100 HPFs;/100 WBC;/10^3 cells;/HPF;/L;/LPF;/VF;/dL;/day;/h;/kg;/mL;/mm3;/month;/nL;/pL;/uL;/wk;/year;1/dilution;100 IU/mL;10^10/L;10^11/L;10^12 IU/L;10^12/L;10^3 CFU;10^3 CFU/g;10^3 CFU/mL;10^3 DNA copies/mL;10^3 RNA copies/mL;10^3 copies/mL;10^3 organisms;10^3 organisms/g;10^3 organisms/mL;10^3/L;10^3/hpf;10^3/mm3;10^3/mm4;10^3/uL;10^4/L;10^4/hpf;10^5/L;10^5/hpf;10^6 CFU;10^6 CFU/g;10^6 CFU/mL;10^6 DNA copies/mL;10^6 IU;10^6 IU/mL;10^6 RNA copies/mL;10^6 copies/mL;10^6 organisms;10^6 organisms/g;10^6 organisms/mL;10^6 organisms/mg;10^6/L;10^6/g;10^6/hpf;10^6/mm3;10^6/uL;10^7/L;10^8/L;10^9 CFU;10^9 CFU/g;10^9 CFU/mL;10^9 organisms;10^9 organisms/g;10^9 organisms/mL;10^9 organisms/mg;10^9/L;AFU;AI;AMPULE;APL U/mL;APPLICATION;ASC;AU;AU/mL;AU/min;AgU/mL;Antibody Unit;BAG;BAR;BAU;BAU/mL;BE/mL;BEATS/MIN;BISCUIT;BLOCKS;BOLUS;BOTTLE;BOX;BREATHS/MIN;BU;BU/mL;Bq;Bq/L;Bq/g;Bq/kg;Bq/mL;Bq/mg;Bq/uL;Bq/ug;C;CAE;CAN;CAPFUL;CAPLET;CAPSULE;CARTRIDGE;CASE;CCID 50/dose;CCID 50/mL;CFU/g;CFU/mL;CIGAR;CIGARETTE;COAT;COI;CONTAINER;CUP;CYLINDER;Ci;Ci/L;Ci/g;Ci/kg;Ci/mL;Ci/mg;Ci/uL;Ci/ug;Coulomb;Ct;DAYS;DAgU;DAgU/mL;DIOPTER;DISK;DNA copies/mL;DPM;DRUM;EID 50/dose;EID 50/mL;ELISA unit;ELISA unit/dose;ELISA unit/mL;EU;Enzyme U;F;FEU;FINGERTIP UNIT;Farad;Frames/s;GBq;GBq/g;GBq/mg;GBq/ug;GI/L;GLASS;GPL U/mL;Gauss;Gy;HAU/100 uL;HEP;HOMEOPATHIC DILUTION;HOURS;HPF;Hb Fract.;Hemolytic Unit;Henry;Hounsfield Unit;Hz;IMPLANT;INDEX VALUE;INHALATION;IU;IU/L;IU/dL;IU/g;IU/kg;IU/kg/h;IU/mL;IU/mg;IU^4;IV;Immune Status Ratio (ISR);JAR;Joule;KALLIKREIN INHIBITOR UNIT;KIT;L;L/L;L/h;L/h/m2;L/kg;L/min;L/min/m2;L/s;LB;LOZENGE;LPF;Log10 ELISA unit;Log10 ELISA unit/dose;Log10 GEq/mL;Log10 PFU/mL;MBq;MBq/uL;MESF;MFI;MHz;MONTHS;MPL U/mL;Mile;NEBULE;NEEDLE GAUGE;NIU;Newton;PACK;PACKAGE;PACKET;PATCH;PELLET;PFU;PFU/dose;PFU/mL;PIPE;PIXEL;PIXELS/cm;PIXELS/in;PNU/mL;POINT;POUCH;PRESSOR UNITS;PUFF;Pa;Pack Year;Perfusion unit;Perfusion unit*sec;QUANTITY SUFFICIENT;RATIO;RING;RNA copies/mL;Rad;Roentgen;SACHET;SBE/mL;SCO;SCOOPFUL;SFC;SFC/10^6 PBMC;SPRAY;SQU/mL;STANDARD DRINK/day;STEPS;STRIP;SUPPOSITORY;SYRINGE;Shock Wave;Siemens;Signals/cells;Sv;TABLET;TAMPON;TCID 50/dose;TI/L;TRACE;TROCHE;TUBE;Tbsp;Tesla;Torr;U;U.CARR;U/L;U/animal;U/cL;U/dL;U/g;U/g/day;U/g/h;U/g/min;U/kg;U/kg/day;U/kg/h;U/kg/min;U/m2;U/m2/day;U/m2/h;U/m2/min;U/mL;U/mg;U/mmol;V;V/sec;VIAL;VIRTUAL PIXEL;WAFER;WEEKS;Watt;Weber;YEARS;ag;amol;amp;amu;anti-Xa IU;anti-Xa IU/mL;atm;bel;cGy;cL;cal;cc;cd;cells/mm3;cells/uL;cg;cm;cm H2O;cm/min;cm/s;cm2;cmol;cmol/L;copies/mL;copies/uL;cpm;cs;cy/cm;cycle/min;cycle/sec;dB;dL;damol/L;deg;dmol;dpm/0.5 mL;dpm/100mg;dpm/mL;dpm/mg;dram;dyn;eq;fL;fg;fmol;fmol/L;fmol/g;foz_br;foz_us;fraction of 1;ft;ft2;ft3;g;g/24h;g/L;g/animal;g/animal/day;g/animal/wk;g/cage;g/cage/day;g/cage/wk;g/cm2;g/dL;g/day;g/g;g/g Creatinine;g/g/day;g/kg;g/kg/day;g/m2;g/m2/day;g/mol;grain;gtt;hPa;in;in2;kAU/L;kBq;kBq/uL;kDa;kHz;kIU;kN/cm2;kPa;kPa/L/sec;kU/L;kUSP;kat;kcal;kg;kg/L;kg/cm;kg/cm2;kg/m2;km;km/h;ks;lbf;lm;log EID 50/dose;log10 CCID 50/dose;log10 CFU/g;log10 CFU/mL;log10 IU/mL;log10 TCID 50/dose;log10 copies/mL;lx;m;m/sec;m/sec2;m2;m3;mCi;mCi/L;mCi/kg;mEq;mEq/L;mEq/dL;mEq/day;mEq/g;mEq/kg;mEq/mL;mEq/mmol;mEq/uL;mEq/ug;mIU/L;mIU/mL;mJoule/cm2;mL;mL/animal;mL/animal/day;mL/animal/wk;mL/breath;mL/cage;mL/cage/day;mL/cage/wk;mL/cm;mL/cm H2O;mL/dL;mL/day;mL/g;mL/g/day;mL/g/h;mL/g/min;mL/h;mL/h/uL of lysat;mL/kg;mL/kg/day;mL/kg/h;mL/kg/min;mL/m2;mL/m2/day;mL/m2/h;mL/m2/min;mL/min;mL/min/1.73m2;mL/min/SSA;mL/min/mmHg;mL/mmHg;mL/mmHg/min/L;mL/s;mL/sec/1.73m2;mOsm;mOsm/kg;mPa;mU/L;mU/mL;mV;mV*min;mV2/Hz;mcg/dL;mg;mg%;mg/24h;mg/L;mg/L FEU;mg/animal;mg/dL;mg/day;mg/g;mg/g Creatinine;mg/g/day;mg/g/h;mg/g/min;mg/h;mg/kg;mg/kg/day;mg/kg/h;mg/kg/min;mg/m2;mg/m2/day;mg/m2/h;mg/m2/min;mg/mL/min;mg/min;mg/mmol Creatinine;mg/mol;min;mkat;mm;mm/2h;mm/h;mm/min;mm/sec;mm2;mm3;mmHg;mmHg/L/min;mmHg/sec;mmol;mmol FA/mL/h;mmol/L;mmol/day;mmol/g;mmol/kg;mmol/min/kPa;mmol/min/kPa/L;mmol/mol;mmol^2/L^2;mol;mol/L;mol/g;mol/mL;mol/mg;mol/mol;mph;msec;nCi;nL;nU/cL;nU/mL;ng;ng/L;ng/dL;ng/mL;nkat;nkat/L;nm;nmol;nmol BCE/L;nmol BCE/mmol;nmol/L;nmol/dL;nmol/hr/mg protein;nmol/mL/min;nmol/min/mg protein;nsec;ohm;osm;oz;pL;per min;per sec;pg;pg/L;pg/dL;pg/mL;pkat;pm;pmol;pmol/L;pmol/min/uL of lysat;pmol/punch/hr;pools/day;pools/h;ppb;ppm;ppth;pptr;psec;psi;pt_br;pt_us;rpm;sABC;sMEC;scm;sec;titer;tsp;tuberculin unit;tuberculin unit/mL;uCi;uCi/L;uCi/kg;uEq;uEq/L;uIU/mL;uL;uL/mL;uOsM;uU/mL;uV;uV*sec;ug;ug/L;ug/animal;ug/dL;ug/day;ug/g/day;ug/g/h;ug/g/min;ug/h;ug/kg;ug/kg/day;ug/kg/h;ug/kg/min;ug/m2;ug/m2/day;ug/m2/h;ug/m2/min;ug/mL;ug/mL/h;ug/min;ugEq;ukat;ukat/L;um;um2;umol;umol/L;umol/L/min;umol/L/sec;umol/day;umol/mg/min;umol/min;usec;v/v;yd;NONE;OTHER,question,70.866,127.671,15.744,89.556
255,35.0,Injection Site Ecchymosis,FA_VAC_ECCHYMOSIS,,34.0,Caused Study Termination,,FADIS,SANOFI,,,NY_YN,Y;N,question,70.866,108.671,15.744,128.532
256,36.0,Injection Site Swelling,FA_VAC_SWELLING,FA,2.0,Category of Reaction,What [is/was] the [type/category/name] (of the [measurement/test/examination/specimen/sample])?,FACAT,IG,FACAT,IG,AECAT,ADVERSE EVENT;ADVERSE EVENT OF SPECIAL INTEREST;ALLERGIC REACTION;ALT INCREASE;ASTHMA EXACERBATION EVENT;BLEEDING EVENT;BONE FRACTURE;DRUG ALLERGY EVENT;EPISTAXIS EVENT;FOREIGN BODY REACTION EVENT;HYPERCALCEMIA;HYPOGLYCEMIA;INCREASED CALCITONIN;INCREASED LIPASE/AMYLASE;INFECTION EVENT;INJECTION SITE REACTION;METABOLIC ACIDOSIS EVENT;NEUROLOGIC DISORDER;OVERDOSE;PANCREATIC EVENT;PERIPHERAL NEUROPATHY EVENT;PREGNANCY;RENAL FAILURE;SERIOUS HYPOGLYCEMIA;SOLICITED;SUSPECTED OR CONFIRMED CEREBROVASCULAR EVENT;SUSPECTED OR CONFIRMED DIABETIC KETOACIDOSIS;SUSPECTED OR CONFIRMED HEART FAILURE;SUSPECTED OR CONFIRMED MYOCARDIAL INFARCTION / UNSTABLE ANGINA;UNSOLICITED;VASCULITIS EVENT;OTHER,question,70.866,666.671,15.744,102.528
257,36.0,Injection Site Swelling,FA_VAC_SWELLING,FA,3.0,Subcategory of Reaction,What [is/was] the [type/subcategory/name] (of the [measurement/test/examination/specimen/sample])?,FASCAT,IG,FASCAT,IG,AESCAT_01,ADMINISTRATION SITE;SYSTEMIC,question,70.866,77.671,15.744,118.524
258,37.0,Injection Site Swelling,FA_VAC_SWELLING,FA,3.0,Solicited Reaction Name,[Sponsored-defined phrase],FAOBJ,IG,FAOBJ,IG,,,question,70.866,647.671,15.744,119.808
905,37.0,Injection Site Swelling,FA_VAC_SWELLING,,4.0,Did the subject report Injection Site Swelling at least once between Day 00 and Day 07 after vaccination?,,PROMPT_FA_01,SANOFI,,,,,question,70.866,630.659,15.948,444.84
260,37.0,Injection Site Swelling,FA_VAC_SWELLING,,6.0,Injection Site Swelling,,FAOCCUR,SANOFI,,,NY_YN,Y;N,question,70.866,599.671,15.744,109.86
261,37.0,Injection Site Swelling,FA_VAC_SWELLING,,9.0,"If the answer is NO, then leave all the fields below blank.",,PROMPT_FA_02,SANOFI,,,,,question,70.866,564.659,15.948,274.68
262,37.0,Injection Site Swelling,FA_VAC_SWELLING,,10.0,Action Taken (Check all that apply),,PROMPT_FAACN,SANOFI,,,,,question,70.866,547.671,15.948,173.448
263,37.0,Injection Site Swelling,FA_VAC_SWELLING,,11.0,None,,FAACTN,SANOFI,,,,,question,80.866,530.671,15.744,25.98
264,37.0,Injection Site Swelling,FA_VAC_SWELLING,,12.0,Medication,,FAACMED,SANOFI,,,,,question,80.866,513.671,15.744,54.588
265,37.0,Injection Site Swelling,FA_VAC_SWELLING,,13.0,Health Care Provider Contact,,FAACTHC,SANOFI,,,,,question,80.866,496.671,15.744,142.14
266,37.0,Injection Site Swelling,FA_VAC_SWELLING,,14.0,Hospitalized,,FAACTHO,SANOFI,,,,,question,80.866,479.671,15.744,60.576
907,37.0,Injection Site Swelling,FA_VAC_SWELLING,,15.0,"Enter the Maximum daily Measurement from Day 00 to Day 07. If the Measurement is missing, enter 'UNK' for Unknown.",,PROMPT_MEAS,SANOFI,,,,,question,70.866,462.659,15.948,457.272
910,37.0,Injection Site Swelling,FA_VAC_SWELLING,,16.0,"Enter the Maximum Measurement considering the interval from Day 08 until the End Date. If the Measurement is missing, enter 'UNK' for Unknown.",,PROMPT_MXMEAS,SANOFI,,,,,question,70.866,448.659,15.948,126.348
267,37.0,Injection Site Swelling,FA_VAC_SWELLING,,17.0,Measurement at Day 00,,FAMEAS00,SANOFI,,,,,question,75.866,431.671,15.744,114.864
268,37.0,Injection Site Swelling,FA_VAC_SWELLING,,21.0,Measurement at Day 01,,FAMEAS01,SANOFI,,,,,question,75.866,341.671,15.744,114.864
269,37.0,Injection Site Swelling,FA_VAC_SWELLING,,24.0,Measurement at Day 02,,FAMEAS02,SANOFI,,,,,question,75.866,251.671,15.744,114.864
270,37.0,Injection Site Swelling,FA_VAC_SWELLING,,27.0,Measurement at Day 03,,FAMEAS03,SANOFI,,,,,question,75.866,161.671,15.744,114.864
271,37.0,Injection Site Swelling,FA_VAC_SWELLING,,30.0,Measurement at Day 04,,FAMEAS04,SANOFI,,,,,question,75.866,71.671,15.744,114.864
906,38.0,Injection Site Swelling,FA_VAC_SWELLING,,0.0,Discontinuation of study vaccination,,FAACNC,SANOFI,,,,,unassigned,-100.0,760.0,15.0,100.0
911,38.0,Injection Site Swelling,FA_VAC_SWELLING,,2.0,"If the reaction is too large to measure, check 'NM' for Non Measurable",,FAMSNMMX,SANOFI,,,,,question,80.866,666.671,15.744,280.008
272,38.0,Injection Site Swelling,FA_VAC_SWELLING,,4.0,Measurement at Day 05,,FAMEAS05,SANOFI,,,,,question,75.866,614.671,15.744,114.864
273,38.0,Injection Site Swelling,FA_VAC_SWELLING,,7.0,Measurement at Day 06,,FAMEAS06,SANOFI,,,,,question,75.866,524.671,15.744,114.864
274,38.0,Injection Site Swelling,FA_VAC_SWELLING,,10.0,Measurement at Day 07,,FAMEAS07,SANOFI,,,,,question,75.866,434.671,15.744,114.864
908,38.0,Injection Site Swelling,FA_VAC_SWELLING,,20.0,"If a reaction is ongoing after Day 07, enter the Maximum Measurement available at the time of reporting.",,PROMPT_ONGOING,SANOFI,,,,,question,70.866,344.659,15.948,457.212
275,38.0,Injection Site Swelling,FA_VAC_SWELLING,,22.0,Ongoing after Day 07?,,FAONGO,SANOFI,,,,,question,80.866,313.671,15.744,110.232
909,38.0,Injection Site Swelling,FA_VAC_SWELLING,,23.0,"When the End Date is obtained, ensure that the Maximum Measurement is still correct while considering the interval from Day 8 until the End Date.",,PROMPT_FASEV1,SANOFI,,,,,question,70.866,296.659,15.948,444.54
276,38.0,Injection Site Swelling,FA_VAC_SWELLING,,25.0,End date,,FAENDAT,SANOFI,,,,,question,80.866,265.671,15.744,42.276
277,38.0,Injection Site Swelling,FA_VAC_SWELLING,,28.0,Maximum Measurement after Day 07,,FAMEASMX,SANOFI,,,,,question,75.866,217.671,15.744,181.128
278,38.0,Injection Site Swelling,FA_VAC_SWELLING,,33.0,Measurement Unit,,FAMEASU,SANOFI,,,UNIT,%;% INHIBITION;%(v/v);%(w/v);%(w/w);%/min;%cells/area;/100 HPFs;/100 WBC;/10^3 cells;/HPF;/L;/LPF;/VF;/dL;/day;/h;/kg;/mL;/mm3;/month;/nL;/pL;/uL;/wk;/year;1/dilution;100 IU/mL;10^10/L;10^11/L;10^12 IU/L;10^12/L;10^3 CFU;10^3 CFU/g;10^3 CFU/mL;10^3 DNA copies/mL;10^3 RNA copies/mL;10^3 copies/mL;10^3 organisms;10^3 organisms/g;10^3 organisms/mL;10^3/L;10^3/hpf;10^3/mm3;10^3/mm4;10^3/uL;10^4/L;10^4/hpf;10^5/L;10^5/hpf;10^6 CFU;10^6 CFU/g;10^6 CFU/mL;10^6 DNA copies/mL;10^6 IU;10^6 IU/mL;10^6 RNA copies/mL;10^6 copies/mL;10^6 organisms;10^6 organisms/g;10^6 organisms/mL;10^6 organisms/mg;10^6/L;10^6/g;10^6/hpf;10^6/mm3;10^6/uL;10^7/L;10^8/L;10^9 CFU;10^9 CFU/g;10^9 CFU/mL;10^9 organisms;10^9 organisms/g;10^9 organisms/mL;10^9 organisms/mg;10^9/L;AFU;AI;AMPULE;APL U/mL;APPLICATION;ASC;AU;AU/mL;AU/min;AgU/mL;Antibody Unit;BAG;BAR;BAU;BAU/mL;BE/mL;BEATS/MIN;BISCUIT;BLOCKS;BOLUS;BOTTLE;BOX;BREATHS/MIN;BU;BU/mL;Bq;Bq/L;Bq/g;Bq/kg;Bq/mL;Bq/mg;Bq/uL;Bq/ug;C;CAE;CAN;CAPFUL;CAPLET;CAPSULE;CARTRIDGE;CASE;CCID 50/dose;CCID 50/mL;CFU/g;CFU/mL;CIGAR;CIGARETTE;COAT;COI;CONTAINER;CUP;CYLINDER;Ci;Ci/L;Ci/g;Ci/kg;Ci/mL;Ci/mg;Ci/uL;Ci/ug;Coulomb;Ct;DAYS;DAgU;DAgU/mL;DIOPTER;DISK;DNA copies/mL;DPM;DRUM;EID 50/dose;EID 50/mL;ELISA unit;ELISA unit/dose;ELISA unit/mL;EU;Enzyme U;F;FEU;FINGERTIP UNIT;Farad;Frames/s;GBq;GBq/g;GBq/mg;GBq/ug;GI/L;GLASS;GPL U/mL;Gauss;Gy;HAU/100 uL;HEP;HOMEOPATHIC DILUTION;HOURS;HPF;Hb Fract.;Hemolytic Unit;Henry;Hounsfield Unit;Hz;IMPLANT;INDEX VALUE;INHALATION;IU;IU/L;IU/dL;IU/g;IU/kg;IU/kg/h;IU/mL;IU/mg;IU^4;IV;Immune Status Ratio (ISR);JAR;Joule;KALLIKREIN INHIBITOR UNIT;KIT;L;L/L;L/h;L/h/m2;L/kg;L/min;L/min/m2;L/s;LB;LOZENGE;LPF;Log10 ELISA unit;Log10 ELISA unit/dose;Log10 GEq/mL;Log10 PFU/mL;MBq;MBq/uL;MESF;MFI;MHz;MONTHS;MPL U/mL;Mile;NEBULE;NEEDLE GAUGE;NIU;Newton;PACK;PACKAGE;PACKET;PATCH;PELLET;PFU;PFU/dose;PFU/mL;PIPE;PIXEL;PIXELS/cm;PIXELS/in;PNU/mL;POINT;POUCH;PRESSOR UNITS;PUFF;Pa;Pack Year;Perfusion unit;Perfusion unit*sec;QUANTITY SUFFICIENT;RATIO;RING;RNA copies/mL;Rad;Roentgen;SACHET;SBE/mL;SCO;SCOOPFUL;SFC;SFC/10^6 PBMC;SPRAY;SQU/mL;STANDARD DRINK/day;STEPS;STRIP;SUPPOSITORY;SYRINGE;Shock Wave;Siemens;Signals/cells;Sv;TABLET;TAMPON;TCID 50/dose;TI/L;TRACE;TROCHE;TUBE;Tbsp;Tesla;Torr;U;U.CARR;U/L;U/animal;U/cL;U/dL;U/g;U/g/day;U/g/h;U/g/min;U/kg;U/kg/day;U/kg/h;U/kg/min;U/m2;U/m2/day;U/m2/h;U/m2/min;U/mL;U/mg;U/mmol;V;V/sec;VIAL;VIRTUAL PIXEL;WAFER;WEEKS;Watt;Weber;YEARS;ag;amol;amp;amu;anti-Xa IU;anti-Xa IU/mL;atm;bel;cGy;cL;cal;cc;cd;cells/mm3;cells/uL;cg;cm;cm H2O;cm/min;cm/s;cm2;cmol;cmol/L;copies/mL;copies/uL;cpm;cs;cy/cm;cycle/min;cycle/sec;dB;dL;damol/L;deg;dmol;dpm/0.5 mL;dpm/100mg;dpm/mL;dpm/mg;dram;dyn;eq;fL;fg;fmol;fmol/L;fmol/g;foz_br;foz_us;fraction of 1;ft;ft2;ft3;g;g/24h;g/L;g/animal;g/animal/day;g/animal/wk;g/cage;g/cage/day;g/cage/wk;g/cm2;g/dL;g/day;g/g;g/g Creatinine;g/g/day;g/kg;g/kg/day;g/m2;g/m2/day;g/mol;grain;gtt;hPa;in;in2;kAU/L;kBq;kBq/uL;kDa;kHz;kIU;kN/cm2;kPa;kPa/L/sec;kU/L;kUSP;kat;kcal;kg;kg/L;kg/cm;kg/cm2;kg/m2;km;km/h;ks;lbf;lm;log EID 50/dose;log10 CCID 50/dose;log10 CFU/g;log10 CFU/mL;log10 IU/mL;log10 TCID 50/dose;log10 copies/mL;lx;m;m/sec;m/sec2;m2;m3;mCi;mCi/L;mCi/kg;mEq;mEq/L;mEq/dL;mEq/day;mEq/g;mEq/kg;mEq/mL;mEq/mmol;mEq/uL;mEq/ug;mIU/L;mIU/mL;mJoule/cm2;mL;mL/animal;mL/animal/day;mL/animal/wk;mL/breath;mL/cage;mL/cage/day;mL/cage/wk;mL/cm;mL/cm H2O;mL/dL;mL/day;mL/g;mL/g/day;mL/g/h;mL/g/min;mL/h;mL/h/uL of lysat;mL/kg;mL/kg/day;mL/kg/h;mL/kg/min;mL/m2;mL/m2/day;mL/m2/h;mL/m2/min;mL/min;mL/min/1.73m2;mL/min/SSA;mL/min/mmHg;mL/mmHg;mL/mmHg/min/L;mL/s;mL/sec/1.73m2;mOsm;mOsm/kg;mPa;mU/L;mU/mL;mV;mV*min;mV2/Hz;mcg/dL;mg;mg%;mg/24h;mg/L;mg/L FEU;mg/animal;mg/dL;mg/day;mg/g;mg/g Creatinine;mg/g/day;mg/g/h;mg/g/min;mg/h;mg/kg;mg/kg/day;mg/kg/h;mg/kg/min;mg/m2;mg/m2/day;mg/m2/h;mg/m2/min;mg/mL/min;mg/min;mg/mmol Creatinine;mg/mol;min;mkat;mm;mm/2h;mm/h;mm/min;mm/sec;mm2;mm3;mmHg;mmHg/L/min;mmHg/sec;mmol;mmol FA/mL/h;mmol/L;mmol/day;mmol/g;mmol/kg;mmol/min/kPa;mmol/min/kPa/L;mmol/mol;mmol^2/L^2;mol;mol/L;mol/g;mol/mL;mol/mg;mol/mol;mph;msec;nCi;nL;nU/cL;nU/mL;ng;ng/L;ng/dL;ng/mL;nkat;nkat/L;nm;nmol;nmol BCE/L;nmol BCE/mmol;nmol/L;nmol/dL;nmol/hr/mg protein;nmol/mL/min;nmol/min/mg protein;nsec;ohm;osm;oz;pL;per min;per sec;pg;pg/L;pg/dL;pg/mL;pkat;pm;pmol;pmol/L;pmol/min/uL of lysat;pmol/punch/hr;pools/day;pools/h;ppb;ppm;ppth;pptr;psec;psi;pt_br;pt_us;rpm;sABC;sMEC;scm;sec;titer;tsp;tuberculin unit;tuberculin unit/mL;uCi;uCi/L;uCi/kg;uEq;uEq/L;uIU/mL;uL;uL/mL;uOsM;uU/mL;uV;uV*sec;ug;ug/L;ug/animal;ug/dL;ug/day;ug/g/day;ug/g/h;ug/g/min;ug/h;ug/kg;ug/kg/day;ug/kg/h;ug/kg/min;ug/m2;ug/m2/day;ug/m2/h;ug/m2/min;ug/mL;ug/mL/h;ug/min;ugEq;ukat;ukat/L;um;um2;umol;umol/L;umol/L/min;umol/L/sec;umol/day;umol/mg/min;umol/min;usec;v/v;yd;NONE;OTHER,question,70.866,127.671,15.744,89.556
279,38.0,Injection Site Swelling,FA_VAC_SWELLING,,34.0,Caused Study Termination,,FADIS,SANOFI,,,NY_YN,Y;N,question,70.866,108.671,15.744,128.532
280,38.0,Injection Site Swelling,FA_VAC_SWELLING,,35.0,Measurement Method at Day 00,,FAMETH00,SANOFI,,,,,question,70.866,73.671,15.744,155.172
281,39.0,Injection Site Swelling,FA_VAC_SWELLING,,2.0,Measurement Method at Day 01,,FAMETH01,SANOFI,,,,,question,70.866,666.671,15.744,155.172
282,39.0,Injection Site Swelling,FA_VAC_SWELLING,,3.0,Measurement Method at Day 02,,FAMETH02,SANOFI,,,,,question,70.866,649.671,15.744,155.172
283,39.0,Injection Site Swelling,FA_VAC_SWELLING,,4.0,Measurement Method at Day 03,,FAMETH03,SANOFI,,,,,question,70.866,632.671,15.744,155.172
284,39.0,Injection Site Swelling,FA_VAC_SWELLING,,5.0,Measurement Method at Day 04,,FAMETH04,SANOFI,,,,,question,70.866,615.671,15.744,155.172
285,39.0,Injection Site Swelling,FA_VAC_SWELLING,,6.0,Measurement Method at Day 05,,FAMETH05,SANOFI,,,,,question,70.866,598.671,15.744,155.172
286,39.0,Injection Site Swelling,FA_VAC_SWELLING,,7.0,Measurement Method at Day 06,,FAMETH06,SANOFI,,,,,question,70.866,581.671,15.744,155.172
287,39.0,Injection Site Swelling,FA_VAC_SWELLING,,8.0,Measurement Method at Day 07,,FAMETH07,SANOFI,,,,,question,70.866,564.671,15.744,155.172
288,39.0,Injection Site Swelling,FA_VAC_SWELLING,,9.0,Maximum Measurement Method,,FAMETHMX,SANOFI,,,,,question,70.866,547.671,15.744,158.508
289,40.0,Injection Site Induration,FA_VAC_INDURATION,FA,2.0,Category of Reaction,What [is/was] the [type/category/name] (of the [measurement/test/examination/specimen/sample])?,FACAT,IG,FACAT,IG,AECAT,ADVERSE EVENT;ADVERSE EVENT OF SPECIAL INTEREST;ALLERGIC REACTION;ALT INCREASE;ASTHMA EXACERBATION EVENT;BLEEDING EVENT;BONE FRACTURE;DRUG ALLERGY EVENT;EPISTAXIS EVENT;FOREIGN BODY REACTION EVENT;HYPERCALCEMIA;HYPOGLYCEMIA;INCREASED CALCITONIN;INCREASED LIPASE/AMYLASE;INFECTION EVENT;INJECTION SITE REACTION;METABOLIC ACIDOSIS EVENT;NEUROLOGIC DISORDER;OVERDOSE;PANCREATIC EVENT;PERIPHERAL NEUROPATHY EVENT;PREGNANCY;RENAL FAILURE;SERIOUS HYPOGLYCEMIA;SOLICITED;SUSPECTED OR CONFIRMED CEREBROVASCULAR EVENT;SUSPECTED OR CONFIRMED DIABETIC KETOACIDOSIS;SUSPECTED OR CONFIRMED HEART FAILURE;SUSPECTED OR CONFIRMED MYOCARDIAL INFARCTION / UNSTABLE ANGINA;UNSOLICITED;VASCULITIS EVENT;OTHER,question,70.866,666.671,15.744,102.528
290,40.0,Injection Site Induration,FA_VAC_INDURATION,FA,3.0,Subcategory of Reaction,What [is/was] the [type/subcategory/name] (of the [measurement/test/examination/specimen/sample])?,FASCAT,IG,FASCAT,IG,AESCAT_01,ADMINISTRATION SITE;SYSTEMIC,question,70.866,77.671,15.744,118.524
291,41.0,Injection Site Induration,FA_VAC_INDURATION,FA,3.0,Solicited Reaction Name,[Sponsored-defined phrase],FAOBJ,IG,FAOBJ,IG,,,question,70.866,647.671,15.744,119.808
912,41.0,Injection Site Induration,FA_VAC_INDURATION,,4.0,Did the subject report Injection Site Induration at least once between Day 00 and Day 07 after vaccination?,,PROMPT_FA_01,SANOFI,,,,,question,70.866,630.659,15.948,454.872
293,41.0,Injection Site Induration,FA_VAC_INDURATION,,6.0,Injection Site Induration,,FAOCCUR,SANOFI,,,NY_YN,Y;N,question,70.866,599.671,15.744,117.192
294,41.0,Injection Site Induration,FA_VAC_INDURATION,,9.0,"If the answer is NO, then leave all the fields below blank.",,PROMPT_FA_02,SANOFI,,,,,question,70.866,564.659,15.948,274.68
295,41.0,Injection Site Induration,FA_VAC_INDURATION,,10.0,Action Taken (Check all that apply),,PROMPT_FAACN,SANOFI,,,,,question,70.866,547.671,15.948,173.448
296,41.0,Injection Site Induration,FA_VAC_INDURATION,,11.0,None,,FAACTN,SANOFI,,,,,question,80.866,530.671,15.744,25.98
297,41.0,Injection Site Induration,FA_VAC_INDURATION,,12.0,Medication,,FAACMED,SANOFI,,,,,question,80.866,513.671,15.744,54.588
298,41.0,Injection Site Induration,FA_VAC_INDURATION,,13.0,Health Care Provider Contact,,FAACTHC,SANOFI,,,,,question,80.866,496.671,15.744,142.14
299,41.0,Injection Site Induration,FA_VAC_INDURATION,,14.0,Hospitalized,,FAACTHO,SANOFI,,,,,question,80.866,479.671,15.744,60.576
914,41.0,Injection Site Induration,FA_VAC_INDURATION,,15.0,"Enter the Maximum daily Measurement from Day 00 to Day 07. If the Measurement is missing, enter 'UNK' for Unknown.",,PROMPT_MEAS,SANOFI,,,,,question,70.866,462.659,15.948,457.272
917,41.0,Injection Site Induration,FA_VAC_INDURATION,,16.0,"Enter the Maximum Measurement considering the interval from Day 08 until the End Date. If the Measurement is missing, enter 'UNK' for Unknown.",,PROMPT_MXMEAS,SANOFI,,,,,question,70.866,448.659,15.948,126.348
300,41.0,Injection Site Induration,FA_VAC_INDURATION,,17.0,Measurement at Day 00,,FAMEAS00,SANOFI,,,,,question,75.866,431.671,15.744,114.864
301,41.0,Injection Site Induration,FA_VAC_INDURATION,,21.0,Measurement at Day 01,,FAMEAS01,SANOFI,,,,,question,75.866,341.671,15.744,114.864
302,41.0,Injection Site Induration,FA_VAC_INDURATION,,24.0,Measurement at Day 02,,FAMEAS02,SANOFI,,,,,question,75.866,251.671,15.744,114.864
303,41.0,Injection Site Induration,FA_VAC_INDURATION,,27.0,Measurement at Day 03,,FAMEAS03,SANOFI,,,,,question,75.866,161.671,15.744,114.864
304,41.0,Injection Site Induration,FA_VAC_INDURATION,,30.0,Measurement at Day 04,,FAMEAS04,SANOFI,,,,,question,75.866,71.671,15.744,114.864
913,42.0,Injection Site Induration,FA_VAC_INDURATION,,0.0,Discontinuation of study vaccination,,FAACNC,SANOFI,,,,,unassigned,-100.0,760.0,15.0,100.0
918,42.0,Injection Site Induration,FA_VAC_INDURATION,,2.0,"If the reaction is too large to measure, check 'NM' for Non Measurable",,FAMSNMMX,SANOFI,,,,,question,80.866,666.671,15.744,280.008
305,42.0,Injection Site Induration,FA_VAC_INDURATION,,4.0,Measurement at Day 05,,FAMEAS05,SANOFI,,,,,question,75.866,614.671,15.744,114.864
306,42.0,Injection Site Induration,FA_VAC_INDURATION,,7.0,Measurement at Day 06,,FAMEAS06,SANOFI,,,,,question,75.866,524.671,15.744,114.864
307,42.0,Injection Site Induration,FA_VAC_INDURATION,,10.0,Measurement at Day 07,,FAMEAS07,SANOFI,,,,,question,75.866,434.671,15.744,114.864
915,42.0,Injection Site Induration,FA_VAC_INDURATION,,20.0,"If a reaction is ongoing after Day 07, enter the Maximum Measurement available at the time of reporting.",,PROMPT_ONGOING,SANOFI,,,,,question,70.866,344.659,15.948,457.212
308,42.0,Injection Site Induration,FA_VAC_INDURATION,,22.0,Ongoing after Day 07?,,FAONGO,SANOFI,,,,,question,80.866,313.671,15.744,110.232
916,42.0,Injection Site Induration,FA_VAC_INDURATION,,23.0,"When the End Date is obtained, ensure that the Maximum Measurement is still correct while considering the interval from Day 8 until the End Date.",,PROMPT_FASEV1,SANOFI,,,,,question,70.866,296.659,15.948,444.54
309,42.0,Injection Site Induration,FA_VAC_INDURATION,,25.0,End date,,FAENDAT,SANOFI,,,,,question,80.866,265.671,15.744,42.276
310,42.0,Injection Site Induration,FA_VAC_INDURATION,,28.0,Maximum Measurement after Day 07,,FAMEASMX,SANOFI,,,,,question,75.866,217.671,15.744,181.128
311,42.0,Injection Site Induration,FA_VAC_INDURATION,,33.0,Measurement Unit,,FAMEASU,SANOFI,,,UNIT,%;% INHIBITION;%(v/v);%(w/v);%(w/w);%/min;%cells/area;/100 HPFs;/100 WBC;/10^3 cells;/HPF;/L;/LPF;/VF;/dL;/day;/h;/kg;/mL;/mm3;/month;/nL;/pL;/uL;/wk;/year;1/dilution;100 IU/mL;10^10/L;10^11/L;10^12 IU/L;10^12/L;10^3 CFU;10^3 CFU/g;10^3 CFU/mL;10^3 DNA copies/mL;10^3 RNA copies/mL;10^3 copies/mL;10^3 organisms;10^3 organisms/g;10^3 organisms/mL;10^3/L;10^3/hpf;10^3/mm3;10^3/mm4;10^3/uL;10^4/L;10^4/hpf;10^5/L;10^5/hpf;10^6 CFU;10^6 CFU/g;10^6 CFU/mL;10^6 DNA copies/mL;10^6 IU;10^6 IU/mL;10^6 RNA copies/mL;10^6 copies/mL;10^6 organisms;10^6 organisms/g;10^6 organisms/mL;10^6 organisms/mg;10^6/L;10^6/g;10^6/hpf;10^6/mm3;10^6/uL;10^7/L;10^8/L;10^9 CFU;10^9 CFU/g;10^9 CFU/mL;10^9 organisms;10^9 organisms/g;10^9 organisms/mL;10^9 organisms/mg;10^9/L;AFU;AI;AMPULE;APL U/mL;APPLICATION;ASC;AU;AU/mL;AU/min;AgU/mL;Antibody Unit;BAG;BAR;BAU;BAU/mL;BE/mL;BEATS/MIN;BISCUIT;BLOCKS;BOLUS;BOTTLE;BOX;BREATHS/MIN;BU;BU/mL;Bq;Bq/L;Bq/g;Bq/kg;Bq/mL;Bq/mg;Bq/uL;Bq/ug;C;CAE;CAN;CAPFUL;CAPLET;CAPSULE;CARTRIDGE;CASE;CCID 50/dose;CCID 50/mL;CFU/g;CFU/mL;CIGAR;CIGARETTE;COAT;COI;CONTAINER;CUP;CYLINDER;Ci;Ci/L;Ci/g;Ci/kg;Ci/mL;Ci/mg;Ci/uL;Ci/ug;Coulomb;Ct;DAYS;DAgU;DAgU/mL;DIOPTER;DISK;DNA copies/mL;DPM;DRUM;EID 50/dose;EID 50/mL;ELISA unit;ELISA unit/dose;ELISA unit/mL;EU;Enzyme U;F;FEU;FINGERTIP UNIT;Farad;Frames/s;GBq;GBq/g;GBq/mg;GBq/ug;GI/L;GLASS;GPL U/mL;Gauss;Gy;HAU/100 uL;HEP;HOMEOPATHIC DILUTION;HOURS;HPF;Hb Fract.;Hemolytic Unit;Henry;Hounsfield Unit;Hz;IMPLANT;INDEX VALUE;INHALATION;IU;IU/L;IU/dL;IU/g;IU/kg;IU/kg/h;IU/mL;IU/mg;IU^4;IV;Immune Status Ratio (ISR);JAR;Joule;KALLIKREIN INHIBITOR UNIT;KIT;L;L/L;L/h;L/h/m2;L/kg;L/min;L/min/m2;L/s;LB;LOZENGE;LPF;Log10 ELISA unit;Log10 ELISA unit/dose;Log10 GEq/mL;Log10 PFU/mL;MBq;MBq/uL;MESF;MFI;MHz;MONTHS;MPL U/mL;Mile;NEBULE;NEEDLE GAUGE;NIU;Newton;PACK;PACKAGE;PACKET;PATCH;PELLET;PFU;PFU/dose;PFU/mL;PIPE;PIXEL;PIXELS/cm;PIXELS/in;PNU/mL;POINT;POUCH;PRESSOR UNITS;PUFF;Pa;Pack Year;Perfusion unit;Perfusion unit*sec;QUANTITY SUFFICIENT;RATIO;RING;RNA copies/mL;Rad;Roentgen;SACHET;SBE/mL;SCO;SCOOPFUL;SFC;SFC/10^6 PBMC;SPRAY;SQU/mL;STANDARD DRINK/day;STEPS;STRIP;SUPPOSITORY;SYRINGE;Shock Wave;Siemens;Signals/cells;Sv;TABLET;TAMPON;TCID 50/dose;TI/L;TRACE;TROCHE;TUBE;Tbsp;Tesla;Torr;U;U.CARR;U/L;U/animal;U/cL;U/dL;U/g;U/g/day;U/g/h;U/g/min;U/kg;U/kg/day;U/kg/h;U/kg/min;U/m2;U/m2/day;U/m2/h;U/m2/min;U/mL;U/mg;U/mmol;V;V/sec;VIAL;VIRTUAL PIXEL;WAFER;WEEKS;Watt;Weber;YEARS;ag;amol;amp;amu;anti-Xa IU;anti-Xa IU/mL;atm;bel;cGy;cL;cal;cc;cd;cells/mm3;cells/uL;cg;cm;cm H2O;cm/min;cm/s;cm2;cmol;cmol/L;copies/mL;copies/uL;cpm;cs;cy/cm;cycle/min;cycle/sec;dB;dL;damol/L;deg;dmol;dpm/0.5 mL;dpm/100mg;dpm/mL;dpm/mg;dram;dyn;eq;fL;fg;fmol;fmol/L;fmol/g;foz_br;foz_us;fraction of 1;ft;ft2;ft3;g;g/24h;g/L;g/animal;g/animal/day;g/animal/wk;g/cage;g/cage/day;g/cage/wk;g/cm2;g/dL;g/day;g/g;g/g Creatinine;g/g/day;g/kg;g/kg/day;g/m2;g/m2/day;g/mol;grain;gtt;hPa;in;in2;kAU/L;kBq;kBq/uL;kDa;kHz;kIU;kN/cm2;kPa;kPa/L/sec;kU/L;kUSP;kat;kcal;kg;kg/L;kg/cm;kg/cm2;kg/m2;km;km/h;ks;lbf;lm;log EID 50/dose;log10 CCID 50/dose;log10 CFU/g;log10 CFU/mL;log10 IU/mL;log10 TCID 50/dose;log10 copies/mL;lx;m;m/sec;m/sec2;m2;m3;mCi;mCi/L;mCi/kg;mEq;mEq/L;mEq/dL;mEq/day;mEq/g;mEq/kg;mEq/mL;mEq/mmol;mEq/uL;mEq/ug;mIU/L;mIU/mL;mJoule/cm2;mL;mL/animal;mL/animal/day;mL/animal/wk;mL/breath;mL/cage;mL/cage/day;mL/cage/wk;mL/cm;mL/cm H2O;mL/dL;mL/day;mL/g;mL/g/day;mL/g/h;mL/g/min;mL/h;mL/h/uL of lysat;mL/kg;mL/kg/day;mL/kg/h;mL/kg/min;mL/m2;mL/m2/day;mL/m2/h;mL/m2/min;mL/min;mL/min/1.73m2;mL/min/SSA;mL/min/mmHg;mL/mmHg;mL/mmHg/min/L;mL/s;mL/sec/1.73m2;mOsm;mOsm/kg;mPa;mU/L;mU/mL;mV;mV*min;mV2/Hz;mcg/dL;mg;mg%;mg/24h;mg/L;mg/L FEU;mg/animal;mg/dL;mg/day;mg/g;mg/g Creatinine;mg/g/day;mg/g/h;mg/g/min;mg/h;mg/kg;mg/kg/day;mg/kg/h;mg/kg/min;mg/m2;mg/m2/day;mg/m2/h;mg/m2/min;mg/mL/min;mg/min;mg/mmol Creatinine;mg/mol;min;mkat;mm;mm/2h;mm/h;mm/min;mm/sec;mm2;mm3;mmHg;mmHg/L/min;mmHg/sec;mmol;mmol FA/mL/h;mmol/L;mmol/day;mmol/g;mmol/kg;mmol/min/kPa;mmol/min/kPa/L;mmol/mol;mmol^2/L^2;mol;mol/L;mol/g;mol/mL;mol/mg;mol/mol;mph;msec;nCi;nL;nU/cL;nU/mL;ng;ng/L;ng/dL;ng/mL;nkat;nkat/L;nm;nmol;nmol BCE/L;nmol BCE/mmol;nmol/L;nmol/dL;nmol/hr/mg protein;nmol/mL/min;nmol/min/mg protein;nsec;ohm;osm;oz;pL;per min;per sec;pg;pg/L;pg/dL;pg/mL;pkat;pm;pmol;pmol/L;pmol/min/uL of lysat;pmol/punch/hr;pools/day;pools/h;ppb;ppm;ppth;pptr;psec;psi;pt_br;pt_us;rpm;sABC;sMEC;scm;sec;titer;tsp;tuberculin unit;tuberculin unit/mL;uCi;uCi/L;uCi/kg;uEq;uEq/L;uIU/mL;uL;uL/mL;uOsM;uU/mL;uV;uV*sec;ug;ug/L;ug/animal;ug/dL;ug/day;ug/g/day;ug/g/h;ug/g/min;ug/h;ug/kg;ug/kg/day;ug/kg/h;ug/kg/min;ug/m2;ug/m2/day;ug/m2/h;ug/m2/min;ug/mL;ug/mL/h;ug/min;ugEq;ukat;ukat/L;um;um2;umol;umol/L;umol/L/min;umol/L/sec;umol/day;umol/mg/min;umol/min;usec;v/v;yd;NONE;OTHER,question,70.866,127.671,15.744,89.556
312,42.0,Injection Site Induration,FA_VAC_INDURATION,,34.0,Caused Study Termination,,FADIS,SANOFI,,,NY_YN,Y;N,question,70.866,108.671,15.744,128.532
313,42.0,Injection Site Induration,FA_VAC_INDURATION,,35.0,Measurement Method at Day 00,,FAMETH00,SANOFI,,,,,question,70.866,73.671,15.744,155.172
314,43.0,Injection Site Induration,FA_VAC_INDURATION,,2.0,Measurement Method at Day 01,,FAMETH01,SANOFI,,,,,question,70.866,666.671,15.744,155.172
315,43.0,Injection Site Induration,FA_VAC_INDURATION,,3.0,Measurement Method at Day 02,,FAMETH02,SANOFI,,,,,question,70.866,649.671,15.744,155.172
316,43.0,Injection Site Induration,FA_VAC_INDURATION,,4.0,Measurement Method at Day 03,,FAMETH03,SANOFI,,,,,question,70.866,632.671,15.744,155.172
317,43.0,Injection Site Induration,FA_VAC_INDURATION,,5.0,Measurement Method at Day 04,,FAMETH04,SANOFI,,,,,question,70.866,615.671,15.744,155.172
318,43.0,Injection Site Induration,FA_VAC_INDURATION,,6.0,Measurement Method at Day 05,,FAMETH05,SANOFI,,,,,question,70.866,598.671,15.744,155.172
319,43.0,Injection Site Induration,FA_VAC_INDURATION,,7.0,Measurement Method at Day 06,,FAMETH06,SANOFI,,,,,question,70.866,581.671,15.744,155.172
320,43.0,Injection Site Induration,FA_VAC_INDURATION,,8.0,Measurement Method at Day 07,,FAMETH07,SANOFI,,,,,question,70.866,564.671,15.744,155.172
321,43.0,Injection Site Induration,FA_VAC_INDURATION,,9.0,Maximum Measurement Method,,FAMETHMX,SANOFI,,,,,question,70.866,547.671,15.744,158.508
322,44.0,Systemic Reaction Temperature,FA_VAC_TEMPERATURE,FA,2.0,Category of Reaction,What [is/was] the [type/category/name] (of the [measurement/test/examination/specimen/sample])?,FACAT,IG,FACAT,IG,AECAT,ADVERSE EVENT;ADVERSE EVENT OF SPECIAL INTEREST;ALLERGIC REACTION;ALT INCREASE;ASTHMA EXACERBATION EVENT;BLEEDING EVENT;BONE FRACTURE;DRUG ALLERGY EVENT;EPISTAXIS EVENT;FOREIGN BODY REACTION EVENT;HYPERCALCEMIA;HYPOGLYCEMIA;INCREASED CALCITONIN;INCREASED LIPASE/AMYLASE;INFECTION EVENT;INJECTION SITE REACTION;METABOLIC ACIDOSIS EVENT;NEUROLOGIC DISORDER;OVERDOSE;PANCREATIC EVENT;PERIPHERAL NEUROPATHY EVENT;PREGNANCY;RENAL FAILURE;SERIOUS HYPOGLYCEMIA;SOLICITED;SUSPECTED OR CONFIRMED CEREBROVASCULAR EVENT;SUSPECTED OR CONFIRMED DIABETIC KETOACIDOSIS;SUSPECTED OR CONFIRMED HEART FAILURE;SUSPECTED OR CONFIRMED MYOCARDIAL INFARCTION / UNSTABLE ANGINA;UNSOLICITED;VASCULITIS EVENT;OTHER,question,70.866,666.671,15.744,102.528
323,44.0,Systemic Reaction Temperature,FA_VAC_TEMPERATURE,FA,3.0,Subcategory of Reaction,What [is/was] the [type/subcategory/name] (of the [measurement/test/examination/specimen/sample])?,FASCAT,IG,FASCAT,IG,AESCAT_01,ADMINISTRATION SITE;SYSTEMIC,question,70.866,77.671,15.744,118.524
324,45.0,Systemic Reaction Temperature,FA_VAC_TEMPERATURE,FA,2.0,Solicited Reaction Name,[Sponsored-defined phrase],FAOBJ,IG,FAOBJ,IG,,,question,70.866,647.671,15.744,119.808
959,45.0,Systemic Reaction Temperature,FA_VAC_TEMPERATURE,,3.0,"Enter the Maximum daily Temperature with one decimal value (e.g. 100.1 or 100.0) from Day 00 to Day 07. If the Temperature is missing, enter 'UNK' for Unknown and leave the Route blank.",,PROMPT_FA_TEM01,SANOFI,,,,,question,70.866,630.659,15.948,478.932
326,45.0,Systemic Reaction Temperature,FA_VAC_TEMPERATURE,,6.0,Temperature at Day 00,,FAMEAS00,SANOFI,,,,,question,75.866,585.671,15.744,110.844
327,45.0,Systemic Reaction Temperature,FA_VAC_TEMPERATURE,,7.0,Temperature Route at Day 00,,FAMETH00,SANOFI,,,MEASMETH_02,ORAL;AXILLARY;RECTAL,question,80.866,547.671,15.744,142.476
328,45.0,Systemic Reaction Temperature,FA_VAC_TEMPERATURE,,8.0,Temperature at Day 01,,FAMEAS01,SANOFI,,,,,question,75.866,496.671,15.744,110.844
329,45.0,Systemic Reaction Temperature,FA_VAC_TEMPERATURE,,9.0,Temperature Route at Day 01,,FAMETH01,SANOFI,,,MEASMETH_02,ORAL;AXILLARY;RECTAL,question,80.866,458.671,15.744,142.476
330,45.0,Systemic Reaction Temperature,FA_VAC_TEMPERATURE,,10.0,Temperature at Day 02,,FAMEAS02,SANOFI,,,,,question,75.866,407.671,15.744,110.844
331,45.0,Systemic Reaction Temperature,FA_VAC_TEMPERATURE,,11.0,Temperature Route at Day 02,,FAMETH02,SANOFI,,,MEASMETH_02,ORAL;AXILLARY;RECTAL,question,80.866,369.671,15.744,142.476
332,45.0,Systemic Reaction Temperature,FA_VAC_TEMPERATURE,,12.0,Temperature at Day 03,,FAMEAS03,SANOFI,,,,,question,75.866,318.671,15.744,110.844
333,45.0,Systemic Reaction Temperature,FA_VAC_TEMPERATURE,,13.0,Temperature Route at Day 03,,FAMETH03,SANOFI,,,MEASMETH_02,ORAL;AXILLARY;RECTAL,question,80.866,280.671,15.744,142.476
334,45.0,Systemic Reaction Temperature,FA_VAC_TEMPERATURE,,14.0,Temperature at Day 04,,FAMEAS04,SANOFI,,,,,question,75.866,229.671,15.744,110.844
335,45.0,Systemic Reaction Temperature,FA_VAC_TEMPERATURE,,15.0,Temperature Route at Day 04,,FAMETH04,SANOFI,,,MEASMETH_02,ORAL;AXILLARY;RECTAL,question,80.866,191.671,15.744,142.476
336,45.0,Systemic Reaction Temperature,FA_VAC_TEMPERATURE,,16.0,Temperature at Day 05,,FAMEAS05,SANOFI,,,,,question,75.866,140.671,15.744,110.844
337,45.0,Systemic Reaction Temperature,FA_VAC_TEMPERATURE,,17.0,Temperature Route at Day 05,,FAMETH05,SANOFI,,,MEASMETH_02,ORAL;AXILLARY;RECTAL,question,80.866,102.671,15.744,142.476
960,46.0,Systemic Reaction Temperature,FA_VAC_TEMPERATURE,,0.0,Discontinuation of study vaccination,,FAACNC,SANOFI,,,,,unassigned,-100.0,760.0,15.0,100.0
338,46.0,Systemic Reaction Temperature,FA_VAC_TEMPERATURE,,2.0,Temperature at Day 06,,FAMEAS06,SANOFI,,,,,question,75.866,666.671,15.744,110.844
339,46.0,Systemic Reaction Temperature,FA_VAC_TEMPERATURE,,3.0,Temperature Route at Day 06,,FAMETH06,SANOFI,,,MEASMETH_02,ORAL;AXILLARY;RECTAL,question,80.866,628.671,15.744,142.476
340,46.0,Systemic Reaction Temperature,FA_VAC_TEMPERATURE,,4.0,Temperature at Day 07,,FAMEAS07,SANOFI,,,,,question,75.866,577.671,15.744,110.844
341,46.0,Systemic Reaction Temperature,FA_VAC_TEMPERATURE,,5.0,Temperature Route at Day 07,,FAMETH07,SANOFI,,,MEASMETH_02,ORAL;AXILLARY;RECTAL,question,80.866,539.671,15.744,142.476
342,46.0,Systemic Reaction Temperature,FA_VAC_TEMPERATURE,,6.0,"If at least one daily Measurement is >=100.4°F, check Presence of Fever =YES.",,PROMPT_FEVER,SANOFI,,,,,question,70.866,488.659,15.948,387.624
343,46.0,Systemic Reaction Temperature,FA_VAC_TEMPERATURE,,7.0,Presence of Fever?,,FAOCCUR,SANOFI,,,NY_YN,Y;N,question,70.866,471.671,15.744,91.212
344,46.0,Systemic Reaction Temperature,FA_VAC_TEMPERATURE,,18.0,"If Presence of Fever is checked NO, then leave all the fields below blank.",,PROMPT_FEVER2,SANOFI,,,,,question,70.866,436.659,15.948,351.156
345,46.0,Systemic Reaction Temperature,FA_VAC_TEMPERATURE,,19.0,Action Taken (Check all that apply),,PROMPT_FAACN,SANOFI,,,,,question,70.866,419.671,15.948,173.448
346,46.0,Systemic Reaction Temperature,FA_VAC_TEMPERATURE,,20.0,None,,FAACTN,SANOFI,,,,,question,80.866,402.671,15.744,25.98
347,46.0,Systemic Reaction Temperature,FA_VAC_TEMPERATURE,,21.0,Medication,,FAACMED,SANOFI,,,,,question,80.866,385.671,15.744,54.588
348,46.0,Systemic Reaction Temperature,FA_VAC_TEMPERATURE,,22.0,Health Care Provider Contact,,FAACTHC,SANOFI,,,,,question,80.866,368.671,15.744,142.14
349,46.0,Systemic Reaction Temperature,FA_VAC_TEMPERATURE,,23.0,Hospitalized,,FAACTHO,SANOFI,,,,,question,80.866,351.671,15.744,60.576
961,46.0,Systemic Reaction Temperature,FA_VAC_TEMPERATURE,,24.0,"If ongoing after Day 07 is checked YES, enter the Maximum Temperature available at the time of reporting, Route and End Date. If NO, leave these questions blank.",,PROMPT_ONGOFEV,SANOFI,,,,,question,70.866,334.659,15.948,466.512
350,46.0,Systemic Reaction Temperature,FA_VAC_TEMPERATURE,,26.0,Ongoing after Day 07?,,FAONGO,SANOFI,,,,,question,75.866,303.671,15.744,110.232
351,46.0,Systemic Reaction Temperature,FA_VAC_TEMPERATURE,,27.0,Maximum Temperature after Day 07,,FAMEASMX,SANOFI,,,,,question,75.866,286.671,15.744,177.108
352,46.0,Systemic Reaction Temperature,FA_VAC_TEMPERATURE,,29.0,Maximum Temperature Route,,FAMETHMX,SANOFI,,,MEASMETH_02,ORAL;AXILLARY;RECTAL,question,80.866,248.671,15.744,145.812
962,46.0,Systemic Reaction Temperature,FA_VAC_TEMPERATURE,,33.0,"When the End Date is obtained, ensure that the Maximum Temperature is still correct while considering the interval from Day 8 until the End Date.",,PROMPT_FASEV1,SANOFI,,,,,question,70.866,197.659,15.948,441.216
353,46.0,Systemic Reaction Temperature,FA_VAC_TEMPERATURE,,35.0,End date,,FAENDAT,SANOFI,,,,,question,80.866,166.671,15.744,42.276
354,46.0,Systemic Reaction Temperature,FA_VAC_TEMPERATURE,,36.0,Caused Study Termination,,FADIS,SANOFI,,,NY_YN,Y;N,question,70.866,149.671,15.744,128.532
355,46.0,Systemic Reaction Temperature,FA_VAC_TEMPERATURE,,37.0,Measurement Unit,,FAMEASU,SANOFI,,,UNIT,%;% INHIBITION;%(v/v);%(w/v);%(w/w);%/min;%cells/area;/100 HPFs;/100 WBC;/10^3 cells;/HPF;/L;/LPF;/VF;/dL;/day;/h;/kg;/mL;/mm3;/month;/nL;/pL;/uL;/wk;/year;1/dilution;100 IU/mL;10^10/L;10^11/L;10^12 IU/L;10^12/L;10^3 CFU;10^3 CFU/g;10^3 CFU/mL;10^3 DNA copies/mL;10^3 RNA copies/mL;10^3 copies/mL;10^3 organisms;10^3 organisms/g;10^3 organisms/mL;10^3/L;10^3/hpf;10^3/mm3;10^3/mm4;10^3/uL;10^4/L;10^4/hpf;10^5/L;10^5/hpf;10^6 CFU;10^6 CFU/g;10^6 CFU/mL;10^6 DNA copies/mL;10^6 IU;10^6 IU/mL;10^6 RNA copies/mL;10^6 copies/mL;10^6 organisms;10^6 organisms/g;10^6 organisms/mL;10^6 organisms/mg;10^6/L;10^6/g;10^6/hpf;10^6/mm3;10^6/uL;10^7/L;10^8/L;10^9 CFU;10^9 CFU/g;10^9 CFU/mL;10^9 organisms;10^9 organisms/g;10^9 organisms/mL;10^9 organisms/mg;10^9/L;AFU;AI;AMPULE;APL U/mL;APPLICATION;ASC;AU;AU/mL;AU/min;AgU/mL;Antibody Unit;BAG;BAR;BAU;BAU/mL;BE/mL;BEATS/MIN;BISCUIT;BLOCKS;BOLUS;BOTTLE;BOX;BREATHS/MIN;BU;BU/mL;Bq;Bq/L;Bq/g;Bq/kg;Bq/mL;Bq/mg;Bq/uL;Bq/ug;C;CAE;CAN;CAPFUL;CAPLET;CAPSULE;CARTRIDGE;CASE;CCID 50/dose;CCID 50/mL;CFU/g;CFU/mL;CIGAR;CIGARETTE;COAT;COI;CONTAINER;CUP;CYLINDER;Ci;Ci/L;Ci/g;Ci/kg;Ci/mL;Ci/mg;Ci/uL;Ci/ug;Coulomb;Ct;DAYS;DAgU;DAgU/mL;DIOPTER;DISK;DNA copies/mL;DPM;DRUM;EID 50/dose;EID 50/mL;ELISA unit;ELISA unit/dose;ELISA unit/mL;EU;Enzyme U;F;FEU;FINGERTIP UNIT;Farad;Frames/s;GBq;GBq/g;GBq/mg;GBq/ug;GI/L;GLASS;GPL U/mL;Gauss;Gy;HAU/100 uL;HEP;HOMEOPATHIC DILUTION;HOURS;HPF;Hb Fract.;Hemolytic Unit;Henry;Hounsfield Unit;Hz;IMPLANT;INDEX VALUE;INHALATION;IU;IU/L;IU/dL;IU/g;IU/kg;IU/kg/h;IU/mL;IU/mg;IU^4;IV;Immune Status Ratio (ISR);JAR;Joule;KALLIKREIN INHIBITOR UNIT;KIT;L;L/L;L/h;L/h/m2;L/kg;L/min;L/min/m2;L/s;LB;LOZENGE;LPF;Log10 ELISA unit;Log10 ELISA unit/dose;Log10 GEq/mL;Log10 PFU/mL;MBq;MBq/uL;MESF;MFI;MHz;MONTHS;MPL U/mL;Mile;NEBULE;NEEDLE GAUGE;NIU;Newton;PACK;PACKAGE;PACKET;PATCH;PELLET;PFU;PFU/dose;PFU/mL;PIPE;PIXEL;PIXELS/cm;PIXELS/in;PNU/mL;POINT;POUCH;PRESSOR UNITS;PUFF;Pa;Pack Year;Perfusion unit;Perfusion unit*sec;QUANTITY SUFFICIENT;RATIO;RING;RNA copies/mL;Rad;Roentgen;SACHET;SBE/mL;SCO;SCOOPFUL;SFC;SFC/10^6 PBMC;SPRAY;SQU/mL;STANDARD DRINK/day;STEPS;STRIP;SUPPOSITORY;SYRINGE;Shock Wave;Siemens;Signals/cells;Sv;TABLET;TAMPON;TCID 50/dose;TI/L;TRACE;TROCHE;TUBE;Tbsp;Tesla;Torr;U;U.CARR;U/L;U/animal;U/cL;U/dL;U/g;U/g/day;U/g/h;U/g/min;U/kg;U/kg/day;U/kg/h;U/kg/min;U/m2;U/m2/day;U/m2/h;U/m2/min;U/mL;U/mg;U/mmol;V;V/sec;VIAL;VIRTUAL PIXEL;WAFER;WEEKS;Watt;Weber;YEARS;ag;amol;amp;amu;anti-Xa IU;anti-Xa IU/mL;atm;bel;cGy;cL;cal;cc;cd;cells/mm3;cells/uL;cg;cm;cm H2O;cm/min;cm/s;cm2;cmol;cmol/L;copies/mL;copies/uL;cpm;cs;cy/cm;cycle/min;cycle/sec;dB;dL;damol/L;deg;dmol;dpm/0.5 mL;dpm/100mg;dpm/mL;dpm/mg;dram;dyn;eq;fL;fg;fmol;fmol/L;fmol/g;foz_br;foz_us;fraction of 1;ft;ft2;ft3;g;g/24h;g/L;g/animal;g/animal/day;g/animal/wk;g/cage;g/cage/day;g/cage/wk;g/cm2;g/dL;g/day;g/g;g/g Creatinine;g/g/day;g/kg;g/kg/day;g/m2;g/m2/day;g/mol;grain;gtt;hPa;in;in2;kAU/L;kBq;kBq/uL;kDa;kHz;kIU;kN/cm2;kPa;kPa/L/sec;kU/L;kUSP;kat;kcal;kg;kg/L;kg/cm;kg/cm2;kg/m2;km;km/h;ks;lbf;lm;log EID 50/dose;log10 CCID 50/dose;log10 CFU/g;log10 CFU/mL;log10 IU/mL;log10 TCID 50/dose;log10 copies/mL;lx;m;m/sec;m/sec2;m2;m3;mCi;mCi/L;mCi/kg;mEq;mEq/L;mEq/dL;mEq/day;mEq/g;mEq/kg;mEq/mL;mEq/mmol;mEq/uL;mEq/ug;mIU/L;mIU/mL;mJoule/cm2;mL;mL/animal;mL/animal/day;mL/animal/wk;mL/breath;mL/cage;mL/cage/day;mL/cage/wk;mL/cm;mL/cm H2O;mL/dL;mL/day;mL/g;mL/g/day;mL/g/h;mL/g/min;mL/h;mL/h/uL of lysat;mL/kg;mL/kg/day;mL/kg/h;mL/kg/min;mL/m2;mL/m2/day;mL/m2/h;mL/m2/min;mL/min;mL/min/1.73m2;mL/min/SSA;mL/min/mmHg;mL/mmHg;mL/mmHg/min/L;mL/s;mL/sec/1.73m2;mOsm;mOsm/kg;mPa;mU/L;mU/mL;mV;mV*min;mV2/Hz;mcg/dL;mg;mg%;mg/24h;mg/L;mg/L FEU;mg/animal;mg/dL;mg/day;mg/g;mg/g Creatinine;mg/g/day;mg/g/h;mg/g/min;mg/h;mg/kg;mg/kg/day;mg/kg/h;mg/kg/min;mg/m2;mg/m2/day;mg/m2/h;mg/m2/min;mg/mL/min;mg/min;mg/mmol Creatinine;mg/mol;min;mkat;mm;mm/2h;mm/h;mm/min;mm/sec;mm2;mm3;mmHg;mmHg/L/min;mmHg/sec;mmol;mmol FA/mL/h;mmol/L;mmol/day;mmol/g;mmol/kg;mmol/min/kPa;mmol/min/kPa/L;mmol/mol;mmol^2/L^2;mol;mol/L;mol/g;mol/mL;mol/mg;mol/mol;mph;msec;nCi;nL;nU/cL;nU/mL;ng;ng/L;ng/dL;ng/mL;nkat;nkat/L;nm;nmol;nmol BCE/L;nmol BCE/mmol;nmol/L;nmol/dL;nmol/hr/mg protein;nmol/mL/min;nmol/min/mg protein;nsec;ohm;osm;oz;pL;per min;per sec;pg;pg/L;pg/dL;pg/mL;pkat;pm;pmol;pmol/L;pmol/min/uL of lysat;pmol/punch/hr;pools/day;pools/h;ppb;ppm;ppth;pptr;psec;psi;pt_br;pt_us;rpm;sABC;sMEC;scm;sec;titer;tsp;tuberculin unit;tuberculin unit/mL;uCi;uCi/L;uCi/kg;uEq;uEq/L;uIU/mL;uL;uL/mL;uOsM;uU/mL;uV;uV*sec;ug;ug/L;ug/animal;ug/dL;ug/day;ug/g/day;ug/g/h;ug/g/min;ug/h;ug/kg;ug/kg/day;ug/kg/h;ug/kg/min;ug/m2;ug/m2/day;ug/m2/h;ug/m2/min;ug/mL;ug/mL/h;ug/min;ugEq;ukat;ukat/L;um;um2;umol;umol/L;umol/L/min;umol/L/sec;umol/day;umol/mg/min;umol/min;usec;v/v;yd;NONE;OTHER,question,70.866,114.671,15.744,89.556
356,47.0,Headache,FA_VAC_HEADACHE,FA,2.0,Category of Reaction,What [is/was] the [type/category/name] (of the [measurement/test/examination/specimen/sample])?,FACAT,IG,FACAT,IG,AECAT,ADVERSE EVENT;ADVERSE EVENT OF SPECIAL INTEREST;ALLERGIC REACTION;ALT INCREASE;ASTHMA EXACERBATION EVENT;BLEEDING EVENT;BONE FRACTURE;DRUG ALLERGY EVENT;EPISTAXIS EVENT;FOREIGN BODY REACTION EVENT;HYPERCALCEMIA;HYPOGLYCEMIA;INCREASED CALCITONIN;INCREASED LIPASE/AMYLASE;INFECTION EVENT;INJECTION SITE REACTION;METABOLIC ACIDOSIS EVENT;NEUROLOGIC DISORDER;OVERDOSE;PANCREATIC EVENT;PERIPHERAL NEUROPATHY EVENT;PREGNANCY;RENAL FAILURE;SERIOUS HYPOGLYCEMIA;SOLICITED;SUSPECTED OR CONFIRMED CEREBROVASCULAR EVENT;SUSPECTED OR CONFIRMED DIABETIC KETOACIDOSIS;SUSPECTED OR CONFIRMED HEART FAILURE;SUSPECTED OR CONFIRMED MYOCARDIAL INFARCTION / UNSTABLE ANGINA;UNSOLICITED;VASCULITIS EVENT;OTHER,question,70.866,666.671,15.744,102.528
357,47.0,Headache,FA_VAC_HEADACHE,FA,3.0,Subcategory of Reaction,What [is/was] the [type/subcategory/name] (of the [measurement/test/examination/specimen/sample])?,FASCAT,IG,FASCAT,IG,AESCAT_01,ADMINISTRATION SITE;SYSTEMIC,question,70.866,77.671,15.744,118.524
358,48.0,Headache,FA_VAC_HEADACHE,FA,2.0,Solicited Reaction Name,[Sponsored-defined phrase],FAOBJ,IG,FAOBJ,IG,,,question,70.866,647.671,15.744,119.808
360,48.0,Headache,FA_VAC_HEADACHE,,3.0,Did the subject report Headache at least once between Day 00 and Day 07 after vaccination?,,PROMPT_FA_01,SANOFI,,,,,question,70.866,630.659,15.948,450.528
361,48.0,Headache,FA_VAC_HEADACHE,,5.0,Headache,,FAOCCUR,SANOFI,,,NY_YN,Y;N,question,70.866,599.671,15.744,47.244
362,48.0,Headache,FA_VAC_HEADACHE,,8.0,"If the answer is NO, then leave all the fields below blank.",,PROMPT_FA_02,SANOFI,,,,,question,70.866,564.659,15.948,274.68
363,48.0,Headache,FA_VAC_HEADACHE,,9.0,Action Taken (Check all that apply),,PROMPT_FAACN,SANOFI,,,,,question,70.866,547.671,15.948,173.448
364,48.0,Headache,FA_VAC_HEADACHE,,10.0,None,,FAACTN,SANOFI,,,,,question,80.866,530.671,15.744,25.98
365,48.0,Headache,FA_VAC_HEADACHE,,11.0,Medication,,FAACMED,SANOFI,,,,,question,80.866,513.671,15.744,54.588
366,48.0,Headache,FA_VAC_HEADACHE,,12.0,Health Care Provider Contact,,FAACTHC,SANOFI,,,,,question,80.866,496.671,15.744,142.14
367,48.0,Headache,FA_VAC_HEADACHE,,13.0,Hospitalized,,FAACTHO,SANOFI,,,,,question,80.866,479.671,15.744,60.576
964,48.0,Headache,FA_VAC_HEADACHE,,14.0,"Enter the Maximum daily Intensity from Day 00 to Day 07. If the Intensity is missing, select Unknown.",,PROMPT_INT,SANOFI,,,,,question,70.866,462.659,15.948,439.536
967,48.0,Headache,FA_VAC_HEADACHE,,15.0,"Enter the Maximum Intensity considering the interval from Day 08 until the End Date. If the Intensity is missing, select Unknown.",,PROMPT_MXINT,SANOFI,,,,,question,70.866,448.659,15.948,48.972
368,48.0,Headache,FA_VAC_HEADACHE,,16.0,Intensity at Day 00,,FAINT00,SANOFI,,,AESEVMD_02,MILD;MODERATE;SEVERE;UNKNOWN;NONE,question,80.866,431.671,15.744,91.572
369,48.0,Headache,FA_VAC_HEADACHE,,40.0,Intensity at Day 01,,FAINT01,SANOFI,,,AESEVMD_02,MILD;MODERATE;SEVERE;UNKNOWN;NONE,question,80.866,348.671,15.744,91.572
370,48.0,Headache,FA_VAC_HEADACHE,,41.0,Intensity at Day 02,,FAINT02,SANOFI,,,AESEVMD_02,MILD;MODERATE;SEVERE;UNKNOWN;NONE,question,80.866,265.671,15.744,91.572
371,48.0,Headache,FA_VAC_HEADACHE,,42.0,Intensity at Day 03,,FAINT03,SANOFI,,,AESEVMD_02,MILD;MODERATE;SEVERE;UNKNOWN;NONE,question,80.866,182.671,15.744,91.572
372,48.0,Headache,FA_VAC_HEADACHE,,43.0,Intensity at Day 04,,FAINT04,SANOFI,,,AESEVMD_02,MILD;MODERATE;SEVERE;UNKNOWN;NONE,question,80.866,99.671,15.744,91.572
963,49.0,Headache,FA_VAC_HEADACHE,,0.0,Discontinuation of study vaccination,,FAACNC,SANOFI,,,,,unassigned,-100.0,760.0,15.0,100.0
373,49.0,Headache,FA_VAC_HEADACHE,,2.0,Intensity at Day 05,,FAINT05,SANOFI,,,AESEVMD_02,MILD;MODERATE;SEVERE;UNKNOWN;NONE,question,80.866,631.671,15.744,91.572
374,49.0,Headache,FA_VAC_HEADACHE,,3.0,Intensity at Day 06,,FAINT06,SANOFI,,,AESEVMD_02,MILD;MODERATE;SEVERE;UNKNOWN;NONE,question,80.866,548.671,15.744,91.572
375,49.0,Headache,FA_VAC_HEADACHE,,4.0,Intensity at Day 07,,FAINT07,SANOFI,,,AESEVMD_02,MILD;MODERATE;SEVERE;UNKNOWN;NONE,question,80.866,465.671,15.744,91.572
965,49.0,Headache,FA_VAC_HEADACHE,,22.0,"If a reaction is ongoing after Day 07, enter the Maximum Intensity available at the time of reporting.",,PROMPT_ONGOING,SANOFI,,,,,question,70.866,382.659,15.948,433.212
376,49.0,Headache,FA_VAC_HEADACHE,,24.0,Ongoing after Day 07?,,FAONGO,SANOFI,,,,,question,80.866,351.671,15.744,110.232
966,49.0,Headache,FA_VAC_HEADACHE,,25.0,"When the End Date is obtained, ensure that the Maximum Intensity is still correct while considering the interval from Day 8 until the End Date.",,PROMPT_FASEV1,SANOFI,,,,,question,70.866,334.659,15.948,480.156
377,49.0,Headache,FA_VAC_HEADACHE,,27.0,End date,,FAENDAT,SANOFI,,,,,question,80.866,303.671,15.744,42.276
378,49.0,Headache,FA_VAC_HEADACHE,,30.0,Maximum Intensity after Day 07,,FAINTMX,SANOFI,,,AESEVMD_01,MILD;MODERATE;SEVERE;UNKNOWN,question,80.866,255.671,15.744,157.836
379,49.0,Headache,FA_VAC_HEADACHE,,31.0,Caused Study Termination,,FADIS,SANOFI,,,NY_YN,Y;N,question,70.866,188.671,15.744,128.532
380,49.0,Headache,FA_VAC_HEADACHE,,32.0,Intensity Method at Day 00,,FAMETH00,SANOFI,,,,,question,70.866,153.671,15.744,131.88
381,49.0,Headache,FA_VAC_HEADACHE,,33.0,Intensity Method at Day 01,,FAMETH01,SANOFI,,,,,question,70.866,136.671,15.744,131.88
382,49.0,Headache,FA_VAC_HEADACHE,,34.0,Intensity Method at Day 02,,FAMETH02,SANOFI,,,,,question,70.866,119.671,15.744,131.88
383,49.0,Headache,FA_VAC_HEADACHE,,35.0,Intensity Method at Day 03,,FAMETH03,SANOFI,,,,,question,70.866,102.671,15.744,131.88
384,49.0,Headache,FA_VAC_HEADACHE,,36.0,Intensity Method at Day 04,,FAMETH04,SANOFI,,,,,question,70.866,85.671,15.744,131.88
385,49.0,Headache,FA_VAC_HEADACHE,,37.0,Intensity Method at Day 05,,FAMETH05,SANOFI,,,,,question,70.866,68.671,15.744,131.88
386,50.0,Headache,FA_VAC_HEADACHE,,2.0,Intensity Method at Day 06,,FAMETH06,SANOFI,,,,,question,70.866,666.671,15.744,131.88
387,50.0,Headache,FA_VAC_HEADACHE,,3.0,Intensity Method at Day 07,,FAMETH07,SANOFI,,,,,question,70.866,649.671,15.744,131.88
388,50.0,Headache,FA_VAC_HEADACHE,,4.0,Maximum Intensity Method,,FAMETHMX,SANOFI,,,,,question,70.866,632.671,15.744,135.216
389,51.0,Malaise,FA_VAC_MALAISE,FA,2.0,Category of Reaction,What [is/was] the [type/category/name] (of the [measurement/test/examination/specimen/sample])?,FACAT,IG,FACAT,IG,AECAT,ADVERSE EVENT;ADVERSE EVENT OF SPECIAL INTEREST;ALLERGIC REACTION;ALT INCREASE;ASTHMA EXACERBATION EVENT;BLEEDING EVENT;BONE FRACTURE;DRUG ALLERGY EVENT;EPISTAXIS EVENT;FOREIGN BODY REACTION EVENT;HYPERCALCEMIA;HYPOGLYCEMIA;INCREASED CALCITONIN;INCREASED LIPASE/AMYLASE;INFECTION EVENT;INJECTION SITE REACTION;METABOLIC ACIDOSIS EVENT;NEUROLOGIC DISORDER;OVERDOSE;PANCREATIC EVENT;PERIPHERAL NEUROPATHY EVENT;PREGNANCY;RENAL FAILURE;SERIOUS HYPOGLYCEMIA;SOLICITED;SUSPECTED OR CONFIRMED CEREBROVASCULAR EVENT;SUSPECTED OR CONFIRMED DIABETIC KETOACIDOSIS;SUSPECTED OR CONFIRMED HEART FAILURE;SUSPECTED OR CONFIRMED MYOCARDIAL INFARCTION / UNSTABLE ANGINA;UNSOLICITED;VASCULITIS EVENT;OTHER,question,70.866,666.671,15.744,102.528
390,51.0,Malaise,FA_VAC_MALAISE,FA,3.0,Subcategory of Reaction,What [is/was] the [type/subcategory/name] (of the [measurement/test/examination/specimen/sample])?,FASCAT,IG,FASCAT,IG,AESCAT_01,ADMINISTRATION SITE;SYSTEMIC,question,70.866,77.671,15.744,118.524
391,52.0,Malaise,FA_VAC_MALAISE,FA,2.0,Solicited Reaction Name,[Sponsored-defined phrase],FAOBJ,IG,FAOBJ,IG,,,question,70.866,647.671,15.744,119.808
393,52.0,Malaise,FA_VAC_MALAISE,,3.0,Did the subject report Malaise at least once between Day 00 and Day 07 after vaccination?,,PROMPT_FA_01,SANOFI,,,,,question,70.866,630.659,15.948,440.544
394,52.0,Malaise,FA_VAC_MALAISE,,4.0,Malaise,,FAOCCUR,SANOFI,,,NY_YN,Y;N,question,70.866,613.671,15.744,37.932
395,52.0,Malaise,FA_VAC_MALAISE,,8.0,"If the answer is NO, then leave all the fields below blank.",,PROMPT_FA_02,SANOFI,,,,,question,70.866,578.659,15.948,274.68
396,52.0,Malaise,FA_VAC_MALAISE,,9.0,Action Taken (Check all that apply),,PROMPT_FAACN,SANOFI,,,,,question,70.866,561.671,15.948,173.448
397,52.0,Malaise,FA_VAC_MALAISE,,10.0,None,,FAACTN,SANOFI,,,,,question,80.866,544.671,15.744,25.98
398,52.0,Malaise,FA_VAC_MALAISE,,11.0,Medication,,FAACMED,SANOFI,,,,,question,80.866,527.671,15.744,54.588
399,52.0,Malaise,FA_VAC_MALAISE,,12.0,Health Care Provider Contact,,FAACTHC,SANOFI,,,,,question,80.866,510.671,15.744,142.14
400,52.0,Malaise,FA_VAC_MALAISE,,13.0,Hospitalized,,FAACTHO,SANOFI,,,,,question,80.866,493.671,15.744,60.576
969,52.0,Malaise,FA_VAC_MALAISE,,14.0,"Enter the Maximum daily Intensity from Day 00 to Day 07. If the Intensity is missing, select Unknown.",,PROMPT_INT,SANOFI,,,,,question,70.866,476.659,15.948,439.536
972,52.0,Malaise,FA_VAC_MALAISE,,15.0,"Enter the Maximum Intensity considering the interval from Day 08 until the End Date. If the Intensity is missing, select Unknown.",,PROMPT_MXINT,SANOFI,,,,,question,70.866,462.659,15.948,48.972
401,52.0,Malaise,FA_VAC_MALAISE,,16.0,Intensity at Day 00,,FAINT00,SANOFI,,,AESEVMD_02,MILD;MODERATE;SEVERE;UNKNOWN;NONE,question,80.866,445.671,15.744,91.572
402,52.0,Malaise,FA_VAC_MALAISE,,41.0,Intensity at Day 01,,FAINT01,SANOFI,,,AESEVMD_02,MILD;MODERATE;SEVERE;UNKNOWN;NONE,question,80.866,362.671,15.744,91.572
403,52.0,Malaise,FA_VAC_MALAISE,,42.0,Intensity at Day 02,,FAINT02,SANOFI,,,AESEVMD_02,MILD;MODERATE;SEVERE;UNKNOWN;NONE,question,80.866,279.671,15.744,91.572
404,52.0,Malaise,FA_VAC_MALAISE,,43.0,Intensity at Day 03,,FAINT03,SANOFI,,,AESEVMD_02,MILD;MODERATE;SEVERE;UNKNOWN;NONE,question,80.866,196.671,15.744,91.572
405,52.0,Malaise,FA_VAC_MALAISE,,44.0,Intensity at Day 04,,FAINT04,SANOFI,,,AESEVMD_02,MILD;MODERATE;SEVERE;UNKNOWN;NONE,question,80.866,113.671,15.744,91.572
968,53.0,Malaise,FA_VAC_MALAISE,,0.0,Discontinuation of study vaccination,,FAACNC,SANOFI,,,,,unassigned,-100.0,760.0,15.0,100.0
406,53.0,Malaise,FA_VAC_MALAISE,,2.0,Intensity at Day 05,,FAINT05,SANOFI,,,AESEVMD_02,MILD;MODERATE;SEVERE;UNKNOWN;NONE,question,80.866,647.671,15.744,91.572
407,53.0,Malaise,FA_VAC_MALAISE,,3.0,Intensity at Day 06,,FAINT06,SANOFI,,,AESEVMD_02,MILD;MODERATE;SEVERE;UNKNOWN;NONE,question,80.866,564.671,15.744,91.572
408,53.0,Malaise,FA_VAC_MALAISE,,4.0,Intensity at Day 07,,FAINT07,SANOFI,,,AESEVMD_02,MILD;MODERATE;SEVERE;UNKNOWN;NONE,question,80.866,481.671,15.744,91.572
970,53.0,Malaise,FA_VAC_MALAISE,,21.0,"If a reaction is ongoing after Day 07, enter the Maximum Intensity available at the time of reporting.",,PROMPT_ONGOING,SANOFI,,,,,question,70.866,398.659,15.948,433.212
409,53.0,Malaise,FA_VAC_MALAISE,,23.0,Ongoing after Day 07?,,FAONGO,SANOFI,,,,,question,80.866,367.671,15.744,110.232
971,53.0,Malaise,FA_VAC_MALAISE,,24.0,"When the End Date is obtained, ensure that the Maximum Intensity is still correct while considering the interval from Day 8 until the End Date.",,PROMPT_FASEV1,SANOFI,,,,,question,70.866,350.659,15.948,480.156
410,53.0,Malaise,FA_VAC_MALAISE,,26.0,End date,,FAENDAT,SANOFI,,,,,question,80.866,319.671,15.744,42.276
411,53.0,Malaise,FA_VAC_MALAISE,,29.0,Maximum Intensity after Day 07,,FAINTMX,SANOFI,,,AESEVMD_01,MILD;MODERATE;SEVERE;UNKNOWN,question,80.866,271.671,15.744,157.836
412,53.0,Malaise,FA_VAC_MALAISE,,30.0,Caused Study Termination,,FADIS,SANOFI,,,NY_YN,Y;N,question,70.866,204.671,15.744,128.532
413,53.0,Malaise,FA_VAC_MALAISE,,31.0,Intensity Method at Day 00,,FAMETH00,SANOFI,,,,,question,70.866,169.671,15.744,131.88
414,53.0,Malaise,FA_VAC_MALAISE,,32.0,Intensity Method at Day 01,,FAMETH01,SANOFI,,,,,question,70.866,152.671,15.744,131.88
415,53.0,Malaise,FA_VAC_MALAISE,,33.0,Intensity Method at Day 02,,FAMETH02,SANOFI,,,,,question,70.866,135.671,15.744,131.88
416,53.0,Malaise,FA_VAC_MALAISE,,34.0,Intensity Method at Day 03,,FAMETH03,SANOFI,,,,,question,70.866,118.671,15.744,131.88
417,53.0,Malaise,FA_VAC_MALAISE,,35.0,Intensity Method at Day 04,,FAMETH04,SANOFI,,,,,question,70.866,101.671,15.744,131.88
418,53.0,Malaise,FA_VAC_MALAISE,,36.0,Intensity Method at Day 05,,FAMETH05,SANOFI,,,,,question,70.866,84.671,15.744,131.88
419,53.0,Malaise,FA_VAC_MALAISE,,37.0,Intensity Method at Day 06,,FAMETH06,SANOFI,,,,,question,70.866,67.671,15.744,131.88
420,54.0,Malaise,FA_VAC_MALAISE,,2.0,Intensity Method at Day 07,,FAMETH07,SANOFI,,,,,question,70.866,666.671,15.744,131.88
421,54.0,Malaise,FA_VAC_MALAISE,,3.0,Maximum Intensity Method,,FAMETHMX,SANOFI,,,,,question,70.866,649.671,15.744,135.216
422,55.0,Myalgia,FA_VAC_MYALGIA,FA,2.0,Category of Reaction,What [is/was] the [type/category/name] (of the [measurement/test/examination/specimen/sample])?,FACAT,IG,FACAT,IG,AECAT,ADVERSE EVENT;ADVERSE EVENT OF SPECIAL INTEREST;ALLERGIC REACTION;ALT INCREASE;ASTHMA EXACERBATION EVENT;BLEEDING EVENT;BONE FRACTURE;DRUG ALLERGY EVENT;EPISTAXIS EVENT;FOREIGN BODY REACTION EVENT;HYPERCALCEMIA;HYPOGLYCEMIA;INCREASED CALCITONIN;INCREASED LIPASE/AMYLASE;INFECTION EVENT;INJECTION SITE REACTION;METABOLIC ACIDOSIS EVENT;NEUROLOGIC DISORDER;OVERDOSE;PANCREATIC EVENT;PERIPHERAL NEUROPATHY EVENT;PREGNANCY;RENAL FAILURE;SERIOUS HYPOGLYCEMIA;SOLICITED;SUSPECTED OR CONFIRMED CEREBROVASCULAR EVENT;SUSPECTED OR CONFIRMED DIABETIC KETOACIDOSIS;SUSPECTED OR CONFIRMED HEART FAILURE;SUSPECTED OR CONFIRMED MYOCARDIAL INFARCTION / UNSTABLE ANGINA;UNSOLICITED;VASCULITIS EVENT;OTHER,question,70.866,666.671,15.744,102.528
423,55.0,Myalgia,FA_VAC_MYALGIA,FA,3.0,Subcategory of Reaction,What [is/was] the [type/subcategory/name] (of the [measurement/test/examination/specimen/sample])?,FASCAT,IG,FASCAT,IG,AESCAT_01,ADMINISTRATION SITE;SYSTEMIC,question,70.866,77.671,15.744,118.524
424,56.0,Myalgia,FA_VAC_MYALGIA,FA,2.0,Solicited Reaction Name,[Sponsored-defined phrase],FAOBJ,IG,FAOBJ,IG,,,question,70.866,647.671,15.744,119.808
426,56.0,Myalgia,FA_VAC_MYALGIA,,3.0,Did the subject report Myalgia at least once between Day 00 and Day 07 after vaccination?,,PROMPT_FA_01,SANOFI,,,,,question,70.866,630.659,15.948,441.876
427,56.0,Myalgia,FA_VAC_MYALGIA,,4.0,Myalgia,,FAOCCUR,SANOFI,,,NY_YN,Y;N,question,70.866,613.671,15.744,39.948
428,56.0,Myalgia,FA_VAC_MYALGIA,,8.0,"If the answer is NO, then leave all the fields below blank.",,PROMPT_FA_02,SANOFI,,,,,question,70.866,578.659,15.948,274.68
429,56.0,Myalgia,FA_VAC_MYALGIA,,9.0,Action Taken (Check all that apply),,PROMPT_FAACN,SANOFI,,,,,question,70.866,561.671,15.948,173.448
430,56.0,Myalgia,FA_VAC_MYALGIA,,10.0,None,,FAACTN,SANOFI,,,,,question,80.866,544.671,15.744,25.98
431,56.0,Myalgia,FA_VAC_MYALGIA,,11.0,Medication,,FAACMED,SANOFI,,,,,question,80.866,527.671,15.744,54.588
432,56.0,Myalgia,FA_VAC_MYALGIA,,12.0,Health Care Provider Contact,,FAACTHC,SANOFI,,,,,question,80.866,510.671,15.744,142.14
433,56.0,Myalgia,FA_VAC_MYALGIA,,13.0,Hospitalized,,FAACTHO,SANOFI,,,,,question,80.866,493.671,15.744,60.576
974,56.0,Myalgia,FA_VAC_MYALGIA,,14.0,"Enter the Maximum daily Intensity from Day 00 to Day 07. If the Intensity is missing, select Unknown.",,PROMPT_INT,SANOFI,,,,,question,70.866,476.659,15.948,439.536
977,56.0,Myalgia,FA_VAC_MYALGIA,,15.0,"Enter the Maximum Intensity considering the interval from Day 08 until the End Date. If the Intensity is missing, select Unknown.",,PROMPT_MXINT,SANOFI,,,,,question,70.866,462.659,15.948,48.972
434,56.0,Myalgia,FA_VAC_MYALGIA,,16.0,Intensity at Day 00,,FAINT00,SANOFI,,,AESEVMD_02,MILD;MODERATE;SEVERE;UNKNOWN;NONE,question,80.866,445.671,15.744,91.572
435,56.0,Myalgia,FA_VAC_MYALGIA,,41.0,Intensity at Day 01,,FAINT01,SANOFI,,,AESEVMD_02,MILD;MODERATE;SEVERE;UNKNOWN;NONE,question,80.866,362.671,15.744,91.572
436,56.0,Myalgia,FA_VAC_MYALGIA,,42.0,Intensity at Day 02,,FAINT02,SANOFI,,,AESEVMD_02,MILD;MODERATE;SEVERE;UNKNOWN;NONE,question,80.866,279.671,15.744,91.572
437,56.0,Myalgia,FA_VAC_MYALGIA,,43.0,Intensity at Day 03,,FAINT03,SANOFI,,,AESEVMD_02,MILD;MODERATE;SEVERE;UNKNOWN;NONE,question,80.866,196.671,15.744,91.572
438,56.0,Myalgia,FA_VAC_MYALGIA,,44.0,Intensity at Day 04,,FAINT04,SANOFI,,,AESEVMD_02,MILD;MODERATE;SEVERE;UNKNOWN;NONE,question,80.866,113.671,15.744,91.572
973,57.0,Myalgia,FA_VAC_MYALGIA,,0.0,Discontinuation of study vaccination,,FAACNC,SANOFI,,,,,unassigned,-100.0,760.0,15.0,100.0
439,57.0,Myalgia,FA_VAC_MYALGIA,,2.0,Intensity at Day 05,,FAINT05,SANOFI,,,AESEVMD_02,MILD;MODERATE;SEVERE;UNKNOWN;NONE,question,80.866,647.671,15.744,91.572
440,57.0,Myalgia,FA_VAC_MYALGIA,,3.0,Intensity at Day 06,,FAINT06,SANOFI,,,AESEVMD_02,MILD;MODERATE;SEVERE;UNKNOWN;NONE,question,80.866,564.671,15.744,91.572
441,57.0,Myalgia,FA_VAC_MYALGIA,,4.0,Intensity at Day 07,,FAINT07,SANOFI,,,AESEVMD_02,MILD;MODERATE;SEVERE;UNKNOWN;NONE,question,80.866,481.671,15.744,91.572
975,57.0,Myalgia,FA_VAC_MYALGIA,,21.0,"If a reaction is ongoing after Day 07, enter the Maximum Intensity available at the time of reporting.",,PROMPT_ONGOING,SANOFI,,,,,question,70.866,398.659,15.948,433.212
442,57.0,Myalgia,FA_VAC_MYALGIA,,23.0,Ongoing after Day 07?,,FAONGO,SANOFI,,,,,question,80.866,367.671,15.744,110.232
976,57.0,Myalgia,FA_VAC_MYALGIA,,24.0,"When the End Date is obtained, ensure that the Maximum Intensity is still correct while considering the interval from Day 8 until the End Date.",,PROMPT_FASEV1,SANOFI,,,,,question,70.866,350.659,15.948,480.156
443,57.0,Myalgia,FA_VAC_MYALGIA,,26.0,End date,,FAENDAT,SANOFI,,,,,question,80.866,319.671,15.744,42.276
444,57.0,Myalgia,FA_VAC_MYALGIA,,29.0,Maximum Intensity after Day 07,,FAINTMX,SANOFI,,,AESEVMD_01,MILD;MODERATE;SEVERE;UNKNOWN,question,80.866,271.671,15.744,157.836
445,57.0,Myalgia,FA_VAC_MYALGIA,,30.0,Caused Study Termination,,FADIS,SANOFI,,,NY_YN,Y;N,question,70.866,204.671,15.744,128.532
446,57.0,Myalgia,FA_VAC_MYALGIA,,31.0,Intensity Method at Day 00,,FAMETH00,SANOFI,,,,,question,70.866,169.671,15.744,131.88
447,57.0,Myalgia,FA_VAC_MYALGIA,,32.0,Intensity Method at Day 01,,FAMETH01,SANOFI,,,,,question,70.866,152.671,15.744,131.88
448,57.0,Myalgia,FA_VAC_MYALGIA,,33.0,Intensity Method at Day 02,,FAMETH02,SANOFI,,,,,question,70.866,135.671,15.744,131.88
449,57.0,Myalgia,FA_VAC_MYALGIA,,34.0,Intensity Method at Day 03,,FAMETH03,SANOFI,,,,,question,70.866,118.671,15.744,131.88
450,57.0,Myalgia,FA_VAC_MYALGIA,,35.0,Intensity Method at Day 04,,FAMETH04,SANOFI,,,,,question,70.866,101.671,15.744,131.88
451,57.0,Myalgia,FA_VAC_MYALGIA,,36.0,Intensity Method at Day 05,,FAMETH05,SANOFI,,,,,question,70.866,84.671,15.744,131.88
452,57.0,Myalgia,FA_VAC_MYALGIA,,37.0,Intensity Method at Day 06,,FAMETH06,SANOFI,,,,,question,70.866,67.671,15.744,131.88
453,58.0,Myalgia,FA_VAC_MYALGIA,,2.0,Intensity Method at Day 07,,FAMETH07,SANOFI,,,,,question,70.866,666.671,15.744,131.88
454,58.0,Myalgia,FA_VAC_MYALGIA,,3.0,Maximum Intensity Method,,FAMETHMX,SANOFI,,,,,question,70.866,649.671,15.744,135.216
978,59.0,Reportable Medications,CM_REPORT,,2.0,"Record reportable medications taken during the 28 days safety follow up period/between D00 and the next visit. Reportable means: Category 1, 2 and 3 medications including ongoing medications on the day of the first vaccination.Category 1: Medications impacting or that may have an impact on the evaluation of the safety (e.g., antipyretics, analgesics, and non-steroidal anti-inflammatory drugs [NSAIDs], steroids/corticosteroids and any other class of medications that could affect the safety as per project needs)Category 2: Medications impacting or that may have an impact on the immune response (e.g. other vaccines, blood products, antibiotic classes that may interfere with bioassays used by the Global Clinical Immunology [GCI], steroids/corticosteroids, immunesuppressors, immune-modulators with immunosuppressive properties, anti-proliferative drugs such as DNA synthesis inhibitors, and any other class of medications that may affect the immune response as per project needs)Category 3: Medications impacting or that may have an impact on both the safety and the immune response (e.g., steroids/corticosteroids)",,PROMPT_CMYN,SANOFI,,,,,question,70.866,666.659,15.948,471.216
455,59.0,Reportable Medications,CM_REPORT,,16.0,Did the subject report any reportable medications?,Were any (concomitant) [medication(s)/treatment(s)/therap(ies)] taken?,CMYN,IG,,,NY_YN,Y;N,question,70.866,425.671,15.744,242.34
456,59.0,Reportable Medications,CM_REPORT,,17.0,"If yes, complete the following questions.",,PROMPT_CMTRT,SANOFI,,,,,question,70.866,390.659,15.948,192.108
457,59.0,Reportable Medications,CM_REPORT,CM,18.0,Unique ID,What is the (concomitant) [medication/treatment/therapy] identifier?,CMSPID,IG,CMSPID,IG,,,question,70.866,370.671,15.744,50.964
458,59.0,Reportable Medications,CM_REPORT,CM,19.0,Medication,What was the (concomitant) [medication/treatment/therapy] (name/term)?,CMTRT,IG,CMTRT,IG,,,question,70.866,353.671,15.744,54.588
459,59.0,Reportable Medications,CM_REPORT,CM,20.0,Category,What is the category for the (concomitant) [medication/treatment/therapy]?,CMCAT,IG,CMCAT,IG,CMCAT_02,MEDICATIONS IMPACTING OR THAT MAY HAVE AN IMPACT ON THE EVALUATION OF THE SAFETY;MEDICATIONS IMPACTING OR THAT MAY HAVE AN IMPACT ON THE IMMUNE RESPONSE;MEDICATIONS IMPACTING OR THAT MAY HAVE AN IMPACT ON BOTH THE SAFETY AND THE IMMUNE RESPONSE,question,70.866,336.671,15.744,43.944
460,59.0,Reportable Medications,CM_REPORT,SUPPCM,21.0,Prophylactic Medication,,CMPROPFL,SANOFI,CMPROPFL,SANOFI,NY_YN,Y;N,question,70.866,285.671,15.744,118.176
461,59.0,Reportable Medications,CM_REPORT,CM,22.0,Start Date,What was the (concomitant) [medication/treatment/therapy/dose] start date?,CMSTDAT,IG,CMSTDTC,IG,,,question,70.866,250.671,15.744,48.252
462,59.0,Reportable Medications,CM_REPORT,CM,23.0,Ongoing at End of Study,Was the (concomitant) [medication/treatment/therapy] ongoing?,CMONGO,IG,CMENRF; CMENRTPT,IG,,,question,70.866,233.671,15.744,119.94
463,59.0,Reportable Medications,CM_REPORT,CM,24.0,End Date,What was the (concomitant) [medication/treatment/therapy/dose] end date?,CMENDAT,IG,CMENDTC,IG,,,question,70.866,216.671,15.744,44.94
464,59.0,Reportable Medications,CM_REPORT,SUPPCM,25.0,Prohibited Medications,,CMPROHFL,SANOFI,CMPROHFL,SANOFI,NY_YN,Y;N,question,70.866,199.671,15.744,112.212
465,60.0,Completion at End of Study,DS_C_ED2,EP,2.0,Completion of Primary Series,What is the trial period?,EPOCH,IG,EPOCH,IG,EPOCH,BLINDED TREATMENT;BOOSTER PHASE;COMPLETION;DOSE-FINDING FOLLOW-UP;DOUBLE BLIND;EXTENSION;EXTENSION FOLLOW-UP;FIRST FOLLOW-UP;FIRST RUN-IN;FIRST SCREENING;FIRST TREATMENT;FIRST WASH-OUT;FOLLOW-UP;IMMUNOGENICITY FOLLOW-UP;LONG-TERM FOLLOW-UP;OPEN LABEL TREATMENT;PRIMARY SERIES;RUN-IN;SAFETY FOLLOW-UP;SCREENING;SECOND FOLLOW-UP;SECOND RUN-IN;SECOND SCREENING;SECOND TREATMENT;SECOND WASH-OUT;SINGLE BLIND;TREATMENT;WASHOUT,question,70.866,666.671,15.744,143.52
466,60.0,Completion at End of Study,DS_C_ED2,EP,2.0,Completion of Primary Series,What is the trial period for this disposition event?,EPOCH,IG,EPOCH,IG,EPOCH,BLINDED TREATMENT;BOOSTER PHASE;COMPLETION;DOSE-FINDING FOLLOW-UP;DOUBLE BLIND;EXTENSION;EXTENSION FOLLOW-UP;FIRST FOLLOW-UP;FIRST RUN-IN;FIRST SCREENING;FIRST TREATMENT;FIRST WASH-OUT;FOLLOW-UP;IMMUNOGENICITY FOLLOW-UP;LONG-TERM FOLLOW-UP;OPEN LABEL TREATMENT;PRIMARY SERIES;RUN-IN;SAFETY FOLLOW-UP;SCREENING;SECOND FOLLOW-UP;SECOND RUN-IN;SECOND SCREENING;SECOND TREATMENT;SECOND WASH-OUT;SINGLE BLIND;TREATMENT;WASHOUT,question,70.866,666.671,15.744,143.52
468,60.0,Completion at End of Study,DS_C_ED2,DS,35.0,Disposition Event,What was the category of the disposition?,DSCAT,IG,DSCAT,IG,DSCAT,DISPOSITION EVENT;PROTOCOL MILESTONE;OTHER EVENT,question,70.866,215.671,15.744,86.256
467,60.0,Completion at End of Study,DS_C_ED2,,34.0,Check Completed if the subject completed the study else check the main reason for discontinuation.,,PROMPT_DSDECOD,SANOFI,,,,,question,70.866,164.659,15.948,477.084
469,60.0,Completion at End of Study,DS_C_ED2,DS,36.0,What was the subject's status?,What was the subject's status?,DSDECOD,IG,DSDECOD,IG,NCOMPLT_50,COMPLETED;ADVERSE EVENT;PROTOCOL DEVIATION;WITHDRAWAL BY SUBJECT;LOST TO FOLLOW-UP,question,70.866,133.671,15.744,144.636
470,61.0,Completion at End of Study,DS_C_ED2,DS,2.0,Status Date,What was the [protocol milestone/disposition event/other event name] date?,DSSTDAT,IG,DSSTDTC,IG,,,question,70.866,666.671,15.744,54.924
474,61.0,Completion at End of Study,DS_C_ED2,,3.0,"If the subject did not complete the study, provide details.",,PROMPT_DSTERM2,SANOFI,,,,,question,70.866,649.659,15.948,271.344
475,61.0,Completion at End of Study,DS_C_ED2,DS,4.0,Provide Details,"What was the subject's status?; If [DSDECOD], specify",DSTERM,IG,DSTERM,IG,,,question,80.866,632.671,15.744,74.244
476,62.0,Comments Per Visit,CO_02,EP,2.0,Trial Period,What is the trial period?,EPOCH,IG,EPOCH,IG,EPOCH,BLINDED TREATMENT;BOOSTER PHASE;COMPLETION;DOSE-FINDING FOLLOW-UP;DOUBLE BLIND;EXTENSION;EXTENSION FOLLOW-UP;FIRST FOLLOW-UP;FIRST RUN-IN;FIRST SCREENING;FIRST TREATMENT;FIRST WASH-OUT;FOLLOW-UP;IMMUNOGENICITY FOLLOW-UP;LONG-TERM FOLLOW-UP;OPEN LABEL TREATMENT;PRIMARY SERIES;RUN-IN;SAFETY FOLLOW-UP;SCREENING;SECOND FOLLOW-UP;SECOND RUN-IN;SECOND SCREENING;SECOND TREATMENT;SECOND WASH-OUT;SINGLE BLIND;TREATMENT;WASHOUT,question,70.866,666.671,15.744,57.588
477,62.0,Comments Per Visit,CO_02,EP,2.0,Trial Period,What is the trial period for this disposition event?,EPOCH,IG,EPOCH,IG,EPOCH,BLINDED TREATMENT;BOOSTER PHASE;COMPLETION;DOSE-FINDING FOLLOW-UP;DOUBLE BLIND;EXTENSION;EXTENSION FOLLOW-UP;FIRST FOLLOW-UP;FIRST RUN-IN;FIRST SCREENING;FIRST TREATMENT;FIRST WASH-OUT;FOLLOW-UP;IMMUNOGENICITY FOLLOW-UP;LONG-TERM FOLLOW-UP;OPEN LABEL TREATMENT;PRIMARY SERIES;RUN-IN;SAFETY FOLLOW-UP;SCREENING;SECOND FOLLOW-UP;SECOND RUN-IN;SECOND SCREENING;SECOND TREATMENT;SECOND WASH-OUT;SINGLE BLIND;TREATMENT;WASHOUT,question,70.866,666.671,15.744,57.588
478,62.0,Comments Per Visit,CO_02,,31.0,Visit,,COVISIT,SANOFI,,,,,question,70.866,215.671,15.744,23.304
479,62.0,Comments Per Visit,CO_02,CO,32.0,Comment,[protocol specified targeted question],COVAL,IG,CO.COVAL,IG,,,question,70.866,198.671,15.744,47.28
979,63.0,Pregnancy YesNo,AE_PREG_YN,AE,2.0,"Category of Adverse Event",What is the category of the adverse event?,AECAT,IG,AECAT,IG,,,question,70.866,666.671,15.744,130.86
480,63.0,Pregnancy YesNo,AE_PREG_YN,,3.0,Did any pregnancy occur?,Were any adverse events experienced?,AEYN,IG,,,NY_YN,Y;N,question,70.866,77.671,15.744,126.192
481,65.0,Pregnancy for Vaccine Studies,AE_PREG_VAC,AE,2.0,Category of Adverse Event,What is the category of the adverse event?,AECAT,IG,AECAT,IG,AECAT,ADVERSE EVENT;ADVERSE EVENT OF SPECIAL INTEREST;ALLERGIC REACTION;ALT INCREASE;ASTHMA EXACERBATION EVENT;BLEEDING EVENT;BONE FRACTURE;DRUG ALLERGY EVENT;EPISTAXIS EVENT;FOREIGN BODY REACTION EVENT;HYPERCALCEMIA;HYPOGLYCEMIA;INCREASED CALCITONIN;INCREASED LIPASE/AMYLASE;INFECTION EVENT;INJECTION SITE REACTION;METABOLIC ACIDOSIS EVENT;NEUROLOGIC DISORDER;OVERDOSE;PANCREATIC EVENT;PERIPHERAL NEUROPATHY EVENT;PREGNANCY;RENAL FAILURE;SERIOUS HYPOGLYCEMIA;SOLICITED;SUSPECTED OR CONFIRMED CEREBROVASCULAR EVENT;SUSPECTED OR CONFIRMED DIABETIC KETOACIDOSIS;SUSPECTED OR CONFIRMED HEART FAILURE;SUSPECTED OR CONFIRMED MYOCARDIAL INFARCTION / UNSTABLE ANGINA;UNSOLICITED;VASCULITIS EVENT;OTHER,question,70.866,666.671,15.744,130.86
483,65.0,Pregnancy for Vaccine Studies,AE_PREG_VAC,AE,3.0,Unique ID,What is the adverse event identifier?,AESPID,IG,AESPID,IG,,,question,70.866,77.671,15.744,50.964
485,66.0,Pregnancy for Vaccine Studies,AE_PREG_VAC,AE,2.0,Event,What is the adverse event term?,AETERM,IG,AETERM,IG,,,question,70.866,666.671,15.744,27.96
487,66.0,Pregnancy for Vaccine Studies,AE_PREG_VAC,AE,3.0,Date of Last Menses,What is the adverse event start date?,AESTDAT,IG,AESTDTC,IG,,,question,70.866,649.671,15.744,98.88
981,66.0,Pregnancy for Vaccine Studies,AE_PREG_VAC,SUPPAE;SQAPAE,4.0,Did the mother experience any adverse event linked to the pregnancy?,,AEPRAEYN,SANOFI,AEPRAEYN,SANOFI,,,question,70.866,632.671,15.744,279.3
489,66.0,Pregnancy for Vaccine Studies,AE_PREG_VAC,SUPPAE;SQAPAE,6.0,Outcome,,AEOUTPRG,SANOFI,AEOUTPRG,SANOFI,OUTPRG,ONGOING;NORMAL DELIVERY;ABNORMAL TERMINATION/DELIVERY WITH COMPLICATION;FATAL,question,70.866,597.671,15.744,43.944
490,66.0,Pregnancy for Vaccine Studies,AE_PREG_VAC,AE,7.0,Termination/Delivery Date,What was the adverse event end date?,AEENDAT,IG,AEENDTC,IG,,,question,70.866,504.671,15.744,130.128
492,67.0,Parent Information,PV_PARENT,AE,2.0,Related AE ID,What is the adverse event identifier?,AESPID,IG,AESPID,IG,,,question,70.866,666.671,15.744,71.232
494,67.0,Parent Information,PV_PARENT,,3.0,Parent,,PVPARENT,SANOFI,,,,,question,70.866,646.671,15.744,30.624
495,67.0,Parent Information,PV_PARENT,,4.0,Age,,PVAGE,SANOFI,,,,,question,70.866,629.671,15.744,19.98
496,67.0,Parent Information,PV_PARENT,,5.0,Rh Factor,,PVRH,SANOFI,,,,,question,70.866,612.671,15.744,47.616
497,67.0,Parent Information,PV_PARENT,,6.0,Height (cm),,PVHEIGHT,SANOFI,,,,,question,70.866,595.671,15.744,58.26
498,67.0,Parent Information,PV_PARENT,,7.0,Weight (kg),,PVWEIGHT,SANOFI,,,,,question,70.866,578.671,15.744,58.272
499,67.0,Parent Information,PV_PARENT,,8.0,Smoking History (Cigarettes per Day),,PVSMOKNB,SANOFI,,,,,question,70.866,561.671,15.744,183.156
500,67.0,Parent Information,PV_PARENT,,9.0,Alcohol (Drinks per Day),,PVALCONB,SANOFI,,,,,question,70.866,544.671,15.744,123.564
501,67.0,Parent Information,PV_PARENT,,10.0,"Substance Abuse, specify",,PVABUSCM,SANOFI,,,,,question,70.866,527.671,15.744,122.88
502,67.0,Parent Information,PV_PARENT,,11.0,Hypertension,,PVHTAYN,SANOFI,,,NY_YNU,Y;N;U,question,70.866,510.671,15.744,64.608
503,67.0,Parent Information,PV_PARENT,,12.0,Diabetes,,PVDIABYN,SANOFI,,,NY_YNU,Y;N;U,question,70.866,459.671,15.744,41.928
504,67.0,Parent Information,PV_PARENT,,13.0,Epilepsy,,PVEPIYN,SANOFI,,,NY_YNU,Y;N;U,question,70.866,408.671,15.744,41.952
505,67.0,Parent Information,PV_PARENT,,14.0,Psychiatric Illness,,PVPSYYN,SANOFI,,,NY_YNU,Y;N;U,question,70.866,357.671,15.744,87.552
506,67.0,Parent Information,PV_PARENT,,15.0,HIV Serology,,PVHIVYN,SANOFI,,,NY_YNU,Y;N;U,question,70.866,306.671,15.744,67.632
507,67.0,Parent Information,PV_PARENT,,16.0,Hepatitis Serology,,PVHEPYN,SANOFI,,,NY_YNU,Y;N;U,question,70.866,255.671,15.744,89.568
982,67.0,Parent Information,PV_PARENT,,17.0,"Other Relevant Medical History (notably thyroid disorders, asthma, allergic disease, heart disease, depression, sexually transmitted disease)",,PVOMHCM,SANOFI,,,,,question,70.866,204.671,15.744,284.7
508,67.0,Parent Information,PV_PARENT,,20.0,Parent,,PVPARENT,SANOFI,,,,,question,70.866,156.671,15.744,30.624
509,67.0,Parent Information,PV_PARENT,,21.0,Age,,PVAGE,SANOFI,,,,,question,70.866,139.671,15.744,19.98
510,67.0,Parent Information,PV_PARENT,,22.0,Rh Factor,,PVRH,SANOFI,,,,,question,70.866,122.671,15.744,47.616
511,67.0,Parent Information,PV_PARENT,,23.0,Height (cm),,PVHEIGHT,SANOFI,,,,,question,70.866,105.671,15.744,58.26
512,67.0,Parent Information,PV_PARENT,,24.0,Weight (kg),,PVWEIGHT,SANOFI,,,,,question,70.866,88.671,15.744,58.272
513,67.0,Parent Information,PV_PARENT,,25.0,Smoking History (Cigarettes per Day),,PVSMOKNB,SANOFI,,,,,question,70.866,71.671,15.744,183.156
514,68.0,Parent Information,PV_PARENT,,2.0,Alcohol (Drinks per Day),,PVALCONB,SANOFI,,,,,question,70.866,666.671,15.744,123.564
515,68.0,Parent Information,PV_PARENT,,3.0,"Substance Abuse, specify",,PVABUSCM,SANOFI,,,,,question,70.866,649.671,15.744,122.88
516,68.0,Parent Information,PV_PARENT,,4.0,Hypertension,,PVHTAYN,SANOFI,,,NY_YNU,Y;N;U,question,70.866,632.671,15.744,64.608
517,68.0,Parent Information,PV_PARENT,,5.0,Diabetes,,PVDIABYN,SANOFI,,,NY_YNU,Y;N;U,question,70.866,581.671,15.744,41.928
518,68.0,Parent Information,PV_PARENT,,6.0,Epilepsy,,PVEPIYN,SANOFI,,,NY_YNU,Y;N;U,question,70.866,530.671,15.744,41.952
519,68.0,Parent Information,PV_PARENT,,7.0,Psychiatric Illness,,PVPSYYN,SANOFI,,,NY_YNU,Y;N;U,question,70.866,479.671,15.744,87.552
520,68.0,Parent Information,PV_PARENT,,8.0,HIV Serology,,PVHIVYN,SANOFI,,,NY_YNU,Y;N;U,question,70.866,428.671,15.744,67.632
521,68.0,Parent Information,PV_PARENT,,9.0,Hepatitis Serology,,PVHEPYN,SANOFI,,,NY_YNU,Y;N;U,question,70.866,377.671,15.744,89.568
522,69.0,Immunization Status and Gynecological Details,PV_IMMU_GYN,AE,2.0,Related AE ID,What is the adverse event identifier?,AESPID,IG,AESPID,IG,,,question,70.866,666.671,15.744,71.232
524,69.0,Immunization Status and Gynecological Details,PV_IMMU_GYN,,3.0,Immunization Status,,PROMPT_PVRUBYN,SANOFI,,,,,question,70.866,649.659,15.948,98.28
525,69.0,Immunization Status and Gynecological Details,PV_IMMU_GYN,,4.0,Rubella,,PVRUBYN,SANOFI,,,NY_YNU,Y;N;U,question,75.866,632.671,15.744,37.272
526,69.0,Immunization Status and Gynecological Details,PV_IMMU_GYN,,5.0,Toxoplasmosis,,PVTOXOYN,SANOFI,,,NY_YNU,Y;N;U,question,75.866,581.671,15.744,72.612
527,69.0,Immunization Status and Gynecological Details,PV_IMMU_GYN,,6.0,CMV,,PVCMVYN,SANOFI,,,NY_YNU,Y;N;U,question,75.866,530.671,15.744,27.324
528,69.0,Immunization Status and Gynecological Details,PV_IMMU_GYN,,7.0,Gynecological Details,,PROMPT_PVCONTYN,SANOFI,,,,,question,70.866,479.659,15.948,107.52
529,69.0,Immunization Status and Gynecological Details,PV_IMMU_GYN,,8.0,Contraception,,PVCONTYN,SANOFI,,,NY_YNU,Y;N;U,question,75.866,462.671,15.744,67.908
530,69.0,Immunization Status and Gynecological Details,PV_IMMU_GYN,,9.0,Specify Contraception,,PVCONTSP,SANOFI,,,ROUTE_02,ORAL;INTRAUTERINE;TOPICAL;OTHER,question,80.866,411.671,15.744,107.532
531,69.0,Immunization Status and Gynecological Details,PV_IMMU_GYN,,10.0,"If Other, specify",,PVCONTCM,SANOFI,,,,,question,80.866,344.671,15.744,78.912
532,69.0,Immunization Status and Gynecological Details,PV_IMMU_GYN,,11.0,Normal Menstrual Cycles,,PVMENSYN,SANOFI,,,NY_YNU,Y;N;U,question,75.866,327.671,15.744,123.852
533,69.0,Immunization Status and Gynecological Details,PV_IMMU_GYN,,12.0,Infertility,,PVINFEYN,SANOFI,,,NY_YNU,Y;N;U,question,75.866,276.671,15.744,45.924
534,69.0,Immunization Status and Gynecological Details,PV_IMMU_GYN,,13.0,Specify Infertility Treatment,,PVINFESP,SANOFI,,,,,question,80.866,225.671,15.744,137.784
535,70.0,Pregnancy Information,PV_PREG,AE,2.0,Related AE ID,What is the adverse event identifier?,AESPID,IG,AESPID,IG,,,question,70.866,666.671,15.744,71.232
537,70.0,Pregnancy Information,PV_PREG,,3.0,Date of Last Menses,,PVMENDAT,SANOFI,,,,,question,70.866,649.671,15.744,98.88
538,70.0,Pregnancy Information,PV_PREG,,4.0,Estimated Date of Delivery,,PVEDLDAT,SANOFI,,,,,question,70.866,632.671,15.744,131.472
539,70.0,Pregnancy Information,PV_PREG,,5.0,Medical Assistance or Hospitalization during Pregnancy,,PVASSIYN,SANOFI,,,NY_YN,Y;N,question,70.866,615.671,15.744,270.684
540,70.0,Pregnancy Information,PV_PREG,,6.0,"If yes, specify",,PVASSISP,SANOFI,,,,,question,75.866,580.671,15.744,67.596
541,70.0,Pregnancy Information,PV_PREG,,7.0,Multiple Fetuses,,PVMLTYN,SANOFI,,,NY_YN,Y;N,question,70.866,563.671,15.744,80.244
542,70.0,Pregnancy Information,PV_PREG,,8.0,Relevant Comments about Pregnancy,,PVNARRAT,SANOFI,,,,,question,70.866,528.671,15.744,180.792
543,70.0,Pregnancy Information,PV_PREG,,9.0,Obstetrical History,,PVOBSTH,SANOFI,,,PV_OBS,1;2;3;4;5;6;7,question,70.866,508.671,15.744,91.548
544,70.0,Pregnancy Information,PV_PREG,,10.0,Number,,PVOBSTNB,SANOFI,,,,,question,70.866,141.671,15.744,39.3
545,70.0,Pregnancy Information,PV_PREG,,11.0,Comments,,PVOBSTSP,SANOFI,,,,,question,70.866,124.671,15.744,51.948
546,70.0,Pregnancy Information,PV_PREG,,12.0,Obstetrical History,,PVOBSTH,SANOFI,,,PV_OBS,1;2;3;4;5;6;7,question,70.866,104.671,15.744,91.548
547,71.0,Pregnancy Information,PV_PREG,,2.0,Number,,PVOBSTNB,SANOFI,,,,,question,70.866,355.671,15.744,39.3
548,71.0,Pregnancy Information,PV_PREG,,3.0,Comments,,PVOBSTSP,SANOFI,,,,,question,70.866,338.671,15.744,51.948
549,71.0,Pregnancy Information,PV_PREG,,4.0,Obstetrical History,,PVOBSTH,SANOFI,,,PV_OBS,1;2;3;4;5;6;7,question,70.866,318.671,15.744,91.548
550,72.0,Pregnancy Information,PV_PREG,,2.0,Number,,PVOBSTNB,SANOFI,,,,,question,70.866,551.671,15.744,39.3
551,72.0,Pregnancy Information,PV_PREG,,3.0,Comments,,PVOBSTSP,SANOFI,,,,,question,70.866,534.671,15.744,51.948
552,72.0,Pregnancy Information,PV_PREG,,4.0,Obstetrical History,,PVOBSTH,SANOFI,,,PV_OBS,1;2;3;4;5;6;7,question,70.866,514.671,15.744,91.548
553,72.0,Pregnancy Information,PV_PREG,,5.0,Number,,PVOBSTNB,SANOFI,,,,,question,70.866,147.671,15.744,39.3
554,72.0,Pregnancy Information,PV_PREG,,6.0,Comments,,PVOBSTSP,SANOFI,,,,,question,70.866,130.671,15.744,51.948
555,72.0,Pregnancy Information,PV_PREG,,7.0,Obstetrical History,,PVOBSTH,SANOFI,,,PV_OBS,1;2;3;4;5;6;7,question,70.866,110.671,15.744,91.548
556,73.0,Pregnancy Information,PV_PREG,,2.0,Number,,PVOBSTNB,SANOFI,,,,,question,70.866,355.671,15.744,39.3
557,73.0,Pregnancy Information,PV_PREG,,3.0,Comments,,PVOBSTSP,SANOFI,,,,,question,70.866,338.671,15.744,51.948
558,73.0,Pregnancy Information,PV_PREG,,4.0,Obstetrical History,,PVOBSTH,SANOFI,,,PV_OBS,1;2;3;4;5;6;7,question,70.866,318.671,15.744,91.548
559,74.0,Pregnancy Information,PV_PREG,,2.0,Number,,PVOBSTNB,SANOFI,,,,,question,70.866,551.671,15.744,39.3
560,74.0,Pregnancy Information,PV_PREG,,3.0,Comments,,PVOBSTSP,SANOFI,,,,,question,70.866,534.671,15.744,51.948
561,74.0,Pregnancy Information,PV_PREG,,4.0,Obstetrical History,,PVOBSTH,SANOFI,,,PV_OBS,1;2;3;4;5;6;7,question,70.866,514.671,15.744,91.548
562,74.0,Pregnancy Information,PV_PREG,,39.0,Number,,PVOBSTNB,SANOFI,,,,,question,70.866,147.671,15.744,39.3
563,74.0,Pregnancy Information,PV_PREG,,40.0,Comments,,PVOBSTSP,SANOFI,,,,,question,70.866,130.671,15.744,51.948
564,75.0,Maternal/ Paternal/ Relative History,PV_MAT_PAT_HIST,AE,2.0,Related AE ID,What is the adverse event identifier?,AESPID,IG,AESPID,IG,,,question,70.866,666.671,15.744,71.232
566,75.0,Maternal/ Paternal/ Relative History,PV_MAT_PAT_HIST,,3.0,Maternal/ Paternal/ Relative Obstetrical History,,PVPRGH,SANOFI,,,,,question,70.866,646.671,15.744,229.632
567,75.0,Maternal/ Paternal/ Relative History,PV_MAT_PAT_HIST,,4.0,Occurred,,PVPRGHYN,SANOFI,,,NY_YN,Y;N,question,70.866,615.671,15.744,44.604
568,75.0,Maternal/ Paternal/ Relative History,PV_MAT_PAT_HIST,,5.0,Specify (Relatives and Details),,PVPRGSP,SANOFI,,,,,question,70.866,580.671,15.744,149.448
569,75.0,Maternal/ Paternal/ Relative History,PV_MAT_PAT_HIST,,6.0,Maternal/ Paternal/ Relative Obstetrical History,,PVPRGH,SANOFI,,,,,question,70.866,560.671,15.744,229.632
570,75.0,Maternal/ Paternal/ Relative History,PV_MAT_PAT_HIST,,7.0,Occurred,,PVPRGHYN,SANOFI,,,NY_YN,Y;N,question,70.866,543.671,15.744,44.604
571,75.0,Maternal/ Paternal/ Relative History,PV_MAT_PAT_HIST,,8.0,Specify (Relatives and Details),,PVPRGSP,SANOFI,,,,,question,70.866,508.671,15.744,149.448
572,75.0,Maternal/ Paternal/ Relative History,PV_MAT_PAT_HIST,,9.0,Maternal/ Paternal/ Relative Obstetrical History,,PVPRGH,SANOFI,,,,,question,70.866,488.671,15.744,229.632
573,75.0,Maternal/ Paternal/ Relative History,PV_MAT_PAT_HIST,,10.0,Occurred,,PVPRGHYN,SANOFI,,,NY_YN,Y;N,question,70.866,457.671,15.744,44.604
574,75.0,Maternal/ Paternal/ Relative History,PV_MAT_PAT_HIST,,11.0,Specify (Relatives and Details),,PVPRGSP,SANOFI,,,,,question,70.866,422.671,15.744,149.448
575,75.0,Maternal/ Paternal/ Relative History,PV_MAT_PAT_HIST,,12.0,Maternal/ Paternal/ Relative Obstetrical History,,PVPRGH,SANOFI,,,,,question,70.866,402.671,15.744,229.632
576,75.0,Maternal/ Paternal/ Relative History,PV_MAT_PAT_HIST,,13.0,Occurred,,PVPRGHYN,SANOFI,,,NY_YN,Y;N,question,70.866,385.671,15.744,44.604
577,75.0,Maternal/ Paternal/ Relative History,PV_MAT_PAT_HIST,,14.0,Specify (Relatives and Details),,PVPRGSP,SANOFI,,,,,question,70.866,350.671,15.744,149.448
578,75.0,Maternal/ Paternal/ Relative History,PV_MAT_PAT_HIST,,15.0,Maternal/ Paternal/ Relative Obstetrical History,,PVPRGH,SANOFI,,,,,question,70.866,330.671,15.744,229.632
579,75.0,Maternal/ Paternal/ Relative History,PV_MAT_PAT_HIST,,16.0,Occurred,,PVPRGHYN,SANOFI,,,NY_YN,Y;N,question,70.866,313.671,15.744,44.604
580,75.0,Maternal/ Paternal/ Relative History,PV_MAT_PAT_HIST,,17.0,Specify (Relatives and Details),,PVPRGSP,SANOFI,,,,,question,70.866,278.671,15.744,149.448
581,75.0,Maternal/ Paternal/ Relative History,PV_MAT_PAT_HIST,,18.0,Maternal/ Paternal/ Relative Obstetrical History,,PVPRGH,SANOFI,,,,,question,70.866,258.671,15.744,229.632
582,75.0,Maternal/ Paternal/ Relative History,PV_MAT_PAT_HIST,,19.0,Occurred,,PVPRGHYN,SANOFI,,,NY_YN,Y;N,question,70.866,227.671,15.744,44.604
583,75.0,Maternal/ Paternal/ Relative History,PV_MAT_PAT_HIST,,20.0,Specify (Relatives and Details),,PVPRGSP,SANOFI,,,,,question,70.866,192.671,15.744,149.448
584,75.0,Maternal/ Paternal/ Relative History,PV_MAT_PAT_HIST,,21.0,Maternal/ Paternal/ Relative Obstetrical History,,PVPRGH,SANOFI,,,,,question,70.866,172.671,15.744,229.632
585,75.0,Maternal/ Paternal/ Relative History,PV_MAT_PAT_HIST,,22.0,Occurred,,PVPRGHYN,SANOFI,,,NY_YN,Y;N,question,70.866,141.671,15.744,44.604
586,75.0,Maternal/ Paternal/ Relative History,PV_MAT_PAT_HIST,,23.0,Specify (Relatives and Details),,PVPRGSP,SANOFI,,,,,question,70.866,106.671,15.744,149.448
587,75.0,Maternal/ Paternal/ Relative History,PV_MAT_PAT_HIST,,24.0,Maternal/ Paternal/ Relative Obstetrical History,,PVPRGH,SANOFI,,,,,question,70.866,86.671,15.744,229.632
588,75.0,Maternal/ Paternal/ Relative History,PV_MAT_PAT_HIST,,25.0,Occurred,,PVPRGHYN,SANOFI,,,NY_YN,Y;N,question,70.866,69.671,15.744,44.604
589,76.0,Maternal/ Paternal/ Relative History,PV_MAT_PAT_HIST,,2.0,Specify (Relatives and Details),,PVPRGSP,SANOFI,,,,,question,70.866,647.671,15.744,149.448
590,77.0,Prenatal Testing,PV_PRENATAL,AE,2.0,Related AE ID,What is the adverse event identifier?,AESPID,IG,AESPID,IG,,,question,70.866,666.671,15.744,71.232
592,77.0,Prenatal Testing,PV_PRENATAL,,3.0,Examination,,PVEXA,SANOFI,,,,,question,70.866,646.671,15.744,61.248
983,77.0,Prenatal Testing,PV_PRENATAL,,4.0,Examination Details for Genetics Screening and Other Examination,,PVEXADTL,SANOFI,,,,,question,70.866,629.671,15.744,261.66
593,77.0,Prenatal Testing,PV_PRENATAL,,5.0,Examination,,PVEXA,SANOFI,,,,,question,70.866,615.671,15.744,61.248
594,77.0,Prenatal Testing,PV_PRENATAL,,6.0,Examination Date,,PVEXADAT,SANOFI,,,,,question,70.866,598.671,15.744,86.868
595,77.0,Prenatal Testing,PV_PRENATAL,,7.0,Result,,PVEXANAB,SANOFI,,,NORMABNM_01,NORMAL;ABNORMAL,question,70.866,581.671,15.744,30.624
596,77.0,Prenatal Testing,PV_PRENATAL,,8.0,Abnormalities,,PVEXASP,SANOFI,,,,,question,70.866,546.671,15.744,68.58
597,77.0,Prenatal Testing,PV_PRENATAL,,9.0,Examination,,PVEXA,SANOFI,,,,,question,70.866,526.671,15.744,61.248
598,77.0,Prenatal Testing,PV_PRENATAL,,11.0,Examination,,PVEXA,SANOFI,,,,,question,70.866,481.671,15.744,61.248
599,77.0,Prenatal Testing,PV_PRENATAL,,12.0,Examination Date,,PVEXADAT,SANOFI,,,,,question,70.866,464.671,15.744,86.868
600,77.0,Prenatal Testing,PV_PRENATAL,,13.0,Result,,PVEXANAB,SANOFI,,,NORMABNM_01,NORMAL;ABNORMAL,question,70.866,447.671,15.744,30.624
601,77.0,Prenatal Testing,PV_PRENATAL,,14.0,Abnormalities,,PVEXASP,SANOFI,,,,,question,70.866,412.671,15.744,68.58
602,77.0,Prenatal Testing,PV_PRENATAL,,15.0,Examination,,PVEXA,SANOFI,,,,,question,70.866,392.671,15.744,61.248
603,77.0,Prenatal Testing,PV_PRENATAL,,17.0,Examination,,PVEXA,SANOFI,,,,,question,70.866,361.671,15.744,61.248
604,77.0,Prenatal Testing,PV_PRENATAL,,18.0,Examination Date,,PVEXADAT,SANOFI,,,,,question,70.866,344.671,15.744,86.868
605,77.0,Prenatal Testing,PV_PRENATAL,,19.0,Result,,PVEXANAB,SANOFI,,,NORMABNM_01,NORMAL;ABNORMAL,question,70.866,327.671,15.744,30.624
606,77.0,Prenatal Testing,PV_PRENATAL,,20.0,Abnormalities,,PVEXASP,SANOFI,,,,,question,70.866,292.671,15.744,68.58
607,77.0,Prenatal Testing,PV_PRENATAL,,21.0,Examination,,PVEXA,SANOFI,,,,,question,70.866,272.671,15.744,61.248
608,77.0,Prenatal Testing,PV_PRENATAL,,23.0,Examination,,PVEXA,SANOFI,,,,,question,70.866,241.671,15.744,61.248
609,77.0,Prenatal Testing,PV_PRENATAL,,24.0,Examination Date,,PVEXADAT,SANOFI,,,,,question,70.866,224.671,15.744,86.868
610,77.0,Prenatal Testing,PV_PRENATAL,,25.0,Result,,PVEXANAB,SANOFI,,,NORMABNM_01,NORMAL;ABNORMAL,question,70.866,207.671,15.744,30.624
611,77.0,Prenatal Testing,PV_PRENATAL,,26.0,Abnormalities,,PVEXASP,SANOFI,,,,,question,70.866,172.671,15.744,68.58
612,77.0,Prenatal Testing,PV_PRENATAL,,27.0,Examination,,PVEXA,SANOFI,,,,,question,70.866,152.671,15.744,61.248
613,77.0,Prenatal Testing,PV_PRENATAL,,29.0,Examination,,PVEXA,SANOFI,,,,,question,70.866,121.671,15.744,61.248
614,77.0,Prenatal Testing,PV_PRENATAL,,30.0,Examination Date,,PVEXADAT,SANOFI,,,,,question,70.866,104.671,15.744,86.868
615,77.0,Prenatal Testing,PV_PRENATAL,,31.0,Result,,PVEXANAB,SANOFI,,,NORMABNM_01,NORMAL;ABNORMAL,question,70.866,87.671,15.744,30.624
616,78.0,Prenatal Testing,PV_PRENATAL,,2.0,Abnormalities,,PVEXASP,SANOFI,,,,,question,70.866,666.671,15.744,68.58
617,78.0,Prenatal Testing,PV_PRENATAL,,3.0,Examination,,PVEXA,SANOFI,,,,,question,70.866,646.671,15.744,61.248
618,78.0,Prenatal Testing,PV_PRENATAL,,5.0,Examination,,PVEXA,SANOFI,,,,,question,70.866,601.671,15.744,61.248
619,78.0,Prenatal Testing,PV_PRENATAL,,6.0,Examination Date,,PVEXADAT,SANOFI,,,,,question,70.866,584.671,15.744,86.868
620,78.0,Prenatal Testing,PV_PRENATAL,,7.0,Result,,PVEXANAB,SANOFI,,,NORMABNM_01,NORMAL;ABNORMAL,question,70.866,567.671,15.744,30.624
621,78.0,Prenatal Testing,PV_PRENATAL,,8.0,Abnormalities,,PVEXASP,SANOFI,,,,,question,70.866,532.671,15.744,68.58
622,78.0,Prenatal Testing,PV_PRENATAL,,9.0,Examination,,PVEXA,SANOFI,,,,,question,70.866,512.671,15.744,61.248
623,78.0,Prenatal Testing,PV_PRENATAL,,11.0,Examination,,PVEXA,SANOFI,,,,,question,70.866,481.671,15.744,61.248
624,78.0,Prenatal Testing,PV_PRENATAL,,12.0,Examination Date,,PVEXADAT,SANOFI,,,,,question,70.866,464.671,15.744,86.868
625,78.0,Prenatal Testing,PV_PRENATAL,,13.0,Result,,PVEXANAB,SANOFI,,,NORMABNM_01,NORMAL;ABNORMAL,question,70.866,447.671,15.744,30.624
626,78.0,Prenatal Testing,PV_PRENATAL,,14.0,Abnormalities,,PVEXASP,SANOFI,,,,,question,70.866,412.671,15.744,68.58
627,79.0,Pregnancy Outcome,PV_OUTCOME,AE,2.0,Related AE ID,What is the adverse event identifier?,AESPID,IG,AESPID,IG,,,question,70.866,666.671,15.744,71.232
984,79.0,Pregnancy Outcome,PV_OUTCOME,,3.0,"Delivery, Spontaneous Abortion, Termination or Fetal Death Date",,PVDLDAT,SANOFI,,,,,question,70.866,649.671,15.744,292.356
629,79.0,Pregnancy Outcome,PV_OUTCOME,,5.0,Enter Details for each Child/Fetus,,PROMPT_PVCHSEX,SANOFI,,,,,question,70.866,618.659,15.948,166.464
630,79.0,Pregnancy Outcome,PV_OUTCOME,,6.0,Sex,,PVCHSEX,SANOFI,,,SEX,M;F,question,70.866,601.671,15.744,17.988
631,79.0,Pregnancy Outcome,PV_OUTCOME,,7.0,APGAR Score (1 min),,PVAPGAR1,SANOFI,,,,,question,70.866,566.671,15.744,109.596
632,79.0,Pregnancy Outcome,PV_OUTCOME,,8.0,APGAR Score (5 min),,PVAPGAR2,SANOFI,,,,,question,70.866,549.671,15.744,109.596
633,79.0,Pregnancy Outcome,PV_OUTCOME,,9.0,Delivery Mode,,PVDLMODE,SANOFI,,,PV_DELMODE,VAGINAL;CAESAREAN SECTION,question,70.866,532.671,15.744,72.924
634,79.0,Pregnancy Outcome,PV_OUTCOME,,10.0,Week of Gestation,,PVGESWK,SANOFI,,,,,question,70.866,497.671,15.744,89.88
635,79.0,Pregnancy Outcome,PV_OUTCOME,,11.0,Weight (g),,PVCHWT,SANOFI,,,,,question,70.866,480.671,15.744,52.272
636,79.0,Pregnancy Outcome,PV_OUTCOME,,12.0,Height (cm),,PVCHHT,SANOFI,,,,,question,70.866,463.671,15.744,58.26
637,79.0,Pregnancy Outcome,PV_OUTCOME,,13.0,Head Circum (cm),,PVCHHC,SANOFI,,,,,question,70.866,446.671,15.744,89.88
638,79.0,Pregnancy Outcome,PV_OUTCOME,,14.0,Outcome,,PVCHOUT,SANOFI,,,PV_OUTCOME,NORMAL LIVE BIRTH;ABNORMAL LIVE BIRTH;STILLBIRTH;LATE FETAL DEATH (AT LEAST 28 WEEKS OF GESTATION);EARLY FETAL DEATH (20-27 WEEKS OF GESTATION);SPONTANEOUS ABORTION (LESS THAN 20 WEEKS OF GESTATION);ECTOPIC PREGNANCY;ELECTIVE TERMINATION;MATERNAL DEATH RESULTING IN FETAL DEATH,question,70.866,429.671,15.744,43.944
639,79.0,Pregnancy Outcome,PV_OUTCOME,,15.0,Congenital Anomaly,,PVCHANYN,SANOFI,,,NY_YN,Y;N,question,70.866,234.671,15.744,100.224
640,79.0,Pregnancy Outcome,PV_OUTCOME,,16.0,"If Yes, specify Anomaly",,PVCHSP,SANOFI,,,,,question,70.866,199.671,15.744,117.888
641,79.0,Pregnancy Outcome,PV_OUTCOME,,17.0,If Neonate Death: Cause,,PVCHDTSP,SANOFI,,,,,question,70.866,182.671,15.744,118.164
985,79.0,Pregnancy Outcome,PV_OUTCOME,,18.0,"In case of abortion, fetal death or maternal death, was an autopsy performed?",,PVAUTYN,SANOFI,,,,,question,70.866,165.671,15.744,311.94
642,79.0,Pregnancy Outcome,PV_OUTCOME,,20.0,If Autopsy: Results,,PVAUTOCM,SANOFI,,,,,question,75.866,114.671,15.744,93.264
643,79.0,Pregnancy Outcome,PV_OUTCOME,,21.0,Labor/Delivery,,PROMPT_PVDLMO,SANOFI,,,,,question,70.866,97.659,15.948,73.908
644,79.0,Pregnancy Outcome,PV_OUTCOME,,22.0,Complication during Labor or Delivery,,PVDLCPYN,SANOFI,,,NY_YN,Y;N,question,75.866,80.671,15.744,189.132
645,80.0,Pregnancy Outcome,PV_OUTCOME,,2.0,"If any complication, specify",,PVDLCPSP,SANOFI,,,,,question,80.866,666.671,15.744,134.496
986,80.0,Pregnancy Outcome,PV_OUTCOME,,3.0,"Medication during Labor (If Yes, report in Medication linked to Pregnancy CRF)",,PVDLCMYN,SANOFI,,,,,question,75.866,649.671,15.744,307.008
646,80.0,Pregnancy Outcome,PV_OUTCOME,,5.0,Clear Amniotic Fluid,,PVCAMNYN,SANOFI,,,NY_YN,Y;N,question,75.866,614.671,15.744,102.54
647,80.0,Pregnancy Outcome,PV_OUTCOME,,6.0,Normal Placenta,,PVNPLAYN,SANOFI,,,NY_YN,Y;N,question,75.866,579.671,15.744,80.208
648,81.0,Newborn Condition,PV_NEWBORN,AE,2.0,Related AE ID,What is the adverse event identifier?,AESPID,IG,AESPID,IG,,,question,70.866,666.671,15.744,71.232
650,81.0,Newborn Condition,PV_NEWBORN,,3.0,Newborn Condition,,PVNBCOND,SANOFI,,,,,question,70.866,646.671,15.744,95.604
651,81.0,Newborn Condition,PV_NEWBORN,,4.0,Occurred,,PVNBYN,SANOFI,,,NY_YN,Y;N,question,70.866,615.671,15.744,44.604
652,81.0,Newborn Condition,PV_NEWBORN,,5.0,"If yes, specify",,PVNBSP,SANOFI,,,,,question,70.866,580.671,15.744,67.596
653,81.0,Newborn Condition,PV_NEWBORN,,6.0,Newborn Condition,,PVNBCOND,SANOFI,,,,,question,70.866,560.671,15.744,95.604
654,81.0,Newborn Condition,PV_NEWBORN,,7.0,Occurred,,PVNBYN,SANOFI,,,NY_YN,Y;N,question,70.866,543.671,15.744,44.604
655,81.0,Newborn Condition,PV_NEWBORN,,8.0,"If yes, specify",,PVNBSP,SANOFI,,,,,question,70.866,508.671,15.744,67.596
656,81.0,Newborn Condition,PV_NEWBORN,,9.0,Newborn Condition,,PVNBCOND,SANOFI,,,,,question,70.866,488.671,15.744,95.604
657,81.0,Newborn Condition,PV_NEWBORN,,10.0,Occurred,,PVNBYN,SANOFI,,,NY_YN,Y;N,question,70.866,457.671,15.744,44.604
658,81.0,Newborn Condition,PV_NEWBORN,,11.0,"If yes, specify",,PVNBSP,SANOFI,,,,,question,70.866,422.671,15.744,67.596
659,81.0,Newborn Condition,PV_NEWBORN,,12.0,Newborn Condition,,PVNBCOND,SANOFI,,,,,question,70.866,402.671,15.744,95.604
660,81.0,Newborn Condition,PV_NEWBORN,,13.0,Occurred,,PVNBYN,SANOFI,,,NY_YN,Y;N,question,70.866,371.671,15.744,44.604
661,81.0,Newborn Condition,PV_NEWBORN,,14.0,"If yes, specify",,PVNBSP,SANOFI,,,,,question,70.866,336.671,15.744,67.596
662,81.0,Newborn Condition,PV_NEWBORN,,15.0,Newborn Condition,,PVNBCOND,SANOFI,,,,,question,70.866,316.671,15.744,95.604
663,81.0,Newborn Condition,PV_NEWBORN,,16.0,Occurred,,PVNBYN,SANOFI,,,NY_YN,Y;N,question,70.866,299.671,15.744,44.604
664,81.0,Newborn Condition,PV_NEWBORN,,17.0,"If yes, specify",,PVNBSP,SANOFI,,,,,question,70.866,264.671,15.744,67.596
665,81.0,Newborn Condition,PV_NEWBORN,,18.0,Newborn Condition,,PVNBCOND,SANOFI,,,,,question,70.866,244.671,15.744,95.604
666,81.0,Newborn Condition,PV_NEWBORN,,19.0,Occurred,,PVNBYN,SANOFI,,,NY_YN,Y;N,question,70.866,171.671,15.744,44.604
667,81.0,Newborn Condition,PV_NEWBORN,,20.0,"If yes, specify",,PVNBSP,SANOFI,,,,,question,70.866,136.671,15.744,67.596
668,82.0,Medications linked to Pregnancy,PV_MED_PREG,AE,2.0,Related AE ID,What is the adverse event identifier?,AESPID,IG,AESPID,IG,,,question,70.866,666.671,15.744,71.232
670,82.0,Medications linked to Pregnancy,PV_MED_PREG,,3.0,Product,,PVCMTERM,SANOFI,,,,,question,70.866,649.671,15.744,37.308
671,82.0,Medications linked to Pregnancy,PV_MED_PREG,,4.0,Prior to or at Time of Conception,,PVCMPRIO,SANOFI,,,,,question,70.866,632.671,15.744,160.5
672,82.0,Medications linked to Pregnancy,PV_MED_PREG,,5.0,During Pregnancy,,PVCMDURI,SANOFI,,,,,question,70.866,615.671,15.744,87.6
673,82.0,Medications linked to Pregnancy,PV_MED_PREG,,6.0,Labor and Delivery,,PVCMDEL,SANOFI,,,,,question,70.866,598.671,15.744,93.888
674,82.0,Medications linked to Pregnancy,PV_MED_PREG,,7.0,Breast Feeding,,PVCMBREA,SANOFI,,,,,question,70.866,581.671,15.744,72.24
675,82.0,Medications linked to Pregnancy,PV_MED_PREG,,8.0,Indication,,PVCMINDI,SANOFI,,,,,question,70.866,564.671,15.744,48.6
676,82.0,Medications linked to Pregnancy,PV_MED_PREG,,9.0,Dose and Unit,,PVCMDOSE,SANOFI,,,,,question,70.866,547.671,15.744,69.276
677,82.0,Medications linked to Pregnancy,PV_MED_PREG,,10.0,Route,,PVCMROUT,SANOFI,,,ROUTE,AURICULAR (OTIC);BUCCAL;CONJUNCTIVAL;CUTANEOUS;DENTAL;DIETARY;ELECTRO-OSMOSIS;ENDOCERVICAL;ENDOSINUSIAL;ENDOTRACHEAL;ENTERAL;EPIDURAL;EXTRA-AMNIOTIC;EXTRACORPOREAL;HEMODIALYSIS;INFILTRATION;INTERSTITIAL;INTRA-ABDOMINAL;INTRA-AMNIOTIC;INTRA-ARTERIAL;INTRA-ARTICULAR;INTRABILIARY;INTRABRONCHIAL;INTRABURSAL;INTRACAMERAL;INTRACARDIAC;INTRACARTILAGINOUS;INTRACAUDAL;INTRACAVERNOUS;INTRACAVITARY;INTRACEREBRAL;INTRACISTERNAL;INTRACORNEAL;INTRACORONAL- DENTAL;INTRACORONARY;INTRACORPORUS CAVERNOSUM;INTRADERMAL;INTRADISCAL;INTRADUCTAL;INTRADUODENAL;INTRADURAL;INTRAEPIDERMAL;INTRAESOPHAGEAL;INTRAGASTRIC;INTRAGINGIVAL;INTRAHEPATIC;INTRAILEAL;INTRAJEJUNAL;INTRALESIONAL;INTRALUMINAL;INTRALYMPHATIC;INTRAMEDULLARY;INTRAMENINGEAL;INTRAMUSCULAR;INTRAMUSCULAR OR SUBCUTANEOUS;INTRANODAL;INTRAOCULAR;INTRAOVARIAN;INTRAPALATAL;INTRAPARENCHYMAL;INTRAPERICARDIAL;INTRAPERITONEAL;INTRAPLEURAL;INTRAPROSTATIC;INTRAPULMONARY;INTRASINAL;INTRASPINAL;INTRASTOMAL;INTRASYNOVIAL;INTRATENDINOUS;INTRATESTICULAR;INTRATHECAL;INTRATHORACIC;INTRATUBULAR;INTRATUMOR;INTRATYMPANIC;INTRAUTERINE;INTRAVASCULAR;INTRAVENOUS;INTRAVENOUS BOLUS;INTRAVENOUS DRIP;INTRAVENTRICULAR;INTRAVESICAL;INTRAVITREAL;IONTOPHORESIS;IRRIGATION;LARYNGEAL;NASAL;NASOGASTRIC;OCCLUSIVE DRESSING TECHNIQUE;OPHTHALMIC;ORAL;ORAL GAVAGE;OROMUCOSAL;OROPHARYNGEAL;PARENTERAL;PERCUTANEOUS;PERIARTICULAR;PERIDURAL;PERINEURAL;PERIODONTAL;PERIVENOUS;RECTAL;RESPIRATORY (INHALATION);RETROBULBAR;SOFT TISSUE;SUBARACHNOID;SUBCONJUNCTIVAL;SUBCUTANEOUS;SUBLINGUAL;SUBMUCOSAL;SUBTENON;TOPICAL;TRANSDERMAL;TRANSMAMMARY;TRANSMUCOSAL;TRANSPLACENTAL;TRANSTRACHEAL;TRANSTYMPANIC;UNASSIGNED;URETERAL;URETHRAL;VAGINAL;OTHER;UNKNOWN;NOT APPLICABLE,question,70.866,530.671,15.744,28.632
678,85.0,Medications linked to Pregnancy,PV_MED_PREG,,2.0,Start Date,,PVCMSDAT,SANOFI,,,,,question,70.866,327.671,15.744,48.252
679,85.0,Medications linked to Pregnancy,PV_MED_PREG,,3.0,End Date,,PVCMEDAT,SANOFI,,,,,question,70.866,310.671,15.744,44.94
680,85.0,Medications linked to Pregnancy,PV_MED_PREG,,4.0,Duration (Days) (If start or end dates are not known),,PVCMDURA,SANOFI,,,,,question,70.866,293.671,15.744,253.428
681,86.0,Non Serious Adverse Events occurring during Pregnancy,PV_NSAE_PREG,AE,2.0,Related AE ID,What is the adverse event identifier?,AESPID,IG,AESPID,IG,,,question,70.866,666.671,15.744,71.232
987,86.0,Non Serious Adverse Events occurring during Pregnancy,PV_NSAE_PREG,,3.0,Did the mother experience any relevant non-serious adverse events during the pregnancy?,,PVNSAEYN,SANOFI,,,,,question,70.866,649.671,15.744,287.976
988,86.0,Non Serious Adverse Events occurring during Pregnancy,PV_NSAE_PREG,,5.0,"If Yes, describe (Diagnosis, start date, stop date and corrective medication)",,PVNSAECM,SANOFI,,,,,question,70.866,614.671,15.744,300.288
683,87.0,6 Month Follow-up,PV_MONTH_FOLLOWUP,,2.0,To be completed only if it is required by local regulation.,,PROMPT_AESPID,SANOFI,,,,,question,70.866,666.659,15.948,274.704
684,87.0,6 Month Follow-up,PV_MONTH_FOLLOWUP,,3.0,Provide information on the neonate outcome at 6 months after birth ( i.e. neonate's health status).,,PROMPT_AESPID2,SANOFI,,,,,question,70.866,649.659,15.948,469.476
685,87.0,6 Month Follow-up,PV_MONTH_FOLLOWUP,AE,4.0,Related AE ID,What is the adverse event identifier?,AESPID,IG,AESPID,IG,,,question,70.866,618.671,15.744,71.232
687,87.0,6 Month Follow-up,PV_MONTH_FOLLOWUP,,5.0,6 Months Follow-up,,PV6MTHFU,SANOFI,,,,,question,70.866,601.671,15.744,98.64
688,88.0,Adverse Events YesNo,AE_YN,AE,2.0,Category of Adverse Event,What is the category of the adverse event?,AECAT,IG,AECAT,IG,AECAT,ADVERSE EVENT;ADVERSE EVENT OF SPECIAL INTEREST;ALLERGIC REACTION;ALT INCREASE;ASTHMA EXACERBATION EVENT;BLEEDING EVENT;BONE FRACTURE;DRUG ALLERGY EVENT;EPISTAXIS EVENT;FOREIGN BODY REACTION EVENT;HYPERCALCEMIA;HYPOGLYCEMIA;INCREASED CALCITONIN;INCREASED LIPASE/AMYLASE;INFECTION EVENT;INJECTION SITE REACTION;METABOLIC ACIDOSIS EVENT;NEUROLOGIC DISORDER;OVERDOSE;PANCREATIC EVENT;PERIPHERAL NEUROPATHY EVENT;PREGNANCY;RENAL FAILURE;SERIOUS HYPOGLYCEMIA;SOLICITED;SUSPECTED OR CONFIRMED CEREBROVASCULAR EVENT;SUSPECTED OR CONFIRMED DIABETIC KETOACIDOSIS;SUSPECTED OR CONFIRMED HEART FAILURE;SUSPECTED OR CONFIRMED MYOCARDIAL INFARCTION / UNSTABLE ANGINA;UNSOLICITED;VASCULITIS EVENT;OTHER,question,70.866,663.671,15.744,130.86
690,88.0,Adverse Events YesNo,AE_YN,AE,3.0,Subcategory of Adverse Event,What is the subcategory of the adverse event?,AESCAT,IG,AESCAT,IG,AESCAT_01,ADMINISTRATION SITE;SYSTEMIC,question,70.866,74.671,15.744,146.856
691,89.0,Adverse Events YesNo,AE_YN,,2.0,Were there any Adverse Event to report?,Were any adverse events experienced?,AEYN,IG,,,NY_YN,Y;N,question,70.866,647.671,15.744,196.404
692,89.0,Adverse Events YesNo,AE_YN,AE,3.0,Category of Adverse Event,What is the category of the adverse event?,AECAT,IG,AECAT,IG,AECAT,ADVERSE EVENT;ADVERSE EVENT OF SPECIAL INTEREST;ALLERGIC REACTION;ALT INCREASE;ASTHMA EXACERBATION EVENT;BLEEDING EVENT;BONE FRACTURE;DRUG ALLERGY EVENT;EPISTAXIS EVENT;FOREIGN BODY REACTION EVENT;HYPERCALCEMIA;HYPOGLYCEMIA;INCREASED CALCITONIN;INCREASED LIPASE/AMYLASE;INFECTION EVENT;INJECTION SITE REACTION;METABOLIC ACIDOSIS EVENT;NEUROLOGIC DISORDER;OVERDOSE;PANCREATIC EVENT;PERIPHERAL NEUROPATHY EVENT;PREGNANCY;RENAL FAILURE;SERIOUS HYPOGLYCEMIA;SOLICITED;SUSPECTED OR CONFIRMED CEREBROVASCULAR EVENT;SUSPECTED OR CONFIRMED DIABETIC KETOACIDOSIS;SUSPECTED OR CONFIRMED HEART FAILURE;SUSPECTED OR CONFIRMED MYOCARDIAL INFARCTION / UNSTABLE ANGINA;UNSOLICITED;VASCULITIS EVENT;OTHER,question,70.866,609.671,15.744,130.86
694,90.0,Adverse Events YesNo,AE_YN,AE,2.0,Subcategory of Adverse Event,What is the subcategory of the adverse event?,AESCAT,IG,AESCAT,IG,AESCAT_01,ADMINISTRATION SITE;SYSTEMIC,question,70.866,631.671,15.744,146.856
695,90.0,Adverse Events YesNo,AE_YN,,3.0,Were there any Adverse Event to report?,Were any adverse events experienced?,AEYN,IG,,,NY_YN,Y;N,question,70.866,596.671,15.744,196.404
696,91.0,Unsolicited Injection Site Reactions,AE_UISR,AE,2.0,Category of Adverse Event,What is the category of the adverse event?,AECAT,IG,AECAT,IG,AECAT,ADVERSE EVENT;ADVERSE EVENT OF SPECIAL INTEREST;ALLERGIC REACTION;ALT INCREASE;ASTHMA EXACERBATION EVENT;BLEEDING EVENT;BONE FRACTURE;DRUG ALLERGY EVENT;EPISTAXIS EVENT;FOREIGN BODY REACTION EVENT;HYPERCALCEMIA;HYPOGLYCEMIA;INCREASED CALCITONIN;INCREASED LIPASE/AMYLASE;INFECTION EVENT;INJECTION SITE REACTION;METABOLIC ACIDOSIS EVENT;NEUROLOGIC DISORDER;OVERDOSE;PANCREATIC EVENT;PERIPHERAL NEUROPATHY EVENT;PREGNANCY;RENAL FAILURE;SERIOUS HYPOGLYCEMIA;SOLICITED;SUSPECTED OR CONFIRMED CEREBROVASCULAR EVENT;SUSPECTED OR CONFIRMED DIABETIC KETOACIDOSIS;SUSPECTED OR CONFIRMED HEART FAILURE;SUSPECTED OR CONFIRMED MYOCARDIAL INFARCTION / UNSTABLE ANGINA;UNSOLICITED;VASCULITIS EVENT;OTHER,question,70.866,666.671,15.744,130.86
698,91.0,Unsolicited Injection Site Reactions,AE_UISR,AE,3.0,Subcategory of Adverse Event,What is the subcategory of the adverse event?,AESCAT,IG,AESCAT,IG,AESCAT_01,ADMINISTRATION SITE;SYSTEMIC,question,70.866,77.671,15.744,146.856
699,92.0,Unsolicited Injection Site Reactions,AE_UISR,AE,3.0,Unique ID,What is the adverse event identifier?,AESPID,IG,AESPID,IG,,,question,70.866,647.671,15.744,50.964
989,92.0,Unsolicited Injection Site Reactions,AE_UISR,,4.0,Enter any Unsolicited Injection Site Reactions occurring within the 28-day collection period as well as SAEs during the entire study period including during the 90-day fup period.,,PROMPT_UNSOL,SANOFI,,,,,question,70.866,630.659,15.948,480.42
701,92.0,Unsolicited Injection Site Reactions,AE_UISR,AE,6.0,Adverse Event,What is the adverse event term?,AETERM,IG,AETERM,IG,,,question,70.866,599.671,15.744,70.92
703,92.0,Unsolicited Injection Site Reactions,AE_UISR,AE,7.0,Start Date,What is the adverse event start date?,AESTDAT,IG,AESTDTC,IG,,,question,70.866,582.671,15.744,48.252
705,92.0,Unsolicited Injection Site Reactions,AE_UISR,SUPPAE,8.0,Appeared after Visit,,AECYCVID,SANOFI,AECYCVID,SANOFI,,,question,70.866,565.671,15.744,97.86
993,92.0,Unsolicited Injection Site Reactions,AE_UISR,,9.0,"If the reaction is ongoing, enter the Maximum Intensity/Measurement available at the time of reporting.",,PROMPT_AEONGO,SANOFI,,,,,question,70.866,548.659,15.948,446.832
706,92.0,Unsolicited Injection Site Reactions,AE_UISR,AE,11.0,Ongoing?,Is the adverse event ongoing?,AEONGO,IG,AEENRTPT; AEENRF,IG,,,question,80.866,517.671,15.744,47.304
994,92.0,Unsolicited Injection Site Reactions,AE_UISR,,12.0,"When the End Date is obtained, ensure that the Maximum Intensity/Measurement is still correct while considering the entire duration.",,PROMPT_AESEV1,SANOFI,,,,,question,70.866,500.659,15.948,460.176
707,92.0,Unsolicited Injection Site Reactions,AE_UISR,AE,14.0,End Date,What was the adverse event end date?,AEENDAT,IG,AEENDTC,IG,,,question,80.866,469.671,15.744,44.94
995,92.0,Unsolicited Injection Site Reactions,AE_UISR,,15.0,Enter the Maximum Measurement OR Maximum Intensity considering the entire Adverse Event duration.,,PROMPT_AESEV2,SANOFI,,,,,question,70.866,452.659,15.948,457.8
996,92.0,Unsolicited Injection Site Reactions,AE_UISR,SUPPAE,17.0,"Maximum Measurement (If the Maximum Measurement is missing, enter 'UNK' for Unknown.)",,AEMS,SANOFI,AEMS,SANOFI,,,question,75.866,421.671,15.948,280.38
709,92.0,Unsolicited Injection Site Reactions,AE_UISR,SUPPAE,20.0,Maximum Measurement Unit,,AEMSU,SANOFI,AEMSU,SANOFI,UNIT,%;% INHIBITION;%(v/v);%(w/v);%(w/w);%/min;%cells/area;/100 HPFs;/100 WBC;/10^3 cells;/HPF;/L;/LPF;/VF;/dL;/day;/h;/kg;/mL;/mm3;/month;/nL;/pL;/uL;/wk;/year;1/dilution;100 IU/mL;10^10/L;10^11/L;10^12 IU/L;10^12/L;10^3 CFU;10^3 CFU/g;10^3 CFU/mL;10^3 DNA copies/mL;10^3 RNA copies/mL;10^3 copies/mL;10^3 organisms;10^3 organisms/g;10^3 organisms/mL;10^3/L;10^3/hpf;10^3/mm3;10^3/mm4;10^3/uL;10^4/L;10^4/hpf;10^5/L;10^5/hpf;10^6 CFU;10^6 CFU/g;10^6 CFU/mL;10^6 DNA copies/mL;10^6 IU;10^6 IU/mL;10^6 RNA copies/mL;10^6 copies/mL;10^6 organisms;10^6 organisms/g;10^6 organisms/mL;10^6 organisms/mg;10^6/L;10^6/g;10^6/hpf;10^6/mm3;10^6/uL;10^7/L;10^8/L;10^9 CFU;10^9 CFU/g;10^9 CFU/mL;10^9 organisms;10^9 organisms/g;10^9 organisms/mL;10^9 organisms/mg;10^9/L;AFU;AI;AMPULE;APL U/mL;APPLICATION;ASC;AU;AU/mL;AU/min;AgU/mL;Antibody Unit;BAG;BAR;BAU;BAU/mL;BE/mL;BEATS/MIN;BISCUIT;BLOCKS;BOLUS;BOTTLE;BOX;BREATHS/MIN;BU;BU/mL;Bq;Bq/L;Bq/g;Bq/kg;Bq/mL;Bq/mg;Bq/uL;Bq/ug;C;CAE;CAN;CAPFUL;CAPLET;CAPSULE;CARTRIDGE;CASE;CCID 50/dose;CCID 50/mL;CFU/g;CFU/mL;CIGAR;CIGARETTE;COAT;COI;CONTAINER;CUP;CYLINDER;Ci;Ci/L;Ci/g;Ci/kg;Ci/mL;Ci/mg;Ci/uL;Ci/ug;Coulomb;Ct;DAYS;DAgU;DAgU/mL;DIOPTER;DISK;DNA copies/mL;DPM;DRUM;EID 50/dose;EID 50/mL;ELISA unit;ELISA unit/dose;ELISA unit/mL;EU;Enzyme U;F;FEU;FINGERTIP UNIT;Farad;Frames/s;GBq;GBq/g;GBq/mg;GBq/ug;GI/L;GLASS;GPL U/mL;Gauss;Gy;HAU/100 uL;HEP;HOMEOPATHIC DILUTION;HOURS;HPF;Hb Fract.;Hemolytic Unit;Henry;Hounsfield Unit;Hz;IMPLANT;INDEX VALUE;INHALATION;IU;IU/L;IU/dL;IU/g;IU/kg;IU/kg/h;IU/mL;IU/mg;IU^4;IV;Immune Status Ratio (ISR);JAR;Joule;KALLIKREIN INHIBITOR UNIT;KIT;L;L/L;L/h;L/h/m2;L/kg;L/min;L/min/m2;L/s;LB;LOZENGE;LPF;Log10 ELISA unit;Log10 ELISA unit/dose;Log10 GEq/mL;Log10 PFU/mL;MBq;MBq/uL;MESF;MFI;MHz;MONTHS;MPL U/mL;Mile;NEBULE;NEEDLE GAUGE;NIU;Newton;PACK;PACKAGE;PACKET;PATCH;PELLET;PFU;PFU/dose;PFU/mL;PIPE;PIXEL;PIXELS/cm;PIXELS/in;PNU/mL;POINT;POUCH;PRESSOR UNITS;PUFF;Pa;Pack Year;Perfusion unit;Perfusion unit*sec;QUANTITY SUFFICIENT;RATIO;RING;RNA copies/mL;Rad;Roentgen;SACHET;SBE/mL;SCO;SCOOPFUL;SFC;SFC/10^6 PBMC;SPRAY;SQU/mL;STANDARD DRINK/day;STEPS;STRIP;SUPPOSITORY;SYRINGE;Shock Wave;Siemens;Signals/cells;Sv;TABLET;TAMPON;TCID 50/dose;TI/L;TRACE;TROCHE;TUBE;Tbsp;Tesla;Torr;U;U.CARR;U/L;U/animal;U/cL;U/dL;U/g;U/g/day;U/g/h;U/g/min;U/kg;U/kg/day;U/kg/h;U/kg/min;U/m2;U/m2/day;U/m2/h;U/m2/min;U/mL;U/mg;U/mmol;V;V/sec;VIAL;VIRTUAL PIXEL;WAFER;WEEKS;Watt;Weber;YEARS;ag;amol;amp;amu;anti-Xa IU;anti-Xa IU/mL;atm;bel;cGy;cL;cal;cc;cd;cells/mm3;cells/uL;cg;cm;cm H2O;cm/min;cm/s;cm2;cmol;cmol/L;copies/mL;copies/uL;cpm;cs;cy/cm;cycle/min;cycle/sec;dB;dL;damol/L;deg;dmol;dpm/0.5 mL;dpm/100mg;dpm/mL;dpm/mg;dram;dyn;eq;fL;fg;fmol;fmol/L;fmol/g;foz_br;foz_us;fraction of 1;ft;ft2;ft3;g;g/24h;g/L;g/animal;g/animal/day;g/animal/wk;g/cage;g/cage/day;g/cage/wk;g/cm2;g/dL;g/day;g/g;g/g Creatinine;g/g/day;g/kg;g/kg/day;g/m2;g/m2/day;g/mol;grain;gtt;hPa;in;in2;kAU/L;kBq;kBq/uL;kDa;kHz;kIU;kN/cm2;kPa;kPa/L/sec;kU/L;kUSP;kat;kcal;kg;kg/L;kg/cm;kg/cm2;kg/m2;km;km/h;ks;lbf;lm;log EID 50/dose;log10 CCID 50/dose;log10 CFU/g;log10 CFU/mL;log10 IU/mL;log10 TCID 50/dose;log10 copies/mL;lx;m;m/sec;m/sec2;m2;m3;mCi;mCi/L;mCi/kg;mEq;mEq/L;mEq/dL;mEq/day;mEq/g;mEq/kg;mEq/mL;mEq/mmol;mEq/uL;mEq/ug;mIU/L;mIU/mL;mJoule/cm2;mL;mL/animal;mL/animal/day;mL/animal/wk;mL/breath;mL/cage;mL/cage/day;mL/cage/wk;mL/cm;mL/cm H2O;mL/dL;mL/day;mL/g;mL/g/day;mL/g/h;mL/g/min;mL/h;mL/h/uL of lysat;mL/kg;mL/kg/day;mL/kg/h;mL/kg/min;mL/m2;mL/m2/day;mL/m2/h;mL/m2/min;mL/min;mL/min/1.73m2;mL/min/SSA;mL/min/mmHg;mL/mmHg;mL/mmHg/min/L;mL/s;mL/sec/1.73m2;mOsm;mOsm/kg;mPa;mU/L;mU/mL;mV;mV*min;mV2/Hz;mcg/dL;mg;mg%;mg/24h;mg/L;mg/L FEU;mg/animal;mg/dL;mg/day;mg/g;mg/g Creatinine;mg/g/day;mg/g/h;mg/g/min;mg/h;mg/kg;mg/kg/day;mg/kg/h;mg/kg/min;mg/m2;mg/m2/day;mg/m2/h;mg/m2/min;mg/mL/min;mg/min;mg/mmol Creatinine;mg/mol;min;mkat;mm;mm/2h;mm/h;mm/min;mm/sec;mm2;mm3;mmHg;mmHg/L/min;mmHg/sec;mmol;mmol FA/mL/h;mmol/L;mmol/day;mmol/g;mmol/kg;mmol/min/kPa;mmol/min/kPa/L;mmol/mol;mmol^2/L^2;mol;mol/L;mol/g;mol/mL;mol/mg;mol/mol;mph;msec;nCi;nL;nU/cL;nU/mL;ng;ng/L;ng/dL;ng/mL;nkat;nkat/L;nm;nmol;nmol BCE/L;nmol BCE/mmol;nmol/L;nmol/dL;nmol/hr/mg protein;nmol/mL/min;nmol/min/mg protein;nsec;ohm;osm;oz;pL;per min;per sec;pg;pg/L;pg/dL;pg/mL;pkat;pm;pmol;pmol/L;pmol/min/uL of lysat;pmol/punch/hr;pools/day;pools/h;ppb;ppm;ppth;pptr;psec;psi;pt_br;pt_us;rpm;sABC;sMEC;scm;sec;titer;tsp;tuberculin unit;tuberculin unit/mL;uCi;uCi/L;uCi/kg;uEq;uEq/L;uIU/mL;uL;uL/mL;uOsM;uU/mL;uV;uV*sec;ug;ug/L;ug/animal;ug/dL;ug/day;ug/g/day;ug/g/h;ug/g/min;ug/h;ug/kg;ug/kg/day;ug/kg/h;ug/kg/min;ug/m2;ug/m2/day;ug/m2/h;ug/m2/min;ug/mL;ug/mL/h;ug/min;ugEq;ukat;ukat/L;um;um2;umol;umol/L;umol/L/min;umol/L/sec;umol/day;umol/mg/min;umol/min;usec;v/v;yd;NONE;OTHER,question,75.866,369.671,15.744,142.512
997,92.0,Unsolicited Injection Site Reactions,AE_UISR,SUPPAE,21.0,"If the reaction is too large to measure, check 'NM' for Non Measurable.",,AEMSNM,SANOFI,AEMSNM,SANOFI,,,question,80.866,350.671,15.744,280.008
998,92.0,Unsolicited Injection Site Reactions,AE_UISR,AE,23.0,"Maximum Intensity (If the Maximum Intensity is missing, select Unknown.)",What is the severity of the adverse event?,AESEV,IG,AESEV,IG,,,question,75.866,298.671,15.948,306.0
710,92.0,Unsolicited Injection Site Reactions,AE_UISR,SUPPAE,25.0,Maximum Measurement or Intensity Method,,AEMSM,SANOFI,AEMSM,SANOFI,,,question,80.866,231.671,15.744,216.456
711,92.0,Unsolicited Injection Site Reactions,AE_UISR,AE,26.0,Relationship to Investigational Product,Was this adverse event related to study treatment?,AEREL,IG,AEREL,IG,AERELA_01,NOT RELATED;RELATED,question,70.866,214.671,15.744,187.452
712,92.0,Unsolicited Injection Site Reactions,AE_UISR,,27.0,Action Taken (Check all that apply.),,PROMPT_AEACN,SANOFI,,,,,question,70.866,179.659,15.948,174.456
713,92.0,Unsolicited Injection Site Reactions,AE_UISR,SUPPAE,28.0,None,,AEACNNO,SANOFI,AEACNNO,SANOFI,,,question,80.866,162.671,15.744,25.98
714,92.0,Unsolicited Injection Site Reactions,AE_UISR,SUPPAE,29.0,Medication,,AEACCMED,SANOFI,AEACCMED,SANOFI,,,question,80.866,145.671,15.744,54.588
715,92.0,Unsolicited Injection Site Reactions,AE_UISR,SUPPAE,30.0,Health Care Provider Contact,,AEACHCP,SANOFI,AEACHCP,SANOFI,,,question,80.866,128.671,15.744,142.14
716,92.0,Unsolicited Injection Site Reactions,AE_UISR,SUPPAE,31.0,Hospitalized,,AEACHOS,SANOFI,AEACHOS,SANOFI,,,question,80.866,111.671,15.744,60.576
717,92.0,Unsolicited Injection Site Reactions,AE_UISR,SU,32.0,Caused Study Discontinuation,Did the adverse event cause the subject to be discontinued from the study?,AEDIS,IG,SUPPAE.QVAL,IG,NY_YN,Y;N,question,70.866,94.671,15.744,145.872
990,93.0,Unsolicited Injection Site Reactions,AE_UISR,,0.0,Vaccine Injection Location List,,AELOCLI,SANOFI,,,,,unassigned,-100.0,760.0,15.0,100.0
991,93.0,Unsolicited Injection Site Reactions,AE_UISR,AE,0.0,Site,What is the anatomical location of the adverse event?,AELOC,IG,AELOC,IG,LOC_01,UPPER ARM;BUTTOCK;THIGH,unassigned,-100.0,760.0,15.0,100.0
992,93.0,Unsolicited Injection Site Reactions,AE_UISR,AE,0.0,Localization,What is the directionality of the anatomical location of the adverse event?,AEDIR,IG,AEDIR,IG,DIR_01,LOWER;UPPER,unassigned,-100.0,760.0,15.0,100.0
999,93.0,Unsolicited Injection Site Reactions,AE_UISR,SUPPAE,0.0,Discontinuation of study vaccination,,AEACNC,SANOFI,AEACNC,SANOFI,,,unassigned,-100.0,760.0,15.0,100.0
1000,93.0,Unsolicited Injection Site Reactions,AE_UISR,SUPPAE,0.0,Is the event an MAAE?,,AEMAAE,SANOFI,AEMAAE,SANOFI,NY_YN,Y;N,unassigned,-100.0,760.0,15.0,100.0
718,93.0,Unsolicited Injection Site Reactions,AE_UISR,SUPPAE,2.0,Is the event an AESI?,,AEMEOI,SANOFI,AEMEOI,SANOFI,NY_YN,Y;N,question,70.866,666.671,15.744,104.544
719,93.0,Unsolicited Injection Site Reactions,AE_UISR,AE,3.0,Serious,Was the adverse event serious?,AESER,IG,AESER,IG,NY_YN,Y;N,question,70.866,631.671,15.744,35.976
1001,93.0,Unsolicited Injection Site Reactions,AE_UISR,,8.0,"If Serious=Yes only, check all seriousness criteria that apply, Outcome, Elapsed time and Relationship to Study Procedures below.",,PROMPT_AESER,SANOFI,,,,,question,70.866,596.659,15.948,430.656
720,93.0,Unsolicited Injection Site Reactions,AE_UISR,AE,10.0,Congenital Anomaly or Birth Defect,Was the adverse event associated with a congenital anomaly or birth defect?,AESCONG,IG,AESCONG,IG,,,question,75.866,565.671,15.744,175.788
721,93.0,Unsolicited Injection Site Reactions,AE_UISR,AE,11.0,Significant Disability,Did the adverse event result in disability or permanent damage?,AESDISAB,IG,AESDISAB,IG,,,question,75.866,548.671,15.744,102.864
722,93.0,Unsolicited Injection Site Reactions,AE_UISR,AE,12.0,Death,Did the adverse event result in death?,AESDTH,IG,AESDTH,IG,,,question,75.866,531.671,15.744,28.62
723,93.0,Unsolicited Injection Site Reactions,AE_UISR,,13.0,"If Yes, complete the Date of Death.",,PROMPT_AEDTH,SANOFI,,,,,question,75.866,514.659,15.948,167.808
724,93.0,Unsolicited Injection Site Reactions,AE_UISR,,14.0,Date of Death,,AEDDDAT,SANOFI,,,,,question,80.866,497.671,15.744,67.236
725,93.0,Unsolicited Injection Site Reactions,AE_UISR,AE,15.0,Hospitalization,Did the adverse event result in initial or prolonged hospitalization for the subject?,AESHOSP,IG,AESHOSP,IG,,,question,75.866,480.671,15.744,73.224
726,93.0,Unsolicited Injection Site Reactions,AE_UISR,AE,16.0,Life Threatening,Was the adverse event life threatening?,AESLIFE,IG,AESLIFE,IG,,,question,75.866,463.671,15.744,80.868
727,93.0,Unsolicited Injection Site Reactions,AE_UISR,AE,17.0,Other Medically Important Event,Was the adverse event a medically important event not covered by other serious criteria?,AESMIE,IG,AESMIE,IG,,,question,75.866,446.671,15.744,160.128
728,93.0,Unsolicited Injection Site Reactions,AE_UISR,AE,18.0,Outcome,What is the outcome of this adverse event?,AEOUT,IG,AEOUT,IG,OUT,RECOVERED/RESOLVED;RECOVERED/RESOLVED WITH SEQUELAE;RECOVERING/RESOLVING;NOT RECOVERED/NOT RESOLVED;FATAL;UNKNOWN,question,75.866,429.671,15.744,43.944
1002,93.0,Unsolicited Injection Site Reactions,AE_UISR,SUPPAE,27.0,"If lower than 24 hours, Elapsed Time from last Administration (Provide the duration in hours and minutes).",,AEELPTIM,SANOFI,AEELPTIM,SANOFI,,,question,70.866,306.671,15.744,300.36
729,93.0,Unsolicited Injection Site Reactions,AE_UISR,SUPPAE,29.0,Relationship to Study Procedures,,AERELPR,SANOFI,AERELPR,SANOFI,AERELA_01,NOT RELATED;RELATED,question,70.866,275.671,15.744,160.188
730,94.0,Unsolicited Systemic Events,AE_USE,AE,2.0,Category of Adverse Event,What is the category of the adverse event?,AECAT,IG,AECAT,IG,AECAT,ADVERSE EVENT;ADVERSE EVENT OF SPECIAL INTEREST;ALLERGIC REACTION;ALT INCREASE;ASTHMA EXACERBATION EVENT;BLEEDING EVENT;BONE FRACTURE;DRUG ALLERGY EVENT;EPISTAXIS EVENT;FOREIGN BODY REACTION EVENT;HYPERCALCEMIA;HYPOGLYCEMIA;INCREASED CALCITONIN;INCREASED LIPASE/AMYLASE;INFECTION EVENT;INJECTION SITE REACTION;METABOLIC ACIDOSIS EVENT;NEUROLOGIC DISORDER;OVERDOSE;PANCREATIC EVENT;PERIPHERAL NEUROPATHY EVENT;PREGNANCY;RENAL FAILURE;SERIOUS HYPOGLYCEMIA;SOLICITED;SUSPECTED OR CONFIRMED CEREBROVASCULAR EVENT;SUSPECTED OR CONFIRMED DIABETIC KETOACIDOSIS;SUSPECTED OR CONFIRMED HEART FAILURE;SUSPECTED OR CONFIRMED MYOCARDIAL INFARCTION / UNSTABLE ANGINA;UNSOLICITED;VASCULITIS EVENT;OTHER,question,70.866,666.671,15.744,130.86
732,94.0,Unsolicited Systemic Events,AE_USE,AE,3.0,Subcategory of Adverse Event,What is the subcategory of the adverse event?,AESCAT,IG,AESCAT,IG,AESCAT_01,ADMINISTRATION SITE;SYSTEMIC,question,70.866,77.671,15.744,146.856
733,95.0,Unsolicited Systemic Events,AE_USE,AE,2.0,Unique ID,What is the adverse event identifier?,AESPID,IG,AESPID,IG,,,question,70.866,647.671,15.744,50.964
1003,95.0,Unsolicited Systemic Events,AE_USE,,3.0,Enter any Unsolicited Systemic Events occurring within the 28-day collection period. Enter SAE and AESI occurring during the entire study period including during the 90-day fup period.,,PROMPT_UNSOLS,SANOFI,,,,,question,70.866,630.659,15.948,484.104
735,95.0,Unsolicited Systemic Events,AE_USE,AE,6.0,Adverse Event,What is the adverse event term?,AETERM,IG,AETERM,IG,,,question,70.866,585.671,15.744,70.92
737,95.0,Unsolicited Systemic Events,AE_USE,SUPPAE,7.0,Immediate,,AEIMM,SANOFI,AEIMM,SANOFI,NY_YN,Y;N,question,70.866,568.671,15.744,51.24
738,95.0,Unsolicited Systemic Events,AE_USE,AE,10.0,Start Date,What is the adverse event start date?,AESTDAT,IG,AESTDTC,IG,,,question,70.866,533.671,15.744,48.252
740,95.0,Unsolicited Systemic Events,AE_USE,SUPPAE,11.0,Appeared after Visit,,AECYCVID,SANOFI,AECYCVID,SANOFI,,,question,70.866,516.671,15.744,97.86
741,95.0,Unsolicited Systemic Events,AE_USE,,12.0,"If the event is ongoing, enter the Maximum Intensity/Temperature available at the time of reporting.",,PROMPT_AEONGO,SANOFI,,,,,question,70.866,499.659,15.948,480.132
742,95.0,Unsolicited Systemic Events,AE_USE,AE,13.0,Ongoing?,Is the adverse event ongoing?,AEONGO,IG,AEENRTPT; AEENRF,IG,,,question,80.866,468.671,15.744,47.304
1004,95.0,Unsolicited Systemic Events,AE_USE,,14.0,"When the End Date is obtained, ensure that the Maximum Intensity/Temperature is still correct while considering the entire duration.",,PROMPT_AESEV1,SANOFI,,,,,question,70.866,451.659,15.948,456.852
743,95.0,Unsolicited Systemic Events,AE_USE,AE,16.0,End Date,What was the adverse event end date?,AEENDAT,IG,AEENDTC,IG,,,question,80.866,420.671,15.744,44.94
1005,95.0,Unsolicited Systemic Events,AE_USE,,17.0,"For Fever episodes, enter the Maximum Temperature with one decimal value (e.g. 38.1). Otherwise, enter the Maximum Intensity of the event considering the entire Adverse Event duration.",,PROMPT_AESEV2,SANOFI,,,,,question,70.866,403.659,15.948,481.824
1006,95.0,Unsolicited Systemic Events,AE_USE,SUPPAE,19.0,"Maximum Temperature (If the Maximum Temperature is missing, enter 'UNK' for Unknown.)",,AEMS,SANOFI,AEMS,SANOFI,,,question,75.866,358.671,15.948,273.036
745,95.0,Unsolicited Systemic Events,AE_USE,SUPPAE,21.0,Maximum Measurement Unit,,AEMSU,SANOFI,AEMSU,SANOFI,UNIT,%;% INHIBITION;%(v/v);%(w/v);%(w/w);%/min;%cells/area;/100 HPFs;/100 WBC;/10^3 cells;/HPF;/L;/LPF;/VF;/dL;/day;/h;/kg;/mL;/mm3;/month;/nL;/pL;/uL;/wk;/year;1/dilution;100 IU/mL;10^10/L;10^11/L;10^12 IU/L;10^12/L;10^3 CFU;10^3 CFU/g;10^3 CFU/mL;10^3 DNA copies/mL;10^3 RNA copies/mL;10^3 copies/mL;10^3 organisms;10^3 organisms/g;10^3 organisms/mL;10^3/L;10^3/hpf;10^3/mm3;10^3/mm4;10^3/uL;10^4/L;10^4/hpf;10^5/L;10^5/hpf;10^6 CFU;10^6 CFU/g;10^6 CFU/mL;10^6 DNA copies/mL;10^6 IU;10^6 IU/mL;10^6 RNA copies/mL;10^6 copies/mL;10^6 organisms;10^6 organisms/g;10^6 organisms/mL;10^6 organisms/mg;10^6/L;10^6/g;10^6/hpf;10^6/mm3;10^6/uL;10^7/L;10^8/L;10^9 CFU;10^9 CFU/g;10^9 CFU/mL;10^9 organisms;10^9 organisms/g;10^9 organisms/mL;10^9 organisms/mg;10^9/L;AFU;AI;AMPULE;APL U/mL;APPLICATION;ASC;AU;AU/mL;AU/min;AgU/mL;Antibody Unit;BAG;BAR;BAU;BAU/mL;BE/mL;BEATS/MIN;BISCUIT;BLOCKS;BOLUS;BOTTLE;BOX;BREATHS/MIN;BU;BU/mL;Bq;Bq/L;Bq/g;Bq/kg;Bq/mL;Bq/mg;Bq/uL;Bq/ug;C;CAE;CAN;CAPFUL;CAPLET;CAPSULE;CARTRIDGE;CASE;CCID 50/dose;CCID 50/mL;CFU/g;CFU/mL;CIGAR;CIGARETTE;COAT;COI;CONTAINER;CUP;CYLINDER;Ci;Ci/L;Ci/g;Ci/kg;Ci/mL;Ci/mg;Ci/uL;Ci/ug;Coulomb;Ct;DAYS;DAgU;DAgU/mL;DIOPTER;DISK;DNA copies/mL;DPM;DRUM;EID 50/dose;EID 50/mL;ELISA unit;ELISA unit/dose;ELISA unit/mL;EU;Enzyme U;F;FEU;FINGERTIP UNIT;Farad;Frames/s;GBq;GBq/g;GBq/mg;GBq/ug;GI/L;GLASS;GPL U/mL;Gauss;Gy;HAU/100 uL;HEP;HOMEOPATHIC DILUTION;HOURS;HPF;Hb Fract.;Hemolytic Unit;Henry;Hounsfield Unit;Hz;IMPLANT;INDEX VALUE;INHALATION;IU;IU/L;IU/dL;IU/g;IU/kg;IU/kg/h;IU/mL;IU/mg;IU^4;IV;Immune Status Ratio (ISR);JAR;Joule;KALLIKREIN INHIBITOR UNIT;KIT;L;L/L;L/h;L/h/m2;L/kg;L/min;L/min/m2;L/s;LB;LOZENGE;LPF;Log10 ELISA unit;Log10 ELISA unit/dose;Log10 GEq/mL;Log10 PFU/mL;MBq;MBq/uL;MESF;MFI;MHz;MONTHS;MPL U/mL;Mile;NEBULE;NEEDLE GAUGE;NIU;Newton;PACK;PACKAGE;PACKET;PATCH;PELLET;PFU;PFU/dose;PFU/mL;PIPE;PIXEL;PIXELS/cm;PIXELS/in;PNU/mL;POINT;POUCH;PRESSOR UNITS;PUFF;Pa;Pack Year;Perfusion unit;Perfusion unit*sec;QUANTITY SUFFICIENT;RATIO;RING;RNA copies/mL;Rad;Roentgen;SACHET;SBE/mL;SCO;SCOOPFUL;SFC;SFC/10^6 PBMC;SPRAY;SQU/mL;STANDARD DRINK/day;STEPS;STRIP;SUPPOSITORY;SYRINGE;Shock Wave;Siemens;Signals/cells;Sv;TABLET;TAMPON;TCID 50/dose;TI/L;TRACE;TROCHE;TUBE;Tbsp;Tesla;Torr;U;U.CARR;U/L;U/animal;U/cL;U/dL;U/g;U/g/day;U/g/h;U/g/min;U/kg;U/kg/day;U/kg/h;U/kg/min;U/m2;U/m2/day;U/m2/h;U/m2/min;U/mL;U/mg;U/mmol;V;V/sec;VIAL;VIRTUAL PIXEL;WAFER;WEEKS;Watt;Weber;YEARS;ag;amol;amp;amu;anti-Xa IU;anti-Xa IU/mL;atm;bel;cGy;cL;cal;cc;cd;cells/mm3;cells/uL;cg;cm;cm H2O;cm/min;cm/s;cm2;cmol;cmol/L;copies/mL;copies/uL;cpm;cs;cy/cm;cycle/min;cycle/sec;dB;dL;damol/L;deg;dmol;dpm/0.5 mL;dpm/100mg;dpm/mL;dpm/mg;dram;dyn;eq;fL;fg;fmol;fmol/L;fmol/g;foz_br;foz_us;fraction of 1;ft;ft2;ft3;g;g/24h;g/L;g/animal;g/animal/day;g/animal/wk;g/cage;g/cage/day;g/cage/wk;g/cm2;g/dL;g/day;g/g;g/g Creatinine;g/g/day;g/kg;g/kg/day;g/m2;g/m2/day;g/mol;grain;gtt;hPa;in;in2;kAU/L;kBq;kBq/uL;kDa;kHz;kIU;kN/cm2;kPa;kPa/L/sec;kU/L;kUSP;kat;kcal;kg;kg/L;kg/cm;kg/cm2;kg/m2;km;km/h;ks;lbf;lm;log EID 50/dose;log10 CCID 50/dose;log10 CFU/g;log10 CFU/mL;log10 IU/mL;log10 TCID 50/dose;log10 copies/mL;lx;m;m/sec;m/sec2;m2;m3;mCi;mCi/L;mCi/kg;mEq;mEq/L;mEq/dL;mEq/day;mEq/g;mEq/kg;mEq/mL;mEq/mmol;mEq/uL;mEq/ug;mIU/L;mIU/mL;mJoule/cm2;mL;mL/animal;mL/animal/day;mL/animal/wk;mL/breath;mL/cage;mL/cage/day;mL/cage/wk;mL/cm;mL/cm H2O;mL/dL;mL/day;mL/g;mL/g/day;mL/g/h;mL/g/min;mL/h;mL/h/uL of lysat;mL/kg;mL/kg/day;mL/kg/h;mL/kg/min;mL/m2;mL/m2/day;mL/m2/h;mL/m2/min;mL/min;mL/min/1.73m2;mL/min/SSA;mL/min/mmHg;mL/mmHg;mL/mmHg/min/L;mL/s;mL/sec/1.73m2;mOsm;mOsm/kg;mPa;mU/L;mU/mL;mV;mV*min;mV2/Hz;mcg/dL;mg;mg%;mg/24h;mg/L;mg/L FEU;mg/animal;mg/dL;mg/day;mg/g;mg/g Creatinine;mg/g/day;mg/g/h;mg/g/min;mg/h;mg/kg;mg/kg/day;mg/kg/h;mg/kg/min;mg/m2;mg/m2/day;mg/m2/h;mg/m2/min;mg/mL/min;mg/min;mg/mmol Creatinine;mg/mol;min;mkat;mm;mm/2h;mm/h;mm/min;mm/sec;mm2;mm3;mmHg;mmHg/L/min;mmHg/sec;mmol;mmol FA/mL/h;mmol/L;mmol/day;mmol/g;mmol/kg;mmol/min/kPa;mmol/min/kPa/L;mmol/mol;mmol^2/L^2;mol;mol/L;mol/g;mol/mL;mol/mg;mol/mol;mph;msec;nCi;nL;nU/cL;nU/mL;ng;ng/L;ng/dL;ng/mL;nkat;nkat/L;nm;nmol;nmol BCE/L;nmol BCE/mmol;nmol/L;nmol/dL;nmol/hr/mg protein;nmol/mL/min;nmol/min/mg protein;nsec;ohm;osm;oz;pL;per min;per sec;pg;pg/L;pg/dL;pg/mL;pkat;pm;pmol;pmol/L;pmol/min/uL of lysat;pmol/punch/hr;pools/day;pools/h;ppb;ppm;ppth;pptr;psec;psi;pt_br;pt_us;rpm;sABC;sMEC;scm;sec;titer;tsp;tuberculin unit;tuberculin unit/mL;uCi;uCi/L;uCi/kg;uEq;uEq/L;uIU/mL;uL;uL/mL;uOsM;uU/mL;uV;uV*sec;ug;ug/L;ug/animal;ug/dL;ug/day;ug/g/day;ug/g/h;ug/g/min;ug/h;ug/kg;ug/kg/day;ug/kg/h;ug/kg/min;ug/m2;ug/m2/day;ug/m2/h;ug/m2/min;ug/mL;ug/mL/h;ug/min;ugEq;ukat;ukat/L;um;um2;umol;umol/L;umol/L/min;umol/L/sec;umol/day;umol/mg/min;umol/min;usec;v/v;yd;NONE;OTHER,question,75.866,306.671,15.744,142.512
746,95.0,Unsolicited Systemic Events,AE_USE,,22.0,Temperature Route,,AEROUTE,SANOFI,,,MEASMETH_02,ORAL;AXILLARY;RECTAL,question,80.866,287.671,15.744,92.856
1007,95.0,Unsolicited Systemic Events,AE_USE,AE,23.0,"Maximum Intensity (If the Maximum Intensity is missing, select Unknown.)",What is the severity of the adverse event?,AESEV,IG,AESEV,IG,,,question,75.866,236.671,15.948,306.0
747,95.0,Unsolicited Systemic Events,AE_USE,SUPPAE,25.0,Maximum Intensity Method,,AEMSM,SANOFI,AEMSM,SANOFI,,,question,80.866,169.671,15.744,135.216
748,95.0,Unsolicited Systemic Events,AE_USE,AE,26.0,Relationship to Investigational Product,Was this adverse event related to study treatment?,AEREL,IG,AEREL,IG,AERELA_01,NOT RELATED;RELATED,question,70.866,152.671,15.744,187.452
749,95.0,Unsolicited Systemic Events,AE_USE,,27.0,Action Taken (Check all that apply.),,PROMPT_AEACN,SANOFI,,,,,question,70.866,117.659,15.948,174.456
750,95.0,Unsolicited Systemic Events,AE_USE,SUPPAE,28.0,None,,AEACNNO,SANOFI,AEACNNO,SANOFI,,,question,80.866,100.671,15.744,25.98
751,95.0,Unsolicited Systemic Events,AE_USE,SUPPAE,29.0,Medication,,AEACCMED,SANOFI,AEACCMED,SANOFI,,,question,80.866,83.671,15.744,54.588
752,95.0,Unsolicited Systemic Events,AE_USE,SUPPAE,30.0,Health Care Provider Contact,,AEACHCP,SANOFI,AEACHCP,SANOFI,,,question,80.866,66.671,15.744,142.14
1008,96.0,Unsolicited Systemic Events,AE_USE,SUPPAE,0.0,Discontinuation of study vaccination,,AEACNC,SANOFI,AEACNC,SANOFI,,,unassigned,-100.0,760.0,15.0,100.0
1009,96.0,Unsolicited Systemic Events,AE_USE,,0.0,"If Dengue AESI is yes, then complete the associated Dengue CRFs.",,PROMPT_AESI,SANOFI,,,,,unassigned,-100.0,760.0,15.0,100.0
1010,96.0,Unsolicited Systemic Events,AE_USE,SUPPAE,0.0,AESI Dengue,,AESIDEN,SANOFI,AESIDEN,SANOFI,NY_YN,Y;N,unassigned,-100.0,760.0,15.0,100.0
1011,96.0,Unsolicited Systemic Events,AE_USE,SUPPAE,0.0,AESI Anaphylactic Reactions,,AESIAR,SANOFI,AESIAR,SANOFI,NY_YN,Y;N,unassigned,-100.0,760.0,15.0,100.0
1012,96.0,Unsolicited Systemic Events,AE_USE,SUPPAE,0.0,AESI Neurotropism/Viscerotropism,,AESINV,SANOFI,AESINV,SANOFI,NY_YN,Y;N,unassigned,-100.0,760.0,15.0,100.0
1013,96.0,Unsolicited Systemic Events,AE_USE,SUPPAE,0.0,Is the event an MAAE?,,AEMAAE,SANOFI,AEMAAE,SANOFI,NY_YN,Y;N,unassigned,-100.0,760.0,15.0,100.0
753,96.0,Unsolicited Systemic Events,AE_USE,SUPPAE,2.0,Hospitalized,,AEACHOS,SANOFI,AEACHOS,SANOFI,,,question,80.866,666.671,15.744,60.576
754,96.0,Unsolicited Systemic Events,AE_USE,SU,3.0,Caused Study Discontinuation,Did the adverse event cause the subject to be discontinued from the study?,AEDIS,IG,SUPPAE.QVAL,IG,NY_YN,Y;N,question,70.866,649.671,15.744,145.872
755,96.0,Unsolicited Systemic Events,AE_USE,SUPPAE,4.0,Is the event an AESI?,,AEMEOI,SANOFI,AEMEOI,SANOFI,NY_YN,Y;N,question,70.866,614.671,15.744,104.544
756,96.0,Unsolicited Systemic Events,AE_USE,AE,5.0,Serious,Was the adverse event serious?,AESER,IG,AESER,IG,NY_YN,Y;N,question,70.866,579.671,15.744,35.976
1014,96.0,Unsolicited Systemic Events,AE_USE,,12.0,"If Serious=Yes only, check all seriousness criteria that apply, Outcome, Elapsed time and Relationship to Study Procedures below.",,PROMPT_AESER,SANOFI,,,,,question,70.866,544.659,15.948,430.656
757,96.0,Unsolicited Systemic Events,AE_USE,AE,14.0,Congenital Anomaly or Birth Defect,Was the adverse event associated with a congenital anomaly or birth defect?,AESCONG,IG,AESCONG,IG,,,question,75.866,513.671,15.744,175.788
758,96.0,Unsolicited Systemic Events,AE_USE,AE,15.0,Significant Disability,Did the adverse event result in disability or permanent damage?,AESDISAB,IG,AESDISAB,IG,,,question,75.866,496.671,15.744,102.864
759,96.0,Unsolicited Systemic Events,AE_USE,AE,16.0,Death,Did the adverse event result in death?,AESDTH,IG,AESDTH,IG,,,question,75.866,479.671,15.744,28.62
760,96.0,Unsolicited Systemic Events,AE_USE,,17.0,"If Yes, complete the Date of Death.",,PROMPT_AEDTH,SANOFI,,,,,question,75.866,462.659,15.948,167.808
761,96.0,Unsolicited Systemic Events,AE_USE,,18.0,Date of Death,,AEDDDAT,SANOFI,,,,,question,80.866,445.671,15.744,67.236
762,96.0,Unsolicited Systemic Events,AE_USE,AE,19.0,Hospitalization,Did the adverse event result in initial or prolonged hospitalization for the subject?,AESHOSP,IG,AESHOSP,IG,,,question,75.866,428.671,15.744,73.224
763,96.0,Unsolicited Systemic Events,AE_USE,AE,20.0,Life Threatening,Was the adverse event life threatening?,AESLIFE,IG,AESLIFE,IG,,,question,75.866,411.671,15.744,80.868
764,96.0,Unsolicited Systemic Events,AE_USE,AE,21.0,Other Medically Important Event,Was the adverse event a medically important event not covered by other serious criteria?,AESMIE,IG,AESMIE,IG,,,question,75.866,394.671,15.744,160.128
765,96.0,Unsolicited Systemic Events,AE_USE,AE,22.0,Outcome,What is the outcome of this adverse event?,AEOUT,IG,AEOUT,IG,OUT,RECOVERED/RESOLVED;RECOVERED/RESOLVED WITH SEQUELAE;RECOVERING/RESOLVING;NOT RECOVERED/NOT RESOLVED;FATAL;UNKNOWN,question,75.866,377.671,15.744,43.944
1015,96.0,Unsolicited Systemic Events,AE_USE,SUPPAE,31.0,"If lower than 24 hours, Elapsed Time from last Administration (Provide the duration in hours and minutes).",,AEELPTIM,SANOFI,AEELPTIM,SANOFI,,,question,70.866,254.671,15.744,300.36
766,96.0,Unsolicited Systemic Events,AE_USE,SUPPAE,33.0,Relationship to Study Procedures,,AERELPR,SANOFI,AERELPR,SANOFI,AERELA_01,NOT RELATED;RELATED,question,70.866,223.671,15.744,160.188
767,97.0,Safety Complementary Information,SAE_ALL,AE,2.0,Related AE ID,What is the adverse event identifier?,AESPID,IG,AESPID,IG,,,question,70.866,666.671,15.744,71.232
769,97.0,Safety Complementary Information,SAE_ALL,,3.0,Subject’s Weight (Kg),,SAEWEIGH,SANOFI,,,,,question,70.866,649.671,15.744,108.552
770,97.0,Safety Complementary Information,SAE_ALL,,4.0,Subject’s Height (cm),,SAEHEIGH,SANOFI,,,,,question,70.866,632.671,15.744,105.876
771,97.0,Safety Complementary Information,SAE_ALL,,5.0,Initial or Prolonged Hospitalization,,SAEHOSP,SANOFI,,,INIPROL,INITIAL;PROLONGED;NOT APPLICABLE,question,70.866,615.671,15.744,170.136
772,97.0,Safety Complementary Information,SAE_ALL,,15.0,"If Not Applicable is checked, Hospitalization and Discharge Dates should be empty.",,PROMPT_SAEHODAT,SANOFI,,,,,question,75.866,564.659,15.948,403.932
773,97.0,Safety Complementary Information,SAE_ALL,,16.0,Hospitalization Date,,SAEHODAT,SANOFI,,,,,question,75.866,547.671,15.744,98.844
774,97.0,Safety Complementary Information,SAE_ALL,,17.0,Discharge Date,,SAEDIDAT,SANOFI,,,,,question,75.866,530.671,15.744,74.22
775,97.0,Safety Complementary Information,SAE_ALL,,18.0,Safety Narrative,,SAEDETL,SANOFI,,,,,question,70.866,513.671,15.744,78.876
776,97.0,Safety Complementary Information,SAE_ALL,,19.0,Rationale for Final Investigator Causality,,SAERATIO,SANOFI,,,,,question,70.866,496.671,15.744,199.068
777,97.0,Safety Complementary Information,SAE_ALL,,20.0,Additional Relevant Medical History,,SAEMH,SANOFI,,,NY_YN,Y;N,question,70.866,479.671,15.744,178.104
778,97.0,Safety Complementary Information,SAE_ALL,,21.0,Additional Relevant Previous or Concomitant Medication,,SAECM,SANOFI,,,NY_YN,Y;N,question,70.866,444.671,15.744,277.344
779,97.0,Safety Complementary Information,SAE_ALL,,22.0,Additional Relevant Laboratory Results,,SAELB,SANOFI,,,NY_YN,Y;N,question,70.866,409.671,15.744,191.424
780,98.0,Safety Medical History,MH_SAE,MH,2.0,MH Category,What was the category of the medical history?,MHCAT,IG,MHCAT,IG,MHCAT,ALLERGY;ASTHMA;BLOOD DISORDER;CARDIOVASCULAR DISORDER;DIABETES;DISEASE HISTORY;EPISTAXIS;HEPATOBILIARY DISORDER;HYPERLIPOPROTEINEMIA;JUVENILE IDIOPATHIC ARTHRITIS;MEDICAL OR SURGICAL;MULTIPLE SCLEROSIS;NEUROLOGIC DISORDER;POLYPOSIS;POMPE DISEASE;RENAL DISORDER;RESPIRATORY DISORDER;RHEUMATOLOGIC DISORDER;RHINOSINUSITIS;SAE COMPLEMENTARY INFORMATION;SCLERODERMA;OTHER,question,70.866,666.671,15.744,66.276
781,98.0,Safety Medical History,MH_SAE,AE,3.0,Related AE ID,What is the adverse event identifier?,AESPID,IG,AESPID,IG,,,question,70.866,299.671,15.744,71.232
783,98.0,Safety Medical History,MH_SAE,MH,4.0,Medical History Term,What is the medical condition or event term?,MHTERM,IG,MHTERM,IG,,,question,70.866,282.671,15.744,107.196
784,98.0,Safety Medical History,MH_SAE,MH,5.0,Start Date,What was the medical condition or event start date?,MHSTDAT,IG,MHSTDTC,IG,,,question,70.866,265.671,15.744,48.252
785,98.0,Safety Medical History,MH_SAE,,6.0,Ongoing at SAE onset,,MHSAEONG,SANOFI,,,,,question,70.866,248.671,15.744,107.592
786,98.0,Safety Medical History,MH_SAE,MH,7.0,End Date,What was the medical condition or event end date?,MHENDAT,IG,MHENDTC,IG,,,question,70.866,231.671,15.744,44.94
787,99.0,Dynamic Safety Medical History,MH_DYN_SAE,MH,2.0,MH Category,What was the category of the medical history?,MHCAT,IG,MHCAT,IG,MHCAT,ALLERGY;ASTHMA;BLOOD DISORDER;CARDIOVASCULAR DISORDER;DIABETES;DISEASE HISTORY;EPISTAXIS;HEPATOBILIARY DISORDER;HYPERLIPOPROTEINEMIA;JUVENILE IDIOPATHIC ARTHRITIS;MEDICAL OR SURGICAL;MULTIPLE SCLEROSIS;NEUROLOGIC DISORDER;POLYPOSIS;POMPE DISEASE;RENAL DISORDER;RESPIRATORY DISORDER;RHEUMATOLOGIC DISORDER;RHINOSINUSITIS;SAE COMPLEMENTARY INFORMATION;SCLERODERMA;OTHER,question,70.866,666.671,15.744,66.276
788,99.0,Dynamic Safety Medical History,MH_DYN_SAE,AE,3.0,Related AE ID,What is the adverse event identifier?,AESPID,IG,AESPID,IG,,,question,70.866,299.671,15.744,71.232
790,99.0,Dynamic Safety Medical History,MH_DYN_SAE,,4.0,Check If No Medical History to report,,MHNOMH,SANOFI,,,,,question,70.866,282.671,15.744,184.476
791,99.0,Dynamic Safety Medical History,MH_DYN_SAE,,5.0,Medical History List,,MHTERMLI,SANOFI,,,,,question,70.866,265.671,15.744,99.876
792,99.0,Dynamic Safety Medical History,MH_DYN_SAE,MH,6.0,Medical History Term,What is the medical condition or event term?,MHTERM,IG,MHTERM,IG,,,question,70.866,248.671,15.744,107.196
793,99.0,Dynamic Safety Medical History,MH_DYN_SAE,MH,7.0,Start Date,What was the medical condition or event start date?,MHSTDAT,IG,MHSTDTC,IG,,,question,70.866,231.671,15.744,48.252
794,99.0,Dynamic Safety Medical History,MH_DYN_SAE,,8.0,Ongoing at SAE onset,,MHSAEONG,SANOFI,,,,,question,70.866,214.671,15.744,107.592
795,99.0,Dynamic Safety Medical History,MH_DYN_SAE,MH,9.0,End Date,What was the medical condition or event end date?,MHENDAT,IG,MHENDTC,IG,,,question,70.866,197.671,15.744,44.94
796,100.0,Safety Concomitant Medication,CM_SAE,CM,2.0,Category for Medication,What is the category for the (concomitant) [medication/treatment/therapy]?,CMCAT,IG,CMCAT,IG,CMCAT,ANTI-CANCER THERAPY;ANTI-HYPERGLYCEMIC THERAPY;ANTIBIOTIC;ASTHMA CONTROLLER;ASTHMA RELIEVER;BASAL INSULIN;HISTORY OF ANTI-HYPERGLYCEMIC THERAPY;HISTORY OF LIPID MODIFYING THERAPY;HISTORY OF VACCINATION;HYPOGLYCEMIC TREATMENT;LIPID LOWERING THERAPY;LIPID MODIFYING THERAPY EXCLUDING STATIN;MEDICATION;NON-MEDICATION THERAPY;RESCUE THERAPY;SAE COMPLEMENTARY INFORMATION;STATIN THERAPY;SYSTEMIC CORTICOID THERAPY;OTHER;MEDICATIONS IMPACTING OR THAT MAY HAVE AN IMPACT ON THE EVALUATION OF THE SAFETY;MEDICATIONS IMPACTING OR THAT MAY HAVE AN IMPACT ON THE IMMUNE RESPONSE;MEDICATIONS IMPACTING OR THAT MAY HAVE AN IMPACT ON BOTH THE SAFETY AND THE IMMUNE RESPONSE,question,70.866,666.671,15.744,118.524
797,100.0,Safety Concomitant Medication,CM_SAE,AE,3.0,Related AE ID,What is the adverse event identifier?,AESPID,IG,AESPID,IG,,,question,70.866,263.671,15.744,71.232
799,100.0,Safety Concomitant Medication,CM_SAE,CM,4.0,Medication,What was the (concomitant) [medication/treatment/therapy] (name/term)?,CMTRT,IG,CMTRT,IG,,,question,70.866,246.671,15.744,54.588
800,100.0,Safety Concomitant Medication,CM_SAE,CM,5.0,Start Date,What was the (concomitant) [medication/treatment/therapy/dose] start date?,CMSTDAT,IG,CMSTDTC,IG,,,question,70.866,229.671,15.744,48.252
801,100.0,Safety Concomitant Medication,CM_SAE,CM,6.0,End Date,What was the (concomitant) [medication/treatment/therapy/dose] end date?,CMENDAT,IG,CMENDTC,IG,,,question,70.866,212.671,15.744,44.94
802,100.0,Safety Concomitant Medication,CM_SAE,,7.0,Ongoing at SAE onset,,CMSAEONG,SANOFI,,,,,question,70.866,195.671,15.744,107.592
803,100.0,Safety Concomitant Medication,CM_SAE,CM,8.0,Route,What was the route of administration of the (concomitant) [medication/treatment/therapy]?,CMROUTE,IG,CMROUTE,IG,ROUTE,AURICULAR (OTIC);BUCCAL;CONJUNCTIVAL;CUTANEOUS;DENTAL;DIETARY;ELECTRO-OSMOSIS;ENDOCERVICAL;ENDOSINUSIAL;ENDOTRACHEAL;ENTERAL;EPIDURAL;EXTRA-AMNIOTIC;EXTRACORPOREAL;HEMODIALYSIS;INFILTRATION;INTERSTITIAL;INTRA-ABDOMINAL;INTRA-AMNIOTIC;INTRA-ARTERIAL;INTRA-ARTICULAR;INTRABILIARY;INTRABRONCHIAL;INTRABURSAL;INTRACAMERAL;INTRACARDIAC;INTRACARTILAGINOUS;INTRACAUDAL;INTRACAVERNOUS;INTRACAVITARY;INTRACEREBRAL;INTRACISTERNAL;INTRACORNEAL;INTRACORONAL- DENTAL;INTRACORONARY;INTRACORPORUS CAVERNOSUM;INTRADERMAL;INTRADISCAL;INTRADUCTAL;INTRADUODENAL;INTRADURAL;INTRAEPIDERMAL;INTRAESOPHAGEAL;INTRAGASTRIC;INTRAGINGIVAL;INTRAHEPATIC;INTRAILEAL;INTRAJEJUNAL;INTRALESIONAL;INTRALUMINAL;INTRALYMPHATIC;INTRAMEDULLARY;INTRAMENINGEAL;INTRAMUSCULAR;INTRAMUSCULAR OR SUBCUTANEOUS;INTRANODAL;INTRAOCULAR;INTRAOVARIAN;INTRAPALATAL;INTRAPARENCHYMAL;INTRAPERICARDIAL;INTRAPERITONEAL;INTRAPLEURAL;INTRAPROSTATIC;INTRAPULMONARY;INTRASINAL;INTRASPINAL;INTRASTOMAL;INTRASYNOVIAL;INTRATENDINOUS;INTRATESTICULAR;INTRATHECAL;INTRATHORACIC;INTRATUBULAR;INTRATUMOR;INTRATYMPANIC;INTRAUTERINE;INTRAVASCULAR;INTRAVENOUS;INTRAVENOUS BOLUS;INTRAVENOUS DRIP;INTRAVENTRICULAR;INTRAVESICAL;INTRAVITREAL;IONTOPHORESIS;IRRIGATION;LARYNGEAL;NASAL;NASOGASTRIC;OCCLUSIVE DRESSING TECHNIQUE;OPHTHALMIC;ORAL;ORAL GAVAGE;OROMUCOSAL;OROPHARYNGEAL;PARENTERAL;PERCUTANEOUS;PERIARTICULAR;PERIDURAL;PERINEURAL;PERIODONTAL;PERIVENOUS;RECTAL;RESPIRATORY (INHALATION);RETROBULBAR;SOFT TISSUE;SUBARACHNOID;SUBCONJUNCTIVAL;SUBCUTANEOUS;SUBLINGUAL;SUBMUCOSAL;SUBTENON;TOPICAL;TRANSDERMAL;TRANSMAMMARY;TRANSMUCOSAL;TRANSPLACENTAL;TRANSTRACHEAL;TRANSTYMPANIC;UNASSIGNED;URETERAL;URETHRAL;VAGINAL;OTHER;UNKNOWN;NOT APPLICABLE,question,70.866,178.671,15.744,28.632
804,104.0,Safety Concomitant Medication,CM_SAE,CM,2.0,Indication,"For what indication, was the (concomitant) [medication/treatment/therapy] taken?",CMINDC,IG,CMINDC,IG,,,question,70.866,583.671,15.744,48.6
805,104.0,Safety Concomitant Medication,CM_SAE,,3.0,Causal Relationship to the SAE,,CMSAEREL,SANOFI,,,NY_YN,Y;N,question,70.866,566.671,15.744,151.824
806,105.0,Dynamic Safety Concomitant Medication,CM_DYN_SAE,CM,2.0,Category for Medication,What is the category for the (concomitant) [medication/treatment/therapy]?,CMCAT,IG,CMCAT,IG,CMCAT,ANTI-CANCER THERAPY;ANTI-HYPERGLYCEMIC THERAPY;ANTIBIOTIC;ASTHMA CONTROLLER;ASTHMA RELIEVER;BASAL INSULIN;HISTORY OF ANTI-HYPERGLYCEMIC THERAPY;HISTORY OF LIPID MODIFYING THERAPY;HISTORY OF VACCINATION;HYPOGLYCEMIC TREATMENT;LIPID LOWERING THERAPY;LIPID MODIFYING THERAPY EXCLUDING STATIN;MEDICATION;NON-MEDICATION THERAPY;RESCUE THERAPY;SAE COMPLEMENTARY INFORMATION;STATIN THERAPY;SYSTEMIC CORTICOID THERAPY;OTHER;MEDICATIONS IMPACTING OR THAT MAY HAVE AN IMPACT ON THE EVALUATION OF THE SAFETY;MEDICATIONS IMPACTING OR THAT MAY HAVE AN IMPACT ON THE IMMUNE RESPONSE;MEDICATIONS IMPACTING OR THAT MAY HAVE AN IMPACT ON BOTH THE SAFETY AND THE IMMUNE RESPONSE,question,70.866,666.671,15.744,118.524
807,105.0,Dynamic Safety Concomitant Medication,CM_DYN_SAE,AE,3.0,Related AE ID,What is the adverse event identifier?,AESPID,IG,AESPID,IG,,,question,70.866,263.671,15.744,71.232
809,105.0,Dynamic Safety Concomitant Medication,CM_DYN_SAE,,4.0,Check If No Medication to report,,CMNOCM,SANOFI,,,,,question,70.866,246.671,15.744,160.824
810,105.0,Dynamic Safety Concomitant Medication,CM_DYN_SAE,,5.0,Medication List,,CMTERMLI,SANOFI,,,,,question,70.866,229.671,15.744,76.224
811,105.0,Dynamic Safety Concomitant Medication,CM_DYN_SAE,CM,6.0,Medication,What was the (concomitant) [medication/treatment/therapy] (name/term)?,CMTRT,IG,CMTRT,IG,,,question,70.866,212.671,15.744,54.588
812,105.0,Dynamic Safety Concomitant Medication,CM_DYN_SAE,CM,7.0,Start Date,What was the (concomitant) [medication/treatment/therapy/dose] start date?,CMSTDAT,IG,CMSTDTC,IG,,,question,70.866,195.671,15.744,48.252
813,105.0,Dynamic Safety Concomitant Medication,CM_DYN_SAE,CM,8.0,End Date,What was the (concomitant) [medication/treatment/therapy/dose] end date?,CMENDAT,IG,CMENDTC,IG,,,question,70.866,178.671,15.744,44.94
814,105.0,Dynamic Safety Concomitant Medication,CM_DYN_SAE,,9.0,Ongoing at SAE onset,,CMSAEONG,SANOFI,,,,,question,70.866,161.671,15.744,107.592
815,105.0,Dynamic Safety Concomitant Medication,CM_DYN_SAE,CM,10.0,Route,What was the route of administration of the (concomitant) [medication/treatment/therapy]?,CMROUTE,IG,CMROUTE,IG,ROUTE,AURICULAR (OTIC);BUCCAL;CONJUNCTIVAL;CUTANEOUS;DENTAL;DIETARY;ELECTRO-OSMOSIS;ENDOCERVICAL;ENDOSINUSIAL;ENDOTRACHEAL;ENTERAL;EPIDURAL;EXTRA-AMNIOTIC;EXTRACORPOREAL;HEMODIALYSIS;INFILTRATION;INTERSTITIAL;INTRA-ABDOMINAL;INTRA-AMNIOTIC;INTRA-ARTERIAL;INTRA-ARTICULAR;INTRABILIARY;INTRABRONCHIAL;INTRABURSAL;INTRACAMERAL;INTRACARDIAC;INTRACARTILAGINOUS;INTRACAUDAL;INTRACAVERNOUS;INTRACAVITARY;INTRACEREBRAL;INTRACISTERNAL;INTRACORNEAL;INTRACORONAL- DENTAL;INTRACORONARY;INTRACORPORUS CAVERNOSUM;INTRADERMAL;INTRADISCAL;INTRADUCTAL;INTRADUODENAL;INTRADURAL;INTRAEPIDERMAL;INTRAESOPHAGEAL;INTRAGASTRIC;INTRAGINGIVAL;INTRAHEPATIC;INTRAILEAL;INTRAJEJUNAL;INTRALESIONAL;INTRALUMINAL;INTRALYMPHATIC;INTRAMEDULLARY;INTRAMENINGEAL;INTRAMUSCULAR;INTRAMUSCULAR OR SUBCUTANEOUS;INTRANODAL;INTRAOCULAR;INTRAOVARIAN;INTRAPALATAL;INTRAPARENCHYMAL;INTRAPERICARDIAL;INTRAPERITONEAL;INTRAPLEURAL;INTRAPROSTATIC;INTRAPULMONARY;INTRASINAL;INTRASPINAL;INTRASTOMAL;INTRASYNOVIAL;INTRATENDINOUS;INTRATESTICULAR;INTRATHECAL;INTRATHORACIC;INTRATUBULAR;INTRATUMOR;INTRATYMPANIC;INTRAUTERINE;INTRAVASCULAR;INTRAVENOUS;INTRAVENOUS BOLUS;INTRAVENOUS DRIP;INTRAVENTRICULAR;INTRAVESICAL;INTRAVITREAL;IONTOPHORESIS;IRRIGATION;LARYNGEAL;NASAL;NASOGASTRIC;OCCLUSIVE DRESSING TECHNIQUE;OPHTHALMIC;ORAL;ORAL GAVAGE;OROMUCOSAL;OROPHARYNGEAL;PARENTERAL;PERCUTANEOUS;PERIARTICULAR;PERIDURAL;PERINEURAL;PERIODONTAL;PERIVENOUS;RECTAL;RESPIRATORY (INHALATION);RETROBULBAR;SOFT TISSUE;SUBARACHNOID;SUBCONJUNCTIVAL;SUBCUTANEOUS;SUBLINGUAL;SUBMUCOSAL;SUBTENON;TOPICAL;TRANSDERMAL;TRANSMAMMARY;TRANSMUCOSAL;TRANSPLACENTAL;TRANSTRACHEAL;TRANSTYMPANIC;UNASSIGNED;URETERAL;URETHRAL;VAGINAL;OTHER;UNKNOWN;NOT APPLICABLE,question,70.866,144.671,15.744,28.632
816,109.0,Dynamic Safety Concomitant Medication,CM_DYN_SAE,CM,2.0,Indication,"For what indication, was the (concomitant) [medication/treatment/therapy] taken?",CMINDC,IG,CMINDC,IG,,,question,70.866,551.671,15.744,48.6
817,109.0,Dynamic Safety Concomitant Medication,CM_DYN_SAE,,3.0,Causal Relationship to the SAE,,CMSAEREL,SANOFI,,,NY_YN,Y;N,question,70.866,534.671,15.744,151.824
818,110.0,Safety Laboratory Test Results,PV_LB_SAE,LB,2.0,Laboratory Category,What was the name of the lab panel?,LBCAT,IG,LBCAT,IG,LBCATEG,BACTERIOLOGY;BANKING;BIOMARKERS;CHEMISTRY;CLAMP GLUCOSE;COAGULATION;CYTOLOGY;DRUG SCREEN;GENETIC VARIATION;HEMATOLOGY;HORMONOLOGY;MEAL TEST;MICROBIOLOGY;PARASITOLOGY;PHARMACODYNAMIC;PHARMACOGENOMIC;PREGNANCY;SAE COMPLEMENTARY INFORMATION;SEROLOGY;URINALYSIS;VIROLOGY,question,70.866,666.671,15.744,100.212
820,110.0,Safety Laboratory Test Results,PV_LB_SAE,LB,2.0,Laboratory Category,What was name of the lab panel?,LBCAT,IG,LBCAT,IG,LBCATEG,BACTERIOLOGY;BANKING;BIOMARKERS;CHEMISTRY;CLAMP GLUCOSE;COAGULATION;CYTOLOGY;DRUG SCREEN;GENETIC VARIATION;HEMATOLOGY;HORMONOLOGY;MEAL TEST;MICROBIOLOGY;PARASITOLOGY;PHARMACODYNAMIC;PHARMACOGENOMIC;PREGNANCY;SAE COMPLEMENTARY INFORMATION;SEROLOGY;URINALYSIS;VIROLOGY,question,70.866,666.671,15.744,100.212
822,110.0,Safety Laboratory Test Results,PV_LB_SAE,SUPPLB;SUPPLBUS,3.0,Normal Range Type,,LBRANTYP,SANOFI,LBRANTYP,SANOFI,RANGTYPE,LOCAL REFERENCE RANGES;SPONSOR REFERENCE RANGES,question,70.866,315.671,15.744,97.884
823,110.0,Safety Laboratory Test Results,PV_LB_SAE,AE,4.0,Related AE ID,What is the adverse event identifier?,AESPID,IG,AESPID,IG,,,question,70.866,280.671,15.744,71.232
825,110.0,Safety Laboratory Test Results,PV_LB_SAE,LB;LBUS,5.0,Specimen Type,,LBSPEC,SANOFI,LBSPEC,SANOFI,SPECTYPE,ADIPOSE TISSUE;AMNIOTIC FLUID;AQUEOUS HUMOR;ARTERIAL BLOOD;ARTERIAL CORD BLOOD;ATHEROSCLEROTIC PLAQUE;BILE;BLOOD;BONE;BONE MARROW;BREAST MILK;BUFFY COAT;CALCULUS;CAPILLARY BLOOD;CARDIAC MUSCLE TISSUE;CEREBROSPINAL FLUID;CERUMEN;CIRCULATING TUMOR CELL;COLOSTRUM;CORD BLOOD;CORD SERUM;DIALYSIS FLUID;DRIED BLOOD SPOT;EMESIS;ERYTHROCYTES;EXPIRED AIR;EXUDATE;FIBROBLAST;FLUID;GASTRIC CONTENTS;HAIR;HAIR FOLLICLE;INFRANATANT- PLASMA;INFRANATANT- PLEURAL FLUID;INFRANATANT- SERUM;INTERSTITIAL FLUID;ISOLATE;LAVAGE FLUID;LEUCOCYTES;LOCHIA;LUNG SURFACTANT;LYMPH;LYSATE;MECONIUM;MENSTRUAL BLOOD;MUCUS;MUSCLE TISSUE;NAIL;NASAL;NASOPHARYNGEAL;PERIPHERAL BLOOD;PERIPHERAL BLOOD MONONUCLEAR CELL;PERSPIRATION;PHARYNGEAL;PLASMA;PLATELET;PLATELET POOR PLASMA;PLATELET RICH PLASMA;PLEURAL FLUID;PROSTATIC FLUID;PUS;SALIVA;SEBUM;SEMEN;SEMINAL FLUID;SERUM;SKELETAL MUSCLE TISSUE;SMEGMA;SMOOTH MUSCLE TISSUE;SOFT TISSUE;SPUTUM;STOOL;STRIATED MUSCLE TISSUE;SUPERNATANT- CELLS;SUPERNATANT- PLASMA;SUPERNATANT- PLEURAL FLUID;SUPERNATANT- SERUM;SYNOVIAL FLUID;TISSUE;TRANSUDATE;TUMOR TISSUE;URINE;VENOUS BLOOD;VENOUS CORD BLOOD;VITREOUS HUMOR;WHOLE BLOOD;OTHER,question,70.866,263.671,15.744,74.904
827,112.0,Safety Laboratory Test Results,PV_LB_SAE,LB,2.0,Collection Date,What was the date of the lab specimen collection?,LBDAT,IG,LBDTC,IG,,,question,70.866,75.671,15.744,75.54
828,112.0,Safety Laboratory Test Results,PV_LB_SAE,LB,2.0,Collection Date,What was the date of lab specimen collection?,LBDAT,IG,LBDTC,IG,,,question,70.866,75.671,15.744,75.54
829,113.0,Safety Laboratory Test Results,PV_LB_SAE,LB,2.0,Test Name,What was the lab test name?,LBTEST,IG,LBTEST; LBTESTCD,IG,LBTEST,1- 25-Dihydroxyvitamin D;11-Dehydro-Thromboxane B2;17p(deletion);25-Hydroxyvitamin D;3-4-Dihydroxyphenylacetic Acid;3-4-Dihydroxyphenylglycol;3-4-methylenedioxymethamphetamine;5 Prime Nucleotidase;5-Hydroxyindoleacetic Acid;6-Monoacetylmorphine;8-Iso-PGF2alpha/Creatinine;8-Iso-Prostaglandin F2 Alpha;A Fetoprotein L3/A Fetoprotein;A Proliferation-Inducing Ligand;A. fumigatus Antigen IgE Antibody;ADV Viral Load;ALT/AST;ANA Pattern;Abnormal Cells;Acanthocytes;Acanthocytes/Erythrocytes;Acetate;Acetoacetic Acid;Acetoacetic Acid (Urine);Acetoacetic Acid Excretion Rate;Acetylcholine;Acetylcholine Receptor Antibody;Acetylcholinesterase;Acid Phosphatase;Acid Urate Crystals;Actin- Beta;Activated Coagulation Time;Activated PTT/Standard;Activated Partial Thromboplastin Time;Activated Protein C Resistance;Active Ghrelin;Acyl Coenzyme A Oxidase;Adenosine Diphosphate;Adenovirus Antibody;Adiponectin;Adrenocorticotropic Hormone;Aggrecan Chondroitin Sulfate Epitope 846;Agranular Neutrophils;Alanine Aminopeptidase;Alanine Aminotransferase;Albumin;Albumin (Urine);Albumin Excretion Rate;Albumin/Creatinine;Albumin/Globulin;Albumin/Total Protein;Alder Grey Pollen IgE;Aldolase;Aldosterone;Alkaline Phosphatase;Alkaline Phosphatase/Creatinine;Alpha Fetoprotein;Alpha Fetoprotein Activity;Alpha Fetoprotein L1;Alpha Fetoprotein L2;Alpha Fetoprotein L3;Alpha Glutathione-S-Transferase;Alpha Hydroxybutyrate Dehydrogenase;Alpha Tocopherol;Alpha Tocopherol/Vitamin E;Alpha-1 Acid Glycoprotein;Alpha-1 Antitrypsin;Alpha-1 Globulin;Alpha-1 Globulin (Urine);Alpha-1 Globulin/Total Protein;Alpha-1 Microglobulin;Alpha-1 Microglobulin/Creatinine;Alpha-2 Antiplasmin;Alpha-2 Globulin;Alpha-2 Globulin (Urine);Alpha-2 Globulin/Total Protein;Alpha-2 Macroglobulin;Alpha-GST Excretion Rate;Alpha-Synuclein;Aluminum;American Elm Pollen lgE;Amino Acid Change 1;Amino Acid Change 2;Ammonia;Ammonium Biurate Crystals;Ammonium Oxalate Crystals;Amorphous Crystals;Amorphous Phosphate Crystals;Amorphous Sediment;Amorphous Urate Crystals;Amphetamine;Amylase;Amylase- Pancreatic;Amylase- Salivary;Amyloid A;Amyloid Alpha Precursor Protein;Amyloid Beta 1-38;Amyloid Beta 1-40;Amyloid Beta 1-41;Amyloid Beta 1-42;Amyloid Beta Precursor Protein;Amyloid P;Amyloid- Beta;Androstenediol;Androstenedione;Angiopoietin 1;Angiotensin Converting Enzyme;Angiotensin I;Angiotensin II;Angiotensinogen;Anion Gap;Anisocytes;Anti-DNA Antibodies;Anti-Double Stranded DNA;Anti-Double Stranded DNA IgG;Anti-Double Stranded DNA IgM;Anti-Drug Antibody Status;Anti-Drug Antibody Titer;Anti-Factor Xa Activity;Anti-GAD Antibody;Anti-HCV Antibody;Anti-Indole 3 Acetic Acid Antibody;Anti-Insulinoma-Associated 2 Antibody;Anti-Islet Cell Antibody;Anti-Mullerian Hormone;Anti-Neutrophil Cytoplasmic Antibody;Anti-Nucleosome Antibody;Anti-Saccharomyces cerevisiae Antibody;Anti-Single Stranded DNA IgG;Anti-Zinc Transporter 8 Antibody;Antidepressants;Antidiuretic Hormone;Antiglobulin Test- Direct;Antiglobulin Test- Indirect;Antimitochondrial Antibodies;Antinuclear Antibodies;Antiphospholipid Antibodies;Antithrombin;Antithrombin Antigen;Apo(a) Isoform Number;Apolipoprotein A1;Apolipoprotein A4;Apolipoprotein A5;Apolipoprotein AII;Apolipoprotein B;Apolipoprotein B/Apolipoprotein A1;Apolipoprotein B100;Apolipoprotein B48;Apolipoprotein C2;Apolipoprotein CI;Apolipoprotein CIII;Apolipoprotein E;Apolipoprotein E4;Apolipoprotein H;Apolipoprotein J;Apolipoprotein J/Creatinine;Arachidonate 5-Lipoxygenase;Arachidonic Acid;Aspartate Aminotransferase;Aspartate Aminotransferase Antigen;Aspartate Aminotransferase/Creatinine;Atrial Natriuretic Peptide;Auer Rods;Azurophilic Granules;B-Cell Activating Factor;BKV Viral Load;BUN/Creatinine;Bacteria;Bacteria (Urine) (Sediment Analysis);Bacterial Casts;Bactericidal/Permeability-Inc Protein Ab;Barbiturates;Base Excess;Basket Cells;Basophilic Stippling;Basophils;Basophils/Leukocytes;Basophils/Total Cells;Bence-Jones Protein;Benzodiazepine;Benzoylecgonine;Beta Carotene;Beta Catenin;Beta Globulin;Beta Globulin (Urine);Beta Globulin/Total Protein;Beta Iso Type I Collagen C-Telopeptides;Beta-1 Globulin;Beta-1 Globulin/Total Protein;Beta-2 Globulin;Beta-2 Globulin/Total Protein;Beta-2 Glycoprotein 1 IgG Antibody;Beta-2 Glycoprotein 1 IgM Antibody;Beta-2 Glycoprotein Antibody;Beta-2 Microglobulin;Beta-2 Microglobulin (Urine);Beta-Glucocerebrosidase;Beta-Hydroxybutyrate;Beta-Hydroxybutyrate (Urine);Beta-Hydroxybutyrate Excretion Rate;Beta-Trace Protein;Bicarbonate;Bile Acid;Bilirubin;Bilirubin (Urine);Bilirubin (qual);Bilirubin Crystals;Bioavailable Testosterone;Bite Cells;Bite Cells/Erythrocytes;Blasts;Blasts/Leukocytes;Bleeding Time;Blister Cell;Blood Urea Nitrogen;Bone Specific Alkaline Phosphatase;Brain Natriuretic Peptide;Brain-Derived Neurotrophic Factor;Broad Casts;Burr Cells;Butyrate;Butyrylcholinesterase;C Reactive Protein;C-peptide;CD1;CD10;CD11A;CD11B;CD13;CD14;CD19;CD19+ B-Cell;CD19+ B-Cell/Lymphocytes;CD19/Lymphocytes;CD2;CD2/Lymphocytes;CD20;CD22;CD23;CD3;CD3 Isoform D;CD3 Isoform E;CD3 Isoform G;CD3+ T-Cell;CD3+ T-Cell/Lymphocytes;CD3-/16+56;CD3-/16+56/Lymphocytes;CD3/Lymphocytes;CD33;CD34;CD38;CD38 Lymphocytes Final Baseline;CD38 MAb1 sABC of Cancer Cells;CD38 MAb1 sABC of Lymphocytes;CD38 MAb1 sABC of Monocytes;CD38 MAb1 sABC of NK Cells;CD38 MAb1 sABC of Polymorph Cells;CD38 MAb2 sABC of Cancer Cells;CD38 MAb2 sABC of Lymphocytes;CD38 MAb2 sABC of Monocytes;CD38 MAb2 sABC of Polymorph Cells;CD38 MRNA All Isoforms;CD38 MRNA Isoform A;CD38 Monocytes Final Baseline;CD38 Polymorph Cells Final Baseline;CD38 Pos Cancer Cells Final Baseline;CD38 Receptor Density of Cancer Cells;CD38 Receptor Density of Lymphocytes;CD38 Receptor Density of Monocytes;CD38 Receptor Density of Polymorph Cells;CD38 Receptor Occupancy;CD38 Receptor Occupancy Polymorph Cells;CD38 Receptor Occupancy of Cancer Cells;CD38 Receptor Occupancy of Lymphocytes;CD38 Receptor Occupancy of Monocytes;CD38 Receptor Occupancy of NK Cells;CD38 Soluble;CD4;CD4+ T-Cell;CD4+ T-Cell/Lymphocytes;CD4/CD8;CD4/Lymphocytes;CD40;CD40 Ligand;CD5;CD56;CD56+(CD3-)/HLA-DR+(NK);CD56+(CD3-)/HLA-DR+/LAMP+;CD56+(CD3-)/LAMP+;CD56+Brght CD16+Low NK Cells/Lymphocytes;CD56+Brght CD16+Low Natural Killer Cells;CD56+Dim CD16+Brght NK Cells/Lymphocytes;CD56+Dim CD16+Brght Natural Killer Cells;CD79A;CD8;CD8 Isoform A;CD8+(CD3+)/HLA-DR+;CD8+(CD3+)/HLA-DR+/LAMP1+;CD8+(CD3+)/LAMP1+;CD8/Lymphocytes;CK Macro 1;CK Macro 2;CMV Viral Load;Cabot Rings;Caffeine;Calcitonin;Calcitriol;Calcium;Calcium (Urine);Calcium - Phosphorus Product;Calcium Carbonate Crystals;Calcium Clearance;Calcium Corrected;Calcium Excretion Rate;Calcium Oxalate Crystals;Calcium Phosphate Crystals;Calcium Sulphate;Calcium- Ionized;Calcium/Creatinine;Calprotectin;Cancer Antigen 1;Cancer Antigen 125;Cancer Antigen 15-3;Cancer Antigen 19-9;Cancer Antigen 27-29;Cancer Antigen 6;Cancer Antigen 72-4;Cannabinoids;Carbohydrate-Deficient Transferrin;Carbon Dioxide;Carboxyhemoglobin;Carcinoembryonic Antigen;Cardiolipin IgG Antibody;Cardiolipin IgM Antibody;Carnitine;Carnitine Acetyl Transferase;Carnitine- Free;Cartilage Oligomeric Matrix Protein;Casts;Cathepsin Antibody;Cellular Casts;Cellularity;Centromere Antibodies;Centromere B Antibodies;Ceruloplasmin;Chemokine (C-C Motif) Ligand 13;Chemokine (C-C Motif) Ligand 17;Chemokine (C-C Motif) Ligand 18;Chemokine (C-C Motif) Ligand 2;Chemokine (C-C Motif) Ligand 22;Chemokine (C-C Motif) Ligand 26;Chemokine (C-X-C Motif) Ligand 10;Chemokine (C-X-C Motif) Ligand 11;Chemokine (C-X-C Motif) Ligand 13;Chemokine (C-X-C Motif) Ligand 9;Chemokine (C-X-C Motif) Receptor 3;Chemokine (C-X-C Motif) Receptor 4;Chitinase 3-Like 1 Gene;Chitotriosidase-1;Chlamydia pneumoniae IgA Antibody;Chlamydia pneumoniae IgM Antibody;Chlamydia trachomatis IgA Antibody;Chlamydia trachomatis IgG Antibody;Chlamydia trachomatis IgM Antibody;Chloride;Chloride (Urine);Chloride Clearance;Chloride Excretion Rate;Chloride/Creatinine;Cholecystokinin;Cholera Toxin B Subunit IgG Antibody;Cholesterol;Cholesterol Crystals;Cholesterol/HDL-Cholesterol;Cholesteryl Ester Transfer Protein;Cholesteryl Ester Transfer Protein Act;Cholinesterase;Choriogonadotropin Beta;Choriogonadotropin Beta (qual);Chromogranin A;Chylomicrons;Chymotrypsin;Circulating Endothelial Cells;Circulating Free DNA;Circulating Tumor Cells;Citrate;Cladosporium Herbarum Pollen IgE;Clarity;Clonal Cells;Clostridium difficile;Clostridium difficile Toxin;Clostridium tetani IgG Antibody;Clue Cells;Coagulation Index;Cocaine;Coccidioides Antibody;Codeine;Collagen Type IV;Color;Complement Bb;Complement C1q Antibody;Complement C3;Complement C3a;Complement C3b;Complement C3c;Complement C3d Antibody;Complement C4;Complement C4a;Complement C5a;Complement CH50;Complement Total;Copeptin;Copper;Corticosterone;Corticosterone/Creatinine;Corticotropin Releasing Hormone;Cortisol;Cortisol (Urine);Cortisol Excretion Rate;Cortisol- Free;Cortisol/Creatinine;Cotinine;Creatine Kinase;Creatine Kinase BB;Creatine Kinase BB/Total Creatine Kinase;Creatine Kinase MB;Creatine Kinase MB/Total Creatine Kinase;Creatine Kinase MM;Creatine Kinase MM/Total Creatine Kinase;Creatinine;Creatinine (Urine);Creatinine Clearance;Creatinine Excretion Rate;Crenated Cells;Cryoglobulin;Crystals;Cyclic Citrullinated Peptide Antibody;Cyclic Guanosine Monophosphate;Cystatin C;Cystatin C/Creatinine;Cysteinyl Leukotriene Receptor 1;Cystine;Cystine Crystals;Cytokeratin Fragment 21-1;Cytomegalovirus IgG Antibody;Cytomegalovirus IgM Antibody;Cytoplasmic Basophilia Neutrophil;D-Dimer;D. farinae Antigen IgE Antibody;D. pteronyssinus Antigen IgE Antibody;DM4 Clearance;DNA Sequence Change 1;DNA Sequence Change 2;DNase-B Antibody;DTPA Clearance;Dacryocytes;Degenerated Leukocytes;Dehydroepiandrosterone;Dehydroepiandrosterone Sulfate;Dengue IgG Antibody;Dengue IgM Antibody;Density;Deoxypyridinoline;Deoxypyridinoline/Creatinine;Dermatophagoides Farinae IgE;Dermatophagoides Pteronyssinus IgE;Dextroamphetamine;Dihydrocodeine;Dihydrotestosterone;Dilute Russell's Viper Venom Time;Dilute Russell's Viper Venom Time Ratio;Dimorphic Erythrocyte Population;Dipeptidyl Peptidase-4 Activity;Diphtheria IgG Antibody;Direct Bilirubin;Direct Removal of VLDL Apo B;Dohle Bodies;Dopamine;Drug Screen;Dysmorphic Erythrocytes;EBV Profile Interpretation;EBV Viral Load;EDTA Clearance;ETP Area Under Curve;ETP Lag Time;ETP Lag Time Relative;ETP Peak Height;ETP Peak Height Relative;ETP Time to Peak;ETP Time to Peak Relative;Ecarin Clotting Time;Eccentrocytes;Elliptocytes;Endogenous Thrombin Potential;Endothelin-1;Eosinophilic Metamyelocytes;Eosinophilic Myelocytes;Eosinophils;Eosinophils (Urine);Eosinophils Band Form;Eosinophils Band Form/Leukocytes;Eosinophils/Inflammatory Population;Eosinophils/Leukocytes;Eosinophils/Total Cells;Eotaxin-1;Eotaxin-2;Eotaxin-3;Epidemic Parotitis IgM Antibody;Epidermal Growth Factor;Epidermal Growth Factor Receptor;Epinephrine;Epith Neutrophil-Activating Peptide 78;Epithelial Casts;Epithelial Cells;Epithelial Cells/Total Cells;Epstein-Barr Capsid IgG Antibody;Epstein-Barr Capsid IgM Antibody;Epstein-Barr Early Antigen;Epstein-Barr Nuclear Antibody;Epstein-Barr Nuclear Antigen;Epstein-Barr Nuclear Antigen 1 IgG Ab;Ery. Mean Corpuscular HGB Concentration;Ery. Mean Corpuscular Hemoglobin;Ery. Mean Corpuscular Volume;Erythrocyte Agglutination;Erythrocyte Cell Clumps;Erythrocyte Cell Morphology;Erythrocyte Fragment;Erythrocyte Ghosts;Erythrocyte Magnesium;Erythrocyte Sedimentation Rate;Erythrocytes;Erythrocytes (Urine);Erythrocytes (Urine) (Sediment Analysis);Erythrocytes (qual);Erythrocytes Distribution Width;Erythropoietin;Estradiol;Estriol;Estriol- Free;Estrogen Receptor;Estrone;Ethanol;Extracell Newly Ident RAGE Bind Protein;Extractable Nuclear Antigen Antibody;F2-Isoprostane;Factor II;Factor III;Factor IX;Factor IX Activity;Factor V;Factor V Activity;Factor V Leiden;Factor VII;Factor VII Activity;Factor VIII;Factor VIII Activity;Factor VIII C;Factor VIIa Activity;Factor X;Factor XI;Factor XII;Factor XIII;Factor XIV;Factor XIV Activity;Fat;Fat Bodies- Oval;Fat Droplet;Fatty Acid Binding Protein 1;Fatty Acid Binding Protein 3;Fatty Casts;Fc Fragment of IgE Receptor II Gene;Ferritin;Fibrin Degradation Products;Fibrinogen;FibroTest Score;Fibroblast Growth Factor 21;Fibroblast Growth Factor 23;Fibroblast Growth Factor Basic Form;Firmicutes/Bacteroidetes Ratio;Fluid Intake;Folded RBC;Follicle Stimulating Hormone;Fractional Calcium Excretion;Fractional Chloride Excretion;Fractional Phosphorus Excretion;Fractional Potassium Excretion;Fractional Sodium Excretion;Free Fatty Acid;Free Fatty Acid- Saturated;Free Fatty Acid- Unsaturated;Free Glycerol;Fructosamine;GFR from B-2 Microglobulin Adj for BSA;GFR from Beta-Trace Protein Adj for BSA;GFR from Creatinine Adjusted for BSA;GFR from Cystatin C Adjusted for BSA;Galanin;Gamma Globulin;Gamma Globulin (Urine);Gamma Globulin/Total Protein;Gamma Glutamyl Transferase;Gamma Glutamyl Transferase (Urine);Gamma Glutamyl Transferase/Creatinine;Gamma Tocopherol;Gastrin;Gated Events;Germline DNA;Ghrelin;Giant Neutrophils;Giant Platelets;Globulin;Glomerular Filtration Rate;Glomerular Filtration Rate Adj for BSA;Glomerular Filtration Rate- Estimated;Glomerular Filtration Rt- Estimated MDRD;Glucagon;Glucagon-Like Peptide-1;Glucagon-Like Peptide-1- Active Form;Glucose;Glucose (Urine);Glucose (qual);Glucose Clearance;Glucose Excretion Rate;Glucose-6-Phosphate Dehydrogenase;Glucose-dep Insulinotropic Pep- Intact;Glucose/Creatinine;Glucosylceramide;Glucosylsphingosine;Glucuronidase- Alpha;Glucuronidase- Beta;Glutamate;Glutamate Dehydrogenase;Glutamic Acid Decarboxylase 1;Glutamic Acid Decarboxylase 2;Glutamic Acid Decarboxylase 2 Antibody;Glutamic Acid Decarboxylase Antibody;Glutathione S-Transferase- Alpha/Creat;Glutathione S-Transferase- Pi;Glutathione S-Transferase- Theta;Glutathione S-Transferase- Total;Glutathione-S-Transferase/Creatinine;Glyceraldehyde-3-Phosphate Dehydrogenase;Gold;Gonadotropin Releasing Hormone;Granular Casts;Granular Coarse Casts;Granular Fine Casts;Granulocyte Colony Stimulating Factor;Granulocyte Macrophage Colony Stm Factor;Granulocytes;Granulocytes/Total Cells;Growth Hormone Inhibiting Hormone;Growth Hormone Releasing Hormone;HAV Viral Load;HBV Viral Load;HCT Corrected Reticulocytes/Erythrocytes;HCV Viral Load;HDL Cholesterol;HDL Cholesterol/LDL Cholesterol Ratio;HDL Particle Size;HDL-Cholesterol Subclass 2;HDL-Cholesterol Subclass 3;HER2 Antigen;HIV Antibody;HIV Interpretation;HIV Viral Load;HIV-1 Antibody;HIV-1 Group M and O Nucleic Acid;HIV-1 Group O Antibody;HIV-1 p24 Antigen;HIV-1/2 Antibody;HIV-1/2 Antigen;HIV-2 Antibody;HIV-2 Nucleic Acid;HIV1 RNA;HLA-B27 Antigen;Hairy Cells;Hairy Cells/Lymphocytes;Haptoglobin;Heinz Bodies;Heinz Bodies/Erythrocytes;Helicobacter pylori IgG Antibody;Helmet Cells;Hematocrit;Hematocrit Corrected Reticulocytes;Hemoglobin;Hemoglobin (Urine);Hemoglobin (qual);Hemoglobin A;Hemoglobin A1C;Hemoglobin A1C/Hemoglobin;Hemoglobin A2;Hemoglobin B;Hemoglobin C;Hemoglobin C Crystals;Hemoglobin Distribution Width;Hemoglobin F;Hemolytic Index;Hemosiderin;Hepatic Lipase;Hepatitis A Virus Antibody;Hepatitis A Virus Antibody IgM;Hepatitis B DNA;Hepatitis B Virus Core Antibody;Hepatitis B Virus Core IgG Antibody;Hepatitis B Virus Core IgM Antibody;Hepatitis B Virus Surface Antibody;Hepatitis B Virus Surface Antigen;Hepatitis B Virus e Antibody;Hepatitis B Virus e Antigen;Hepatitis C Virus Antibody;Hepatitis C Virus Antigen;Hepatitis D Virus Antibody;Hepatitis D Virus IgG Antibody;Hepatitis D Virus IgM Antibody;Hepatitis E Virus Antibody;Hepatitis E Virus IgG Antibody;Hepatitis E Virus IgM Antibody;Hepatitis G RNA;Hepcidin;Herpes Simplex Virus 1 IgG Antibody;Herpes Simplex Virus 1 IgM Antibody;Herpes Simplex Virus 1/2 IgG Antibody;Herpes Simplex Virus 1/2 IgM Antibody;Herpes Simplex Virus 2 IgG Antibody;Herpes Simplex Virus 2 IgM Antibody;Herpes Simplex Virus 6 Antibody;Herpes Simplex Virus Common Antigen;Heterophile Antibodies;Heterophils;Heterophils/Leukocytes;Hexokinase;High Absorption Retic/Reticulocytes;High Absorption Reticulocytes;High Sensitivity Troponin I;High Sensitivity Troponin T;Hippuric Acid Crystals;Histamine;Histone 1 Antibody;Histone 2A Antibody;Histone 2B Antibody;Histone 3 Antibody;Histone 4 Antibody;Histone Antibodies;Homocysteine;Homostat Model Assess of Insulin Rstn;Homovanillic Acid;Howell-Jolly Bodies;Human Albumin Antibody;Human Anti-Mouse Antibody;Human Anti-Sheep IgE Antibody;Human Anti-Sheep IgG Antibody;Human Anti-Sheep IgM Antibody;Human Epidermal Growth Factor Receptor 2;Hyaline Casts;Hyaluronic Acid;Hydrocodone;Hydrogen;Hydromorphone;Hydroxyproline;Hyperchromia;Hypersegmented Cells;Hypochromia;Hypogranular Neutrophils;Hyposegmented Neutrophils;Hypoxanthine Phosphoribosyltransferase 1;IDL Apolipoprotein B;IDL Cholesterol;IDL Particles;IDL Triglycerides;IDL to LDL Conversion;Icteric Index;IgA/C3 Ratio;IgG IgM IgA Total;Immature Basophils;Immature Basophils/Leukocytes;Immature Cells;Immature Cells/Total Cells;Immature Eosinophils;Immature Eosinophils/Leukocytes;Immature Granulocytes;Immature Granulocytes/Leukocytes;Immature Lymphocytes;Immature Lymphocytes/Leukocytes;Immature Monocytes;Immature Monocytes/Leukocytes;Immature Neutrophils;Immature Neutrophils/Leukocytes;Immature Plasma Cells;Immature Plasma Cells/Lymphocytes;Immature Reticulocyte Fraction;Immunoblasts;Immunoblasts/Lymphocytes;Immunogenetics FCGR2A rs1801274;Immunogenetics FCGR2B rs1050501;Immunogenetics FCGR3A rs396991;Immunogenetics HLA-A Genotype;Immunogenetics HLA-A Motif;Immunogenetics HLA-B Genotype;Immunogenetics HLA-B Motif;Immunogenetics HLA-C Genotype;Immunogenetics HLA-C Motif;Immunogenetics KIR2DL1;Immunogenetics KIR2DL2;Immunogenetics KIR2DL3;Immunogenetics KIR2DL4;Immunogenetics KIR2DL5;Immunogenetics KIR2DP1;Immunogenetics KIR2DS1;Immunogenetics KIR2DS2;Immunogenetics KIR2DS3;Immunogenetics KIR2DS4;Immunogenetics KIR2DS4 Full Length;Immunogenetics KIR2DS4 Short;Immunogenetics KIR2DS5;Immunogenetics KIR3DL1;Immunogenetics KIR3DL2;Immunogenetics KIR3DL3;Immunogenetics KIR3DP1;Immunogenetics KIR3DP1 Full Length;Immunogenetics KIR3DP1 Short;Immunogenetics KIR3DS1;Immunoglobulin A;Immunoglobulin D;Immunoglobulin E;Immunoglobulin G;Immunoglobulin G/Creatinine;Immunoglobulin M;Inclusion Bodies;Indican;Indirect Bilirubin;Indocyanine Green;Inflammatory Cells;Inflammatory Cells/Total Cells;Influenza A H1N1 Viral Load;Influenza A IgG Antibody;Influenza A Viral Load;Influenza B IgG Antibody;Inhibin A;Inhibin B;Insulin;Insulin Antibody;Insulin Autoantibody;Insulin-Like Growth Factor Binding Prot3;Insulin-like Growth Factor-1;Insulin-like Growth Factor-2;Insulinoma-Associated Protein 2 Antibody;Interferon Alpha;Interferon Beta;Interferon Gamma;Interleukin 1;Interleukin 1 Beta;Interleukin 1 Receptor Antagonist;Interleukin 10;Interleukin 11;Interleukin 12;Interleukin 13;Interleukin 13 Receptor- Alpha 2 Gene;Interleukin 14;Interleukin 15;Interleukin 16;Interleukin 17;Interleukin 18;Interleukin 19;Interleukin 2;Interleukin 20;Interleukin 21;Interleukin 22;Interleukin 23;Interleukin 24;Interleukin 25;Interleukin 26;Interleukin 27;Interleukin 28;Interleukin 29;Interleukin 3;Interleukin 30;Interleukin 31;Interleukin 32;Interleukin 33;Interleukin 4;Interleukin 5;Interleukin 6;Interleukin 7;Interleukin 8;Interleukin 9;Interleukin-17A;Intestinal Specific Alkaline Phosphatase;Intraerythrocyte Crystals;Inulin Clearance;Iohexol Clearance;Iothalamate Clearance;Iothalamate Clearance Adjusted for BSA;Iron;Iron Excretion Rate;Islet Cell 512 Antibody;Islet Cell 512 Antigen;Islet Neogenesis Assoc Protein Antibody;Isoleucine;Italian Cypress Pollen IgE;JC Virus Antibody;Jo-1 Antibody;Johnson Grass Pollen lgE;June Grass/Kentucky Blue Pollen IgE;Kappa Light Chain- Free;Kappa Lt Chain-Free/Lambda Lt Chain-Free;Ketone Bodies;Ketone Bodies Excretion Rate;Ketones;Ketones (Urine);Ketones (qual);Kidney Injury Molecule-1;Kurloff Cells;LDH Isoenzyme 1;LDH Isoenzyme 1/LDH;LDH Isoenzyme 2;LDH Isoenzyme 2/LDH;LDH Isoenzyme 3;LDH Isoenzyme 3/LDH;LDH Isoenzyme 4;LDH Isoenzyme 4/LDH;LDH Isoenzyme 5;LDH Isoenzyme 5/LDH;LDL Apolipoprotein B;LDL Cholesterol;LDL Cholesterol/HDL Cholesterol;LDL Particle Size;LDL Particles;LDL Subtype Pattern;LDL Triglycerides;Lactate Dehydrogenase;Lactate Dehydrogenase/Creatinine;Lactic Acid;Lactoferrin;Lactoferrin Antibody;Lambda Light Chain- Free;Large Platelets;Large Unstained Cells;Large Unstained Cells/Leukocytes;Left Shift Neutrophils;Legionella pneumophila Antigen;Legionella pneumophila IgG Antibody;Legionella pneumophila IgG IgM Antibody;Legionella pneumophila IgM Antibody;Leptin;Leucine Aminopeptidase;Leucine Crystals;Leukemic Blasts;Leukemic Blasts/Lymphocytes;Leukemic Cells;Leukocyte Cell Clumps;Leukocyte Cell Morphology;Leukocyte Esterase;Leukocytes;Leukocytes (Urine);Leukocytes (Urine) (Sediment Analysis);Leukocytes (qual);Leukotriene B4;Leukotriene C4 Synthase;Leukotriene D4;Leukotriene E4;Lipase;Lipase- Gastric;Lipase- Lysosomal Acid;Lipase- Pancreatic;Lipemic Index;Lipocalin-2;Lipocalin-2/Creatinine;Lipoprotein Associated Phospholipase A2;Lipoprotein Lipase;Lipoprotein-a;Liver Cytostolic Protein Type 1 Antibody;Liver Kidney Microsomal Type 1 Antibody;Liver Kidney Microsomal Type 1 IgA Ab;Liver Kidney Microsomal Type 1 IgG Ab;Liver Kidney Microsomal Type 1 IgM Ab;Liver Specific Alkaline Phosphatase;Low Absorption Retic/Reticulocytes;Low Absorption Reticulocytes;Lupus Anticoagulant Sensitive APTT;Luteinizing Hormone;Lymphoblasts;Lymphoblasts/Leukocytes;Lymphocytes;Lymphocytes Activated;Lymphocytes Atypical;Lymphocytes Atypical/Leukocytes;Lymphocytes/Leukocytes;Lymphocytes/Total Cells;Lymphoma Cells;Lymphoma Cells/Lymphocytes;Lymphotactin;Lysergic Acid Diethylamide;Lysozyme;M. tuberculosis IFN Gamma Response;MCV Reticulocytes;Macroamylase;Macrocytes;Macrophage Colony Stimulating Factor;Macrophage Inflammatory Protein 1 Alpha;Macrophage Inflammatory Protein 1 Beta;Macrophage-Derived Chemokine;Macrophages;Macrophages/Total Cells;Magnesium;Magnesium/Creatinine;Malignant Cells- NOS;Malignant Cells- NOS/Blood Cells;Mast Cells;Mast Cells/Inflammatory Population;Mast Cells/Total Cells;Matrix Metalloproteinase 1;Matrix Metalloproteinase 2;Matrix Metalloproteinase 3;Matrix Metalloproteinase 7;Matrix Metalloproteinase 8;Matrix Metalloproteinase 9;Mature Plasma Cells;Mature Plasma Cells/Lymphocytes;May-Hegglin Anomaly;Meadow Fescue Pollen IgE;Mean Platelet Component;Mean Platelet Dry Mass;Mean Platelet Volume;Medium Absorption Retic/Reticulocytes;Medium Absorption Reticulocytes;Megakaryoblasts;Megakaryoblasts/Total Cells;Megakaryocytes;Megakaryocytes/Total Cells;Melatonin;Meningeal Cells;Meningeal Cells/Total Cells;Metamyelocytes;Metamyelocytes/Leukocytes;Metamyelocytes/Total Cells;Metanephrine;Methadone;Methamphetamine;Methaqualone;Methemoglobin;Methylmalonic Acid;Methyltransferase;Methyltransferase Km;Methyltransferase Vmax;Microcytes;Microfilaria;Mid Cell Fraction;Minimal Residual Disease;Mixed Casts;Mixed Lymphocyte Reaction;Monoblasts;Monoblasts/Leukocytes;Monoclonal Protein;Monoclonal Protein (Urine);Monoclonal Protein (qual);Monoclonal Protein Excretion Rate;Monoclonal Protein Spike;Monoclonal Protein Spike Region 1;Monoclonal Protein Spike Region 2;Monoclonal Protein Spike Region 3;Monocyte Chemotactic Protein 1;Monocytes;Monocytes/Leukocytes;Monocytes/Macrocytes;Monocytes/Total Cells;Monocytoid Cells;Monocytoid Cells/Leukocytes;Monocytoid Cells/Total Cells;Monosodium Urate Crystals;Morphine;Mu Glutathione-S-Transferase;Mu Glutathione-S-Transferase/Creatinine;Mucin 5AC- Oligomeric Mucus/Gel-Forming;Mucous Threads;Mucus Cells;Mucus Cells/Epithelial Population;Mumps Virus IgG Antibody;Mumps Virus IgM Antibody;Mycobacterium tuberculosis Nucleic Acid;Myelin Antibodies;Myelo Immunofixation Impression 1;Myelo Immunofixation Impression 2;Myelo Immunofixation Impression 3;Myeloblasts;Myeloblasts/Leukocytes;Myeloblasts/Total Cells;Myelocytes;Myelocytes/Leukocytes;Myelocytes/Total Cells;Myeloid/Erythroid Ratio;Myeloperoxidase;Myeloperoxidase Antibody;Myeloperoxidase IgG Antibody;Myeloperoxidase Index;Myoglobin;Myoglobin (Urine);Myoglobin/Creatinine;Myosin Light Chain 3;N-Acetyl Glucosamide;N-Acetyl Glucosamide/Creatinine;N-Terminal ProB-type Natriuretic Peptide;N-acetyl-beta-D-glucosaminidase;N-acetyl-beta-D-glucosaminidase (Urine);N-telopeptide;N-telopeptide/Creatinine;Natural Killer Cell Function;Natural Killer Cells;Natural Killer Cells/Lymphocytes;Neisseria gonorrhoeae Screening;Neopterin;Nettle Pollen IgE;Neurofilament Light Chain;Neuron Specific Enolase;Neuropeptide Y;Neutrophil Elastase;Neutrophil Elastase- Polymorphonuclear;Neutrophilic Metamyelocytes;Neutrophilic Myelocytes;Neutrophils;Neutrophils Band Form;Neutrophils Band Form/ Neutrophils;Neutrophils Band Form/Leukocytes;Neutrophils- Segmented;Neutrophils- Segmented/Leukocytes;Neutrophils- Segmented/Neutrophils;Neutrophils/Inflammatory Population;Neutrophils/Leukocytes;Neutrophils/Total Cells;Niacin;Nitric Oxide;Nitric Oxide Synthase 2- Inducible Gene;Nitrite;Nitrite (qual);Non Identifiable Cells;Non Identifiable Cells/Total Cells;Non-HDL Cholesterol;Non-HDL Cholesterol/HDL Cholesterol;Non-Phosphorylated Tau Protein;Non-Prostatic Acid Phosphatase;Norepinephrine;Normoblasts/Total Cells;Nuclear Mitotic Apparatus Protein 1;Nuclear Swelling;Nucleated Erythrocytes;Nucleated Erythrocytes/Erythrocytes;Nucleated Erythrocytes/Leukocytes;Oak White Pollen IgE;Oat Cultivated Pollen lgE;Occult Blood;Occult Blood (qual);Opiate;Orchard Grass Pollen IgE;Osmolality;Osmolarity;Osteocalcin;Osteoprotegerin;Other Cells;Other Cells/Leukocytes;Ova and Parasite;Ovalocyte Count;Oxalate;Oxalate/Creatinine;Oxidized LDL Cholesterol;Oxidized LDL Cholesterol Antibody;Oxycodone;Oxygen Capacity;Oxygen Content;Oxygen Saturation;Oxyhemoglobin;Oxytocin;P-Selectin;P100 Polymyositis-scleroderma Autoag Ab;P50 Oxygen;PP Arterial O2/Fraction Inspired O2;Pancreatic Elastase 1;Pancreatic Elastase 1- Polymorphonuclear;Pancreatic Polypeptide;Panel Reactive Antibody;Pappenheimer Bodies;Parasites;Parathyroid Hormone- C-Terminal;Parathyroid Hormone- Fragmented;Parathyroid Hormone- Intact;Parathyroid Hormone- Mid-Molecule;Parathyroid Hormone- N-Terminal;Parathyroid Hormone- Whole;Parathyroid Hormone-related Protein;Parietal Cell Antibody;Partial Pressure Carbon Dioxide;Partial Pressure Oxygen;Parvovirus B19 IgG Antibody;Parvovirus B19 IgM Antibody;Pelger Huet Anomaly;Pemphigoid Antibodies;Pepsinogen;Pepsinogen A;Pepsinogen C;Pepsinogen I;Pepsinogen II;Peptide YY;Peptidylprolyl Isomerase A;Perennial Rye Grass Pollen IgE;Periostin;Pertussis FHA;Pertussis Toxin;Phencyclidine;Phenothiazine;Phosphate;Phosphate (Urine);Phosphate Clearance;Phosphate/Creatinine;Phospholipid;Phosphorus Excretion Rate;Phosphorylated Tau Protein;Pi-GST Excretion Rate;Pigment Casts;Plasma Cells/Total Cells;Plasmacytoid Lymphocytes;Plasmacytoid Lymphocytes/Lymphocytes;Plasminogen Activator Inhibitor-1;Plasminogen Activator Inhibitor-1 AG;Plasmodium;Platelet Activating Factor;Platelet Aggregation;Platelet Aggregation Amplitude;Platelet Aggregation Curve Type;Platelet Aggregation Mean Amplitude;Platelet Aggregation Mean Curve Type;Platelet Clumps;Platelet Component Distribution Width;Platelet Derived Growth Factor IsoformAB;Platelet Distribution Width;Platelet Function Closure Time;Platelet Hematocrit;Platelet Morphology;Platelet Satellitism;Platelets;Poikilocytes;Poikilocytes/Erythrocytes;Polychromasia;Porphyrin;Potassium;Potassium (Urine);Potassium Clearance;Potassium Excretion Rate;Potassium/Creatinine;Prealbumin;Precursor Plasma Cells;Precursor Plasma Cells/Lymphocytes;Pregnancy-Associated Plasma Protein-A;ProB-type Natriuretic Peptide;Procalcitonin;Procollagen 1 N-Terminal Propeptide;Procollagen Type I Carboxy Term Peptide;Proerythroblast;Progesterone;Progesterone Receptor;Proinsulin;Proinsulin/Insulin Ratio;Prolactin;Proleukocytes;Proleukocytes/Leukocytes;Proliferating Cell Nuclear Antigen;Prolymphocytes;Prolymphocytes/Leukocytes;Prolymphocytes/Lymphocytes;Promonocytes;Promonocytes/Leukocytes;Promyeloblasts;Promyelocytes;Promyelocytes/Leukocytes;Promyelocytes/Total Cells;Pronormoblasts/Total Cells;Propionate;Propoxyphene;Proprotein Convertase Subtilisin/Kexin 9;Prostaglandin;Prostaglandin D2;Prostaglandin D2 Receptor 2;Prostaglandin D2 Synthase;Prostaglandin E Synthase;Prostaglandin E1;Prostaglandin E2;Prostaglandin F1 Alpha;Prostaglandin F2 Alpha;Prostate Specific Antigen;Prostatic Acid Phosphatase;Protein;Protein (Urine);Protein (qual);Protein Excretion Rate;Protein S;Protein/Creatinine;Protein/Osmolality;Proteinase 3 Antibody;Prothrombin Activity;Prothrombin Fragment 2;Prothrombin Fragments 1 + 2;Prothrombin Intl. Normalized Ratio;Prothrombin Time;Protozoa;Pseudoephedrine;Pyknotic Cells;Pyridinoline;Quantiferon Antigen;Quantiferon Mitogen Minus NIL;Quantiferon NIL;Quantiferon TB Minus NIL;RBC Casts;RIBA Anti-HCV;RLP Cholesterol;RNA Polymerase III Antibody;RSV A Neutralization;Rapid Plasma Reagin;Reactive Lymphocytes;Reactive Lymphocytes/Lymphocytes;Receptor Activator Nuclear KappaB Ligand;Reg upon Act Normal T-cell Exprd Secrtd;Regulatory T-Cell;Regulatory T-Cell/Lymphocytes;Remnant Lipoprotein;Renin;Renin Activity;Reptilase Time;Resistin;Respiratory Cells;Ret. Corpuscular Hemoglobin Content;Ret. Mean Corpuscular Hemoglobin;Reticulocyte Distribution Width;Reticulocyte Hemoglobin;Reticulocytes;Reticulocytes/Erythrocytes;Retinol Binding Protein;Rheumatoid Factor;Rheumatoid Factor Antibody IgA;Rheumatoid Factor Antibody IgG;Rheumatoid Factor Antibody IgM;Riboflavin;Ribonucleoprotein Antibody;Ribonucleoprotein Smith Complex Antibody;Ribonucleoprotein-70 Antibody;Ribosomal P Protein Antibody;Ringed Sideroblasts;Rouleaux Formation;Round Epithelial Cells;Rubella IgG Antibody;Rubella IgM Antibody;Rubeola IgG Antibody;Rubeola IgM Antibody;S. Enterotoxin A Antigen IgE Antibody;S. Enterotoxin B Antigen IgE Antibody;Sagebrush Mugwort Pollen IgE;Schistocytes;Schuffner's Granules;Scl-70 Antibody;Sclerostin;Secretin;Sediment Examination;Serine Protease 3 IgG Antibody;Serotonin;Sex Hormone Binding Globulin;Sezary Cells;Sezary Cells/Lymphocytes;Short/Common Ragweed Pollen IgE;Sialyl SSEA-1 Antigen;Sickle Cells;Sickle Cells/Erythrocytes;Sideroblast;Sjogrens SS-A Antibody;Sjogrens SS-A52 Antibody;Sjogrens SS-A60 Antibody;Sjogrens SS-B Antibody;Smith Antibody;Smooth Muscle Antibody;Smooth Muscle IgG Antibody;Smudge Cells;Smudge Cells/Leukocytes;Sodium;Sodium (Urine);Sodium Clearance;Sodium Excretion Rate;Sodium/Creatinine;Soluble E-Selectin;Soluble Immunoglobulin;Soluble Intercell Adhesion Molecule 1;Soluble Interleukin 2 Receptor Activity;Soluble Interleukin 6 Receptor;Soluble Interleukin-1 Receptor Type I;Soluble P-Selectin;Soluble TNF Receptor Type I;Soluble TNF Receptor Type II;Soluble Transferrin Receptor;Soluble Tumor Necrosis Factor Receptor;Soluble Vasc Cell Adhesion Molecule 1;Somatotrophin;Sorbitol Dehydrogenase;Specific Gravity;Specimen Appearance;Specimen Weight;Sperm Motility;Spermatozoa;Spherocytes;Squamous Cell Carcinoma Antigen;Squamous Cells;Squamous Epithelial Cells;Squamous Transitional Epithelial Cells;Starch Crystals;Stem Cell Factor;Stomatocytes;Streptolysin O Antibody;Strongyloides IgG Antibody;Sulfa Crystals;Sulfur Dioxide;Surfactant Protein D;TATA Sequence-Binding Protein;TIMP1/Creatinine;TNF-a Production Inhibitory Activity;Target Cells;Tartrate-Resistant Acid Phosphatase 5b;Tau Protein;Terminal Deoxynucleotidyl Transferase Ag;Testosterone;Testosterone- Free;Theophylline;Thiamine;Thrombin Time;Thrombin/Antithrombin;Thrombocytes;Thrombopoietin;Thromboxane B2;Thymic Stromal Lymphopoietin;Thymidine Kinase;Thyroglobulin;Thyroid Antibodies;Thyroid Antimicrosomal Antibodies;Thyroid Antithyroglobulin Antibodies;Thyroperoxidase;Thyroperoxidase Antibody;Thyrotropin;Thyrotropin Releasing Hormone;Thyroxine;Thyroxine Binding Globulin;Thyroxine- Free;Thyroxine- Free- Indirect;Tissue Inhibitor of Metalloproteinase 1;Tissue Plasminogen Activator Antigen;Total Amyloid Precursor Protein;Total Cells;Total Iron Binding Capacity;Total Neutrophil Count;Total Radical-Trap Antioxidant Potential;Toxic Granulation;Toxigenic Culture;Toxoplasma IgG Antibody;Toxoplasma IgM Antibody;Transferrin;Transferrin Saturation;Transforming Growth Factor Beta 1;Transitional Epithelial Cells;Trichomonas;Tricyclic Antidepressants;Triglycerides;Triglycerides/HDL Cholesterol;Triiodothyronine;Triiodothyronine Uptake;Triiodothyronine- Free;Triiodothyronine- Reverse;Triple Phosphate Crystals;Troponin;Troponin I;Troponin T;Tryptase;Tubular Epithelial Cells;Tumor Necrosis Factor;Tumor Necrosis Factor Receptor 1;Turbidity;Type I Collagen C-Telopeptides;Type I Collagen N-Telopeptides;Type I Myeloblasts;Type II Collagen C-Telopeptides;Type II Collagen N-Telopeptides;Type II Myeloblasts;Type II Secretory Phospholipase A2;Type III Myeloblasts;Tyrosine Crystals;Ubiquitin C;Unclassified Casts;Unclassified Crystals;Unsaturated Iron Binding Capacity;Unspecified Cells;Unspecified Cells/Total Cells;Urate;Urate (Urine);Urate/Creatinine;Urea;Urea (Urine);Urea Nitrogen (Urine);Urea/Creatinine;Uric Acid Crystals;Urinary Oligosaccharides (Glc4/Hex4);Urine Conductivity;Urobilinogen;Urobilinogen (qual);VLDL Apolipoprotein B;VLDL Cholesterol;VLDL Cholesterol Subtype 1;VLDL Cholesterol Subtype 2;VLDL Cholesterol Subtype 3;VLDL Particle Size;VLDL TG from Lipogenesis;VLDL Triglycerides;VLDL to IDL Conversion;VLDL to LDL Conversion;Vacuolated Lymphocytes;Vacuolated Neutrophils;Vanillyl Mandelic Acid;Varicella Zoster Virus Antibody;Varicella Zoster Virus IgA Antibody;Varicella Zoster Virus IgG Antibody;Varicella Zoster Virus IgM Antibody;Vascular Cell Adhesion Molecule 1;Vascular Endothelial Growth Factor;Viscosity;Vitamin A;Vitamin B12;Vitamin B17;Vitamin B5;Vitamin B6;Vitamin B7;Vitamin B9;Vitamin C;Vitamin D;Vitamin D2;Vitamin D3;Vitamin E;Vitamin E/Cholesterol;Vitamin K;Vitamin K1;Volume;WBC Casts;Wall Pellitory Pollen IgE;Waxy Casts;Yeast Budding;Yeast Cells;Yeast Hyphae;Zinc;pH;t(4.14);von Willebrand Factor,question,70.866,666.671,15.744,52.248
831,113.0,Safety Laboratory Test Results,PV_LB_SAE,LB,2.0,Test Name,What is the lab test name?,LBTEST,IG,LBTEST; LBTESTCD,IG,LBTEST,1- 25-Dihydroxyvitamin D;11-Dehydro-Thromboxane B2;17p(deletion);25-Hydroxyvitamin D;3-4-Dihydroxyphenylacetic Acid;3-4-Dihydroxyphenylglycol;3-4-methylenedioxymethamphetamine;5 Prime Nucleotidase;5-Hydroxyindoleacetic Acid;6-Monoacetylmorphine;8-Iso-PGF2alpha/Creatinine;8-Iso-Prostaglandin F2 Alpha;A Fetoprotein L3/A Fetoprotein;A Proliferation-Inducing Ligand;A. fumigatus Antigen IgE Antibody;ADV Viral Load;ALT/AST;ANA Pattern;Abnormal Cells;Acanthocytes;Acanthocytes/Erythrocytes;Acetate;Acetoacetic Acid;Acetoacetic Acid (Urine);Acetoacetic Acid Excretion Rate;Acetylcholine;Acetylcholine Receptor Antibody;Acetylcholinesterase;Acid Phosphatase;Acid Urate Crystals;Actin- Beta;Activated Coagulation Time;Activated PTT/Standard;Activated Partial Thromboplastin Time;Activated Protein C Resistance;Active Ghrelin;Acyl Coenzyme A Oxidase;Adenosine Diphosphate;Adenovirus Antibody;Adiponectin;Adrenocorticotropic Hormone;Aggrecan Chondroitin Sulfate Epitope 846;Agranular Neutrophils;Alanine Aminopeptidase;Alanine Aminotransferase;Albumin;Albumin (Urine);Albumin Excretion Rate;Albumin/Creatinine;Albumin/Globulin;Albumin/Total Protein;Alder Grey Pollen IgE;Aldolase;Aldosterone;Alkaline Phosphatase;Alkaline Phosphatase/Creatinine;Alpha Fetoprotein;Alpha Fetoprotein Activity;Alpha Fetoprotein L1;Alpha Fetoprotein L2;Alpha Fetoprotein L3;Alpha Glutathione-S-Transferase;Alpha Hydroxybutyrate Dehydrogenase;Alpha Tocopherol;Alpha Tocopherol/Vitamin E;Alpha-1 Acid Glycoprotein;Alpha-1 Antitrypsin;Alpha-1 Globulin;Alpha-1 Globulin (Urine);Alpha-1 Globulin/Total Protein;Alpha-1 Microglobulin;Alpha-1 Microglobulin/Creatinine;Alpha-2 Antiplasmin;Alpha-2 Globulin;Alpha-2 Globulin (Urine);Alpha-2 Globulin/Total Protein;Alpha-2 Macroglobulin;Alpha-GST Excretion Rate;Alpha-Synuclein;Aluminum;American Elm Pollen lgE;Amino Acid Change 1;Amino Acid Change 2;Ammonia;Ammonium Biurate Crystals;Ammonium Oxalate Crystals;Amorphous Crystals;Amorphous Phosphate Crystals;Amorphous Sediment;Amorphous Urate Crystals;Amphetamine;Amylase;Amylase- Pancreatic;Amylase- Salivary;Amyloid A;Amyloid Alpha Precursor Protein;Amyloid Beta 1-38;Amyloid Beta 1-40;Amyloid Beta 1-41;Amyloid Beta 1-42;Amyloid Beta Precursor Protein;Amyloid P;Amyloid- Beta;Androstenediol;Androstenedione;Angiopoietin 1;Angiotensin Converting Enzyme;Angiotensin I;Angiotensin II;Angiotensinogen;Anion Gap;Anisocytes;Anti-DNA Antibodies;Anti-Double Stranded DNA;Anti-Double Stranded DNA IgG;Anti-Double Stranded DNA IgM;Anti-Drug Antibody Status;Anti-Drug Antibody Titer;Anti-Factor Xa Activity;Anti-GAD Antibody;Anti-HCV Antibody;Anti-Indole 3 Acetic Acid Antibody;Anti-Insulinoma-Associated 2 Antibody;Anti-Islet Cell Antibody;Anti-Mullerian Hormone;Anti-Neutrophil Cytoplasmic Antibody;Anti-Nucleosome Antibody;Anti-Saccharomyces cerevisiae Antibody;Anti-Single Stranded DNA IgG;Anti-Zinc Transporter 8 Antibody;Antidepressants;Antidiuretic Hormone;Antiglobulin Test- Direct;Antiglobulin Test- Indirect;Antimitochondrial Antibodies;Antinuclear Antibodies;Antiphospholipid Antibodies;Antithrombin;Antithrombin Antigen;Apo(a) Isoform Number;Apolipoprotein A1;Apolipoprotein A4;Apolipoprotein A5;Apolipoprotein AII;Apolipoprotein B;Apolipoprotein B/Apolipoprotein A1;Apolipoprotein B100;Apolipoprotein B48;Apolipoprotein C2;Apolipoprotein CI;Apolipoprotein CIII;Apolipoprotein E;Apolipoprotein E4;Apolipoprotein H;Apolipoprotein J;Apolipoprotein J/Creatinine;Arachidonate 5-Lipoxygenase;Arachidonic Acid;Aspartate Aminotransferase;Aspartate Aminotransferase Antigen;Aspartate Aminotransferase/Creatinine;Atrial Natriuretic Peptide;Auer Rods;Azurophilic Granules;B-Cell Activating Factor;BKV Viral Load;BUN/Creatinine;Bacteria;Bacteria (Urine) (Sediment Analysis);Bacterial Casts;Bactericidal/Permeability-Inc Protein Ab;Barbiturates;Base Excess;Basket Cells;Basophilic Stippling;Basophils;Basophils/Leukocytes;Basophils/Total Cells;Bence-Jones Protein;Benzodiazepine;Benzoylecgonine;Beta Carotene;Beta Catenin;Beta Globulin;Beta Globulin (Urine);Beta Globulin/Total Protein;Beta Iso Type I Collagen C-Telopeptides;Beta-1 Globulin;Beta-1 Globulin/Total Protein;Beta-2 Globulin;Beta-2 Globulin/Total Protein;Beta-2 Glycoprotein 1 IgG Antibody;Beta-2 Glycoprotein 1 IgM Antibody;Beta-2 Glycoprotein Antibody;Beta-2 Microglobulin;Beta-2 Microglobulin (Urine);Beta-Glucocerebrosidase;Beta-Hydroxybutyrate;Beta-Hydroxybutyrate (Urine);Beta-Hydroxybutyrate Excretion Rate;Beta-Trace Protein;Bicarbonate;Bile Acid;Bilirubin;Bilirubin (Urine);Bilirubin (qual);Bilirubin Crystals;Bioavailable Testosterone;Bite Cells;Bite Cells/Erythrocytes;Blasts;Blasts/Leukocytes;Bleeding Time;Blister Cell;Blood Urea Nitrogen;Bone Specific Alkaline Phosphatase;Brain Natriuretic Peptide;Brain-Derived Neurotrophic Factor;Broad Casts;Burr Cells;Butyrate;Butyrylcholinesterase;C Reactive Protein;C-peptide;CD1;CD10;CD11A;CD11B;CD13;CD14;CD19;CD19+ B-Cell;CD19+ B-Cell/Lymphocytes;CD19/Lymphocytes;CD2;CD2/Lymphocytes;CD20;CD22;CD23;CD3;CD3 Isoform D;CD3 Isoform E;CD3 Isoform G;CD3+ T-Cell;CD3+ T-Cell/Lymphocytes;CD3-/16+56;CD3-/16+56/Lymphocytes;CD3/Lymphocytes;CD33;CD34;CD38;CD38 Lymphocytes Final Baseline;CD38 MAb1 sABC of Cancer Cells;CD38 MAb1 sABC of Lymphocytes;CD38 MAb1 sABC of Monocytes;CD38 MAb1 sABC of NK Cells;CD38 MAb1 sABC of Polymorph Cells;CD38 MAb2 sABC of Cancer Cells;CD38 MAb2 sABC of Lymphocytes;CD38 MAb2 sABC of Monocytes;CD38 MAb2 sABC of Polymorph Cells;CD38 MRNA All Isoforms;CD38 MRNA Isoform A;CD38 Monocytes Final Baseline;CD38 Polymorph Cells Final Baseline;CD38 Pos Cancer Cells Final Baseline;CD38 Receptor Density of Cancer Cells;CD38 Receptor Density of Lymphocytes;CD38 Receptor Density of Monocytes;CD38 Receptor Density of Polymorph Cells;CD38 Receptor Occupancy;CD38 Receptor Occupancy Polymorph Cells;CD38 Receptor Occupancy of Cancer Cells;CD38 Receptor Occupancy of Lymphocytes;CD38 Receptor Occupancy of Monocytes;CD38 Receptor Occupancy of NK Cells;CD38 Soluble;CD4;CD4+ T-Cell;CD4+ T-Cell/Lymphocytes;CD4/CD8;CD4/Lymphocytes;CD40;CD40 Ligand;CD5;CD56;CD56+(CD3-)/HLA-DR+(NK);CD56+(CD3-)/HLA-DR+/LAMP+;CD56+(CD3-)/LAMP+;CD56+Brght CD16+Low NK Cells/Lymphocytes;CD56+Brght CD16+Low Natural Killer Cells;CD56+Dim CD16+Brght NK Cells/Lymphocytes;CD56+Dim CD16+Brght Natural Killer Cells;CD79A;CD8;CD8 Isoform A;CD8+(CD3+)/HLA-DR+;CD8+(CD3+)/HLA-DR+/LAMP1+;CD8+(CD3+)/LAMP1+;CD8/Lymphocytes;CK Macro 1;CK Macro 2;CMV Viral Load;Cabot Rings;Caffeine;Calcitonin;Calcitriol;Calcium;Calcium (Urine);Calcium - Phosphorus Product;Calcium Carbonate Crystals;Calcium Clearance;Calcium Corrected;Calcium Excretion Rate;Calcium Oxalate Crystals;Calcium Phosphate Crystals;Calcium Sulphate;Calcium- Ionized;Calcium/Creatinine;Calprotectin;Cancer Antigen 1;Cancer Antigen 125;Cancer Antigen 15-3;Cancer Antigen 19-9;Cancer Antigen 27-29;Cancer Antigen 6;Cancer Antigen 72-4;Cannabinoids;Carbohydrate-Deficient Transferrin;Carbon Dioxide;Carboxyhemoglobin;Carcinoembryonic Antigen;Cardiolipin IgG Antibody;Cardiolipin IgM Antibody;Carnitine;Carnitine Acetyl Transferase;Carnitine- Free;Cartilage Oligomeric Matrix Protein;Casts;Cathepsin Antibody;Cellular Casts;Cellularity;Centromere Antibodies;Centromere B Antibodies;Ceruloplasmin;Chemokine (C-C Motif) Ligand 13;Chemokine (C-C Motif) Ligand 17;Chemokine (C-C Motif) Ligand 18;Chemokine (C-C Motif) Ligand 2;Chemokine (C-C Motif) Ligand 22;Chemokine (C-C Motif) Ligand 26;Chemokine (C-X-C Motif) Ligand 10;Chemokine (C-X-C Motif) Ligand 11;Chemokine (C-X-C Motif) Ligand 13;Chemokine (C-X-C Motif) Ligand 9;Chemokine (C-X-C Motif) Receptor 3;Chemokine (C-X-C Motif) Receptor 4;Chitinase 3-Like 1 Gene;Chitotriosidase-1;Chlamydia pneumoniae IgA Antibody;Chlamydia pneumoniae IgM Antibody;Chlamydia trachomatis IgA Antibody;Chlamydia trachomatis IgG Antibody;Chlamydia trachomatis IgM Antibody;Chloride;Chloride (Urine);Chloride Clearance;Chloride Excretion Rate;Chloride/Creatinine;Cholecystokinin;Cholera Toxin B Subunit IgG Antibody;Cholesterol;Cholesterol Crystals;Cholesterol/HDL-Cholesterol;Cholesteryl Ester Transfer Protein;Cholesteryl Ester Transfer Protein Act;Cholinesterase;Choriogonadotropin Beta;Choriogonadotropin Beta (qual);Chromogranin A;Chylomicrons;Chymotrypsin;Circulating Endothelial Cells;Circulating Free DNA;Circulating Tumor Cells;Citrate;Cladosporium Herbarum Pollen IgE;Clarity;Clonal Cells;Clostridium difficile;Clostridium difficile Toxin;Clostridium tetani IgG Antibody;Clue Cells;Coagulation Index;Cocaine;Coccidioides Antibody;Codeine;Collagen Type IV;Color;Complement Bb;Complement C1q Antibody;Complement C3;Complement C3a;Complement C3b;Complement C3c;Complement C3d Antibody;Complement C4;Complement C4a;Complement C5a;Complement CH50;Complement Total;Copeptin;Copper;Corticosterone;Corticosterone/Creatinine;Corticotropin Releasing Hormone;Cortisol;Cortisol (Urine);Cortisol Excretion Rate;Cortisol- Free;Cortisol/Creatinine;Cotinine;Creatine Kinase;Creatine Kinase BB;Creatine Kinase BB/Total Creatine Kinase;Creatine Kinase MB;Creatine Kinase MB/Total Creatine Kinase;Creatine Kinase MM;Creatine Kinase MM/Total Creatine Kinase;Creatinine;Creatinine (Urine);Creatinine Clearance;Creatinine Excretion Rate;Crenated Cells;Cryoglobulin;Crystals;Cyclic Citrullinated Peptide Antibody;Cyclic Guanosine Monophosphate;Cystatin C;Cystatin C/Creatinine;Cysteinyl Leukotriene Receptor 1;Cystine;Cystine Crystals;Cytokeratin Fragment 21-1;Cytomegalovirus IgG Antibody;Cytomegalovirus IgM Antibody;Cytoplasmic Basophilia Neutrophil;D-Dimer;D. farinae Antigen IgE Antibody;D. pteronyssinus Antigen IgE Antibody;DM4 Clearance;DNA Sequence Change 1;DNA Sequence Change 2;DNase-B Antibody;DTPA Clearance;Dacryocytes;Degenerated Leukocytes;Dehydroepiandrosterone;Dehydroepiandrosterone Sulfate;Dengue IgG Antibody;Dengue IgM Antibody;Density;Deoxypyridinoline;Deoxypyridinoline/Creatinine;Dermatophagoides Farinae IgE;Dermatophagoides Pteronyssinus IgE;Dextroamphetamine;Dihydrocodeine;Dihydrotestosterone;Dilute Russell's Viper Venom Time;Dilute Russell's Viper Venom Time Ratio;Dimorphic Erythrocyte Population;Dipeptidyl Peptidase-4 Activity;Diphtheria IgG Antibody;Direct Bilirubin;Direct Removal of VLDL Apo B;Dohle Bodies;Dopamine;Drug Screen;Dysmorphic Erythrocytes;EBV Profile Interpretation;EBV Viral Load;EDTA Clearance;ETP Area Under Curve;ETP Lag Time;ETP Lag Time Relative;ETP Peak Height;ETP Peak Height Relative;ETP Time to Peak;ETP Time to Peak Relative;Ecarin Clotting Time;Eccentrocytes;Elliptocytes;Endogenous Thrombin Potential;Endothelin-1;Eosinophilic Metamyelocytes;Eosinophilic Myelocytes;Eosinophils;Eosinophils (Urine);Eosinophils Band Form;Eosinophils Band Form/Leukocytes;Eosinophils/Inflammatory Population;Eosinophils/Leukocytes;Eosinophils/Total Cells;Eotaxin-1;Eotaxin-2;Eotaxin-3;Epidemic Parotitis IgM Antibody;Epidermal Growth Factor;Epidermal Growth Factor Receptor;Epinephrine;Epith Neutrophil-Activating Peptide 78;Epithelial Casts;Epithelial Cells;Epithelial Cells/Total Cells;Epstein-Barr Capsid IgG Antibody;Epstein-Barr Capsid IgM Antibody;Epstein-Barr Early Antigen;Epstein-Barr Nuclear Antibody;Epstein-Barr Nuclear Antigen;Epstein-Barr Nuclear Antigen 1 IgG Ab;Ery. Mean Corpuscular HGB Concentration;Ery. Mean Corpuscular Hemoglobin;Ery. Mean Corpuscular Volume;Erythrocyte Agglutination;Erythrocyte Cell Clumps;Erythrocyte Cell Morphology;Erythrocyte Fragment;Erythrocyte Ghosts;Erythrocyte Magnesium;Erythrocyte Sedimentation Rate;Erythrocytes;Erythrocytes (Urine);Erythrocytes (Urine) (Sediment Analysis);Erythrocytes (qual);Erythrocytes Distribution Width;Erythropoietin;Estradiol;Estriol;Estriol- Free;Estrogen Receptor;Estrone;Ethanol;Extracell Newly Ident RAGE Bind Protein;Extractable Nuclear Antigen Antibody;F2-Isoprostane;Factor II;Factor III;Factor IX;Factor IX Activity;Factor V;Factor V Activity;Factor V Leiden;Factor VII;Factor VII Activity;Factor VIII;Factor VIII Activity;Factor VIII C;Factor VIIa Activity;Factor X;Factor XI;Factor XII;Factor XIII;Factor XIV;Factor XIV Activity;Fat;Fat Bodies- Oval;Fat Droplet;Fatty Acid Binding Protein 1;Fatty Acid Binding Protein 3;Fatty Casts;Fc Fragment of IgE Receptor II Gene;Ferritin;Fibrin Degradation Products;Fibrinogen;FibroTest Score;Fibroblast Growth Factor 21;Fibroblast Growth Factor 23;Fibroblast Growth Factor Basic Form;Firmicutes/Bacteroidetes Ratio;Fluid Intake;Folded RBC;Follicle Stimulating Hormone;Fractional Calcium Excretion;Fractional Chloride Excretion;Fractional Phosphorus Excretion;Fractional Potassium Excretion;Fractional Sodium Excretion;Free Fatty Acid;Free Fatty Acid- Saturated;Free Fatty Acid- Unsaturated;Free Glycerol;Fructosamine;GFR from B-2 Microglobulin Adj for BSA;GFR from Beta-Trace Protein Adj for BSA;GFR from Creatinine Adjusted for BSA;GFR from Cystatin C Adjusted for BSA;Galanin;Gamma Globulin;Gamma Globulin (Urine);Gamma Globulin/Total Protein;Gamma Glutamyl Transferase;Gamma Glutamyl Transferase (Urine);Gamma Glutamyl Transferase/Creatinine;Gamma Tocopherol;Gastrin;Gated Events;Germline DNA;Ghrelin;Giant Neutrophils;Giant Platelets;Globulin;Glomerular Filtration Rate;Glomerular Filtration Rate Adj for BSA;Glomerular Filtration Rate- Estimated;Glomerular Filtration Rt- Estimated MDRD;Glucagon;Glucagon-Like Peptide-1;Glucagon-Like Peptide-1- Active Form;Glucose;Glucose (Urine);Glucose (qual);Glucose Clearance;Glucose Excretion Rate;Glucose-6-Phosphate Dehydrogenase;Glucose-dep Insulinotropic Pep- Intact;Glucose/Creatinine;Glucosylceramide;Glucosylsphingosine;Glucuronidase- Alpha;Glucuronidase- Beta;Glutamate;Glutamate Dehydrogenase;Glutamic Acid Decarboxylase 1;Glutamic Acid Decarboxylase 2;Glutamic Acid Decarboxylase 2 Antibody;Glutamic Acid Decarboxylase Antibody;Glutathione S-Transferase- Alpha/Creat;Glutathione S-Transferase- Pi;Glutathione S-Transferase- Theta;Glutathione S-Transferase- Total;Glutathione-S-Transferase/Creatinine;Glyceraldehyde-3-Phosphate Dehydrogenase;Gold;Gonadotropin Releasing Hormone;Granular Casts;Granular Coarse Casts;Granular Fine Casts;Granulocyte Colony Stimulating Factor;Granulocyte Macrophage Colony Stm Factor;Granulocytes;Granulocytes/Total Cells;Growth Hormone Inhibiting Hormone;Growth Hormone Releasing Hormone;HAV Viral Load;HBV Viral Load;HCT Corrected Reticulocytes/Erythrocytes;HCV Viral Load;HDL Cholesterol;HDL Cholesterol/LDL Cholesterol Ratio;HDL Particle Size;HDL-Cholesterol Subclass 2;HDL-Cholesterol Subclass 3;HER2 Antigen;HIV Antibody;HIV Interpretation;HIV Viral Load;HIV-1 Antibody;HIV-1 Group M and O Nucleic Acid;HIV-1 Group O Antibody;HIV-1 p24 Antigen;HIV-1/2 Antibody;HIV-1/2 Antigen;HIV-2 Antibody;HIV-2 Nucleic Acid;HIV1 RNA;HLA-B27 Antigen;Hairy Cells;Hairy Cells/Lymphocytes;Haptoglobin;Heinz Bodies;Heinz Bodies/Erythrocytes;Helicobacter pylori IgG Antibody;Helmet Cells;Hematocrit;Hematocrit Corrected Reticulocytes;Hemoglobin;Hemoglobin (Urine);Hemoglobin (qual);Hemoglobin A;Hemoglobin A1C;Hemoglobin A1C/Hemoglobin;Hemoglobin A2;Hemoglobin B;Hemoglobin C;Hemoglobin C Crystals;Hemoglobin Distribution Width;Hemoglobin F;Hemolytic Index;Hemosiderin;Hepatic Lipase;Hepatitis A Virus Antibody;Hepatitis A Virus Antibody IgM;Hepatitis B DNA;Hepatitis B Virus Core Antibody;Hepatitis B Virus Core IgG Antibody;Hepatitis B Virus Core IgM Antibody;Hepatitis B Virus Surface Antibody;Hepatitis B Virus Surface Antigen;Hepatitis B Virus e Antibody;Hepatitis B Virus e Antigen;Hepatitis C Virus Antibody;Hepatitis C Virus Antigen;Hepatitis D Virus Antibody;Hepatitis D Virus IgG Antibody;Hepatitis D Virus IgM Antibody;Hepatitis E Virus Antibody;Hepatitis E Virus IgG Antibody;Hepatitis E Virus IgM Antibody;Hepatitis G RNA;Hepcidin;Herpes Simplex Virus 1 IgG Antibody;Herpes Simplex Virus 1 IgM Antibody;Herpes Simplex Virus 1/2 IgG Antibody;Herpes Simplex Virus 1/2 IgM Antibody;Herpes Simplex Virus 2 IgG Antibody;Herpes Simplex Virus 2 IgM Antibody;Herpes Simplex Virus 6 Antibody;Herpes Simplex Virus Common Antigen;Heterophile Antibodies;Heterophils;Heterophils/Leukocytes;Hexokinase;High Absorption Retic/Reticulocytes;High Absorption Reticulocytes;High Sensitivity Troponin I;High Sensitivity Troponin T;Hippuric Acid Crystals;Histamine;Histone 1 Antibody;Histone 2A Antibody;Histone 2B Antibody;Histone 3 Antibody;Histone 4 Antibody;Histone Antibodies;Homocysteine;Homostat Model Assess of Insulin Rstn;Homovanillic Acid;Howell-Jolly Bodies;Human Albumin Antibody;Human Anti-Mouse Antibody;Human Anti-Sheep IgE Antibody;Human Anti-Sheep IgG Antibody;Human Anti-Sheep IgM Antibody;Human Epidermal Growth Factor Receptor 2;Hyaline Casts;Hyaluronic Acid;Hydrocodone;Hydrogen;Hydromorphone;Hydroxyproline;Hyperchromia;Hypersegmented Cells;Hypochromia;Hypogranular Neutrophils;Hyposegmented Neutrophils;Hypoxanthine Phosphoribosyltransferase 1;IDL Apolipoprotein B;IDL Cholesterol;IDL Particles;IDL Triglycerides;IDL to LDL Conversion;Icteric Index;IgA/C3 Ratio;IgG IgM IgA Total;Immature Basophils;Immature Basophils/Leukocytes;Immature Cells;Immature Cells/Total Cells;Immature Eosinophils;Immature Eosinophils/Leukocytes;Immature Granulocytes;Immature Granulocytes/Leukocytes;Immature Lymphocytes;Immature Lymphocytes/Leukocytes;Immature Monocytes;Immature Monocytes/Leukocytes;Immature Neutrophils;Immature Neutrophils/Leukocytes;Immature Plasma Cells;Immature Plasma Cells/Lymphocytes;Immature Reticulocyte Fraction;Immunoblasts;Immunoblasts/Lymphocytes;Immunogenetics FCGR2A rs1801274;Immunogenetics FCGR2B rs1050501;Immunogenetics FCGR3A rs396991;Immunogenetics HLA-A Genotype;Immunogenetics HLA-A Motif;Immunogenetics HLA-B Genotype;Immunogenetics HLA-B Motif;Immunogenetics HLA-C Genotype;Immunogenetics HLA-C Motif;Immunogenetics KIR2DL1;Immunogenetics KIR2DL2;Immunogenetics KIR2DL3;Immunogenetics KIR2DL4;Immunogenetics KIR2DL5;Immunogenetics KIR2DP1;Immunogenetics KIR2DS1;Immunogenetics KIR2DS2;Immunogenetics KIR2DS3;Immunogenetics KIR2DS4;Immunogenetics KIR2DS4 Full Length;Immunogenetics KIR2DS4 Short;Immunogenetics KIR2DS5;Immunogenetics KIR3DL1;Immunogenetics KIR3DL2;Immunogenetics KIR3DL3;Immunogenetics KIR3DP1;Immunogenetics KIR3DP1 Full Length;Immunogenetics KIR3DP1 Short;Immunogenetics KIR3DS1;Immunoglobulin A;Immunoglobulin D;Immunoglobulin E;Immunoglobulin G;Immunoglobulin G/Creatinine;Immunoglobulin M;Inclusion Bodies;Indican;Indirect Bilirubin;Indocyanine Green;Inflammatory Cells;Inflammatory Cells/Total Cells;Influenza A H1N1 Viral Load;Influenza A IgG Antibody;Influenza A Viral Load;Influenza B IgG Antibody;Inhibin A;Inhibin B;Insulin;Insulin Antibody;Insulin Autoantibody;Insulin-Like Growth Factor Binding Prot3;Insulin-like Growth Factor-1;Insulin-like Growth Factor-2;Insulinoma-Associated Protein 2 Antibody;Interferon Alpha;Interferon Beta;Interferon Gamma;Interleukin 1;Interleukin 1 Beta;Interleukin 1 Receptor Antagonist;Interleukin 10;Interleukin 11;Interleukin 12;Interleukin 13;Interleukin 13 Receptor- Alpha 2 Gene;Interleukin 14;Interleukin 15;Interleukin 16;Interleukin 17;Interleukin 18;Interleukin 19;Interleukin 2;Interleukin 20;Interleukin 21;Interleukin 22;Interleukin 23;Interleukin 24;Interleukin 25;Interleukin 26;Interleukin 27;Interleukin 28;Interleukin 29;Interleukin 3;Interleukin 30;Interleukin 31;Interleukin 32;Interleukin 33;Interleukin 4;Interleukin 5;Interleukin 6;Interleukin 7;Interleukin 8;Interleukin 9;Interleukin-17A;Intestinal Specific Alkaline Phosphatase;Intraerythrocyte Crystals;Inulin Clearance;Iohexol Clearance;Iothalamate Clearance;Iothalamate Clearance Adjusted for BSA;Iron;Iron Excretion Rate;Islet Cell 512 Antibody;Islet Cell 512 Antigen;Islet Neogenesis Assoc Protein Antibody;Isoleucine;Italian Cypress Pollen IgE;JC Virus Antibody;Jo-1 Antibody;Johnson Grass Pollen lgE;June Grass/Kentucky Blue Pollen IgE;Kappa Light Chain- Free;Kappa Lt Chain-Free/Lambda Lt Chain-Free;Ketone Bodies;Ketone Bodies Excretion Rate;Ketones;Ketones (Urine);Ketones (qual);Kidney Injury Molecule-1;Kurloff Cells;LDH Isoenzyme 1;LDH Isoenzyme 1/LDH;LDH Isoenzyme 2;LDH Isoenzyme 2/LDH;LDH Isoenzyme 3;LDH Isoenzyme 3/LDH;LDH Isoenzyme 4;LDH Isoenzyme 4/LDH;LDH Isoenzyme 5;LDH Isoenzyme 5/LDH;LDL Apolipoprotein B;LDL Cholesterol;LDL Cholesterol/HDL Cholesterol;LDL Particle Size;LDL Particles;LDL Subtype Pattern;LDL Triglycerides;Lactate Dehydrogenase;Lactate Dehydrogenase/Creatinine;Lactic Acid;Lactoferrin;Lactoferrin Antibody;Lambda Light Chain- Free;Large Platelets;Large Unstained Cells;Large Unstained Cells/Leukocytes;Left Shift Neutrophils;Legionella pneumophila Antigen;Legionella pneumophila IgG Antibody;Legionella pneumophila IgG IgM Antibody;Legionella pneumophila IgM Antibody;Leptin;Leucine Aminopeptidase;Leucine Crystals;Leukemic Blasts;Leukemic Blasts/Lymphocytes;Leukemic Cells;Leukocyte Cell Clumps;Leukocyte Cell Morphology;Leukocyte Esterase;Leukocytes;Leukocytes (Urine);Leukocytes (Urine) (Sediment Analysis);Leukocytes (qual);Leukotriene B4;Leukotriene C4 Synthase;Leukotriene D4;Leukotriene E4;Lipase;Lipase- Gastric;Lipase- Lysosomal Acid;Lipase- Pancreatic;Lipemic Index;Lipocalin-2;Lipocalin-2/Creatinine;Lipoprotein Associated Phospholipase A2;Lipoprotein Lipase;Lipoprotein-a;Liver Cytostolic Protein Type 1 Antibody;Liver Kidney Microsomal Type 1 Antibody;Liver Kidney Microsomal Type 1 IgA Ab;Liver Kidney Microsomal Type 1 IgG Ab;Liver Kidney Microsomal Type 1 IgM Ab;Liver Specific Alkaline Phosphatase;Low Absorption Retic/Reticulocytes;Low Absorption Reticulocytes;Lupus Anticoagulant Sensitive APTT;Luteinizing Hormone;Lymphoblasts;Lymphoblasts/Leukocytes;Lymphocytes;Lymphocytes Activated;Lymphocytes Atypical;Lymphocytes Atypical/Leukocytes;Lymphocytes/Leukocytes;Lymphocytes/Total Cells;Lymphoma Cells;Lymphoma Cells/Lymphocytes;Lymphotactin;Lysergic Acid Diethylamide;Lysozyme;M. tuberculosis IFN Gamma Response;MCV Reticulocytes;Macroamylase;Macrocytes;Macrophage Colony Stimulating Factor;Macrophage Inflammatory Protein 1 Alpha;Macrophage Inflammatory Protein 1 Beta;Macrophage-Derived Chemokine;Macrophages;Macrophages/Total Cells;Magnesium;Magnesium/Creatinine;Malignant Cells- NOS;Malignant Cells- NOS/Blood Cells;Mast Cells;Mast Cells/Inflammatory Population;Mast Cells/Total Cells;Matrix Metalloproteinase 1;Matrix Metalloproteinase 2;Matrix Metalloproteinase 3;Matrix Metalloproteinase 7;Matrix Metalloproteinase 8;Matrix Metalloproteinase 9;Mature Plasma Cells;Mature Plasma Cells/Lymphocytes;May-Hegglin Anomaly;Meadow Fescue Pollen IgE;Mean Platelet Component;Mean Platelet Dry Mass;Mean Platelet Volume;Medium Absorption Retic/Reticulocytes;Medium Absorption Reticulocytes;Megakaryoblasts;Megakaryoblasts/Total Cells;Megakaryocytes;Megakaryocytes/Total Cells;Melatonin;Meningeal Cells;Meningeal Cells/Total Cells;Metamyelocytes;Metamyelocytes/Leukocytes;Metamyelocytes/Total Cells;Metanephrine;Methadone;Methamphetamine;Methaqualone;Methemoglobin;Methylmalonic Acid;Methyltransferase;Methyltransferase Km;Methyltransferase Vmax;Microcytes;Microfilaria;Mid Cell Fraction;Minimal Residual Disease;Mixed Casts;Mixed Lymphocyte Reaction;Monoblasts;Monoblasts/Leukocytes;Monoclonal Protein;Monoclonal Protein (Urine);Monoclonal Protein (qual);Monoclonal Protein Excretion Rate;Monoclonal Protein Spike;Monoclonal Protein Spike Region 1;Monoclonal Protein Spike Region 2;Monoclonal Protein Spike Region 3;Monocyte Chemotactic Protein 1;Monocytes;Monocytes/Leukocytes;Monocytes/Macrocytes;Monocytes/Total Cells;Monocytoid Cells;Monocytoid Cells/Leukocytes;Monocytoid Cells/Total Cells;Monosodium Urate Crystals;Morphine;Mu Glutathione-S-Transferase;Mu Glutathione-S-Transferase/Creatinine;Mucin 5AC- Oligomeric Mucus/Gel-Forming;Mucous Threads;Mucus Cells;Mucus Cells/Epithelial Population;Mumps Virus IgG Antibody;Mumps Virus IgM Antibody;Mycobacterium tuberculosis Nucleic Acid;Myelin Antibodies;Myelo Immunofixation Impression 1;Myelo Immunofixation Impression 2;Myelo Immunofixation Impression 3;Myeloblasts;Myeloblasts/Leukocytes;Myeloblasts/Total Cells;Myelocytes;Myelocytes/Leukocytes;Myelocytes/Total Cells;Myeloid/Erythroid Ratio;Myeloperoxidase;Myeloperoxidase Antibody;Myeloperoxidase IgG Antibody;Myeloperoxidase Index;Myoglobin;Myoglobin (Urine);Myoglobin/Creatinine;Myosin Light Chain 3;N-Acetyl Glucosamide;N-Acetyl Glucosamide/Creatinine;N-Terminal ProB-type Natriuretic Peptide;N-acetyl-beta-D-glucosaminidase;N-acetyl-beta-D-glucosaminidase (Urine);N-telopeptide;N-telopeptide/Creatinine;Natural Killer Cell Function;Natural Killer Cells;Natural Killer Cells/Lymphocytes;Neisseria gonorrhoeae Screening;Neopterin;Nettle Pollen IgE;Neurofilament Light Chain;Neuron Specific Enolase;Neuropeptide Y;Neutrophil Elastase;Neutrophil Elastase- Polymorphonuclear;Neutrophilic Metamyelocytes;Neutrophilic Myelocytes;Neutrophils;Neutrophils Band Form;Neutrophils Band Form/ Neutrophils;Neutrophils Band Form/Leukocytes;Neutrophils- Segmented;Neutrophils- Segmented/Leukocytes;Neutrophils- Segmented/Neutrophils;Neutrophils/Inflammatory Population;Neutrophils/Leukocytes;Neutrophils/Total Cells;Niacin;Nitric Oxide;Nitric Oxide Synthase 2- Inducible Gene;Nitrite;Nitrite (qual);Non Identifiable Cells;Non Identifiable Cells/Total Cells;Non-HDL Cholesterol;Non-HDL Cholesterol/HDL Cholesterol;Non-Phosphorylated Tau Protein;Non-Prostatic Acid Phosphatase;Norepinephrine;Normoblasts/Total Cells;Nuclear Mitotic Apparatus Protein 1;Nuclear Swelling;Nucleated Erythrocytes;Nucleated Erythrocytes/Erythrocytes;Nucleated Erythrocytes/Leukocytes;Oak White Pollen IgE;Oat Cultivated Pollen lgE;Occult Blood;Occult Blood (qual);Opiate;Orchard Grass Pollen IgE;Osmolality;Osmolarity;Osteocalcin;Osteoprotegerin;Other Cells;Other Cells/Leukocytes;Ova and Parasite;Ovalocyte Count;Oxalate;Oxalate/Creatinine;Oxidized LDL Cholesterol;Oxidized LDL Cholesterol Antibody;Oxycodone;Oxygen Capacity;Oxygen Content;Oxygen Saturation;Oxyhemoglobin;Oxytocin;P-Selectin;P100 Polymyositis-scleroderma Autoag Ab;P50 Oxygen;PP Arterial O2/Fraction Inspired O2;Pancreatic Elastase 1;Pancreatic Elastase 1- Polymorphonuclear;Pancreatic Polypeptide;Panel Reactive Antibody;Pappenheimer Bodies;Parasites;Parathyroid Hormone- C-Terminal;Parathyroid Hormone- Fragmented;Parathyroid Hormone- Intact;Parathyroid Hormone- Mid-Molecule;Parathyroid Hormone- N-Terminal;Parathyroid Hormone- Whole;Parathyroid Hormone-related Protein;Parietal Cell Antibody;Partial Pressure Carbon Dioxide;Partial Pressure Oxygen;Parvovirus B19 IgG Antibody;Parvovirus B19 IgM Antibody;Pelger Huet Anomaly;Pemphigoid Antibodies;Pepsinogen;Pepsinogen A;Pepsinogen C;Pepsinogen I;Pepsinogen II;Peptide YY;Peptidylprolyl Isomerase A;Perennial Rye Grass Pollen IgE;Periostin;Pertussis FHA;Pertussis Toxin;Phencyclidine;Phenothiazine;Phosphate;Phosphate (Urine);Phosphate Clearance;Phosphate/Creatinine;Phospholipid;Phosphorus Excretion Rate;Phosphorylated Tau Protein;Pi-GST Excretion Rate;Pigment Casts;Plasma Cells/Total Cells;Plasmacytoid Lymphocytes;Plasmacytoid Lymphocytes/Lymphocytes;Plasminogen Activator Inhibitor-1;Plasminogen Activator Inhibitor-1 AG;Plasmodium;Platelet Activating Factor;Platelet Aggregation;Platelet Aggregation Amplitude;Platelet Aggregation Curve Type;Platelet Aggregation Mean Amplitude;Platelet Aggregation Mean Curve Type;Platelet Clumps;Platelet Component Distribution Width;Platelet Derived Growth Factor IsoformAB;Platelet Distribution Width;Platelet Function Closure Time;Platelet Hematocrit;Platelet Morphology;Platelet Satellitism;Platelets;Poikilocytes;Poikilocytes/Erythrocytes;Polychromasia;Porphyrin;Potassium;Potassium (Urine);Potassium Clearance;Potassium Excretion Rate;Potassium/Creatinine;Prealbumin;Precursor Plasma Cells;Precursor Plasma Cells/Lymphocytes;Pregnancy-Associated Plasma Protein-A;ProB-type Natriuretic Peptide;Procalcitonin;Procollagen 1 N-Terminal Propeptide;Procollagen Type I Carboxy Term Peptide;Proerythroblast;Progesterone;Progesterone Receptor;Proinsulin;Proinsulin/Insulin Ratio;Prolactin;Proleukocytes;Proleukocytes/Leukocytes;Proliferating Cell Nuclear Antigen;Prolymphocytes;Prolymphocytes/Leukocytes;Prolymphocytes/Lymphocytes;Promonocytes;Promonocytes/Leukocytes;Promyeloblasts;Promyelocytes;Promyelocytes/Leukocytes;Promyelocytes/Total Cells;Pronormoblasts/Total Cells;Propionate;Propoxyphene;Proprotein Convertase Subtilisin/Kexin 9;Prostaglandin;Prostaglandin D2;Prostaglandin D2 Receptor 2;Prostaglandin D2 Synthase;Prostaglandin E Synthase;Prostaglandin E1;Prostaglandin E2;Prostaglandin F1 Alpha;Prostaglandin F2 Alpha;Prostate Specific Antigen;Prostatic Acid Phosphatase;Protein;Protein (Urine);Protein (qual);Protein Excretion Rate;Protein S;Protein/Creatinine;Protein/Osmolality;Proteinase 3 Antibody;Prothrombin Activity;Prothrombin Fragment 2;Prothrombin Fragments 1 + 2;Prothrombin Intl. Normalized Ratio;Prothrombin Time;Protozoa;Pseudoephedrine;Pyknotic Cells;Pyridinoline;Quantiferon Antigen;Quantiferon Mitogen Minus NIL;Quantiferon NIL;Quantiferon TB Minus NIL;RBC Casts;RIBA Anti-HCV;RLP Cholesterol;RNA Polymerase III Antibody;RSV A Neutralization;Rapid Plasma Reagin;Reactive Lymphocytes;Reactive Lymphocytes/Lymphocytes;Receptor Activator Nuclear KappaB Ligand;Reg upon Act Normal T-cell Exprd Secrtd;Regulatory T-Cell;Regulatory T-Cell/Lymphocytes;Remnant Lipoprotein;Renin;Renin Activity;Reptilase Time;Resistin;Respiratory Cells;Ret. Corpuscular Hemoglobin Content;Ret. Mean Corpuscular Hemoglobin;Reticulocyte Distribution Width;Reticulocyte Hemoglobin;Reticulocytes;Reticulocytes/Erythrocytes;Retinol Binding Protein;Rheumatoid Factor;Rheumatoid Factor Antibody IgA;Rheumatoid Factor Antibody IgG;Rheumatoid Factor Antibody IgM;Riboflavin;Ribonucleoprotein Antibody;Ribonucleoprotein Smith Complex Antibody;Ribonucleoprotein-70 Antibody;Ribosomal P Protein Antibody;Ringed Sideroblasts;Rouleaux Formation;Round Epithelial Cells;Rubella IgG Antibody;Rubella IgM Antibody;Rubeola IgG Antibody;Rubeola IgM Antibody;S. Enterotoxin A Antigen IgE Antibody;S. Enterotoxin B Antigen IgE Antibody;Sagebrush Mugwort Pollen IgE;Schistocytes;Schuffner's Granules;Scl-70 Antibody;Sclerostin;Secretin;Sediment Examination;Serine Protease 3 IgG Antibody;Serotonin;Sex Hormone Binding Globulin;Sezary Cells;Sezary Cells/Lymphocytes;Short/Common Ragweed Pollen IgE;Sialyl SSEA-1 Antigen;Sickle Cells;Sickle Cells/Erythrocytes;Sideroblast;Sjogrens SS-A Antibody;Sjogrens SS-A52 Antibody;Sjogrens SS-A60 Antibody;Sjogrens SS-B Antibody;Smith Antibody;Smooth Muscle Antibody;Smooth Muscle IgG Antibody;Smudge Cells;Smudge Cells/Leukocytes;Sodium;Sodium (Urine);Sodium Clearance;Sodium Excretion Rate;Sodium/Creatinine;Soluble E-Selectin;Soluble Immunoglobulin;Soluble Intercell Adhesion Molecule 1;Soluble Interleukin 2 Receptor Activity;Soluble Interleukin 6 Receptor;Soluble Interleukin-1 Receptor Type I;Soluble P-Selectin;Soluble TNF Receptor Type I;Soluble TNF Receptor Type II;Soluble Transferrin Receptor;Soluble Tumor Necrosis Factor Receptor;Soluble Vasc Cell Adhesion Molecule 1;Somatotrophin;Sorbitol Dehydrogenase;Specific Gravity;Specimen Appearance;Specimen Weight;Sperm Motility;Spermatozoa;Spherocytes;Squamous Cell Carcinoma Antigen;Squamous Cells;Squamous Epithelial Cells;Squamous Transitional Epithelial Cells;Starch Crystals;Stem Cell Factor;Stomatocytes;Streptolysin O Antibody;Strongyloides IgG Antibody;Sulfa Crystals;Sulfur Dioxide;Surfactant Protein D;TATA Sequence-Binding Protein;TIMP1/Creatinine;TNF-a Production Inhibitory Activity;Target Cells;Tartrate-Resistant Acid Phosphatase 5b;Tau Protein;Terminal Deoxynucleotidyl Transferase Ag;Testosterone;Testosterone- Free;Theophylline;Thiamine;Thrombin Time;Thrombin/Antithrombin;Thrombocytes;Thrombopoietin;Thromboxane B2;Thymic Stromal Lymphopoietin;Thymidine Kinase;Thyroglobulin;Thyroid Antibodies;Thyroid Antimicrosomal Antibodies;Thyroid Antithyroglobulin Antibodies;Thyroperoxidase;Thyroperoxidase Antibody;Thyrotropin;Thyrotropin Releasing Hormone;Thyroxine;Thyroxine Binding Globulin;Thyroxine- Free;Thyroxine- Free- Indirect;Tissue Inhibitor of Metalloproteinase 1;Tissue Plasminogen Activator Antigen;Total Amyloid Precursor Protein;Total Cells;Total Iron Binding Capacity;Total Neutrophil Count;Total Radical-Trap Antioxidant Potential;Toxic Granulation;Toxigenic Culture;Toxoplasma IgG Antibody;Toxoplasma IgM Antibody;Transferrin;Transferrin Saturation;Transforming Growth Factor Beta 1;Transitional Epithelial Cells;Trichomonas;Tricyclic Antidepressants;Triglycerides;Triglycerides/HDL Cholesterol;Triiodothyronine;Triiodothyronine Uptake;Triiodothyronine- Free;Triiodothyronine- Reverse;Triple Phosphate Crystals;Troponin;Troponin I;Troponin T;Tryptase;Tubular Epithelial Cells;Tumor Necrosis Factor;Tumor Necrosis Factor Receptor 1;Turbidity;Type I Collagen C-Telopeptides;Type I Collagen N-Telopeptides;Type I Myeloblasts;Type II Collagen C-Telopeptides;Type II Collagen N-Telopeptides;Type II Myeloblasts;Type II Secretory Phospholipase A2;Type III Myeloblasts;Tyrosine Crystals;Ubiquitin C;Unclassified Casts;Unclassified Crystals;Unsaturated Iron Binding Capacity;Unspecified Cells;Unspecified Cells/Total Cells;Urate;Urate (Urine);Urate/Creatinine;Urea;Urea (Urine);Urea Nitrogen (Urine);Urea/Creatinine;Uric Acid Crystals;Urinary Oligosaccharides (Glc4/Hex4);Urine Conductivity;Urobilinogen;Urobilinogen (qual);VLDL Apolipoprotein B;VLDL Cholesterol;VLDL Cholesterol Subtype 1;VLDL Cholesterol Subtype 2;VLDL Cholesterol Subtype 3;VLDL Particle Size;VLDL TG from Lipogenesis;VLDL Triglycerides;VLDL to IDL Conversion;VLDL to LDL Conversion;Vacuolated Lymphocytes;Vacuolated Neutrophils;Vanillyl Mandelic Acid;Varicella Zoster Virus Antibody;Varicella Zoster Virus IgA Antibody;Varicella Zoster Virus IgG Antibody;Varicella Zoster Virus IgM Antibody;Vascular Cell Adhesion Molecule 1;Vascular Endothelial Growth Factor;Viscosity;Vitamin A;Vitamin B12;Vitamin B17;Vitamin B5;Vitamin B6;Vitamin B7;Vitamin B9;Vitamin C;Vitamin D;Vitamin D2;Vitamin D3;Vitamin E;Vitamin E/Cholesterol;Vitamin K;Vitamin K1;Volume;WBC Casts;Wall Pellitory Pollen IgE;Waxy Casts;Yeast Budding;Yeast Cells;Yeast Hyphae;Zinc;pH;t(4.14);von Willebrand Factor,question,70.866,666.671,15.744,52.248
833,113.0,Safety Laboratory Test Results,PV_LB_SAE,LB,3.0,Result,What was the result of the test?,LBORRES,IG,LBORRES,IG,,,question,70.866,649.671,15.744,30.624
835,113.0,Safety Laboratory Test Results,PV_LB_SAE,LB,3.0,Result,What was the result of the lab test?,LBORRES,IG,LBORRES,IG,,,question,70.866,649.671,15.744,30.624
837,113.0,Safety Laboratory Test Results,PV_LB_SAE,LB,4.0,Units,What was the unit of the lab result?,LBORRESU,IG,LBORRESU,IG,UNIT,%;% INHIBITION;%(v/v);%(w/v);%(w/w);%/min;%cells/area;/100 HPFs;/100 WBC;/10^3 cells;/HPF;/L;/LPF;/VF;/dL;/day;/h;/kg;/mL;/mm3;/month;/nL;/pL;/uL;/wk;/year;1/dilution;100 IU/mL;10^10/L;10^11/L;10^12 IU/L;10^12/L;10^3 CFU;10^3 CFU/g;10^3 CFU/mL;10^3 DNA copies/mL;10^3 RNA copies/mL;10^3 copies/mL;10^3 organisms;10^3 organisms/g;10^3 organisms/mL;10^3/L;10^3/hpf;10^3/mm3;10^3/mm4;10^3/uL;10^4/L;10^4/hpf;10^5/L;10^5/hpf;10^6 CFU;10^6 CFU/g;10^6 CFU/mL;10^6 DNA copies/mL;10^6 IU;10^6 IU/mL;10^6 RNA copies/mL;10^6 copies/mL;10^6 organisms;10^6 organisms/g;10^6 organisms/mL;10^6 organisms/mg;10^6/L;10^6/g;10^6/hpf;10^6/mm3;10^6/uL;10^7/L;10^8/L;10^9 CFU;10^9 CFU/g;10^9 CFU/mL;10^9 organisms;10^9 organisms/g;10^9 organisms/mL;10^9 organisms/mg;10^9/L;AFU;AI;AMPULE;APL U/mL;APPLICATION;ASC;AU;AU/mL;AU/min;AgU/mL;Antibody Unit;BAG;BAR;BAU;BAU/mL;BE/mL;BEATS/MIN;BISCUIT;BLOCKS;BOLUS;BOTTLE;BOX;BREATHS/MIN;BU;BU/mL;Bq;Bq/L;Bq/g;Bq/kg;Bq/mL;Bq/mg;Bq/uL;Bq/ug;C;CAE;CAN;CAPFUL;CAPLET;CAPSULE;CARTRIDGE;CASE;CCID 50/dose;CCID 50/mL;CFU/g;CFU/mL;CIGAR;CIGARETTE;COAT;COI;CONTAINER;CUP;CYLINDER;Ci;Ci/L;Ci/g;Ci/kg;Ci/mL;Ci/mg;Ci/uL;Ci/ug;Coulomb;Ct;DAYS;DAgU;DAgU/mL;DIOPTER;DISK;DNA copies/mL;DPM;DRUM;EID 50/dose;EID 50/mL;ELISA unit;ELISA unit/dose;ELISA unit/mL;EU;Enzyme U;F;FEU;FINGERTIP UNIT;Farad;Frames/s;GBq;GBq/g;GBq/mg;GBq/ug;GI/L;GLASS;GPL U/mL;Gauss;Gy;HAU/100 uL;HEP;HOMEOPATHIC DILUTION;HOURS;HPF;Hb Fract.;Hemolytic Unit;Henry;Hounsfield Unit;Hz;IMPLANT;INDEX VALUE;INHALATION;IU;IU/L;IU/dL;IU/g;IU/kg;IU/kg/h;IU/mL;IU/mg;IU^4;IV;Immune Status Ratio (ISR);JAR;Joule;KALLIKREIN INHIBITOR UNIT;KIT;L;L/L;L/h;L/h/m2;L/kg;L/min;L/min/m2;L/s;LB;LOZENGE;LPF;Log10 ELISA unit;Log10 ELISA unit/dose;Log10 GEq/mL;Log10 PFU/mL;MBq;MBq/uL;MESF;MFI;MHz;MONTHS;MPL U/mL;Mile;NEBULE;NEEDLE GAUGE;NIU;Newton;PACK;PACKAGE;PACKET;PATCH;PELLET;PFU;PFU/dose;PFU/mL;PIPE;PIXEL;PIXELS/cm;PIXELS/in;PNU/mL;POINT;POUCH;PRESSOR UNITS;PUFF;Pa;Pack Year;Perfusion unit;Perfusion unit*sec;QUANTITY SUFFICIENT;RATIO;RING;RNA copies/mL;Rad;Roentgen;SACHET;SBE/mL;SCO;SCOOPFUL;SFC;SFC/10^6 PBMC;SPRAY;SQU/mL;STANDARD DRINK/day;STEPS;STRIP;SUPPOSITORY;SYRINGE;Shock Wave;Siemens;Signals/cells;Sv;TABLET;TAMPON;TCID 50/dose;TI/L;TRACE;TROCHE;TUBE;Tbsp;Tesla;Torr;U;U.CARR;U/L;U/animal;U/cL;U/dL;U/g;U/g/day;U/g/h;U/g/min;U/kg;U/kg/day;U/kg/h;U/kg/min;U/m2;U/m2/day;U/m2/h;U/m2/min;U/mL;U/mg;U/mmol;V;V/sec;VIAL;VIRTUAL PIXEL;WAFER;WEEKS;Watt;Weber;YEARS;ag;amol;amp;amu;anti-Xa IU;anti-Xa IU/mL;atm;bel;cGy;cL;cal;cc;cd;cells/mm3;cells/uL;cg;cm;cm H2O;cm/min;cm/s;cm2;cmol;cmol/L;copies/mL;copies/uL;cpm;cs;cy/cm;cycle/min;cycle/sec;dB;dL;damol/L;deg;dmol;dpm/0.5 mL;dpm/100mg;dpm/mL;dpm/mg;dram;dyn;eq;fL;fg;fmol;fmol/L;fmol/g;foz_br;foz_us;fraction of 1;ft;ft2;ft3;g;g/24h;g/L;g/animal;g/animal/day;g/animal/wk;g/cage;g/cage/day;g/cage/wk;g/cm2;g/dL;g/day;g/g;g/g Creatinine;g/g/day;g/kg;g/kg/day;g/m2;g/m2/day;g/mol;grain;gtt;hPa;in;in2;kAU/L;kBq;kBq/uL;kDa;kHz;kIU;kN/cm2;kPa;kPa/L/sec;kU/L;kUSP;kat;kcal;kg;kg/L;kg/cm;kg/cm2;kg/m2;km;km/h;ks;lbf;lm;log EID 50/dose;log10 CCID 50/dose;log10 CFU/g;log10 CFU/mL;log10 IU/mL;log10 TCID 50/dose;log10 copies/mL;lx;m;m/sec;m/sec2;m2;m3;mCi;mCi/L;mCi/kg;mEq;mEq/L;mEq/dL;mEq/day;mEq/g;mEq/kg;mEq/mL;mEq/mmol;mEq/uL;mEq/ug;mIU/L;mIU/mL;mJoule/cm2;mL;mL/animal;mL/animal/day;mL/animal/wk;mL/breath;mL/cage;mL/cage/day;mL/cage/wk;mL/cm;mL/cm H2O;mL/dL;mL/day;mL/g;mL/g/day;mL/g/h;mL/g/min;mL/h;mL/h/uL of lysat;mL/kg;mL/kg/day;mL/kg/h;mL/kg/min;mL/m2;mL/m2/day;mL/m2/h;mL/m2/min;mL/min;mL/min/1.73m2;mL/min/SSA;mL/min/mmHg;mL/mmHg;mL/mmHg/min/L;mL/s;mL/sec/1.73m2;mOsm;mOsm/kg;mPa;mU/L;mU/mL;mV;mV*min;mV2/Hz;mcg/dL;mg;mg%;mg/24h;mg/L;mg/L FEU;mg/animal;mg/dL;mg/day;mg/g;mg/g Creatinine;mg/g/day;mg/g/h;mg/g/min;mg/h;mg/kg;mg/kg/day;mg/kg/h;mg/kg/min;mg/m2;mg/m2/day;mg/m2/h;mg/m2/min;mg/mL/min;mg/min;mg/mmol Creatinine;mg/mol;min;mkat;mm;mm/2h;mm/h;mm/min;mm/sec;mm2;mm3;mmHg;mmHg/L/min;mmHg/sec;mmol;mmol FA/mL/h;mmol/L;mmol/day;mmol/g;mmol/kg;mmol/min/kPa;mmol/min/kPa/L;mmol/mol;mmol^2/L^2;mol;mol/L;mol/g;mol/mL;mol/mg;mol/mol;mph;msec;nCi;nL;nU/cL;nU/mL;ng;ng/L;ng/dL;ng/mL;nkat;nkat/L;nm;nmol;nmol BCE/L;nmol BCE/mmol;nmol/L;nmol/dL;nmol/hr/mg protein;nmol/mL/min;nmol/min/mg protein;nsec;ohm;osm;oz;pL;per min;per sec;pg;pg/L;pg/dL;pg/mL;pkat;pm;pmol;pmol/L;pmol/min/uL of lysat;pmol/punch/hr;pools/day;pools/h;ppb;ppm;ppth;pptr;psec;psi;pt_br;pt_us;rpm;sABC;sMEC;scm;sec;titer;tsp;tuberculin unit;tuberculin unit/mL;uCi;uCi/L;uCi/kg;uEq;uEq/L;uIU/mL;uL;uL/mL;uOsM;uU/mL;uV;uV*sec;ug;ug/L;ug/animal;ug/dL;ug/day;ug/g/day;ug/g/h;ug/g/min;ug/h;ug/kg;ug/kg/day;ug/kg/h;ug/kg/min;ug/m2;ug/m2/day;ug/m2/h;ug/m2/min;ug/mL;ug/mL/h;ug/min;ugEq;ukat;ukat/L;um;um2;umol;umol/L;umol/L/min;umol/L/sec;umol/day;umol/mg/min;umol/min;usec;v/v;yd;NONE;OTHER,question,70.866,632.671,15.744,25.98
839,113.0,Safety Laboratory Test Results,PV_LB_SAE,,5.0,"Other Test Unit, Specify",,LBUNSP,SANOFI,,,,,question,70.866,615.671,15.744,117.864
840,113.0,Safety Laboratory Test Results,PV_LB_SAE,SUPPLB;SUPPLBUS,6.0,What was the lower limit of the reference range for this test?,,LBSONRLO,SANOFI,LBSONRLO,SANOFI,,,question,70.866,598.671,15.744,291.252
841,113.0,Safety Laboratory Test Results,PV_LB_SAE,SUPPLB;SUPPLBUS,7.0,What was the upper limit of the reference range for this test?,,LBSONRHI,SANOFI,LBSONRHI,SANOFI,,,question,70.866,581.671,15.744,291.264
842,114.0,Other Safety Examination,LB2_SAE,LB,2.0,Laboratory Category,What was the name of the lab panel?,LBCAT,IG,LBCAT,IG,LBCATEG,BACTERIOLOGY;BANKING;BIOMARKERS;CHEMISTRY;CLAMP GLUCOSE;COAGULATION;CYTOLOGY;DRUG SCREEN;GENETIC VARIATION;HEMATOLOGY;HORMONOLOGY;MEAL TEST;MICROBIOLOGY;PARASITOLOGY;PHARMACODYNAMIC;PHARMACOGENOMIC;PREGNANCY;SAE COMPLEMENTARY INFORMATION;SEROLOGY;URINALYSIS;VIROLOGY,question,70.866,666.671,15.744,100.212
844,114.0,Other Safety Examination,LB2_SAE,LB,2.0,Laboratory Category,What was name of the lab panel?,LBCAT,IG,LBCAT,IG,LBCATEG,BACTERIOLOGY;BANKING;BIOMARKERS;CHEMISTRY;CLAMP GLUCOSE;COAGULATION;CYTOLOGY;DRUG SCREEN;GENETIC VARIATION;HEMATOLOGY;HORMONOLOGY;MEAL TEST;MICROBIOLOGY;PARASITOLOGY;PHARMACODYNAMIC;PHARMACOGENOMIC;PREGNANCY;SAE COMPLEMENTARY INFORMATION;SEROLOGY;URINALYSIS;VIROLOGY,question,70.866,666.671,15.744,100.212
846,114.0,Other Safety Examination,LB2_SAE,AE,3.0,Related AE ID,What is the adverse event identifier?,AESPID,IG,AESPID,IG,,,question,70.866,315.671,15.744,71.232
848,114.0,Other Safety Examination,LB2_SAE,SUPPLB;SUPPLBUS,4.0,Complementary Investigations,,LBCOVAL,SANOFI,LBCOVAL,SANOFI,,,question,70.866,298.671,15.744,147.492
849,115.0,Nullification Reason,NUL_SAE,AE,2.0,Related AE ID,What is the adverse event identifier?,AESPID,IG,AESPID,IG,,,question,70.866,666.671,15.744,71.232
851,115.0,Nullification Reason,NUL_SAE,,3.0,Nullification Reason,,SAENULL,SANOFI,,,,,question,70.866,649.671,15.744,99.528
852,116.0,Investigator Validation,INVVAL_SAE,AE,2.0,Related AE ID,What is the adverse event identifier?,AESPID,IG,AESPID,IG,,,question,70.866,666.671,15.744,71.232
1016,116.0,Investigator Validation,INVVAL_SAE,,3.0,"<I>I, as Investigator, reviewed the current set of information and I confirm a SAE/Safety Event case is declared for this subject.</I>",,PROMPT_SAEINVTK,SANOFI,,,,,question,70.866,649.659,15.948,474.144
854,116.0,Investigator Validation,INVVAL_SAE,,5.0,Investigator Validation,,SAEINVTK,SANOFI,,,,,question,75.866,618.671,15.744,110.856
855,117.0,Death Complementary Information,DD_PV_ALL,,2.0,Subject Death Date,,DDAEDAT,SANOFI,,,,,question,70.866,666.671,15.744,93.192
856,117.0,Death Complementary Information,DD_PV_ALL,,3.0,Primary Cause of Death,,DDPRCS,SANOFI,,,,,question,70.866,649.671,15.744,115.536
857,117.0,Death Complementary Information,DD_PV_ALL,,4.0,Secondary Causes of Death,,DDSECCS,SANOFI,,,,,question,70.866,632.671,15.744,132.192
858,117.0,Death Complementary Information,DD_PV_ALL,,5.0,Autopsy Performed,,DDAUTOP,SANOFI,,,NY_YNU,Y;N;U,question,70.866,615.671,15.744,94.272
859,117.0,Death Complementary Information,DD_PV_ALL,,6.0,"If No or Unknown, was a verbal autopsy performed?",,DDVAUTOP,SANOFI,,,NY_YN,Y;N,question,70.866,564.671,15.744,253.464
860,117.0,Death Complementary Information,DD_PV_ALL,,12.0,"If autopsy was performed, please update the causes of death according to death certificate.",,PROMPT_DDVAUTOP,SANOFI,,,,,question,70.866,529.659,15.948,437.22
861,118.0,Subject Status Technical Form,SUBJSTAT,,2.0,Subject Status Code,,SUBJECT_STATUS_CODE,SANOFI,,,,,question,70.866,666.671,15.744,96.564
862,118.0,Subject Status Technical Form,SUBJSTAT,,3.0,Subject Status Start Date,,SUBJECT_STATUS_START_DATE,SANOFI,,,,,question,70.866,649.671,15.744,119.508
863,118.0,Subject Status Technical Form,SUBJSTAT,,4.0,Subject Status End Date,,SUBJECT_STATUS_END_DATE,SANOFI,,,,,question,70.866,632.671,15.744,116.196
864,118.0,Subject Status Technical Form,SUBJSTAT,,5.0,Subject Status Comment,,SUBJECT_STATUS_COMMENT,SANOFI,,,,,question,70.866,615.671,15.744,118.536
